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The research presented herein describes the development of synthetic methods 
to one-carbon bridged twisted amides and the study of properties of one-carbon 
bridged lactams.  
Initial investigations focused on electrostatic cation–π and cation–n 
interactions as regiochemistry controlling feature of the intramolecular Schmidt 
reaction to provide access to one-carbon bridged amides. In cases where the reactive 
conformation of the azidohydrin intermediate is locked, the selectivity of the reaction 
depends on the electron density of an aromatic ring oriented in 1,3-diaxial 
relationship with regard to the diazonium cation. However, a placement of a 
heteroatom in the α-position to the ketone permits the synthesis of otherwise 
unsubstituted bridged amides from conformationally flexible ring systems. Also, 
described is the development of a general method of synthesis of one-carbon bridged 
amides relying on a transannular cyclization strategy.  
Next, experiments directed towards investigation of unusual properties of 
distorted amides are presented. One-carbon bridged lactams display superior to other 
bridged amides levels of hydrolytic stability. These lactams participate in a number of 
interesting and potentially useful reactions unknown to traditional amide bonds, 
including synthesis of remarkably stable tetrahedral intermediates and a direct 
conversion into bridged spiro-epoxyamines. The influence of the amide bond 
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Amide bonds. The amide bond is one of the most fundamental functional 
groups in chemistry and biology. Above all, amide bonds provide a linkage between 
amino acids in peptides and proteins, which are the key building blocks of life. Amide 
bonds also serve as scaffolds allowing molecular association and recognition through 
hydrogen bonding, and are vital structural units in a number of synthetic polyamides 
and pharmaceuticals.1  
The amide bond properties are commonly explained by Pauling resonance 
theory introduced almost 70 years ago.2 In general, amide bonds can be regarded as a 
hybrid of two major resonance canonical structures with ~40% double bond character 










Figure 1. Electron delocalization in amides.  
 
The amide bond resonance results in a number of unique properties of amide 
bonds, such as: (1) short N–C bonds, (2) high rotational barrier around the N–C(O) 
bond of ca. 15-20 kcal/mol, (3) planar geometry in which all six atoms of the amide 
bond lie in one plane, (4) resistance of the carbonyl towards nucleophilic attack and 
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hydrolysis, (5) minimized coordination at nitrogen (manifested in the predominant 
protonation of amides at oxygen), and (6) spectroscopic characteristics including 
lower C=O infrared stretching frequencies and more upfield shifts in 13C NMR as 
compared to other carboxylic acid derivatives.1 
 
Distorted amide bonds. Although the importance of the delocalization of π 
electrons in amide bonds (with the resulting planarity of amides) is a generally 
accepted property, it has been found that not all of the peptidic amide bonds are 
perfectly planar.3-6 In 1968, Ramachandran recognized the need for non-planar 
geometry of amide bonds in cyclic peptides.7 In 1996, MacArthur and Thornton 
carried out a survey of peptide torsion angles in the Cambridge Structural Database, 
concluding that flexibility is an important property of amide bonds; for a set of cyclic 
and linear peptides a standard deviation of 6° was found (from the ideal value of 180° 
for planar bonds).8 Subsequent X-ray protein data suggested even larger deviations, 
up to 20°.9 Even Pauling, by estimating the strain energies for distortion of amide 
bonds (0.9 kcal/mol for 10 degree distortion, 3.5 kcal/mol for 20 degree distortion), 






(τ = 0, ±180°) (τ = ±90°)  
Figure 2. Twisting of the amide bond by rotation around the N–C(O) bond. Note the 
accompanying pyramidalization of the nitrogen atom. 
3 
 
An implication of the flexibility of amide bonds is its effect on stability and 
reactivity. For example, upon distortion, amide bonds are expected to undergo facile 
nucleophilic attack and hydrolysis. This distortion also increases the sp3 character and 
therefore the basicity of the amide bond nitrogen, so that it is now available for 
coordination and protonation.11  
A number of examples exist in which a twist around the N–C(O) bond plays a 
critical role in enzymatic catalysis, including enzymatic hydrolysis of amide bonds (a 
vital process for all living organisms)12-15 and a family of enzymes catalyzing cis-
trans isomerization of amide bonds (a process crucial to protein folding and 
maturation).16-18 The latter enzymes operate through distortion of amide bonds via a 
stabilized twisted transition state, with an intramolecular hydrogen bond engaging the 
amidic nitrogen and assisting the isomerization.  
Distorted amides are key elements of β-lactam antibiotics. The very selective 
acylation of bacterial peptidoglycan transpeptidase by β-lactams (the first effective, 
broad-spectrum antibiotics) arises from the fine tuning of the increased reactivity of 
moderately distorted amide bonds contained in β-lactam systems. It is worth 
mentioning that since the Second World War β-lactams have saved the lives of 
millions of people and were the first step towards the elimination of some infectious 
diseases from society.19-22  
In organic chemistry the potential flexibility of amide bonds leads to a number 
of fundamental and intriguing questions: What is the distortion barrier that marks the 
amide and the keto–amine-like reactivity of amide bonds?23-26 What are the effects of 
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distortion of amides on their properties? Can distorted amides benefit from the 
border-like reactivity and be used as versatile synthetic intermediates?27-30 Is it 
possible to selectively functionalize distorted amide bonds, and if so, to then translate 
these effects into their planar counterparts?31-36 What types of reactivity are yet to be 
found in distorted amides? In addition to providing chemists with a better 
understanding of amide bonds26 and supplying them with novel synthetic tools, 
answering these questions may have significant biological implications. For example, 
non-traditional amides could be useful in the design of novel enzyme inhibitors with 
new mechanism of action.11  
However, the study of effects arising from the distortion of amide bonds is 
challenging, and given the prevalence of planar amide bonds, there are very few 
examples of their distorted analogues described in the literature. In general, enzymes 
enforce deformation of amide bonds by forming stabilized enzyme-substrate 
complexes. Of course, this type of intermolecular steric interaction cannot be utilized 
for probing strain influence on properties of amide bonds beyond biological systems. 
Deformation of amide bonds can be also achieved by intramolecular steric effects, 














Figure 3. a) Steric repulsion and b) conformational restriction of amide bonds. 
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Types of distorted amides. In the steric repulsion approach, the amide bond 
is substituted with a relatively large group, so that the C–N(O) bond rotates to avoid 
the steric repulsion at the expense of the resonance stabilization. In other words, the 
twisted amide bond is more stable than the planar amide bond.38  
In the conformational restriction approach, the amide bond is contained in a 
rigid ring system that prohibits the amide bond from adopting its usual planar 
geometry. This class of amides is represented by small and medium-bridged cyclic 
lactams, which contain nitrogen at the bridgehead position.39-41  
To allow for quantitative description of distortion of amide bonds, Winkler 
and Dunitz introduced three independent parameters, τ (twist angle), χN 
(pyramidalization at nitrogen) and χC (pyramidalization at carbon).42 Twist angle 
describes the magnitude of rotation around the N–C(O) bond, χN and χC define the 
tetragonal character of the corresponding atoms. A twist angle of 0° corresponds to a 
planar amide bond and of 90° corresponds to fully orthogonal bonds, χN and χC are 0° 
for planar bonds and 60° for fully pyramidalized amide bonds. Since in distorted 
amides changes in χC are minimal, this value is often not reported. In addition, 
pyramidalization at nitrogen is sometimes quantified by the sum of three bond angles 
at nitrogen (for an ideally sp3 hybridized atom θ = 328.4°, for sp2 atom θ = 360.0°).43  
To allow for qualitative description of distorted amides, Yamada has 
suggested a useful classification of amide bonds based on twist angle (τ) and 
pyramidalization at nitrogen (χN) (Scheme 1).37 Type A includes amides with 
perpendicularly twisted N–C(O) bonds and virtually non-pyramidalized nitrogen 
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atoms, for example N-pivaloylphtalimide (τ = 83.2°, χN = 14.9°). Type B features 
amides with planar N–C(O) bonds and sp3 hybridized nitrogen atoms, for example N-
acetylaziridine and the N-acyl-7-azabicyclo[2.2.1]heptanes (τ = 18.9°, χN = 39.9° for 
the example in Scheme 1). Type C contains amides with perpendicular amide bonds 




































Geometrical deformations of amide bonds occur typically by rotation around 
the N–C(O) bond (Figure 2). As a result of rotation, the nN→π* C=O donation is 
progressively removed, and this effect is accompanied by the change of hybridization 
at nitrogen.43-45 Although much less common, nitrogen inversion can also lead to 
geometrical transformations of amide bonds. For example, amides in which nitrogen 
is substituted with electronegative atoms (XXN–CO) exhibit large negative anomeric 
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effects within the XNX system, leading to pyramidalized amide bonds.46 These 
compounds belong to Type B in Yamada’s classification.  
Rotation of N–C(O) bond affects bond lengths and spectroscopic properties of 
amide bonds. Only a limited number of structurally characterized distorted amides are 
available;40 however, inspection of their X-ray structures indicates that upon rotation 
the length of N–C(O) significantly increases, while the C=O bond is barely affected. 
This tendency is explained by resonance theory, and reflects the change of 
pyramidalization at nitrogen from sp2 to sp3 (for examples of bond lengths in planar 
and distorted amides see Table 1, page 14).   
Infrared C=O stretching frequencies and carbonyl shifts in 13C NMR spectrum 
are very sensitive to changes in the extent of lone pair resonance stabilization of the 
amide bond and to changes in the charge density of the carbonyl carbon, respectively. 
Due to the reduced resonance contribution from the zwitterionic canonical form, 
distorted amides are characterized by increased νC=O values and more downfield 
13C=O resonances as compared to traditional amides,47 typically lying in the range 
between isolated ketones and planar amides (examples are provided in Table 19, 
Chapter 2).  
Other examples of distorted amides arising from geometrical repulsion 
include N-acylpyrroles,48 N-acylthiazolidine-2-thiones,49 N-acyl-2,5-dithioglycoluril50 
and N-acylamides51 (Figure 4). As expected, these compounds are characterized by 
unusual amide bonds properties. For example, Evans discovered a family of 
remarkably stable tetrahedral intermediates based on N-acylpyrrole scaffold,52 while 
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Yamada has shown that the increased reactivity of N-thiazolidine-2-thiones depends 






R = tBu, τ = 74.3°, χN = 29.5°
















R = H, τ = 7.9°, χN = 10.1°





τ = 50.6°, χN = 11.9°
a b c d
 
Figure 4. Examples of distorted amides resulting from steric repulsion. a) N-
acylpyrroles, b) N-acylthiazolidine-2-thiones, c) 2,5-dithioglycoluril, d) N-
benzyloxycarbonylamide. 
 
Although a steric repulsion approach has been successful in the preparation 
and investigation of properties of a number of distorted amides, these compounds 
suffer from excessive steric hindrance around the amide bonds, a feature which likely 
changes their properties in and of itself.11 Delocalization of nitrogen electrons onto 
the aromatic ring in the pyrrole derivatives or the attachment of a second C=O (or 
analogous) group to the amide bond significantly reduces the rotational barrier around 
the amide bonds, also influencing their character.37  
In contrast, geometrically restricted amides offer a certain advantage in 
determining the influence of rotation on properties of amide bonds. For example, 
bridged amides lacking a steric hindrance around the amide bond can readily be 
imagined.11 Bridged amide scaffolds can also be more easily modified and 
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diversified, when compared to sterically hindered amides.54 The hurdle prohibiting a 
widespread use of bridged amides in chemistry and biology is their lability towards 
hydrolysis.12 
 
Synthesis of bridged amides. Chemists have been intrigued by bridged 
amides for more than 70 years; the first mention of a bridged lactam dates back to 
1938 (the same time as the origin of Pauling’s resonance theory). In that year, Lukeš 
proposed that incorporating a nitrogen at a bridgehead position in a bicyclic ring 
system would result in a violation of Bredt’s rule by the amide zwitterionic resonance 
structure.55 Being unsuccessful in preparing three bridged amides by cyclizations 
(Scheme 2), Lukeš concluded that such amides are “sterically impossible”56 and if 
they were ever made they would exhibit properties of ketones rather than amides.  
 





















It is worth noting that despite the commonly invoked analogy of bridged 
amides to bridgehead olefins, the major difference between two classes of compounds 
is that the diradical formed from a bridgehead olefin violates the octet rule, while the 
apolar resonance structure of a bridgehead amide does not (Scheme 3).56-59 
Nonetheless, the increased reactivity of bridged amides (leading to hydrolytic 
instability and tendency to polymerization) has prevented the successful synthesis and 







anti-Bredt olefin anti-Bredt amide  
 
In 1941, R. B. Woodward initiated a research program directed towards the 
problem of synthesizing 2-quinuclidone (Figure 5).25 Although Woodward was 
unsuccessful in this endeavor, the experience gained in the synthesis of anti-Bredt 
amides allowed him to point correctly at the structure of penicillins. Sir Robert 
Robinson had argued that penicillin antibiotics containing a β-lactam bond would be 
too reactive to hydrolysis to have an amide bond. However, Woodward, aware that 
bridged and related amides can exhibit the reactive properties of more or less isolated 





























Figure 5. a) Difficulties in cyclization to a bridged amide. b) Ease of synthesis of its 
geometrical isomer. c) Resonance structures in strained penicillin antibiotics.  
 
In 1949, Albertson reported60 the first successful synthesis of a bridged lactam 
(Scheme 4) (curiously, this pioneering example has been regularly omitted in 
literature regarding bridged amides). The feasibility of Albertson’s synthesis 
suggested that the stability of amides with C=O bond placed on a 3-carbon bridge is 

























Between 1956 and 1973 the research groups of Yakhontov61-65 and Pracejus66-
68 studied a family of quinuclidone derivatives prepared by the condensation of 
amines and acyl chlorides (Scheme 5). These researchers also examined properties of 
methyl substituted 2-quinuclidones, suggesting that these structures behave as 
isolated amino ketones (see Scheme 25 for details). It should be noted that the 
isolation of the parent 2-quinuclidone as reported by Yakhontov and Rubitsov has 
been questioned in the literature. Given the vigorous conditions utilized for the 
synthesis and the lack of any characterization data save elemental analysis it is 
possible that these researchers had obtained a polymerized material.61 However, it is 
rarely mentioned that Yakhontov converted 2-quinuclidone into its oxime, and 
















R1, R2, R3 = H
R1, R2, R3 = Me
R1, R2 = H, R3 = Me
R1 = H, R2, R3 = Me









In the early 1980s Blackburn69 and Brown70-79 engaged independently in a 
very important study addressing the increased rate of hydrolysis of bridged amides 
(Scheme 6 and Table 1). Blackburn observed an increase of seven and nine orders of 
magnitude in the rate of basic and acidic hydrolysis of the stabilized 2-quinuclidone 
as compared to planar amides. Brown measured the rate of hydrolysis of four 2-
13 
 
quinuclidone derivatives characterized by different distortion parameters, finding a 
good relationship between the rate of hydrolysis and twist angles. For two of these 
amides, the correlation was better when pyramidalizations at nitrogen were 
considered (Table 1).12, 77 Brown has pioneered another application of distorted 
amides by using bridged lactams as model systems for activated peptide units in 








































1 [2.2.2] 1.423d 1.179d 90.0d 63.4d 0.0d 2.6 x 102 2.3 x 104 
2 [3.2.2] 1.401 1.216 30.7 57.2 9.0 6.0 x 101 5.6 x 101 
3 [2.3.2] 1.413 1.225 33.2 52.8 11.0 1.7 x 101 3.0 x 101 
4 [3.2.2] 1.370 1.233 15.3 38.6 6.7 5.1 x 10-4 1.2 x 10-4 
5 planar  
acetanilidee 
1.338 1.235 1.3 3.7 -1.5 2.2 x 10-5 2.2 x 10-7 
a Obtained by X-ray crystallography unless otherwise noted. b Constant for base 
hydrolysis. c Constant for acid hydrolysis. d Calculated values. e N-(4-bromo-2-
methylphenyl)-N-methylacetamide. 
 
Although the half-life for hydrolysis of a typical planar amide bond is 
measured in hundreds of years at rt and pH = 7, the half-life of a stabilized 2-
quinuclidone was determined to be ~ 5 min at rt and neutral pH (Table 1, entry 1). 
Interestingly, even a much less distorted amide with [3.2.2] scaffold (entry 2) was 
hydrolytically labile and characterized as having a t1/2 ~ 1.5 days at neutral pH, and 
t1/2 ~11 min at pH = 4.5.70 These values correspond to a faster hydrolysis of 
moderately distorted amides when compared to the hydrolysis of β-lactam antibiotics 
(for example, hydrolysis of benzylpenicillin occurs with: t1/2 ~ 2 weeks at neutral pH, 
15 
 
t1/2 ~ 3 h at pH = 9 and t1/2 = 3 min at pH = 1),80 a fact that underscores the difficulty 
in synthesis and handling of bridged lactams.  
In the 1980s and early 1990s other sporadic reports regarding synthesis of 
bridged amides appeared in literature. Most synthetic methods for preparation of 
bridged amides focused on amine condensation with acyl chlorides (e.g. 
Blackburn),69, 81 however Brown noticed the advantage of DCC as the coupling 
reagent in the synthesis of stabilized or relaxed systems based on the 2-quinuclidone 
scaffold.70 In addition, Steliou and Pouppart introduced Bu2SnO as an efficient 
promoter for difficult lactamizations,82, 83 Hall reported preparation of bridged 
amides,84, 85 ureas86, 87 and urethanes88, 89 under flash vacuum pyrolysis, and 
Greenberg90 optimized conditions for synthesis of tetramethyl 2-quinuclidone 
(Scheme 7).  Two additional bridged amides with [3.3.1] scaffold were structurally 
characterized (Buchanan,91-93 χN = 48.8°, τ = 20.8° and Sim,94 χN = 49.1°, τ = 16.3°), 
confirming that the placement of the C=O at one of the largest bridges results in a 
large pyramidalization at nitrogen and much smaller twist angles (type B according to 




























































Metal-catalyzed reactions and thermal cycloadditions were also applied to 
preparation of bridged amides. The use of the Heck reaction in this end was pioneered 
by Grigg, delivering a number of lactams featuring the C=O on the external bridge.95-
98 This method was also employed for synthesis of analogous bridged 
sulfonamides.96-98 A similar cyclization was subsequently used by Paquette99-102 and 
Ribelin.103 Currently the Heck reaction is one of the most popular methods for 













































Paquette also used a Heck reaction to prepare a family of bridged bicyclic 
sultams104-106 (typically prepared by intramolecular cyclization of α-sulfonyl 
radicals). In a sharp contrast to the amide analogues, it was determined that 
incorporation of a sulfonamide bond in a bridged structure does not result in its 


















non-planar sulf onamide bonds
 
Figure 6. Bridged bicyclic sultams. 
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Shea applied a type II intramolecular imino Diels-Alder reaction for synthesis 
of unusual bridged amides that also contained bridgehead olefins in the same 
molecules (Scheme 9).40, 59, 107 Interestingly, these bridged olefins were found to be 
more reactive than bridged amides. This methodology was recently extended by 
Shea’s group to the synthesis of structurally related oxazinolactams108-110 and 1,2-














n = 1, 2, 3, 4
200 - 215 °C




Williams utilized Rh-catalyzed carbenoid insertion for the synthesis of a 
number of very strained bridged β-lactam analogues possessing [4.1.1] ring 
system.113, 114 A similar insertion was recently used by chemists at Sanofi-Aventis for 
synthesis of bridged carbapenems.115 In both cases, the rationale included the 
potential antibacterial activity of bridged amides, however, these lactams proved to be 
too unstable for biological testing (Scheme 10).  
In an interesting approach to bridged lactams, Arata utilized an aziridinium 
rearrangement to prepare a bridged amide with [4.4.1] scaffold.116-119 Also, 
noteworthy is a study of the chemistry of indole-derived bridged amides as potential 
precursors for higher analogues of vinblastine alkaloids by Schill29, 30, 120-123 and the 
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use of a more relaxed bridged lactam as the key precursor in the total synthesis of 



















R1 = iPr, Me










































































A number of heteroatom-substituted bridged lactams have also been 
investigated (Scheme 12). They include pyrazoline-5-ones prepared by Chuche126 and 
hydantoins and oxazolidinediones first suggested by Smissman127-134 and ultimately 
prepared by Brouillette135-138 (see also Scheme 9). However, these compounds are 
significantly easier to prepare than their carbon counterparts due to the conjugation of 















































Despite the above developments, until 1998 the area of bridged amides 
remained rather unexplored. While a relatively large number of bridged lactams have 
been reported (it should be noted that except for the above mentioned examples, the 
remaining bridged amides are limited to very specific cases,139-145 unconfirmed 
structures146-149 and more relaxed ring systems150-162), besides Blackburn’s and 
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Brown’s investigation of hydrolysis, there were no systematic studies addressing the 
properties of bridged lactams. The geometries of the majority of bridged lactams were 
close to typical amides, and most of the reports focused on isolated structures rather 
than families of compounds, thus prohibiting their thorough investigation.  
The last decade has witnessed major developments addressing the challenges 
of versatile synthesis of bridged amides, and conceptually new lactams marked by 
large distortions of N–C(O) bonds have been prepared.  
In 1998, Kirby studying the reverse anomeric effect synthesized 1-aza-2-
adamantanone,163-166 which he subsequently described as the “most twisted amide” 
(Scheme 13). This perfectly perpendicular amide (τ = 90.5°, θ = 325.7°) displayed 
some very unusual keto–amine-like reactivity (see page 35), including instantaneous 
hydrolysis in water (t1/2 < 50 s), high basicity of amide nitrogen (pKa ~5.2) and 
spectroscopic properties typical of an amino ketone (IR νCO = 1732 cm-1, δ 13C NMR 













In 2003, Coe utilized a one-carbon higher homologue of 1-aza-2-
adamantanone167 as an intermediate in the synthesis of nicotinic receptor ligands by 
subjecting it to an unprecedented Wolff-Kishner reduction (Scheme 14; see page 36 
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for details). It should be noted that in both of the studies by Kirby and Coe the 
proximity of the amino and the carbonyl groups, enforced by rigid adamantane-type 








10 mol % t-BuOK
Toluene, Dean-Stark
18 h, 49-58%  
 
In 2006, Tani and Stoltz synthesized the iconic twisted amide, 2-
quinuclidone26, 168 (isolated as its tetrafluoroborate salt), utilizing an intramolecular 
Schmidt ring expansion reaction (Scheme 15). This method differs significantly from 
the classical amide bond formation but it allowed for the scrupulously anhydrous 
conditions required for isolation of 2-quinuclidone. The X-ray structure of the 
protonated amide indicated a fully orthogonal amide bond (τ = 90.9° and χN = 59.5°). 
As expected, 2-quinuclidone was found to be extremely unstable to hydrolysis 
conditions (in water t1/2 < 15 s); even other nucleophilic solvents (including DMSO, 





















Schmidt reaction and bridged lactams. Stoltz’s synthesis was preceded by 
the Aubé’s group findings regarding the Schmidt reaction. In 2002, in the context of a 
total synthesis of stenine, Golden and Aubé reported a synthesis of a tricyclic bridged 
amide utilizing a domino Diels-Alder/Schmidt reaction (Scheme 16).169 
Mechanistically, the endo Diels-Alder reaction locked the azido-alkyl chain in the 
axial orientation in the cis-decalin-type system. The subsequent migration of the bond 
antiperiplanar to the diazonium cation located in the pseudoequatorial position led to 
the fused lactam, while the migration of the bond antiperiplanar to the N2+ in the 
pseudoaxial orientation afforded the bridged analogue. The amides could be easily 

































13C NMR 174 ppm
νC=O 1690 cm-1








This reaction was significant since it demonstrated for the first time that a 
bridged lactam could be prepared from an intramolecular Schmidt reaction and that 
the loss of nitrogen is a powerful driving force enabling the preparation of strained 
amides. However, the formation of the bridged product was unexpected. Despite the 
very extensive use of the intramolecular Schmidt reaction by Aubé and other groups 
for more than a decade,170-172 all previous examples of similar Schmidt reactions led 
exclusively to fused amides.  
In the intramolecular Schmidt reactions when the azide-containing side chain 
is placed at the carbon adjacent to the electrophile, in theory two regiochemical 
outcomes can be envisioned (Scheme 17).173 Formal insertion of the azide into the 
proximal C–C bond of the reactive electrophile would give a fused structure (path a), 


















Before the stenine synthesis, the only example of the intramolecular Schmidt 
reaction with the azidoalkyl chain placed in the α position to the electrophile 
affording a bridged product had occurred during synthetic studies toward 
aspidospermidine (Scheme 18).174, 175 However, this involved the reaction of the 
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azidoalkyl chain with a ketal, affording a bridged orthoaminal product. It is very 
likely that in this rather specific case, the fused ring system containing a four-
membered ring did not form due to strain, and that the azido-Schmidt reaction of the 
ketal better accommodates formation of the bridged product than the ketone version. 
Furthermore, similar variants of the Schmidt reaction utilizing epoxides,176, 177 olefins, 
178-180 diketones181, 182 and carbocations (generated in semipinacol rearrangement)183, 
184 as electrophiles did not afford bridged systems resulting from the migration of the 



























By contrast, in the related versions of the Schmidt reaction, when the azide-
containing side chain is placed at the carbon non-adjacent to the ketone, products 
resulting from the azide insertion into both bonds have been observed. In particular, 
in 1993 Pearson et al. showed that tertiary alcohols react intramolecularly with alkyl 
azides to afford ca. 2:1 mixture of bridged bicyclic enamines after treatment with 
protic and Lewis acids (Scheme 19).178 Due to the limited overlap of the lone pair of 
electrons at nitrogen and the p orbital of the carbocation, the bridgehead iminium ion 













It should be noted that with the β-positioned tether, the migration of either of 
the bonds leads to bridged structures: bridged enamines when olefins are utilized as 
electrophiles (Scheme 19)178 and bridged amides, when ketones serve as electrophilic 
components (Scheme 15).26 In addition, the crucial difference between the Schmidt 
reaction utilizing α- and β-alkyl tethers is a type of the bridged structure that is 
obtained. As will be seen in the following sections, one-carbon bridged amides,169 
prepared from α-azidoalkyl tethers offer distinct advantages over bridged amides in 
which C=O bond is placed on a larger bridge (obtained from β-alkyl tethers).26  
Interestingly, as early as in 1996 Morton and Aubé subjected two β-azidoalkyl 
cyclohexanones to the intramolecular Schmidt reaction.185 These azides would 
provide amides analogous to the Stoltz’s 2-quinuclidone after the rearrangement. 
However, only starting materials were recovered despite forcing reaction conditions, 




















The generally accepted mechanism of the intramolecular Schmidt reaction 
with an azidoalkyl chain placed in the α position to the ketone involves formation of 
chair-like azidohydrins followed by the selective migration of the C–C bond 
antiperiplanar to the leaving diazonium group (Scheme 21).173, 178 In this scenario, a 
bridged lactam can only be obtained from the azidohydrin intermediate, in which: (1) 
the azide-containing chain occupies a pseudoaxial orientation and (2) the leaving 
diazonium cation is placed in the pseudoaxial position. Both of these conditions must 
be satisfied in order to form a bridged amide. It is likely that this intermediate is 
energetically unfavorable, which explains why bridged lactams had not been 






































Very interestingly, during a second generation approach to stenine a similar 
cis-decalin-type intermediate was formed by Diels-Alder reaction. However, the 
migration of the bond antiperiplanar to the diazonium cation in the pseudoaxial 
orientation was not observed, suggesting that subtle stereoelectronic factors 























Figure 7. Comparison of reactive intermediates in the first and the second generation 
syntheses of stenine. 
 
In 2005, Yao, Wrobleski, and Aubé reported the synthesis and novel reactions 
of several other tricyclic amides based on the Diels-Alder/Schmidt sequence.31 
Importantly, the structure of bridged amides was confirmed by X-ray crystallography, 
indicating that these compounds contain amide bonds from a previously unknown 
distortion range (τ = ~50°, see Table 35 for details), and offer very attractive 
possibilities for investigating the properties of half-way rotated amide bonds.  
 
Schmidt reaction and electrostatic interactions. In 2007, Yao and Aubé 
obtained a bridged amide as the major product of the intramolecular Schmidt reaction 
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for the first time (Scheme 22).188 In this study, the regiochemical control was 
achieved by combining two effects: (1) axial orientation of the azide-containing tether 
and (2) a stabilizing cation-π interaction between an aromatic group and the leaving 
diazonium cation in the key azidohydrin intermediate (Scheme 22, box). Control 
reactions demonstrated that both the tert-butyl substituent and the aromatic ring were 
necessary for the efficient formation of the bridged products. The fact that the 
bridged/fused ratio increased with a more electron-rich aromatic ring system provided 
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Interestingly, the (2R,4S)-2-(3-azidopropyl)-4-tert-butylcyclohexanone (see 
Scheme 33 for details) had already been subjected to a Schmidt reaction using TiCl4, 
but the bridged amide was not obtained under these reaction conditions.173 This 
suggested that the regiochemistry of the Schmidt reaction is promoter-dependent, and 
suggested an attractive possibility to control the outcome of the reaction by the 
appropriate choice of reaction conditions. 
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These studies allowed for a very efficient preparation of one-carbon bridged 
amides, requiring only four steps from commercially available materials as opposed 
to the much longer syntheses of triene precursors for the Diels-Alder/Schmidt 
sequence.189 This investigation also represented a rare example of utilizing an 
electrostatic cation–π interaction to control the outcome of chemical reactions.  
Although cation–π interactions have been commonly invoked as key forces in 
ligand recognition and binding, these effects are highly underutilized in organic 
synthesis.190-193 In one related case, Katz and Aubé proposed cation–π interactions as 
a controlling feature of certain asymmetric Schmidt reactions of symmetrical ketones 
with chiral hydroxyalkyl azides (Scheme 23).194, 195 Diastereoselectivity in this 
reaction was explained by the stabilization of the reactive intermediate ax by cation–π 
interactions between the aromatic group and the diazonium cation. In addition, it was 
found that the selectivity could be correlated with the electron density on aromatic 
systems. The stabilization of the diazonium cation by aromatic rings followed the 



































































In a similar study of the Schmidt ring expansion reaction, Ribelin and 
Aubé,196 utilized heteroatoms placed on hydroxyalkyl azides to function as 
electronegative components in the electrostatic interactions with diazonium cations 
(Scheme 23, two last examples). In this study, these cation–n interactions were found 
to be more effective in inducing diastereoselectivity in this reaction than cation–π 
effects.  
In Chapter 2, I discuss a thorough study of the cation–π effects in the context 
of regiochemical control in the intramolecular Schmidt reaction leading to one-carbon 
bridged amides. This section also describes the discovery of a heteroatom directed 
variant of the Schmidt reaction, which obviates the need for a locked conformation of 
the reactive azidohydrin to afford bridged lactams. Chapter 2 culminates in the 
development of a general methodology for the synthesis of one-carbon bridged 




Reactivity of bridged amides. As mentioned earlier, due to limited 
nN→π*C=O overlap, bridged amides are expected to display reactivity divergent from 
traditional amides.41 In the most distorted amide bonds, the carbonyl group is more 
electrophilic and its properties are more closely related to those of isolated ketones 
rather than amides. Meanwhile, the lone pair of electrons at nitrogen is not engaged in 
conjugation with the C=O system and participates in amine-like reactivity.  
There are very few prior studies addressing the reactivity of bridged amides. 
Accordingly, the potential to utilize the unique properties of distorted amide bonds in 
organic synthesis has largely been overlooked. Two major factors preventing study on 
the reactivity of bridged amides are hydrolytic instability of bridged lactams, which 
complicates their handling and significantly limits the number of potential reaction 
types that can be examined, and the fact that most of the bridged amides known exist 
in geometries resembling traditional amides.11 
The first example of a reaction of a bridged amide was reported in 1946 by 
Doering and Chanley during the oxidation of a quininone-derived enolate (Scheme 
24).197 In this transformation, tert-butyl alcohol (used a solvent) led to a rapid 
alcoholysis of the corresponding amide to the amino ester, a reaction forecasting the 





















Yakhontov has studied the chemistry of a tetramethyl-substituted 2-
quinuclidone, finding that this amide participates in three types of reactions (Scheme 
25).62, 64, 65 Despite the perpendicular amide bond, this compound does not serve as a 
good model for reactivity of bridged amides due to a steric hindrance around the 
amide bonds and the ease of formation of the tertiary carbocation. Using related 
compounds, Pracejus suggested that 2-quinuclidones behave as reactive amino–
ketones.66-68 He also determined the pKa of 2,2-dimethylquinuclidone to be 5.33,66 
which was the first quantitative evaluation of a high electron density at nitrogen in 
bridged amides.  
An interesting example was reported by Denzer and Ott,81 who found that the 
reduction of the bridged amide can be performed with NaBH4, a reagent that typically 
is unreactive with amides (Scheme 26). The resulting hemiaminal collapsed to the 






















































Cleavage of N-C(O) bond
































In an important study, Brown demonstrated that the methylation of the amide 
with [3.2.2] ring system takes place at nitrogen, while in the less distorted [3.3.2] 
system the oxygen is the reactive site (Scheme 27).198 These results had been 
predicted by ab initio calculations by Greenberg,23, 24 which indicated that similar 



























By converting 1-aza-2-adamantanone into the ketal, hydrazide and enamine, 
as well as into quaternary ammonium salts, Kirby has unambiguously demonstrated 
that this compound displays keto amine like properties, which are, however, expected 




















after treatment with 0.1 M HCl)  
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Coe found the one-carbon higher homologue of Kirby’s amide to be one of 
the very few examples of a twisted amide which is reactive and stable in alcoholic 
solvents.167 The reduction of this compound terminated at the hemiaminal stage; the 
iminium ion was not formed due to the geometrical constraints imposed by the rigid 
adamantane-like structure. Furthermore, the twisted amide underwent hydrazone 
formation and full reduction to the amine under Wolff-Kishner conditions. Coe also 
observed (MS analysis) that after addition of hydrazine the mixed ethanol-
aminohydrazine intermediate (which probably exists in equilibrium with the open 





























In a breakthrough study, Lei, Wrobleski, Golden and Aubé demonstrated that 
one-carbon bridged amides undergo unprecedented C–N bond cleavage reactions 
under very mild reaction conditions (Scheme 30).31 It was determined that the 
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hydrogenolysis is completely regioselective, a fact suggested to arise from a 
decreased overlap of the bond that is being cleaved with the C=O system. In this 
reaction, N-activation of amides by hydrogen bond with alcoholic solvents was 
proposed. Furthermore, tricyclic amides were found to undergo novel 
functionalization reactions on treatment with DDQ and MeI. Thus, for the first time it 
was shown that distorted amides can display unique reactivity reaching far beyond the 
enhanced rate of hydrolysis or ketone-like reactions of amides. Importantly, the 









































Lei and Aubé extended the above study to the nitrogen and carbonyl reactivity 
of tricyclic and bicyclic one-carbon bridged amides (Scheme 31).189 Importantly, a 
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number of N-protonated and N-methylated amides were prepared. In contrast to 
Kirby’s amide, the N-protonated amides could be isolated before undergoing 
hydration and their structures were confirmed by X-ray crystallography. It was also 
found that N-protonation of amide bonds results in a dramatic increase in the 
magnitude of rotation around the N–C(O) bond.  
Similar to Kirby’s amide, these tricyclic lactams were also found to react with 
ethylene glycol and hydrazine (Scheme 31). The reduction of bridged amides was 
facile with NaBH4 and the resulting hemiaminals were stable to the isolation 
conditions (compare with Schemes 26 and 29). Interestingly, a bicylic amide 
substituted with an electron-withdrawing group in the α position collapsed to the 
formamide (Scheme 32). In a preliminary study it was also found that incubation of 
tricyclic amides at different pH conditions resulted in the recovery of the parent 
amides, suggesting unprecedented levels of hydrolytic stability in the distorted 





























































In Chapter 2, I report the study of reactivity of one-carbon bridged amides. 
First, the hydrolytic stability of one-carbon bridged amides is investigated. These 
amides are shown to display superior hydrolytic profile as compared to other bridged 
lactams, allowing for a number of unique transformations. Next, nucleophilic addition 
reactions to twisted amides, resulting in formation of exceptionally stable 
hemiaminals, are reported. Lastly, bridged amides are demonstrated to undergo the 
Corey-Chaykovsky reaction to afford isolable aminoepoxides. Other aspects of the 
reactivity of one-carbon bridged amides are also discussed.  
 
Transannular amine-carbonyl interactions. Transannular interactions 
between the amine and carbonyl groups are relevant to this study of one-carbon 
bridged amides. For example, interactions between amines and electrophilic ketones 
or aldehydes can lead to a pseudo-tetrahedral hemiaminal-type carbon, adopting a 
hybridization state between sp2 and sp3, and which are easily observed by 
spectroscopic methods (Figure 8a). This type of transannular interaction has been 
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utilized extensively in conformational analysis,200 mechanistic physical-organic 
chemistry,201, 202 total synthesis projects,203, 204 medicinal chemistry,205-207 and in drug 
design.208-210 The most widely recognized example of transannular N…C=O 
interaction is the fundamental study by Bürgi and Dunitz211 designating the general 
trajectory of the attack of nucleophiles on C=O bonds. In this investigation, a set of 
conformationally-frozen tertiary amine and ketone groups was necessary to keep the 
reactive groups in close proximity to limit the number of unproductive conformations 















































































Figure 8. a) Examples of N…C=O interactions.212-217 b) Compounds whose X-ray 
structures provided the basis for Bürgi-Dunitz trajectory211 (the trajectory is shown in 




Interestingly, the majority of nitrogen-carbonyl transannular interactions 
reported so far involve electrophiles placed directly on a ring or otherwise 
conformationally restricted tropane-type structures. In contrast, the opening of one-
carbon bridged amides would provide reasonably flexible systems with the carbonyl 
moved one-carbon away from the ring. Furthermore, a transannular condensation 
between a secondary amine and a carbonyl group placed on the other side of the ring 
can in principle lead to the formation of bridged amides. However, prior to the 
present study a very limited precedent of such transannular condensation reactions in 
the synthesis of bridged amides existed.  
The synergy between the opening and closing of bridged amides led to the 
development of a general method for the synthesis of one-carbon bridged lactams 
discussed in Chapter 2, and also to the observation of the proximity induced 
transannular effects (Chapter 3).  
 
Tetrahedral intermediates. Condensation of amines and carboxylic acid 
derivatives affords tetrahedral intermediates.218 However, typical tetrahedral 
intermediates formed during nucleophilic addition to carboxylic acid derivatives are 
unstable. These short-lived species could sometimes be detected219 but are rarely 
isolated.52, 164, 220, 221 When thiol-, alcohol- and amine-based nucleophiles are 
employed, such species are commonly encountered in enzymatic acylation reactions, 
where enzymes stabilize the reactive intermediates. In addition to their synthetic 
value, isolated tetrahedral intermediates would provide models for in vivo 
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transacylation processes.218 Although, tetrahedral intermediates formed in the reaction 
of tertiary amides and N-methoxy-N-methylamides with organometallic reagents are 
relatively stable as their salts, and have been used extensively for synthesis of 











X = Hal, OR, SR, NR2


















Figure 9. a) Reaction of carboxylic acid derivatives with nucleophiles. b) Examples 
of isolable tetrahedral adducts (see also N-brosylmitomycin C in Figure 8, and 
Scheme 18).  
 
Due to the limited conjugation of amide bonds in rigid ring systems, bridged 
amides offer scaffolds that can be utilized for the isolation of otherwise unstable 
tetrahedral intermediates. Chapter 3 describes isolation of a number of remarkably 
stable and structurally diverse tetrahedral intermediates based on one-carbon bridged 
amide scaffolds. Structural requirements necessary for the isolation of these 





Synthesis of Medium-Bridged Twisted Amides  
 
 As described in the introductory chapter, the intramolecular Schmidt reaction 
has emerged as a reliable method for the synthesis of bridged amides. Tani and 
Stoltz’s approach permitted the isolation of the archetypal twisted amide, 2-
quinuclidone (after more than 60 years of attempts to prepare this compound), while 
the research of Aubé’s group focusing on α-azidoalkyl azides led to the first 
examples of half-way rotated lactams, allowing for the initial exploration of their 
unusual reactivity.  
Following these examples, we were interested in broadening the scope of the 
intramolecular Schmidt reaction in the synthesis of one-carbon bridged amides. In 
addition to exploring the uncommon rearrangement pathway in the Schmidt reaction 
of α-azidoalkyl ketones, we wished to prepare a diverse family of bridged lactams to 
further investigate the chemistry of non-planar amides.  
When we began our study, the Schmidt reaction was limited to the synthesis 
of [4.3.1] ring system of bridged amides.189 Furthermore, when the conformation of 
the reactive azidohydrin intermediate was not locked (even in the presence of 
stabilizing cation–π interactions), only fused lactams could be obtained. 
Consequently, our goal was to determine whether the Schmidt reaction could be 
utilized for preparation of other bridged amide scaffolds, and to identify whether 
flexible ring systems could serve as precursors to bridged amides.  
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Pyramidalization at nitrogen in Schmidt reaction. One promising example 
reported by Lei and Aubé189 was the trans α-unsubstituted azidoketone 1, which after 
exposure to MeAlCl2 afforded the fused amide 2 as the major product of the Schmidt 
reaction, and the bridged analogue 3 in a modest yield (Scheme 33a). The same azide 
1, however, was first utilized a decade earlier in the original investigation of the 
intramolecular Schmidt reaction173 to confirm that the reaction proceeds with the 
retention of configuration at the migrating carbon. Upon exposure to TiCl4, 1 
provided the fused lactam 2 as the only product of the Schmidt reaction (Scheme 
33b), while the diasteroisomeric 4 cleanly furnished the lactam 5 (Scheme 33c). The 
acid dependence on the product distribution of the reaction of azide 1 (Scheme 33a 
vs. 33c) suggested an opportunity to evaluate the effects of reaction conditions on the 











































Importantly, the main factor governing the outcome of the Schmidt reaction 
with 1 is the configuration at nitrogen. Previous studies indicated that in the 
aminodiazonium intermediates involved in the Schmidt reaction, the barrier to 
pyramidal inversion at nitrogen is relatively small (ca. 1 kcal/mol).178 We reasoned 
that the appropriate choice of promoters, solvents and temperatures could influence 
the reactive conformations leading to lactams 2 and 3. Furthermore, a better 
understanding of this system would facilitate the extension of the scope of cation–π 
effects, which we envisioned to pursue afterwards.  
It is worthwhile to examine the reactive intermediates in the Schmidt reaction 
in the α-unsubstituted system (Scheme 34). After activation, the trans azide 1 
furnishes two azidohydrin intermediates 1a and 1b, which could interconvert through 
nitrogen inversion (1a→1b and 1b→1a) or by reversion to the keto azide (1a→1 and 
1b→1). The intermediate 1a with the pseudoequatorially disposed N2+ affords the 
fused lactam while the intermediate 1b with the N2+ in pseudoaxial position gives the 
bridged isomer.  
Although epimerization (by acid mediated enolization, 1→4) is not predicted 
to be a significant problem in this system, such a side reaction had been noticed in the 
original study of the Schmidt reaction. If epimerization occurs, the diastereoisomer 4 
can undergo azide attack from the equatorial direction to give the intermediate 4a, or 
the axial azide attack to give the intermediate 4b. Rearrangement of either 
azidohydrin would give the fused lactam 5. It is important to notice that although the 
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nitrogen inversion can occur in 4a and 4b, it would result in N2+ being antiperiplanr 
to the hydroxyl group (Figure 10); in either case the carbon migration is not possible.  
 
Scheme 34 





























































f rom 4a f rom 4b  
Figure 10. Unproductive azidohydrin intermediates arising from cyclohexanone 
bearing equatorial azidoalkyl tether (bonds antiperiplanar to N2+ marked in bold). 
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Accordingly, I undertook a detailed study of the rearrangement of keto azide 
1. The effect of different acids, temperatures and solvents on the product distribution 
in the Schmidt reaction of azide 1 is summarized in Tables 2, 3 and 4.   
 
Table 2. Effect of Lewis Acid on Product Distribution with Azide 1.a 
entry acid equiv t 2:3b conversionb trans/cis 
   [h]   lactamsb,c 
1 MeAlCl2 1.1 2 71:29 >95 >95:5 
2 TiCl4 5.0 1 >95:5 >95 >95:5 
3 TFA 85d 2 86:14 >95 70:30 
4 MeAlCl2 1.1 24 71:29 >95 >95:5 
5 MeAlCl2 25 3 71:29 >95 >95:5 
6 EtAlCl2 1.1 8 71:29 >95 >95:5 
7 AlCl3 1.1 1 77:23 >95 >95:5 
8 Me2AlCl 1.1 24 75:25 60 71:29 
9 Me3Al 2.2 24 - <5 - 
10 TMSOTf 1.1 2 77:23 >95 57:43 
11 BF3•Et2O 1.1 2 78:22 >95 >95:5 
12 TfOH 5.0 1 79:21 >95 >95:5 
13 SnCl4 1.1 2 85:15 >95 >95:5 
14 SnBr4 1.1 24 >95:5 >95 >95:5 
15 TiBr4 1.1 1 90:10 >95 80:20 
16 SbCl5 1.1 1 87:13 >95 94:6 
17 YbCl3 1.1 24 88:12 >95 >95:5 
18 AgBF4e 1.1 24 82:18 80 83:17 
19 Sc(OTf)2e 1.1 6 86:14 >95 96:4 
20 Yb(OTf)3e 1.1 24 - <5 - 
21 Ti(OiPr)4e 5.0 24 - <5 - 
22 Zn(OTf)2e 1.1 24 - <5 - 
23 Cu(OTf)2e 1.1 24 - 9 - 
24 CuCl2e 1.1 24 - <5 - 
25 SnCl2e 1.1 24 - 17 - 
a 0 °C to rt, c = 0.05−0.15 M in CH2Cl2. b Determined by 1H NMR.  
c Trans/cis lactams ratio indicates 2,3:5 ratio. d Neat. e Reflux. 
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Table 3. Effect of Temperature on Product Distribution with Azide 1.a 
entry acid temperature t 2:3b conversionb trans/cis
   [h]   lactamsb,c
1 MeAlCl2 0 °C → rt 2 71:29 >95 >95:5
2 MeAlCl2 -78 °C → rt 24 79:21 >95 94:6 
3 MeAlCl2 -78 °C (6 h) → rt 24 93:7 55 93:7 
4 MeAlCl2 45 °Cd 1 74:26 >95 >95:5
5 MeAlCl2 90 °Ce 0.2 80:20 >95 92:8
6 MeAlCl2 110 °Cd, f 0.5 77:23 >95 >95:5
a 1.1 equiv of MeAlCl2,  c = 0.05–0.15 M in CH2Cl2. b Determined by 1H NMR. c 
Trans/cis lactams ratio indicates (2+3):5 ratio. d MeAlCl2 added at rt, and the 
reaction vessel was placed in the oil bath preheated to the indicated temperature. 
e MW irradiation. f Toluene as a solvent. 
 
Table 4. Effect of Solvent on Product Distribution with Azide 1.a 
entry acid solvent t 2:3b conversionb trans/cis 
   [h]   lactamsb,c 
1 MeAlCl2 CH2Cl2 2 71:29 >95 >95:5 
2 MeAlCl2 Et2O 24 71:29 >95 51:49 
3 MeAlCl2 CH3CN 6 73:27 >95 93:7 
4 MeAlCl2 PhCH3 1 75:25 >95 >95:5 
5 MeAlCl2 CCl4 24 75:25 >95 92:8 
6 MeAlCl2 CH3Cl 24 - 20 - 
7 MeAlCl2 MeOH 24 ketald - - 
a 0 °C to rt, 1.1 equiv of MeAlCl2,  c = 0.05–0.15 M in indicated solvent. b 
Determined by 1H NMR. c Trans/cis lactams ratio indicates 2,3:5 ratio.  d 2-
(3-Azidopropyl)-4-tert-butyl-1,1-dimethoxy cyclohexane was formed. 
 
As noted above, we expected that the bond migration in this simple system, in 
which the reactive intermediates 1a and 1b differ only by the orientation of the 
diazonium cation (Scheme 34), could be influenced by application of different Lewis 
acids. Indeed, examination of the reaction conditions confirmed this to be the case. 
Migration of the bond distal to the azide was regularly observed, and the resulting 
bridged amide 3 was found to be stable to the reaction conditions (Table 2, entries 1, 
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4 and 5). In general, aluminum-containing acids afforded the highest ratio of the 
bridged to the fused amide (entries 4-9). The migration of the proximal C–C bond 
was favored by sterically demanding Lewis acids (entries 2 and 13-17). The vast 
majority of acids led to the clean ring expansion reaction; only few of the studied 
acids did not promote the rearrangement (entries 9 and 20-25). A significant amount 
of epimerization occurred only in three instances (entries 3, 8 and 10), reflecting the 
general facility of the intramolecular Schmidt reaction.  
We determined that the distribution of lactams formed from azide 1 could also 
be influenced by changes in the reaction temperature (Table 3). The formation of the 
bridged amide could be almost entirely suppressed by lowering the temperature (entry 
3). Similarly, the bridged/fused amide ratio was decreased when the reaction was 
performed at the higher temperatures (entries 2 and 6). By contrast, changing solvents 
had a minor influence on the selectivity of the rearrangement (Table 4).   
Overall, the regioselectivity of the rearrangement of azide 1 proved to be 
condition-dependent and a variety of acids were found to promote the formation of 
the bridged amide. Although, the ratio of the bridged to the fused lactam formed from 
the azide 1 could not be improved, the above results suggested a possibility of 
influencing the outcome of Schmidt reactions in more complex systems. The reaction 
with azide 1 could be easily scaled up to provide gram quantities of lactam 3, 
allowing for examination of properties of the α-unsubstitiuted [4.3.1] bridged system 
(see Chapter 3).  
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Cation–π control of regiochemistry in the Schmidt reaction. Lei and Aubé 
discovered a significant increase in the bridged/fused amide ratio when phenyl and 4-
methoxy phenyl substituents were placed in the α-position to the ketone in the 
intramolecular Schmidt reaction (Scheme 22). Cation–π interactions were suggested 
to be a key controlling feature in this reaction.188, 189  
In an attempt to improve the synthesis of distorted amides, we wished to 
further enhance the regioselectivity of the Schmidt rearrangement by utilizing 
substrates with higher electron density on aromatic rings than 4-methoxy phenyl. We 
also wanted to confirm the presence of cation–π interactions by using a substrate 
bearing an electron withdrawing group on the aromatic ring. Following Katz’s 
precedence194, 195 (Scheme 23), it seemed likely that 3,4,5-trimethoxyphenyl and 4-
nitrophenyl groups would fulfill these tasks. Examination of additional substrates 
bearing aromatic rings with different substitution patterns would provide both insights 
into this type of the intramolecular Schmidt reaction and further examples of bridged 
amides.   
The selected 2-azidoalkyl-2-arylketones and their synthesis are presented in 
Table 5. In all cases, diastereomerically pure samples of the required trans 




























step 1 step 2 step 3
Cl(CH2)3I
 
entry Ar product (yield, %) 
  step 1 step 2 step 3 
1 C6H5 6 (50) 13 (40) 20 (89) 
2 4-(MeO)C6H4 7 (52) 14 (45) 21 (96) 
3 4-(NO2)C6H4 8 (61)a 15 (41) 22 (88) 
4 3,4,5-(MeO)3C6H2 9 (46) 16 (40) 23 (99) 
5 3,4-(MeO)2C6H3 10 (52) 17 (45) 24 (87) 
6 3,4-(CH2OCH2)C6H3 11 (37) 18 (37) 25 (86) 
7 3,5-(MeO)2C6H3 12 (62) 19 (43) 26 (89) 
a TMS enol ether used instead of the ketone. 
 
Having determined earlier (Tables 2 and 3) that the regiochemical outcome of 
the Schmidt rearrangement depends significantly on the reaction conditions, we 
started the investigation of the cation–π directed version by a short optimization of 
the reaction conditions, utilizing α-phenyl containing azide 20 as a model substrate 

















20 27 34  
 
entry acid equiv t [h] 27:34b 
1 MeAlCl2 1.1 3i 26:74 
2 EtAlCl2 1.1 18 50:50 
3 TfOH 5.0 1 63:37 
4 TiCl4 5.0 1 50:50 
5 SnCl4 1.1 18 71:29 
6 BF3•Et2O 1.1 6 60:40 
7c MeAlCl2 1.1 6 26:74 
8d MeAlCl2 2.2 18 47:53 
9e MeAlCl2 2.0 24 71:29 
10f MeAlCl2 2.0 24 47:53 
11g MeAlCl2 2.0 24 26:74 
12h MeAlCl2 2.0 24 37:63 
a 0 °C to rt, c = 0.05−0.15 M in CH2Cl2 unless otherwise 
noted. b Determined by 1H NMR. c -78 °C to rt. d Reflux, 1.1 
equiv added after 2 h. e c = 0.0007 M.  f c = 0.007 M. g c = 
0.05 M. h c = 0.23 M. i The ratio did not change after next 12 
h. 
 
These studies revealed that a number of Lewis and protic acids could be used 
to provide the desired bridged lactam 34 (entries 1−6). Changes in temperature did 
not improve the bridged/fused ratio (entries 7−8). Interestingly, the product 
distribution proved to be dependent on the concentration of the reaction, with the 
ideal results obtained at c = 0.05 M (entries 9−12).  
Next, we probed the effect of the electronic nature of the aromatic substituent 
in the α position on the outcome of the Schmidt reaction (Table 7). In these 
experiments bridged amides 34-40 arise from cation–π stabilized intermediates, 
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bearing the diazonium cation in the pseudoaxial orientation (Scheme 35, ax-cation), 
whereas fused lactams 27-33 arise from a competing reaction pathway involving 
pseudoequatorial diazonium cation (Scheme 35, eq-cation). 
  


















  product (yield, %) 
entry azide R fused bridged 
1 20 C6H5 27 (22) 34 (61) 
2 21 4-(MeO)C6H4 28 (11) 35 (71) 
3 22 4-(NO2)C6H4 29 (38) 36 (39) 
4 23 3,4,5-(MeO)3C6H2 30 (19) 37 (66) 
5 24 3,4-(MeO)2C6H3 31 (18) 38 (65) 
6 25 3,4-(CH2OCH2)C6H3 32 (13) 39 (72) 
7 26 3,5-(MeO)2C6H3 33 (25) 40 (65) 
































The observed overall dependence of selectivity is consistent with the ability of 
aryl rings to stabilize the N2+ group in 1,3-diaxial relationship.195 Thus, under the 
optimized conditions, the azide 20 bearing phenyl in the α position afforded 61% of 
the bridged lactam 34 along with 22% of the fused product 27 (Table 7, entry 1). The 
azide 21, featuring a more electron-rich 4-methoxyphenyl system, led to an increased 
bridged/fused lactam ratio delivering the amides 35 and 28 in 71 and 11% yield, 
respectively (Table 7, entry 2). Conversely, azide 22, decorated with an electron-
withdrawing 4-nitrophenyl substituent, decreased the ratio, leading to ca. 1:1 
distribution of the final products (Table 7, entry 3). This trend is fully consistent with 
the expectation that the observed selectivities are a direct result of the axial/equatorial 
preference of the diazonium cation and the strength of the cation–π interaction.  
Interestingly, introduction of the 3,4,5-trimethoxyphenyl substituent in the α 
position of the azido-alkyl cyclohexanone afforded the bridged amide in 66% and its 
fused analogue in 19% yields, respectively (Table 7, entry 4). This ratio is 
intermediate between that of the phenyl and 4-methoxyphenyl substituted azido-
ketones. Moreover, it does not follow the trend observed in the Schmidt reaction with 
hydroxyalkyl azides (Scheme 23), which is a closely related system probing the 
strength of cation–π interactions between N2+ and aromatic rings. Furthermore, the 
use of 3,4-dimethoxyphenyl substrate 24 provided products having a bridged/fused 
lactam ratio similar to that of substrate 23 (entry 5), while the 3,4-
dioxomethylenephenyl-containing azide 25 (entry 6) increased the selectivity, 
matching the ratio obtained with azide 21 (entry 2). In addition, 3,5-
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dimethoxyphenyl-containing azide 26 (entry 7) gave a ratio similar to the α-phenyl 
keto-azide from entry 1.  
We reasoned that these unanticipated results could be ascribed to coordination 
of the Lewis acid to the oxygen ethers. To probe this hypothesis we performed a set 
of experiments, in which the azido-ketones were subjected to varying number of 
equivalents of MeAlCl2. The results are summarized in Table 8.  
 
Table 8. Influence of Lewis Acid Stoichiometry on Product Distribution in Cation–π 
Directed Schmidt Reaction.a,b 
 
   bridged:fused
entry equiv acid 27:34 28:35 29:36 30:37 31:38 33:40 
1 1.0 MeAlCl2 26:74 12:88 50:50 16:84 15:85 24:76
2 1.5 MeAlCl2 26:74 12:88 49:51 21:79 22:78 31:69 
3 2.0 MeAlCl2 28:72 14:86 47:53 30:70 39:61 42:58 
4 3.0 MeAlCl2 30:70 29:71 nd 46:54 52:48 61:39 
5 2.0 BF3•CH3CN 56:44 32:68 nd 42:58 nd 65:35 
a 0 °C to rt, 24 h, c = 0.05 M in CH2Cl2. b Product ratio determined by 1H NMR. 
     nd = not determined. 
 
In the case of the α-phenyl-containing azide the bridged/fused amide ratio 
remains practically constant, regardless of the stoichiometry of MeAlCl2 (Table 8, 
27:34, entries 1-4). However, with alkyloxygen-substituted phenyl rings, the ratio 
significantly decreases with the increase of equivalents of the acid used. In addition, 
this tendency is more pronounced in substrates capable of coordination of MeAlCl2 to 
multiple oxygens (Table 8, series 30:37, 31:38, 33:40). Furthermore, the application 
of a monodentate Lewis acid to promote the rearrangement afforded a similar trend of 
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bridged/fused lactams to that obtained with MeAlCl2 (4-methoxyphenyl > 3,4,5-
trimethoxyphenyl > phenyl > 3,5-dimethoxyphenyl) (Table 8, entry 5).  
These results are consistent with coordination of the acid to oxygens placed on 
the aromatic ring, leading to the decrease of the electron density of π-systems, and 
weakening of cation–π interactions. The net outcome is the increased amount of the 
fused lactam formed from the intermediate bearing N2+ group in the pseudoequatorial 
orientation (Scheme 35, eq-cation). A steric interaction between the acid coordinated 
to aromatic ring oxygens and diazonium cation in the pseudoaxial orientation might 
also be responsible for a lower selectivity in the C–C bond migration. Overall, these 
results emphasize the importance of selecting appropriate reaction conditions to 
obtain maximum cation–π stabilization effects.  
We also subjected azide 42 bearing a four-carbon tether to the above Schmidt 
reaction conditions (Scheme 36a). However, lengthening of the azide-side chain did 
not lead to any productive reaction, even under very forcing reaction conditions 
(Sc(OTf)3, 0.5 equiv, H2O, 180 °C, 3 h or TiCl4, 5.0 equiv, toluene, 105 °C, 18 h). It 
is very likely that in this case the azidohydrin intermediates 42-ax/42-eq are formed, 
however the α-phenyl substitutent slows down the migration of the C–C bond 
(Scheme 36b). A deleterious effect of electron-withdrawing substituents on the rate of 























































Motivated by Yamada et al. findings that carbonyl groups can serve as 
effective π-systems,224 we examined the potential of ester and amide functionalities as 
cation-stabilizing groups in the intramolecular Schmidt reaction (Scheme 37 and 
Table 9).  
 
Scheme 37 














43, R = CO2Et
I(CH2)3Cl
44, R = CONHBu
45, R = CO2Et, 62%
46, R = CONHBu, 47%
47, R = CO2Et, 81%




Table 9. Schmidt Reactions of α-Carbonyl Substituted Azides.  
49, R = CO2Et











  product (yield, %) 
entry azide R acid fused bridged 
1 47 CO2Et MeAlCl2 49 (80) - 
2 47 CO2Et TfOH 49 (92) - 
3 47 CO2Et TFA 49 (88) - 
4 47 CO2Et BF3•Et2O 49 (78) - 
5 48 CONHBu TfOH 50 (52) 51 (13) 
6 48 CONHBu MeAlCl2 50 (77) - 
 
However, the α-ethoxycarbonyl group embedded in a conformationally-
locked system afforded only the fused amide, albeit in good yields (Table 9, entries 1-
4). The placement of a secondary amide in the α position permitted the formation of 
the bridged amide 51 (entry 5), but the bridged/fused lactam ratio resembled the 
outcome obtained with the azide 1 rather than cases in which cation–π interactions 
were operative. Interestingly, when the reaction of the azide 48 was promoted by the 
Lewis acid, the formation of the bridged amide was not observed (entry 6). This 
suggests that the Lewis acid coordinates to the amide, possibly forming a six-
membered chelate, which might disfavor the placement of the diazonium cation in the 
pseudoaxial position (Scheme 38, eq-cation).  
The behavior of azide 48 is reminiscent of another α-amide-containing 
azidoketone (52, Scheme 39), which affords the fused and the bridged amide when 
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subjected to TfOH, however it gives only the fused analogue in reactions mediated by 




when protic acid is used
reactive conformation




















































Distortion parameters of [4.3.1] bridged amide ring system. Bridged 
amides prepared by cation–π directed intramolecular Schmidt reaction contain 
nitrogen atoms at a bridgehead position in [4.3.1] ring system. This arrangement 
prohibits the nitrogen and the carbonyl group from adopting co-planarity. 
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Consequently, the nitrogen lone pair is partially orthogonal to the amide C=O bond, 
and unable to participate in full conjugation with the C=O π* orbital. This results in 
keto amine-like character of these compounds. The X-ray structure of 38 confirms 
that the amide bond is significantly distorted (Figure 11).226 Dunitz-Winkler 
distortion parameters show that in 38, the N–C(O) bond has τ = 43.2°, χN = 33.8°, 
and χC = 16.3°. This indicates that the N–C(O) bond is halfway rotated, and that the 
hybridization at nitrogen is nearly halfway between sp2 and sp3 in character. In 
contrast, the carbon of the amide bond is nearly planar; this property has also been 
observed in other distorted amides.37 The N–C(O) bond length of 1.363 Å in 38 is 
longer than the typical N–C(O) bond in planar amides and the C=O bond length of 
1.234 Å is slightly shorter than the average C=O bond in traditional lactams. These 
values are consistent with a significantly distorted amide bond resulting from 








Figure 11. X-ray structure of bridged amide 38. 
 
The comparison of distortion parameters of 38 and 53 along with tricyclic 
bridged amides obtained in the Schmidt reaction and representative other distorted 
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lactams is presented in Table 35, Chapter 3. The X-ray structure of 38 provides key 
evidence to explain the differences in reactivity between distorted amides.  
 
 
Cation–n control of regiochemistry in Schmidt reaction. Although cation–
π interactions have proven to be a very efficient method for synthesis of one-carbon 
bridged amides, a major limitation of this approach is the necessity for a locked 
conformation of the reactive azidohydrin intermediate to form a twisted amide 
(Scheme 22). In addition, only the [4.3.1] ring system could be prepared utilizing the 
cation–π directed Schmidt reaction (Scheme 36). These limitations could be partially 
overcome by applying cation–n interactions as a controlling feature of the Schmidt 
reaction. 
Lei and Aubé have found that the bridged amide is formed as the major 
product of the Schmidt reaction when a thiomethyl group is placed in the α-position 
in the conformationally locked 2-azidoalkylcyclohexanone, (Scheme 40).189 By 
contrast, the methoxy group led exclusively to the fused lactam. It was proposed that 
attractive cation–n interactions between the N2+ leaving group and n electrons on the 
polarizable sulfur atom could be responsible for the formation of the bridged lactam 
(Scheme 40, box). These experiments were preceded by realization that the 
spectroscopic properties reported earlier by Aubé and coworkers173 for the fused α-
thiophenyl-containing lactam are likely to correspond to a bridged rather than fused 






















R = SMe 51%




We wondered if a similar cation–n effect could be utilized for the synthesis of 
bridged amides in a system in which the conformation of the reactive azidohydrin 
intermediate is not locked. We hypothesized that a thiomethyl group might have a 
beneficial effect on the rearrangement of the distal C–C bond in the Schmidt reaction. 
Firstly, similar to the phenyl group, an electron-withdrawing SR group should slow 
down the rearrangement step. Importantly, this will also disfavor the migration of the 
C–C bond proximal to the azide. Secondly, due to a similar A value to the azidoalkyl 
tether (1.1 kcal/mol of SMe vs. 1.79 kcal/mol of C2H5),227 it is possible that the 
required conformation of the azidohydrin bearing the azidoalkyl chain in the axial 
orientation will be present not only in the ground state but also during the reaction. In 
this arrangement, the diazonium cation in the axial orientation could be stabilized by 
the interaction with sulfur.  
It should be noted that despite a relatively large A value of the phenyl group 
(2.8 kcal/mol), this substituent does not always occupy the equatorial orientation 
predicted by steric requirements.195 For example, in 1-methyl-2-phenylcyclohexane 
the phenyl preferentially occupies an axial orientation, since after rotation it can avoid 
steric interactions with adjacent hydrogens that are unavoidable when the phenyl is 
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equatorial. Phenyl rotation is likely to be one of the major factors contributing to the 
exclusive formation of the fused lactam from the unlocked α-phenyl azidoalkyl 
cyclohexanone (Scheme 21).    
After a two-step synthesis of the required precursor, we were delighted to 
discover that the azide 57 with a thiomethyl placed in the α position to the ketone 
afforded a bridged bicyclic lactam without relying on the locked conformation of 
cyclohexanone (Scheme 41).228 Given the original hypothesis for the mechanism of 
the intramolecular Schmidt reactions (Scheme 20), we hypothesized that the lactam 
58 is formed from the azidohydrin intermediate (Scheme 41, box) subjected to a 
































Control experiments demonstrated that the axial orientation of the azide-
containing side-chain is required for the formation of bridged lactams (Scheme 42 
and Table 10, entries 2 and 3). In this particular case, the preparation of azides was 
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complicated due to the difficulties in separation of the diastereoisomers (Scheme 
42a). Despite extensive investigation of methods based on reduction of the ketone or 
oxidation of the sulfur to increase the polarity of intermediates, direct alkylation 
followed by careful chromatography still afforded the best results.  
The use of thiomethyl is crucial to the outcome of the reaction (Table 10, 
entries 1, 4 and 5). The selectivity observed with the conformationally locked azide 
61 equals the highest selectivity obtained in the previous study (entries 2 and 6). 
Thus, in the cyclic intermediates involved in the Schmidt reaction the strength of 
thiomethyl cation–n interactions is comparable with the well-established cation–π 
interactions. However, the remarkable advantage is that when the thiomethyl 
occupies the α position to the ketone the reactive intermediate contains the azide 
chain in the axial orientation (entries 1 and 6), allowing for the synthesis of otherwise 














































































entry azide R1 R2 bridged:fused 
ratioa 
yield (%)b 
1 57 SMe H 80:20 80 


























a Determined by 1H NMR of the crude reaction mixture. b Combined yield, see the 





The reactive intermediates are shown in Scheme 43. The fact that the isomer 
61 leads primarily to the bridged product while the isomer 62 affords only the fused 
product provides the first experimental support for the hypothesis that the 
intramolecular Schmidt reaction requires the azidoalkyl chain to adopt an axial 
orientation to give a bridged lactam. Here, we suggest that the bridged isomer 65 is 
formed due to stabilizing cation–n interaction favoring the orientation of diazonium 
cation in pseudoaxial position in the azidohydrin intermediate. The effect of an α 
substituent is shown in the bottom part of Scheme 43. In 57, the thermodynamically 
favored conformation ax-tether affords the azidohydrin intermediate that leads to 58. 
It is very likely, however, that the alternative conformation with the azidoalkyl chain 














































favored when XR = SMe (57)
reactive conformation















We also probed the effect of heteroatom substituents and ring sizes on the 
outcome of the reaction (Schemes 44 and 45, Table 11). Thiophenyl and methoxy 
groups allowed for the synthesis of bridged lactams, albeit in lower yield. Sulfur 
substitution with either an electron-withdrawing group (entry 2) or a less polarizable 
heteroatom (entry 3) led to diminished cation–n interactions. Sulfonyl was also found 
to be an efficient directing group, however in this case the interaction takes place 
between cation and oxygen and a cation–π component cannot be excluded.  
Examination of different ring sizes revealed that bridged lactams are formed 
efficiently from six and seven membered rings in which the azide is separated from 
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the ring by a three-carbon tether. Extending the ring size or the tether length 
decelerated the reaction and decomposition of azide to aldehyde was the only reaction 
pathway observed (entries 7 and 8). As determined earlier for other intramolecular 
Schmidt reactions, substitution with an electron-withdrawing substitutent slows down 
the rate of reaction.173 This effect is similar to that seen in the reaction of azide 42 
(Scheme 36), which was found unable to undergo the rearrangement.  
 
Scheme 44 

























Scheme 45  














n = 0, m = 1, (86) 37%, (87)
64%, (91)
75%, (97)




n = 1, m = 2, (55)
n = 3, m = 1, (96)



























     yield (%) 
entry azide XR n m bridged fused aldehyde 
1 57 SMe 1 1 58 (65) 59 (15) - 
2 72 SPh 1 1 73 (35) 74 (32) - 
3 79 OMe 1 1 80 (23) 81+82 (52)a - 
4 83 SO2Me 1 1 84 (48) 85 (13) - 
5 88 SMe 0 1 - 89 (43) - 
6 92 SMe 2 1 93 (62) 94 (11)b 95 (20) 
7 98 SMe 3 1 - - 99 (30) 
8 101 SMe 1 2 - - 102 (53) 
a Combined yield of 81 and 82 (see below). b Keto amide (see below). 
 
Some of the α-heteroatom-substituted fused lactams were found to be 
unstable. For example, the Schmidt reaction of azide 79, instead of the expected 
lactam, afforded elimination and ring-opening products in ca. 1:1 ratio (Scheme 46a). 
Mechanistically, this involves protonation of the methoxy group, N-acyliminum ion 
formation, and deprotonation or hydrolysis. Similarly, the azide 92 afforded the 11-
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membered keto amide (Scheme 46b). Additionally, lactams 85 and 89 were found to 
eliminate readily upon exposure to acids and mild heating. Analogous ring opening of 






























Interestingly, cation–n directed Schmidt reactions were found to be very 
dependent on the acid used for rearrangement, suggesting the importance of 
coordination effects on the product distribution (Table 12).   
 
Table 12. Acid Influence on Bridged/Fused Lactam Ratios in Cation–n Directed 
Schmidt Reactions. 
entry azide XR acid equiv time bridged:fused bridged:fused
      lactama products 
1 57 SMe TfOH 5.0 60 s 80 : 20 58 : 59 
2 57 SMe HBF4 5.0 5 min 75 : 25 58 : 59 
3 57 SMe BF3•CH3CN 2.0 2 h 76 : 24 58 : 59 
4 57 SMe MeAlCl2 1.0 4 h 77 : 23 58 : 59 
5 57 SMe TiCl4 2.0 2 h 27 : 73 58 : 59 
6 72 SPh TfOH 5.0 60 s 53 : 47  73 : 74 
7 72 SPh HBF4 5.0 5 min 33 : 67  73 : 74 
8 72 SPh BF3•CH3CN 2.0 2 h 44 : 56  73 : 74 
9 72 SPh MeAlCl2 1.0 4 h 27 : 73  73 : 74 
10 72 SPh TiCl4 2.0 2 h >5 : 95  73 : 74 
11 79 OMe TfOH 5.0 60 s 32 : 68  80 : 81+82 
12 79 OMe BF3•CH3CN 2.0 6 h 37 : 63  80 : 81+82 
13 79 OMe MeAlCl2 2.0 6 h 22 : 78  80 : 81+82 
14 79 OMe TiCl4 2.0 6 h 16 : 84  80 : 81+82 
a Determined by 1H NMR of crude reaction mixtures.  
 
With the α-thiomethyl azide 57 the bridged/fused amide ratio (58:59) drops 
significantly only when TiCl4 is used to promote the reaction (Table 12, entry 5). 
Other acids gave a comparable 58:59 ratio (entries 1-4). However, in the case of 72, 
HBF4 and MeAlCl2 led to a significantly decrease in the 73:74 ratio (entries 7 and 9), 
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while TiCl4 does not lead to the bridged amide at all (entry 10). In the case of 79, a 
trend similar to 72 was observed, with TfOH and BF3•CH3CN (entries 11 and 12) 
giving superior results to MeAlCl2 and TiCl4 (entries 13 and 14).  
The product distribution with a seven-membered azidoketone 93 was also 
dependent on the acid used to promote the rearrangement. Thus, TfOH gave 93, 94 
and 95 in 62%, 11% and 20% yields, respectively (Table 11, entry 6). Similar to the 
examples in Table 12, TiCl4 afforded 93 and 94 in the opposite ratio (22% and 43% 
yield), while BF3•CH3CN gave comparable results to TfOH (71% and 13% yield). 
The aldehyde was not detected in reactions mediated by TiCl4 and BF3•CH3CN. 
The increased formation of fused lactams can be caused either by favoring the 
reactive conformation in which the leaving diazonium cation is placed in the 
pseudoequatorial orientation (Scheme 47, eq-cation) or by favoring the reactive 
conformation of cyclohexanone in which the azidoalkyl chain occupies the equatorial 
position (eq-tether). MeAlCl2 and TiCl4 may favor eq-cation by formation of stable 
5-membered chelates between the carbonyl oxygen and the α-heteroatom (Scheme 
47, top box). Alternatively, metal chelation may favor placing the tether in the 
pseudoequatorial orientation (eq-tether, bottom box). As a consequence, the 
formation of bridged amides is minimized. This dependence resembles the 
stoichiometry relationship in the cation–π directed Schmidt reaction (Table 8), and 

























XR = SMe, OMe,


















XR = SMe, OMe,
and M = Ti or Al  
 
 
In addition to the substrates presented in Table 11, we attempted the Schmidt 
reaction with three other α-thiomethyl substituted azido ketones. However, 105 
afforded only the fused lactam and the aldehyde in very low yields (Scheme 48a), 
while 108 and 109 decomposed under the Schmidt reaction conditions (Scheme 48b). 
The results with 105 may reflect the difficulty of the migration of benzylic C–C bond 
combined with a slower rate of the rearrangement of the α-thiomethyl-substituted 










































Thiomethyl ethers are valuable synthetic intermediates.230 We demonstrated 
the utility of the thiomethyl-substituted lactams to obtain a family of structurally 
related bridged amides (Scheme 49, only products shown). Noteworthy is the 
chemoselective oxidation of the thiomethyl in the presence of sensitive twisted amide 
functionalities (110, 111, 113), reductive thiomethyl removal proceeding via 
generation of a bridgehead radical (112), and isolation of the bridged amide 114 
containing a bridgehead olefin in the same molecule. In addition, Raney Ni reduction 
of the tert-butyl substituted amide 65 led to the formation of two diastereoisomeric 
amides, confirming the intermediacy of the bridgehead radical (Scheme 50). 
Interestingly the amide bond in 115 (IR νC=O = 1697 cm-1, 13C NMR δ = 188.9 ppm) 
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is more distorted than in 3 (IR νC=O = 1682 cm-1, 13C NMR δ = 186.9 ppm), 
suggesting that even minor changes around a twisted amide bond can have an 
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65 1153  
 
In an effort to gain more insight into the cation–n directed Schmidt reactions, 
we studied the rearrangement of azides 57, 61 and 62 by NMR. Thus, the reaction of 
azide 61 with BF3•Et2O (t1/2 = 45 min) proceeded about three times more slowly than 
the analogous reactions of azides 62 and 57 (t1/2 = 15 and t1/2 = 13 min, respectively). 
However, at this point we cannot conclude whether the differences in the reaction rate 
result from the cation–n stabilization or rather from other factors affecting the 
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Schmidt reaction (for example, axial vs. equatorial azide attack, rearrangement of cis- 
vs. trans-azadecalin-type system or ring inversions).  
Monitoring the above reactions by 13C NMR permitted the detection of some 
unusual properties of one-carbon bridged amides contained in a [4.3.1] ring system 
(Scheme 51). After rearrangement, the carbonyl peak of the isomer 61 appeared at 
174 ppm in 13C NMR. Addition of D2O gave amide 65, in which the carbonyl peak 
shifted downfield to 182 ppm. In contrast, values corresponding to the isomer 62 
appeared at 179 and 174 ppm, respectively. We ascribe this difference to a change of 
coordination site between nitrogen (Scheme 51a, bridged lactam) and oxygen 
(Scheme 51b, fused lactam). The 174 ppm shift is in good agreement with previously 
reported carbonyl shifts of N-protonated lactams.26, 189 The switch of the protonation 
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Transannular cyclization strategy. Although the studies on cation–π and 
cation–n control of the Schmidt reaction have significantly expanded the utility of the 
Schmidt reaction in synthesis of one-carbon bridged amides, we remained aware of 
limitations of the Schmidt reaction for this purpose. While only two different ring 
systems of one-carbon bridged amides could be prepared by the Schmidt reaction,228 
we wished to test the properties of a wider range of ring systems containing bridged 
amides. In particular we wished to determine whether more strained analogues of 
[4.3.1] or [5.3.1] ring systems are isolable and synthetically useful.  
Due to their inherent strain, the synthesis of distorted amides is challenging.41 
Although a relatively large number of amides in which C=O bond is placed on two-
carbon or longer bridges are known (Figure 12a),39-41 there are a very few known-
examples of amides in which the C=O group is situated on one-carbon bridge (Figure 
12b).31, 114, 117 However, as will be seen in more detail in Chapter 3, due to the 
increased hydrolytic stability, one-carbon-bridge-containing amides are superior to 2-
quinuclidone derivatives insofar as they can be used as an effective platform for 













C=O on ≥2 carbon C=O on 1 carbon
•limited utility due to hydrolytic instability •desirable structures





Figure 12. Types of bridged amides.  
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Traditional condensation approaches are commonly utilized for preparation of 
amides with C=O bond placed on 2 or longer bridge.41 However, when these 
reactions were attempted in the context of one-carbon bridged amide synthesis they 
were reported to be unsuccessful (Scheme 52).30  
Other failed approaches to one-carbon bridged amides include intramolecular 
nucleophilic displacement reactions,127, 130, 131 electrophilic cyclization231-233 and 
condensation reactions,132 all of which are compromised by the inherent 
nucleophilicity of the amide bond oxygen, resulting in the formation of oxygen–





























































Direct ring-closing metathesis results in isomerization of double bonds and 
polymerized material but not in closure to the strained twisted amides (Scheme 
54).189, 234 In addition, direct ring-closing metathesis fails in synthesis of bicyclic 
sultams, which are significantly easier to prepare than bridged amides.106 
Furthermore, [2+2] cycloaddition also does not lead to the expected products 































not formed  
 
The only reported examples of one-carbon bridged amides were in the context 
of single scaffold preparation114, 117, 144 and were limited to specific examples.30, 121-123 
When the present work was undertaken, Schmidt reaction was the most general 
method of the synthesis of one-carbon bridged twisted amides. 
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Aware of these difficulties, we envisioned a strategy based on two sequential 
reactions: 1) efficient formation of medium-sized ring, followed by 2) transannular 
























step 1 step 2
 
 
Although the synthesis of medium-ring nitrogen-containing heterocycles with 
appropriately placed amine and carboxylic acid derivative functionalities was 
expected to be a major challenge (Scheme 56, step 1),235-240 we anticipated that 
transannular lactamization (Scheme 56, step 2) could be capable of overcoming the 
inherent strain associated with the formation of twisted amide bonds. Evidence 
supporting the feasibility of this reaction was provided by our studies of hydrolytic 
stability of bridged amides54 (see Chapter 3 for details) in which it was determined 
that some of the open-form amino acids exist in equilibrium with the corresponding 
bridged amides, even in water (Scheme 57a). Furthermore, we found that the open-
form 9-membered amino-methyl ester closes spontaneously to the corresponding 
bridged amide (Scheme 57b). A limited precedent from previously reported twisted 

























The spontaneous cyclization of 116 to 34 deserves a comment. The 
methanolysis of 34 was performed as a control reaction to study along with the 
reduction of 34 under Borch conditions. As expected, the distorted amide bond 
undergoes facile opening under acidic conditions. Intriguingly, the standard 
purification by chromatography followed by removal of the residual solvent under 
vacuum afforded the product 116 contaminated with ca. 6% of the parent amide 34.  
Optimization of the spontaneous amidation revealed that prolonged storage of 
116 under vacuum (24 h, rt) led to 11% conversion to amide, while higher 
temperature (120 °C, 5 h, vacuum) gave ca. 50% conversion along with significant 
decomposition. In addition, when 116 was kept in a flask open to air, ca. 80% 
conversion to 34 was observed after two weeks, confirming that the transannular 
cyclization is a thermodynamically favored reaction pathway. Finally, we determined 
that a short exposure of 116 to DBU results in a convenient lactamization. Next, the 
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transannular cyclization of various open-form aminoesters (obtained by alcoholysis of 
the corresponding amides) back to the bridged lactams was evaluated (Table 13).  
 













entry amino ester R1 R2 LG amide time yield [%] 
1 116 Ph t-Bu OMe 34 1 h 91 
2 117 H t-Bu OMe 3 1 h 48 
3 118 SPh H OMe 73 1 h 84 
4 119 Ph t-Bu OEt 34 18 h 85 
5 120 Ph t-Bu Oi-Pr 34 7 days 49 
 
 
Gem-dimethyl substitution is not required for the reaction (entry 2). The lower 
yield obtained in this case is most likely caused by instability of amide 3 (see Chapter 
3). It is noteworthy that even this compound could be obtained by the transannular 
route. The good correlation between the pKa of the leaving group and the relative rate 
of the reaction (entries 1, 4 and 5, pKa MeOH = 15.5, pKa EtOH = 15.9, pKa i-PrOH 
= 16.5) suggests that the amino ester exists in equilibrium with the tetrahedral 
intermediate, and that the expulsion of the alkoxide is the rate-determining step of the 
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reaction. Importantly, cleavage of the C−C bond (see Chapter 3) was not observed 
under relatively forcing reaction conditions.  
As an alternative, we found that traditional peptide coupling conditions can 














(121), R = Ph
(122), R = H
(34), R = Ph, 79%
(3), R = H, 59%  
 
Having performed these initial studies, we were prepared for de novo 
synthesis of bridged amides. The first ring system that we wished to prepare was the 
[3.3.1] scaffold, not accessible by the Schmidt reaction. The comparison of ring strain 
energies in systems containing bridgehead olefins suggested that the targeted 
structure might be very strained (Figure 13).241-243 
 
38 16 1337 34 25 66  
Figure 13. Ring strain energy (kcal/mol) in bridgehead olefins analogous to 1-aza-2-
adamantanone, 2-qunuclidone, [4.3.1], [5.3.1] and [3.3.1] one-carbon bridged amides. 
Planar olefin and saturated hydrocarbon are shown for comparison.241-243    
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Bicycle opening. The initial approach to a medium-sized nitrogen-containing 
heterocycle, a precursor to test the key cyclization reaction, relied on the cleavage of 
the zero-bridged single bond in a bicyclic pyrrolizidine (Scheme 59, m = n = 1).  
 
Scheme 59 








m = 0, 1, 2, 3  
 
We originally envisioned that opening of analogous bicycles (Scheme 59, m, 
n ≠ 1) would afford access to a range of additional precursors for the transannular 
cyclization, especially since the cleavage of zero-bridged bond in fused bicyclic ring 
systems is a common procedure in the synthesis of indole alkaloids.244 We found, 
however, that the cleavage of the internal bond in 125 is problematic (Scheme 60). 
After alkylation of 125 and exposure to nucleophiles, demethylation was the only 

































not observed  
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Conversion of 125 to a series of corresponding carbamates resulted in the 
cleavage of the external C−N bond by the chloride released from the activating agent 
(Scheme 61a). Performing the reaction in the presence of other nucleophiles also 
resulted in the cleavage of the same C−N bond by the chloride, while exposure of 125 
to a less reactive benzyl methyl carbonate (toluene, 110 °C, 24 h) led to the recovery 
of the starting material. We found, however, that activation of 125 with benzyl 
chloroformate followed by addition of sodium cyanoborohydride245 afforded ca. 1:1 
mixture of reduction products resulting from the cleavage of the desired internal C−N 










128, R = Alloc, 91%
129, R = Cbz, 89%




















The steric hindrance around the quaternary carbon prevents the efficient 
cleavage of the zero-bridged bond in the unactivated pyrrolizidine. It is likely that this 
problem could be circumvented by attaching an aromatic ring (for example, indole or 
benzene)244 to the bicycle or by removing the ester group. However, since we wished 
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to test the properties of unsubstituted bridged amides rather than their heavily 
modified versions and sought an efficient method for the synthesis of precursors for 
the transannular cyclization, we did not pursue these pathways.  
With 131 in hand, after hydrogenative Cbz removal, the stage was set to 
perform the key transannular cyclization (Scheme 62). Disappointingly, exposure of 
132 to our previously developed conditions afforded no conversion to the desired 
lactam after 1 h and complete decomposition of the starting material after 24 h. The 
difference of reactivity between 132 and amino ester 117 (Table 13) may suggest that 














Aware of the lability of α-unsubstituted one-carbon bridged amides (see 
Chapter 3), we reasoned that substitution α to the ester might enhance the stability of 
the putative [3.3.1] amide. Being unsuccessful in alkylation of the hindered 131 and 
because of the previously described problems with the cleavage of the internal C–N 




Fukuyama amine synthesis. Fukuyama has developed a practical synthesis 
of secondary amines utilizing 2,4-dinitrobenzenosulfonyl and 2-nitrobenzenesulfonyl 
groups as activating substituents for selective alkylation and Mitsunobu reactions of 
amines.240 Fukuyama’s group applied this methodology to the synthesis of a number 





























Figure 14. Synthesis of medium-sized heterocycles containing nitrogen by 
Fukuyama.240 
 
Our second generation approach towards synthesis of precursors for the 
transannular cyclization relied on Fukuyama’s amine synthesis. Following the lesson 
learned with aminoester 132 we envisioned that the α-substituent would be installed 
in the early stages of the synthesis. To favor the transannular amidation reaction, 
malonate was chosen as a suitable precursor for the cyclization. The synthesis is 











































The desired eight-membered ring 138 was prepared in six steps from diethyl 
malonate. The chloride to bromide exchange (136→137) was necessary to form 138; 
when 136 was subjected to the cyclization conditions the reaction did not occur. The 
lower yield for the formation of 138 and the significant amount of the elimination 
product 138a as compared to model systems (Figure 14) suggested that the reaction is 
sensitive to steric hindrance created by malonate groups.  
After the nosyl group removal, we attempted the transannular cyclization to 
the twisted amide (Scheme 64). In contrast to aminoester 132 (Scheme 62), the 
reaction proceeded smoothly. However, instead of the [3.3.1] bridged amide, 
carbamate 140 was formed. Clearly, the transannular attack of the amine on the ester 
functionality was followed by the breaking of the C−C bond, which was more favored 
than the expulsion of the ethoxy leaving group to form the strained [3.3.1] bridged 
amide. This transformation resembled the cleavage of the unactivated C−C bond 
89 
 
observed earlier in the course of reduction of one-carbon bridged amides (see Chapter 


















139 140  
 
We envisioned three methods to divert the transannular reaction into the 
desired course: 1) modification of the reaction conditions; 2) replacement of the 
ethoxy group with a better leaving group; 3) use of an α-substituted acetate instead of 
the malonate.  
It is well-known that an increase in solvent polarity can favor SN2 reactions.246 
However, when deprotection of 138 was carried out with thioglycolic acid and LiOH 
in DMF at rt for 1 h, 140 was formed directly from 138, indicating that the 
transannular migration proceeds faster in polar solvents. It suggested that other 
reaction conditions would not change the course of this transannular reaction.  
As a second method to favor the transannular cyclization, 138 was converted 
into 142 (Scheme 65). The subsequent deprotection with thioglycolic acid and LiOH 
in DMF led to decomposition, while the use of thiophenol and Cs2CO3 afforded a 
complex mixture of products. Interestingly, the HRMS analysis indicated the 
presence of the desired product (calcd for C11H18NO3 (M+ + H) 212.1287, found 
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212.1287). As we would learn later, the desired [3.3.1] lactam was indeed formed in 























Being unable to convert the aminoester 139 into the desired [3.3.1] amide, we 
synthesized the eight-membered precursor containing phenyl group in the α position 
to the ester (148, Scheme 66). The choice of the phenyl group was dictated by the fact 
that the α-phenyl substituted amide 34 afforded a stable hemiaminal after treatment 
with NaBH4. In contrast, the hemiaminal resulting from the reduction of α-(4-
nitrophenyl) substituted amide 36 collapsed with the C–C bond cleavage (see Chapter 
3, Table 24 for details). The synthesis of 148 (Scheme 66) mirrored the synthesis of 
138 (Scheme 64). The only noteworthy difference is a slightly lower yield of the 
Fukuyama reaction (147→148), reflecting the increase of the steric hindrance around 












































In contrast to 138 (Scheme 64), deprotection of 148 with both PhSH and 
thioglycolic acid afforded the aminoester 150 (Scheme 67). Furthermore, vigorous 
treatment with DBU did not lead to any productive reaction, clearly indicating the 
difference in reactivity between these two systems. Thus, ester to phenyl exchange 
prevented the transannular migration, however this modification did not provide the 
















As a next resort, 148 was converted to 152 (Scheme 68). Similar to the 
malonate 142, the exposure of acetate 152 to thioglycolic acid led to complete 
decomposition (Scheme 65). To our delight, treatment with the alternative 
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Compared to the bridged lactam 34 with [4.3.1] ring system, 153 bearing 
[3.3.1] scaffold is very unstable. The compound decomposed in CDCl3 within 48 h 
(presumably by polymerization and/or hydrolysis). Attempted purification by 
chromatography also led to its complete degradation. Although all of the one-carbon 
bridged amides exhibit similar characteristic polarity on TLC (Rf = 0.2–0.5 in 1/4 
EtOAc/hexanes), 153 could not be observed by this method, which is further 
consistent with its rapid decomposition.  
The structure of 153 was secured through detailed NMR analysis (1H NMR, 
13C NMR, COSY, NOESY, HMBC and HSQC) of the unpurified reaction mixture 
(only peaks in the aromatic region were not resolved), and confirmed by HRMS 
measurements. Particularly noteworthy is the dramatic shift of the carbonyl group in 
the 13C NMR spectrum at 199.5 ppm. This value matches the N–C=O resonance of 
the Kirby’s amide,166 strongly suggesting that both compounds exhibit similar 
distortion of the amide bond. In other words, 153 is one of the most distorted amides 
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prepared to date. However, in contrast to 1-aza-2-adamantanone, which is embedded 
in a rigid adamantane structure and stabilized by three additional methyl groups, 153 
readily decomposes, which prohibits its use for synthesis and limits its suitability for 
study.   
The instability of 153 was supported by MS measurements. Thus, peaks 
corresponding to 153 could only be observed when acetone, CH2Cl2, or acetonitrile 
was used as a solvent for ionization in ESI MS experiments. The amide 153 was not 
detected when H2O, MeOH or MeOH/water/formic acid were used as diluents (Table 
14; note that tricyclic and bicyclic amides containing [4.3.1] ring system are detected 
in ESI MS when the above solvents are used for ionization). In addition, the carbonyl 
IR stretching frequency at 1730.5 cm-1 is also consistent with a significant degree of 
twist of the amide bond in 153.  
 
Table 14. ESI MS Experiments with Lactam 153.a 





1 CH3CN 216.1391 153 
2 CH2Cl2 216.1407 153 
3 CH3COCH3 216.1405 153 
4 THF - - 
5 H2O 234.1498 amino acid 
6 MeOH 234.1484; 248.1661 amino acid and the methyl ester 
7 MeOH/H2O/
HCO2H 
234.1484; 248.1635 amino acid and the methyl ester 
a Relevant HRMS calculations: HRMS calcd for C14H18NO (M+ + H) 216.1388 (153); 
HRMS calcd for C14H20NO2 (M+ + H) 234.1494 (amino acid of 153); HRMS calcd 
for C15H22NO2 (M+ + H) 248.1651 (methyl ester of amino acid of 153). 
94 
 
It is possible that 153 or a related [3.3.1] bridged amide could be isolated by 
crystallization (most likely after its N-protonation, in a manner similar to 2-
quinuclidone),26 however due to the limited synthetic value of 153 and the relatively 
lengthy synthetic route to 153, we did not attempt this.  
The significant change of stability in transition from [4.3.1] to [3.3.1] ring 
system of bridged amides is surprising, and suggests that the seven-membered ring 
secures the stability of one-carbon bridged amides. It is worthwhile to point out that 
all of the [4.3.1] amides described above could be easily purified by standard 
chromatography, are bench stable over long periods of time, and do not decompose in 
CDCl3189, 225 or in THF/D2O mixtures.54 Even the α-unsubstituted amide with a 
[4.3.1] scaffold, which is considerably less stable than α-substituted bridged amides, 
could be easily observed in THF/D2O mixtures (see Chapter 3). Based on the above, 
it seems likely that one-carbon bridged amides with bridges shorter than in [3.3.1] 
ring system (for example, [3.2.1] and [3.1.1] scaffolds) are too unstable to be isolated.  
Having discovered the instability of the [3.3.1] bridged amide, the focus of 
our study turned towards testing the stability of the isomeric [4.2.1] ring system. 
Williams reported that a number of substituted [4.1.1] bridged amides have a 
reasonable stability.114 We also hypothesized that the presence of a seven-membered 
ring in the unsubstituted [4.2.1] bridged system would enhance its stability (as 
compared to [3.3.1] system), allowing for its isolation and further manipulations.  
As before (Scheme 66), ethyl phenylacetate was advanced to the appropriate 
amino chloride 157 (Scheme 69). However, in contrast to the regioisomeric 146, the 
95 
 
SN2 displacement with bromide did not afford the desired product 158. Under 
standard reaction conditions the reaction did not proceed, while more forcing 
conditions led to the formation of lactone 159 as the major product. These results 
suggested that even if the bromide could be installed in this system, the subsequent 
cyclization to the eight-membered ring is unlikely to succeed. Molecular models 
showed that the backside attack at the chloride in 158 is prohibited by the steric 
arrangement of the phenyl and ester moieties. This result also explains low yields in 



































158 159  
 
To circumvent the above problem, we envisioned that a much smaller cyano 
group, serving as a latent carbonyl equivalent, would replace the ester (A value of CN 
= 0.17 kcal/mol, A value of CO2Me = 1.27 kcal/mol). To avoid halide elimination 
during the SN2 closing, Mitsunobu reaction would be used to cyclize the medium-









































In agreement with our design, nitrile permitted the SN2 displacement 
(161→162). However, the harsh conditions required for this reaction (NaN3, 10 
equiv, DMF, 90 °C, 6 h) emphasize the steric hindrance around the homoneopentyl 
carbon. Hydrogenation of 162 provided the primary amine, which was directly 
protected with the nosyl group. Interestingly, Staudinger reduction of 162 afforded 
the 5-membered lactam resulting from the cyclization of the amine into the nitrile. 
This potential for lactamization or lactonization during substrate preparation is a 
major shortcoming of the Fukuyama’s amine synthesis in this context. Overall, this 
approach requires careful choice of precursors and lengthy manipulations involving 
numerous changes of protective groups.  
Under the Mitsunobu conditions, the amino alcohol 164 was cyclized to the 
desired 165. However, we encountered two significant problems with this reaction. 
First, despite considerable optimization, the yield of the cyclization did not improve 
as compared to the direct SN2 displacement (Schemes 63 and 66). Secondly, the 
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separation of 165 from the hydrazine by-products was problematic. While the use of 
di-tert-butyl azodicarboxylate allowed for removal of di-alkyl hydrazine-1,2-
dicarboxylate by-product, the eight-membered 165 was always contaminated with 
varying amounts of 167 arising from the intermolecular attack of the hydrazine anion 
on 166 (Scheme 71). The formation of 167 emphasizes the difficulty in cyclization to 






























164 166  
 
Despite a low purity of 165, we attempted a number of further elaborations 
towards the precursor for the cyclization to the [4.2.1] bridged amide. However, the 
hydrolysis of the nitrile in the presence of nosyl group was unsuccessful. The 
DIBAL-H reduction afforded the aldehyde, but again it was inseparable from the 
aldehyde resulting from the reduction of 167. The above difficulties, combined with 
low yields of the cyclization reaction and chemoselectivity problems in the substrate 
preparation, led us to reconsider the synthetic approach to nitrogen-containing 




RCM cyclization. In the last fifteen years ring-closing metathesis has 
emerged as a reliable method for synthesis of nitrogen-containing heterocycles.247-251 
However, one of the areas that has been relatively underdeveloped is the synthesis of 
medium-sized nitrogen-containing heterocycles without conformational control. This 
is exemplified by the early work by Grubbs and coworkers, who demonstrated that 
cyclization to an eight-membered nitrogen-containing ring was possible only in the 
presence of the benzene functionality which rigidifies the system (Scheme 72).252 It is 
worth noting that for both enthalpic and entropic reasons eight-membered rings are 

























Despite a tremendous interest of organic chemists in RCM methodologies, 
manifesting in thousands of examples and applications, there are very few reported 
instances of efficient synthesis of nine and ten-membered ring systems containing 
nitrogen.247-251 Most of these are limited to rigidified scaffolds and specific cases. For 
example, cyclization to the nine-membered heterocycle in the Enders synthesis of the 
cripowellins aglycon150, 151 is permitted by the rigidifying nature of the amide and the 








Hiemstra’s example.254 Amino acid mimics prepared by Brimble255 and Lubell256 also 






























































A careful literature search revealed the examples in Scheme 73 to be the 
closest systems to those that we would target in the synthesis of precursors for the 
transannular cyclization. This limited precedence was the major reason why we did 
not pursue earlier the RCM avenue for the synthesis of medium-sized heterocycles. 
Although it seemed plausible that RCM could be used for preparation of rigidified 
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and stabilized systems, it was this modification that we wanted to avoid from the 
beginning of our approach. Having explored two other and better-precedented 
methods for the synthesis of medium-sized nitrogen-containing heterocycles with 
limited success, we turned our attention to the ring-closing metathesis. Gratifyingly, 
the cyclization to the model 9-membered ring system proceeded in excellent yields. 
Table 15 summarizes results of extensive optimization of the RCM reaction.257  
Grubbs 1 catalyst promoted the cyclization, however one equivalent was 
necessary to achieve full conversion (entry 1). Fürstner indenylidene catalyst258 had 
earlier proved to be efficient in cyclization to unsubstituted medium-sized nitrogen-
containing rings,204 however in our system it was not superior to other ruthenium 
catalysts (entries 2 and 3). Grubbs 2 and Hoveyda–Grubbs 2 catalysts performed 
efficiently in the reaction (entries 6 and 10). The ideal results were obtained in the 
presence of HG2 catalyst when argon was bubbled through the reaction mixture to 
facilitate ethylene removal or when the reaction mixture was simply opened to air 
(entries 13 and 14).259-261 It is of note that HG2 catalyst was superior to phosphine-
based catalysts.  
Typically, the RCM reaction was carried out in degassed, refluxing 
dichloroethane, however toluene could also be used as a solvent with no decreases in 
yield (entry 8, G2 catalyst). The catalysis was not inhibited by the close presence of 
carbamate groups (entry 7).262-264 In addition, the cyclization could be performed at rt, 
however much catalyst higher loadings were necessary to promote the reaction (entry 
9, G2 catalyst).  
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Interestingly, a direct comparison of the cyclization of amines 169 and 172 
substituted with tosyl and nosyl groups respectively, revealed that 169 undergoes 
cyclization more efficiently than 172 (entries 11 vs. 1, and 12 vs. 10). As expected, 
the low concentration was crucial to obtain a high yield of the 9-membered 
heterocycle (entry 18). The RCM was extended to a number of orthogonally protected 
ring systems, including easily removable carbamate functionalities (entries 15-17). 
Curiously, the DEPT spectrum of heterocycle 173 indicated the presence of 
four CH2 carbons instead of five. The structure of 173 was confirmed after 
hydrogenation of the double bond to afford 177, which displayed the expected 
spectroscopic characteristics (Scheme 75). In addition, 176 bearing nosyl instead of 
tosyl group exhibited the usual spectroscopic properties.  
 
Scheme 74 
Preparation of substrates for RCM reaction 
CO2MeMeO2C




(169) R = Ts, 75%
(170) R = Boc, 59%
(171) R = Cbz, 69%






















c = 0.003 M
169-172 (173) R = Ts
(174) R = Boc
(175) R = Cbz
(176) R = Ns  
entry diene catalyst mol % solvent T t conversiona yielda 
     [°C] [h] [%] [%] 
1 169 G1 100 DCM 40 26 >95 87 
2 169 F 50 DCM 24 25 60 54 
3 169 F 20 DCM 40 22 43 41 
4 169 G2 50 DCM 40 21 79 43 
5 169 G2 20 DCE 80 21 89 76 
6 169 G2 5 DCE 80 21 75 72 
7 169 G2c 5 DCE 80 21 75 69 
8 169 G2 5 toluene 90 21 80 72 
9 169 G2 40 DCM 24 48 >95 77 
10 169 HG2 5 DCE 80 21 85 81 
11 172 G1 100 DCM 40 21 66 58 
12 172 HG2 5 DCE 80 20 74 57 
13 169 HG2d 5 DCE 80 8 >95 87b 
14 169 HG2e 5 DCE 80 8 >95 95b 
15 172 HG2d 5 DCE 80 16 >95 93b 
16 170 HG2d 5 DCE 80 17 >95 85b 
17 171 HG2e 5 DCE 80 8 >95 89b 
18 172 HG2d,f 5 DCE 80 17 >95 66 
a Determined by 1H NMR. b Isolated yields. c With Ti(OiPr)4. d Argon bubbled 
through the reaction. e Open to air. f Run at 0.01 M. G1 = Grubbs catalyst 1, G2 













173 177  
 
With a number of differently N-substituted 9-membered heterocycles 
available, we were ready to test the key transannular cyclization to twisted amides. 
We were delighted to discover that deprotection and cyclization of the nosyl 
containing precursor 176 could be performed in a single operation to provide access 
to the model [4.3.1] bridged amide ring system (Scheme 76). In contrast to 139 
(Scheme 64), the cleavage of C–C bond was not observed, indicating a significant 
difference in stability between [3.3.1] and [4.3.1] ring systems. Lactam 178 displayed 













CH3CN, 60 °C, 2 h
176 178  
 
We have also determined that the Boc-containing precursor 174 could be used 
for synthesis of bridged amides although the use of Cbz carbamates could be 
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problematic. In the case of 175, deprotection and cyclization occurred easily but the 
amide proved to be too unstable to the hydrogenation conditions, giving the 




























Fully saturated 179 showed lower sensitivity to chromatography than 178 and 
could easily be obtained after standard purification on silica gel. This suggests that 
the internal double bond enhances reactivity of bridged amides with a [4.3.1] 
scaffold. Importantly, the three-step sequence (174→179) could be carried out 
without purification of intermediates, facilitating the synthesis of the saturated amide. 
As an alternative, 179 could be prepared from the nosyl precursor 176 by 
chemoselective hydrogenation of the double bond (Willkinson’s catalyst),265 followed 


















176 181 179  
 
To extend the sequential RCM/transannular cyclization strategy a number of 
dienes were subjected to the catalytic RCM reaction conditions to provide a family of 
medium-sized rings with varying distances between the amine and the ester groups 
(Scheme 79 and Table 16, step 1). In all cases RCM proceeded in very good yields; 
only one ring was obtained as a mixture of cis/trans double bond isomers (Table 16, 
entry 3). This study provides very rare examples of the successful formation of 9- and 
10-membered nitrogen containing ring systems with minimal conformational 
constraints by catalytic RCM.247-251 
Next, we determined the generality of the transannular cyclization reaction, 
and demonstrated that this transformation can be utilized for preparation of a number 
of twisted amide scaffolds (Table 16, step 2). When 195 was subjected to the 
previously developed conditions [4.2.1] twisted amide was formed in excellent 75% 
yield. Remarkably, the amide with [4.2.1] scaffold could be easily purified by PTLC 
showing much superior stability to the regioisomeric [3.3.1] ring system. Thus, a 














(183), n = 1, 70%
(184), n = 2, 75%



























(191), R = Me, 84%
(192), R = Ph, 69%
(193), R = Me, 72%
(194), R = Ph, 65%
189, R = Me








Extending the larger ring by one carbon had a minor effect on the cyclization 
rate. Thus the [5.2.1] lactam was obtained in 85% yield (Table 16, entry 2). Although, 
the cyclization of compound 197 was found to be sluggish under initially developed 
conditions, the [5.3.1] bridged amide could be generated by treatment with DBU after 
deprotection (Table 16, entry 3). Although, malonate could not be used for 
preparation of the [4.4.1] ring system, replacement with phenyl acetate to prevent 
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decarboxylation pathways allowed for preparation of the desired compound. The 
experiment in entry 7 was performed to explore the effect of the leaving group on 
cyclization reaction. Replacing methoxide (pKa = 15) with phenoxide (pKa = 10) 
dramatically increased the yield of the transannular cyclization, delivering the twisted 
amide in excellent 86% yield. 
 










Ns HG 2, 5 mol% PhSH, Cs2CO3
CH3CN, 60 °C, 2 h







183-194 195-201 202-207  











1 183 (1, 1) 195 202 CO2Me [4.2.1] 90/75  
2 184 (1, 2) 196 203 CO2Me [5.2.1] 94/85 a 
3 186 (2, 2) 197 204 CO2Me [5.3.1] 90/64 b, c 
4 185 (1, 3) 198 205 CO2Me [6.2.1] 92/41 d 
5 188 (3, 1) 199 206 CO2Me [4.4.1] 79/0  
6 193 (3, 1) 200 207 Ph [4.4.1] 76/33 e 
7 194 (3, 1) 201 207 Phf [4.4.1] 60/86 g 
a Step 2 run for 13 h. b Compound 197 obtained as 5:1 mixture of Z/E isomers. c Step 
2: (i) PhSH, Cs2CO3; (ii) DBU, PhMe, 200 °C, 3 h. d Step 2: (i) PhSH, Cs2CO3; (ii) 
DBU, PhMe, 180 °C, 12 h. e Step 2: (i) PhSH, Cs2CO3; (ii) DBU, PhMe, 220 °C, 10 




As a testament to the efficiency of this methodology, we demonstrated that the 
RCM/deprotection/cyclization reactions could be combined in a one-pot process to 
deliver a previously inaccessible [5.2.1] ring system from a very simple acyclic 


















184 203  
 
Another advantage of the sequential RCM/transannular strategy is the ease of 
preparation of the diene precursors for the RCM reaction. In most cases the required 
dienes are synthesized in 2-3 steps from commercially available materials (Scheme 
79). In contrast to the Fukuyama’s amine synthesis, often plagued by undesired side-
reactions during the preparation of precursors, the dienes are chemically inert until 
the RCM step. This property bodes well for the use of this methodology for synthesis 
of bridged amides with diverse substitution patterns. The overall synthesis of the 
lactam 178 featuring a [4.3.1] scaffold proceeds in four steps from dimethyl allyl 
malonate, matching the efficiency of the Schmidt reaction in the synthesis of the same 
type of bridged amides. 
The examination of different ring systems allowed us to determine the relative 
rates of the transannular amidation reactions. Tables 17 and 18 show the conditions 
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utilized for cyclization of the most difficult to close ring systems. The closure to 
[5.3.1] system was sluggish in refluxing toluene (Table 17, entry 5). The optimum 
results were obtained upon short exposure to high temperatures (entry 9). However, 
the reaction time had to be carefully controlled to prevent decomposition (entry 7). 
The cyclization to the isomeric [4.4.1] system was even more difficult. With dimethyl 
malonate, conversion was not observed in refluxing toluene, and decomposition 
occurred at higher temperatures (Table 18, entry 3). With methyl phenyl acetate, the 
cyclization proceeded between 200 and 220 °C (entries 4 and 5). The facility of the 
closure could be dramatically improved by using a better leaving group (entry 7). The 
above results suggest that the relative rates for the transannular cyclization reaction 
are in following order: [4.2.1] > [4.3.1] > [5.2.1] > [5.3.1] > [6.2.1] > [4.4.1].  
 








entry base solvent T [°C] t [h] conversion [%]  
1 Cs2CO3 CH3CN 60 3 <5 
2 Cs2CO3 Toluene 110 1 <5 
3 Cs2CO3 CH3CN 150 1 <5 
4 NaH THF 60 14 <5 
5 DBU Toluene 110 17 6 
6 DBU Toluene 110 48 24 
7 DBU Toluene 140 24 >95b 
8 DBU Toluene 180 3 46 
9 DBU Toluene 200 3 >95c 
10 DBU THF 180 3 23 
a Determined by 1H NMR. b Isolated in 20%. c Isolated in 65%. 
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entry R1 R2 base solvent T [°C] t [h] conversion [%]
1 CO2Me Me DBU Toluene 110 2 <5 
2 CO2Me Me DBU Toluene 180 12 <5 
3 CO2Me Me DBU Toluene 220 5 decomp. 
4 Ph Me DBU Toluene 200 20 <5 
5 Ph Me DBU Toluene 220 10 60b 
6 Ph Ph Cs2CO3 Cs2CO3 60 2 5 
7 Ph Ph DBU Toluene 110 16 >95c 
a Determined by 1H NMR. b Isolated in 34%. c Isolated in 86%. 
 
 
Using RCM/transannular cyclization strategy we attempted to prepare two 
additional scaffolds of bridged amides, the relaxed [5.4.1] system (Scheme 81) and 
strained [5.1.1] system (Scheme 82). In both cases RCM reactions proceeded 
uneventfully. However, transannular lactamization to [5.4.1] system did not occur 
(only the starting material was observed by NMR), while the [5.1.1] system behaved 
similarly to the α-unsubstituted [3.3.1] scaffold (Scheme 62, decomposition 
depending on temperature). Both of these systems should be accessible when a better 
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Having prepared six different ring systems of bridged amides, we briefly 
explored the influence of strain on the properties of these compounds. We chose 
hydrogenation reaction as a test reaction. Previously we reported that some twisted 
amides undergo an unprecedented C−N cleavage reaction under mild hydrogenolysis 
conditions.31 When twisted amides prepared in the current study were subjected to 
standard hydrogenation conditions, [4.3.1] and [4.4.1] systems showed the highest 
reactivity, participating in C−N cleavage to afford the corresponding monocyclic 
amides (Scheme 83a). In contrast, [4.2.1], [5.2.1], [5.3.1] and [6.2.1] scaffolds were 
less reactive, undergoing only the traditional reduction to the saturated analogues 
(Scheme 83b, only products shown). As expected, allylic olefins are more susceptible 
to hydrogenolysis than isolated π bonds; the control reactions with saturated amides 
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179 and 37 bearing [4.3.1] ring system resulted only in the recovery of starting 
materials. It should be noted, however, that the only other bicyclic amide that had 
been previously noted to participate in the C−N cleavage reaction so far also contains 
an internal double bond (53, hydrogenation under high pressure). Possibly, the 
presence of internal olefin increases the strain and hence the reactivity of bicyclic 
bridged amides (see also Schemes 77 and 78). Interestingly, when hydrogenation of 
[4.4.1] ring system was carried out in the presence of Willkinson’s catalyst, the amide 
bond remained intact (Scheme 83c).  
Intriguingly, the reactivity of twisted amides in the hydrogenation reaction 
does not follow the trend predicted from the cyclization rates to twisted amides and 
from the comparison of spectroscopic properties of these compounds (see Table 19). 
These results suggest that the N–C cleavage reaction of distorted lactams depends 
more on the alignment of the bond that is being cleaved relative to the amide C=O 
































































One of the goals of our study was to obtain a family of bridged amides with 
varying ring systems to allow systematic investigation of the twist influence on 
spectroscopic properties of bridged lactams.38 Although most of the amides prepared 
so far do not contain perfectly orthogonal amide bonds, these compounds exhibit 
more downfield shifts in 13C NMR spectrum and higher stretching frequencies in 
infrared spectrum corresponding to the amide bonds (Table 19). This is consistent 
with a considerable degree of twist and ketone-like character of these amides. As 
expected, some of the relaxed ring systems have spectral properties close to those of 
the fused amides.  
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Interestingly, the infrared stretching frequencies of one-carbon bridged 
lactams cover a spectrum that starts in the range for planar amides (entry 6), and ends 
close to that of a traditional ketone (entry 1). This suggests that the family of one-
carbon bridged amides is well-suited for the systematic evaluation of the effect of 
geometry on properties of amide bonds.  
 
Table 19. Comparison of Spectroscopic Properties of Saturated Lactams.  
entry lactam α-substituent ring system C=O 13C NMR IR νC=O 
    [ppm] [cm-1] 
1 215 CO2Me [4.2.1] 183.4 1716 
2 216 CO2Me [5.2.1] 180.1 1693 
3 218 CO2Me [6.2.1] 173.4 1685 
4 179 CO2Me [4.3.1] 181.0 1679 
5 217 CO2Me [5.3.1] 176.6 1647 
6 214 Ph [4.4.1] 186.3 1643 
7 37 Ph [4.3.1] 184.4 1668 
8 153 Ph [3.3.1] 199.5 1730 
9 27 Pha [5.3.0] 172.4 1635 
10 219 CO2Etb [5.3.0] 173.2 1630 
a Reference 188. b Reference 173.  
 
It is likely that the RCM/transannular strategy could also be applied for the 
preparation of a set of distorted amides with varying distortion parameters. This in 
turn, will allow for the systematic investigation of the strain influence on the chemical 
and biological properties of amide bonds.  
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Oxidative cyclization approach. In an effort to improve synthesis of 
distorted lactams, we briefly examined the possibility of using radical cyclizations as 
a method for preparation of one-carbon bridged amides.  
Although only bridged lactams with relatively relaxed ring systems could be 
prepared by direct SN2 displacement (e.g., the [6.3.1] ring system),27 we expected that 
a radical cyclization might overcome the inherent strain associated with the formation 
of bridged amide bonds. It is well precedented that manganese (III) acetate-mediated 
radical cyclizations266 and oxidative enolate couplings267-269 can be used for synthesis 






































However, when we subjected β-amidoesters with pendant olefins to the 
manganese acetate-mediated radical cyclization, only α-hydroxylated products were 
obtained. Clearly, the radical was unable to react with the olefin and was instead 
eventually trapped by acetate or oxygen. This suggests that the cyclization to bridged 
amides cannot occur due to a large distance between the radical and the olefin 
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Similarly, attempts to prepare bridged amides by oxidative enolate coupling 
resulted in complex mixtures, arising from side reactions of the radicals (Scheme 86). 






















Having in sight more viable routes to bridged amides, we did not further 
pursue the oxidative cyclization approach. However, these results emphasize the 
difficulty in synthesis of bridged lactams as compared to other strained systems which 
do not contain bridged amide moieties.   
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Summary. Synthesis of one-carbon bridged amides using different 
approaches has been investigated. Electrostatic cation–π control between aromatic 
ring systems and the leaving diazonium cation in the intramolecular Schmidt reaction 
provides efficient access to amides with [4.3.1] ring systems. This reaction occurs by 
the uncommon migration of the distal C–C bond relative to the reactive ketone. The 
selectivity of the rearrangement depends on the electron density on the aromatic ring 
system. The reactive conformation of the azidohydrin intermediate must be locked to 
prevent the exclusive migration of the C–C bond proximal to the ketone.  
Electrostatic cation–n control between the lone pair of electrons on the 
heteroatom and the diazonium cation in the Schmidt reaction also provides access to 
bridged amides with [4.3.1] and [5.3.1] ring systems. This method does not require a 
locked conformation of the azidohydrin intermediate, significantly expanding the 
scope of the Schmidt reaction in the synthesis of bridged lactams. In addition, a 
thiomethyl substituent, which is used as a directing group, can be readily modified to 
furnish additional examples of twisted amides, following initial ring expansion.  
In addition to providing access to one-carbon bridged amides, which are very 
difficult to synthesize using alternative routes, another highlight of the Schmidt 
methodology is the application of electrostatic cation–π and cation–n interactions to 
control the regiochemistry of this reaction. The synthesis of bridged amides from 
conformationally flexible ring systems constitutes one of the first examples of 
utilizing cation–n effect in organic chemistry.   
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Transannular cyclization strategy has been found to allow synthesis of bridged 
amide scaffolds not available by the Schmidt reaction. The major difficulty in this 
approach is the synthesis of appropriately functionalized medium-sized heterocycles 
to serve as precursors to bridged amides. The initial route relied on Fukuyama’s 
amine synthesis and permitted the synthesis of a bridged amide with [3.3.1] scaffold. 
This amide contains one of the most distorted amide bonds prepared to date.  
The application of ring-closing metathesis allowed for significant 
improvements in the synthesis of nitrogen-containing heterocycles set up for the 
cyclization step to bridged lactams. The following transannular condensation has 
been successfully applied to the preparation of six different ring systems of one-
carbon bridged amides. These compounds, as evidenced by their spectroscopic 
properties, span a wide range of amide bond distortion. Depending of the geometry of 
the amide bond, the hydrogenation of bridged amides provides fully saturated 
analogues or results in hydrogenative cleavage of C−N bond.  
Overall, both the Schmidt reaction and the transannular cyclization 
approaches have been shown to provide general routes to one-carbon bridged amides. 
As a result of this work a variety of bridged amide systems is now accessible, some of 
them by alternative methods. This will allow for a systematic study of the twist 
influence on chemical and biological properties of amide bonds. In addition, the 
lower limits for the scaffold-dependent stability of one-carbon bridged amides have 




Reactivity of Medium-Bridged Twisted Amides 
 
As described in the introductory chapter, due to the limited conjugation of 
amide bonds, distorted amides exhibit reactivity dissimilar to traditional amides. In 
general, C=O group is more electrophilic than in planar amides, while nitrogen, 
depending on the twist of the amide bond, might behave as a basic amine. Despite the 
considerable synthetic potential of these amides, there are very few reports addressing 
the reactivity of bridged amides. Indeed, the reader may note that all known examples 
are presented in the introductory chapter. Furthermore, the fundamental question of 
just how much distortion is necessary for the shift from the amide-like to the keto 
amine-like reactivity of amide bonds has remained largely unanswered.  
The discovery that the intramolecular Schmidt reaction affords tricyclic and 
bicyclic bridged amides with [4.3.1] scaffold provided us with the opportunity to 
explore the properties of bridged amides in which the amide bond is almost exactly 
half-way rotated. The initial studies of Aubé’s group focused on a novel C−N bond 
cleavage reaction, clearly demonstrating that synthetic potential of bridged amides 
extends far beyond the enhanced reactivity towards hydrolysis (Scheme 30).31 
Furthermore, Lei and Aubé189 discovered a number of intriguing reactions of bridged 
lactams, including the isolation and the first crystallographic characterization of N-
protonated amides, synthesis of isolable hemiaminals upon reduction of tricyclic 
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amides with mild NaBH4, and the collapse of hemiaminal corresponding to amide 53 
with the cleavage of an unactivated C–C bond (Schemes 31 and 32).  
Accordingly, we were interested in further expanding the scope of reactivity 
of bridged amides. First, we wished to investigate whether the unique placement of 
nitrogen next to a heteroatom in a bridged twisted amide could deliver compounds 
that cannot be prepared from unstrained lactams. Secondly, we wished to further 
examine nucleophilic addition reactions to the carbonyl group and electrophilic 
activation of the nitrogen, with the major goal of identifying the border of the keto 
amine-like reactivity of bridged amides. However, the study that would lay the 
foundations for investigation of reactivity of bridged amides was the examination of 
hydrolytic stability of one-carbon bridged amides.54 
 
Hydrolytic stability of one-carbon bridged amides. Due to the limited 
nN→π*C=O donation (with resulting enhanced electrophilicity of the amide carbonyl 
group), the vast majority of bridged amides is unstable to aqueous conditions. This 
hydrolytic instability is the major factor complicating the synthesis and isolation of 
some of the more distorted bridged amides and has prevented a thorough 
investigation of the properties of bridged lactams.11 Comparison of the rate constants 
for hydrolysis of 2-quinuclidone derivatives with the notoriously unstable β-lactam 
antibiotics underscores the difficulty of synthetic manipulations with bridged amides 
(Table 1).  
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While very few bridged amides are both reactive electrophiles and stable in 
protic nucleophilic solvents,81, 167 the hydrogenolysis study of one-carbon bridged 
amides (Scheme 30, typically performed in MeOH or EtOH) suggested that one-
carbon bridged lactams do not readily decompose upon exposure to alcohols. In a 
preliminary investigation, Lei and Aubé demonstrated that incubation of tricyclic 
amides at different pH conditions resulted in the recovery of the parent amides, 
suggesting unprecedented levels of hydrolytic stability.189 Now, we wished to 
examine the stability of one-carbon bridged amides in greater detail, aware that 
elucidation of limits of the hydrolytic stability would also facilitate the study of other 
chemical properties of one-carbon bridged amides. 
Our investigation started with a set of simple extraction experiments of the 
tricyclic amide 229, readily available from the Diels-Alder/Schmidt reaction sequence 







































Initial studies were carried out using acetonitrile as a solvent due to a good 
solubility of 229 in this solvent. Thus, samples of 229 were dissolved in acetonitrile 
and either water or an aqueous solution of NaOH or HCl was added to afford ca. 4:1-
24:1 CH3CN:aqueous solution ratio (Table 20 entries 1-3). This was vigorously 
stirred for ca. 20 h and extracted with ethyl acetate. A typical twisted amide 
(including bridged amides with a twist angle much lower than that corresponding to 
229; see Table 1) would be expected to exclusively afford amino acid following 
treatment with such conditions. However, unchanged 229 could be recovered in high 
yield from the above experiments. In addition, samples of 229 could be directly 
recovered from strongly acidic solutions without prior neutralization of the reaction 
mixtures.  
We found that the reaction time could be extended to one week under acidic 
conditions (entry 4), and the temperature increased to 80 °C under basic conditions 
(entry 5) with no changes in recovery levels of 229. The only irreversible chemical 
reaction occurred when 229 was heated to reflux in HCl/acetonitrile mixture (entry 
6). However in this case, the cleavage of the C−N bond adjacent to the amide bond 
occurred, while the amide bond remained intact. This reaction resembles the cleavage 
of the C−N bond upon hydrogenation of tricyclic amides and highlights the unusual 




Table 20. Extraction Studies of Lactam 229.  
entry conditionsa time, temp result 
1 1:4 H2O/CH3CN 20 h, rt >85% recovery of 229 
2 1:8 aq NaOH/CH3CN (pH ca. 14) 20 h, rt >85% recovery of 229 
3 1:24 aq NaOH/CH3CN (pH ca. 14) 22 h, 80 °C >80% recovery of 229 
4 1:8 aq HCl/CH3CN (pH ca. 1) 20 h, rt >80% recovery of 229 
5 1:8 aq HCl/CH3CN (pH ca. 1) 8 days, rt >85% recovery of 229 
6 1:24 aq HCl/CH3CN (pH ca. 1) 23 h, 80 °C conversion to 232b 























































The recovery of 229 is consistent with two scenarios. The one-carbon bridged 
amide linkage could be thermodynamically stabilized in the medium-sized 
heterocycle. Thus, the dissolution of 229 in an aqueous environment would result in 
reversible hydrolysis, with re-closure to the parent amide occurring during the 
extraction with organic solvents. Alternatively, the amide bond in 229 could be 
kinetically stabilized towards hydrolysis. Some of the species that could be present 
upon treatment of 229 with acidic or basic conditions are presented in Scheme 87. 
 To address the question of thermodynamic or kinetic stability of 229 we 
performed a set of NMR experiments. Thus, 229 was dissolved in THF-d8, treated 
with D2O, DCl or NaOD, respectively, and the solutions were examined by NMR 
(Scheme 88). The resonance of the carbonyl group in 13C NMR provided the most 
useful information about the species present in the solution (Figure 16 and Table 21). 
The chemical shift of the signal corresponding to the carbonyl group in CDCl3 
appears at 187 ppm and at 185 ppm in THF-d8 (Figure 16a and Table 21). Upon 
dissolution in 1:1 D2O/THF-d8 this signal moves slightly downfield to 189 ppm 
(Figure 16b), while the rest of spectrum bears a close similarity to the spectrum of 
229 in CDCl3. The broadening of the carbonyl signal observed in Figure 16b most 
likely results from hydrogen bonding to water and is typically observed for aqueous 















































Figure 16. 13C NMR spectra of compound 229 in (a) CDCl3, (b) 1:1 D2O:THF-d8, (c) 







Table 21. 13C NMR Carbonyl Shifts of Lactam 229 and Its Derivatives. 
entry conditions assignment shift [ppm] 
1 CDCl3 229 187.1 
2 THF-d8 229 185.0 
3 DMSO-d6 229 186.2 
4 1:1 D2O/THF-d8 229 189.6 




6 1:6 DCl (1 N in D2O)/DMSO-d6 232 (conjugate acid) 





7 1:6 NaOD (1 N in D2O)/THF-d8 232 (conjugate base) 182.3 
8 1:6 NaOD (1 N in D2O)/DMSO-d6 232 (conjugate base) 179.0 
9 CDCl3 229 176.9 
 
 
In contrast, at pH ca. 1, several species were observed by 13C NMR. We 
assigned the predominant peak in the THF-d8 solution at 178 ppm to the N-protonated 
form of 232 (Scheme 87 and Figure 16c), and the minor peak observed at 106 ppm to 
the hydrate 229•H2O, also protonated at nitrogen (Table 21, entry 5). Interestingly, 
when 229 was dissolved in DMSO-d6 at pH ca. 1, in addition to the same two species 
observed in THF-d8, the N-protonated form of 229 was present (Table 21, entry 6). 
The shift of 176.9 ppm is in very good agreement with fully characterized N-
protonated salts of tricyclic lactams.189  
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At pH ca. 14, the carbonyl signal of 229 was replaced by an upfield resonance 
at 182 ppm. In this case, the most reasonable assignment is the conjugate base of the 
amino acid 232 (Scheme 87). This assignment is consistent with values observed for 
simple carboxylic acids (for example, the carbonyl of acetic acid in CDCl3 appears at 
178.1 ppm and the corresponding signal for the conjugate base is at 181.5 ppm in 
aqueous solution).270  
The presence of various species arising from 229 under highly acidic and 
basic conditions was supported by mass spectrometry measurements taken from 
samples prepared as described above (Table 22). Aliquots from each experiment were 
diluted by the solvents indicated in Table 22 to prepare them for ionization. Thus, 
only the starting lactam 229 was observed in samples dissolved in D2O/THF (entries 
1 and 2). Note a remarkable difference in stability between 229 and the lactam 153 
with [3.3.1] ring system (Table 14). Under basic conditions (entries 3-6) the parent 
lactam 229 or the corresponding amino acid 232 is observed, depending on the 
solvent used for ionization. Samples of 229 dissolved under acidic conditions (entries 
7-10) indicated the presence of both 229 and 232. The ratio 229/232 was also 
dependent on the solvent used for ionization, with higher contribution of 229 
observed when water was used as a diluent vs. either THF or acetonitrile. In addition, 
the methyl ester of 232 was observed when samples for MS experiments were 
prepared by dissolution with MeOH/water/aqueous formic acid mixtures (entry 9).  
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Table 22. ESI MS Experiments with Lactam 229.a  
entry conditions solventb  exact mass  assignments 
1 1:1 D2O/THF THF 346.0818 229 
2 1:1 D2O/THF H2O 346.0797 229 
3 1:6 NaOD (1 N in D2O)/THF THF 346.0856 229 
4 1:6 NaOD (1 N in D2O)/THF CH3CN 346.0792 229 
5 1:6 NaOD (1 N in D2O)/THF H2O 364.0918 232 
6 1:6 NaOD (1 N in D2O)/THF DMSO 364.0920 232 
7 1:6 DCl (1 N in D2O)/THF THF 346.0752; 
364.0903 
(ratio ca. 1:1) 
229 and 232 
8 1:6 DCl (1 N in D2O)/THF H2O 346.0722; 
364.0913 
229 and 232 




(ratio ca. 3:1) 
229 and the 
methyl ester 
of 232 
10 1:6 DCl (1 N in D2O)/THF CH3CN 346.0776; 
364.0916 
(ratio ca. 1:1) 
229 and 232 
a Relevant HRMS calculations: HRMS calcd for C18H21BrNO (M+ + H) 346.0806 
(compound 229); HRMS calcd for C18H23BrNO2 (M+ + H) 364.0912 (compound 
232); HRMS calcd for C19H25BrNO2 (M+ + H) 378.1069 (methyl ester of compound 
232). b Solvent used for ionization. 
 
 
Overall, NMR and MS data obtained with lactam 229 are consistent with both 
kinetic and thermodynamic stability of 229 at neutral pH. When 229 is subjected to 
strong acid or base the hydrolysis occurs, but remarkably the bridged amide bond is 
able to spontaneously reform even in a medium saturated with water.  
We made considerable efforts to retrieve the samples of zwitterions 232 by 
concentrating the aqueous solutions (prepared under acidic and basic conditions) and 
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examining the residues by NMR and IR. However, only the starting lactam 229 was 
observed in these experiments, strongly suggesting that simple removal of water is 
sufficient to move the equilibrium back to the lactam 229.  
Interestingly, although the species arising from 229 are present in solution for 
a considerable period of time (see Experimental Section for details), the parent lactam 
229 crystallized spontaneously from the NMR sample at pH = 14 (structure 
confirmed by X-ray crystallography),54 suggesting that the bridged amide is the 
thermodynamically favored compound in the equilibrium. Selected recovery and 
NMR experiments were repeated with tricyclic amide 230, which behaved identically 
to the lactam 229, confirming that the properties of tricyclic amides are general.  
Having investigated the stability of tricyclic amides, we investigated 
hydrolytic properties of some bicyclic analogues. Of particular interest was the role of 
conformation in constraining the nine-membered amino acid. Open-form species 
arising from tricyclic amides (for example 232) exhibit in/out isomerism271 around 
the six-membered ring, which likely contributes to holding the carboxylic acid in a 
close proximity to the amino group, facilitating the closure to the parent lactam.  
Thus, a bicyclic lactam 53 was treated with D2O/THF-d8 solutions at neutral, 
acidic and basic conditions. A direct observation of the samples by 13C NMR 
spectroscopy indicated a behavior identical to the tricyclic 229 (no reaction under 
neutral conditions, hydrolysis to the amino acid at pH ca. 1 and 14). However, when 
we attempted recovery studies of the bicyclic 53, the parent lactam could be re-
isolated only after treatment with 1:4 H2O/acetonitrile mixtures. The lactam 53 could 
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not be recovered after exposure to aqueous solutions (pH ca. 1 and 14), in a manner 
analogous to the described for tricyclic 229. Similarly, recovery of other bicyclic 
amides (233, 3, 34 and 35) was also attempted but these compounds could not be re-
isolated from strongly acidic or basic conditions. These results suggested that the 
additional six-membered ring in the tricyclic lactams enhances the thermodynamic 
stability of one-carbon bridged amides.  
Although the exposure of lactam 3 to strongly acidic and basic conditions did 
not permit its recovery, the removal of solvent afforded a quantitative yield of the 
amino acid 237 (Scheme 89). The X-ray crystallography54 established that this 
compound was able to undergo conformational change, in which the carboxylic acid 
has flipped outside of the nine-membered heterocycle and is unable to reach the 
amide group. Thus, conformation is crucial in the reversibility of the amide bond 


















Next, we investigated the limits of the kinetic stability of these bicyclic 
bridged lactams (Table 23). Although the α-unsubstituted amide 3 exhibited good 
stability in neutral solutions (entry 1), it underwent irreversible conversion to amino 
acid under moderately acidic (pH ca. 4) or basic (pH ca. 10) conditions. However, α-
aryl-substituted amides 34 and 35 could be completely recovered after the exposure to 
aqueous solutions where pH = 4, 7 or 10 (entries 4-6). Importantly, the lactam 58 
substituted with α-methylthio group and lacking the tert-butyl substituent was fully 
water-soluble, which allowed its study in aqueous solutions at pH = 4, 7 and 10 
(entries 7-9). Under all of these conditions 58 was kinetically stable. Additionally, the 
stability of 58 was demonstrated by comparison of its 13C NMR spectra recorded in 
CDCl3 and D2O (Figure 17), which are very similar to each other. To the best of our 
knowledge lactam 58 represents the first example of a significantly distorted bridged 
amide that is both stable and soluble in water.11  
 
Table 23. Extraction Studies of Bicyclic Lactams. 
entry lactam solvent time, conditions result 
1 3 1: 1 D2O/THF-d8 13 d, rt ca. 50% recovery of 3 
2 3 aq HCl (1.0 N) 0.25 h, rt conversion to 237 
3 3 aq NaOH (1.0 N) 3 h, rt conversion to 237 
4 35 1: 1 D2O/THF-d8 7 d, rt >95% recovery of 35 
5 34 buffer (pH 4)/CH3CN 2 h, rt >90% recovery of 34 
6 34 buffer (pH 10)/CH3CN 2 h, rt >90% recovery of 34 
7 58 D2O 6 d, rt >95% recovery of 58 
8 58 buffer (pH 4) 2 h, rt >90% recovery of 58 





Figure 17. 13C NMR spectra of lactam 58 in (a) CDCl3 and (b) D2O.  
 
Overall, these results indicate that incorporation of the amide carbonyl into a 
one-carbon bridge situated across a medium-sized heterocycle results in an enhanced 
hydrolytic stability of twisted amides. Inherent distortion parameters of amide bonds 
(for example, [3.3.1] bridged amide 153) and scaffolding effects of particular ring 
systems (for example, tricyclic lactam 229) are additional factors that need to be 
considered in predicting hydrolytic stability of one-carbon bridged amides. 
Furthermore, α-substituted lactams are more hydrolytically stable than the α-
unsubstituted analogues.  
We believe that the hydrolytic stability of one-carbon bridged amides, 





structural diversification, will increase the range of biological and chemical studies 
available with lactams containing distorted amide bonds.  
Although it has been suggested that twisted amides could provide an attractive 
platform for the study of enzymatic processes,11 the previously available bridged 
amides were too unstable in water and/or insufficiently diversifiable to allow for their 
exploration in biological settings. One of the more intriguing potential biological 
applications of bridged amides would be as inhibitors of cis/trans isomerases (see 
Introductory Chapter).17, 18 Furthermore, with the knowledge that one-carbon bridged 
amides are stable under biologically relevant pH conditions, these compounds can 
serve as templates for enzymatic hydrolysis of amide bonds26, 41 and be used as 
scaffolds272-275 or conformationally constrained analogues128 in medicinal chemistry.  
Similarly, the investigation of chemical properties of twisted amides has been 
severely limited by their hydrolytic instability. However, the first examples of novel 
reactivity of amide bonds contained in distorted and hydrolytically robust one-carbon 
bridged amides have already emerged (see Scheme 30).31 Additional examples are 
presented in the next parts of the Chapter 3, and we expect that distorted amide bonds 




Proximity Effects in Nucleophilic Addition Reactions. The study of 
hydrolytic stability of one-carbon bridged amides clearly demonstrated that despite 
having significant twist values of their amide bonds, one-carbon bridged lactams are 
not hydrolyzed by nucleophilic solvents. This unusual (to twisted amides) property 
was ascribed to destabilization of the potentially formed carboxylic acid and amine 
functionalities by their placement on the opposite sides of the medium-sized ring, 
where they would be subjected to strong proximity effects.54 
The presence of transannular amine-carbonyl interactions in tetrahedral 
intermediates resulting from addition of nucleophiles to carboxylic acid derivatives 
was discussed in the introductory chapter. We wondered if the enhanced carbonyl 
reactivity of one-carbon bridged lactams unified with transannular proximity effects 
could be combined to allow for the isolation of stable tetrahedral intermediates. 
Preliminary results regarding the stability of hemiaminals derived from tricyclic 
amides reported by Lei and Aubé (Scheme 32)189 further suggested that one-carbon 
bridged amides would provide a useful platform for investigating tetrahedral 
intermediates. 
We began our study by examining the behavior of one-carbon bridged amides 
in addition reactions of hydride, the smallest available nucleophile (Table 24). In 
agreement with our hypothesis, treatment of the bridged bicyclic amide 34 with 
NaBH4 in EtOH led to the formation of stable hemiaminal 238 in excellent yield 
(entry 1). Since planar amides are typically not reduced by NaBH4,276 this 
transformation occurs due to the increased reactivity of the bridged amide bond. The 
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stability of 238 indicates that lone pairs of electrons at oxygen do not overlap with 
σ*C–N bond in the bicyclic hemiaminal system. Furthermore, since the reduction stops 
at the tetrahedral intermediate stage, the bridged nitrogen is incapable of donation of 
its n electrons into the σ*C-O, which would ordinarily led to the formation of the 
corresponding iminium ion. 
 
Table 24. Hydride Addition to One-Carbon Bridged Amides.  











1 (34), R1 = Ph, R2 = t-Bu 238 (90) 
2 (35), R1 = 4-MeOC6H4, R2 = t-Bu 239 (91) 
3 (40), R1 = 3,5-(MeO)2C6H4, R2 = t-Bu 240 (94) 
4 (39), R1 = 3,4-(OCH2O)C6H4, R2 = t-Bu 241 (95) 
















5 (3), R1 = H, R2 = t-Bu 242 (24) and 243 (52) 
6 (58), R1 = SMe, R2 = H 244 (40) and 245 (48) 












8 (84), R1 = SO2Me, R2 = H 248 (98) 




To examine the effect of structure on the stability of hemiaminals, the 
reduction was carried out on a number of related bridged amides (Table 24, entries 2-
9). Thus, bicyclic amides with electron-rich aromatic rings in the α-position smoothly 
underwent the reduction, providing isolable hemiaminals in all cases (Table 24, 
entries 2-4). Note that two tricyclic lactams previously reported by Lei and Aubé also 
provided stable hemiaminals (Scheme 32).189 However, analogous reactions of the α-
unsubstituted bridged amide and amides possessing heteroatoms α to the carbonyl led 
to mixtures of hemiaminals and primary alcohols (entries 5-7). The net result is the 
traditional cleavage of the C−N bond. Remarkably, reduction of bridged amides 
decorated with α-electron-withdrawing substituents afforded formamides (entries 8 
and 9). Note that these examples are analogous to the C–C cleavage with the bicyclic 
amide 53 (Scheme 32),189 however in the latter case it was unclear whether the anion 
was stabilized by the α-carbonyl group or by the internal double bond in 53. In all 
three cases the driving force in the collapse of hemiaminals is the formation of a 
stabilized anion. This transformation is unique in that it results in the cleavage of 
unactivated C−C bond. Overall, these results demonstrate that the identity of the α-
substituent strongly affects the stability of tetrahedral intermediates constrained in 





Using amide 34 as a model substrate, we also briefly investigated the role of 
the hydride source and reaction conditions on the formation of stable hemiaminals.277 
These results are summarized in Table 25.  
  











34 238  







1 NaBH4 EtOH 24 20 96 80:20 
2 NaBH4b MeOH 24 20 32c 86:14 
3 NaBH4/CeCl3 EtOH 24 20 31c 81:19 
4 LiBH4 EtOH  24 20 94 82:18 
5 LiAl(OtBu)3H THF 24 24 <5d nd 
6 L-Selectride THF 24 24 <5d nd 
7 LiAlH4 Et2O 24 5 99 82:18 
8 Red-Al PhMe 110 2 96 80:20 
9 DIBAL-H PhMe 110 2 97 81:19 
10 BH3 THF 66 24 47 74:26 
11 LiEt3BH THF 24 3 92e 84:16 
a Determined by 1H NMR; b 4-MeOC6H4 derivative was used; c Conversion; d Only 
starting material was observed by 1H NMR; e Combined yield of aminal and primary 
alcohol 250 (isolated in 38% and 54% yield, respectively); nd = not determined. 
 
Reaction of 34 with a number of different hydride sources afforded stable 
hemiaminal 238. Interestingly, the reduction with NaBH4 was found to be slower 
when methanol was used as a solvent (entry 2); typically, the reduction of carbonyl 
groups by NaBH4 proceeds more readily in MeOH than EtOH.278 Similarly, the 
reaction was suppressed when a combination of NaBH4 and CeCl3 was used (entry 
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3).279 Hydrogen bonding and coordination to the amide bond oxygen might be 
responsible for lower reaction rates in entries 2 and 3. Tributoxyaluminum hydride280 
and L-Selectride281 (entries 5 and 6) did not reduce 34, while LiAlH4,282 Red-Al and 
DIBAL-H283 smoothly provided hemiaminal 238 (entries 7-9). In contrast, 
LiEt3BH284 promoted the collapse of 238 to the aldehyde (entry 11), indicating that 
the outcome of the reduction of one-carbon bridged amides could also be modified by 
changes in reaction conditions.  
Importantly, when a higher homologue of 34 was reacted with NaBH4, no 
reduction was observed, indicating that this [5.3.1] scaffold is more similar in 










Reactions of bridged hemiaminals. Bridged hemiaminals are valuable 
synthetic intermediates and we explored their potential utility by performing a set of 
transformations. Noteworthy is the oxidation of 238 to the parent amide 34, full 
reduction to the amide 251 (proceeding via the intermediacy of rarely encountered 
bridgehead iminium ion)285-287 and preparation of protected hemiaminals 252 and 253 
as single diastereoisomers (stereochemistry not determined) (Scheme 91). We also 
determined that hemiaminal 238 readily epimerizes upon treatment with acids 
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(Scheme 92). This reaction could occur either via the intermediate bridged iminium 
ion 238a or through the acid-promoted opening to the aldehyde 238b with re-closure 
to the more thermodynamically favored isomer. Overall, the success of these 
reactions bodes well for synthetic applications of bridged hemiaminals derived from 



















239, R = 4-(MeO)C6H4








































238 238238a 238b  
141 
 
Having determined the stability of hemiaminals derived from hydride addition 
to one-carbon bridged amides, next we evaluated the stability of hemiaminals formed 
in the addition of more sterically demanding organometallic reagents (Table 26).  
 











34 254-257  
entry reagent conditionsa product (yield, %)
1 MeLi Et2O, -78 °C → rt, 3 h 254 (89) 
2 MeLi•LiBr Et2O, -78 °C → rt, 3 h 254 (85) 
3 n-BuLi Et2O, -78 °C → rt, 3 h 255 (83) 
4 sec-BuLi Et2O, -78 °C → rt, 3 h 256 (93) 
5 t-BuLi Et2O, -78 °C → rt, 3 h 257 (80) 
6 MeMgI Et2O, -78 °C → rt, 24 h 254 (73) 
7 TMSCH2Li  Et2O, -78 °C → rt, 3 h b 
8 PhLi Et2O, -78 °C → rt, 24 h c 
9 PhCCLi THF, -78 °C → reflux,  24 h b 
10 CH2CHMgBr THF, -78 °C → reflux, 20 h d 
11 MeMgCl THF, rt → reflux, 24 h e 
12 HCCMgBr THF, rt → reflux, 24 h b 
a The reactions were typically carried out with 3 equiv of the organometallic reagent. 
b Only starting material was observed by NMR. c <10% yield of the desired phenyl 
ketone, obtained as 1:2.5 mixture with aminal 238, 44% conversion. d Formation of 
the desired product not observed. Occasionally 238 was formed (presumably via 
radical reduction). e Complex mixture of products.  
 
Treatment of bicyclic amide 34 with MeLi afforded keto amine 254 (entry 1). 
Thus, an increase of the steric hindrance at the hemiaminal carbon results in the 
collapse of the tetrahedral intermediate. Similarly, the reaction of 34 with other 
reagents, including secondary and tertiary organolithiums furnished the 
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corresponding amino ketones (entries 3-5). While it was previously known that 
tertiary amides react with organolithiums,288-290 the addition of organometallic 
reagents to sterically congested bridged amide bonds is without precedent and results 
from the increased electrophilicity of  distorted lactams.  
We also determined that MeMgI could be utilized for transfer the alkyl group 
(entry 6), however TMSCH2Li (which is only slightly less nucleophilic than MeLi) 
was unreactive with 34 (entry 7). A number of other organometallic reagents were 
also tested, however the addition product was formed in low yield or was not 
observed (Table 26, entries 8-12). These results exemplify the difficulty of addition of 
organometallic reagents to the sterically hindered amide bonds.  
Interestingly, in the case of amide 34 the addition stopped at the ketone stage. 
Re-subjection of the aminoketone 254 to the reaction conditions did not result in the 
formation of the tertiary alcohol, suggesting that the steric hindrance around the 
quaternary carbon prohibits further addition of the organometallic reagent. However, 
it is also possible that the initially formed addition product persists in the reaction 
mixture prior to workup. In contrast, α-unsubstituted amide 3 undergoes partial 






















3 258 259  
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The instability of the bicyclic hemiaminals corresponding to amino ketones 
254−257, prompted us to examine the behavior of their tricyclic analogues. We 
reasoned that the six-membered ring attached to the bridged system could stabilize 
the closed hemiaminal, in a manner similar to the results observed in the hydrolytic 
stability studies (Scheme 87).54 Indeed, exposure of 230 to MeLi afforded 
hemiaminal 261 (Table 27, entry 1). Increased bulk close to the reactive amide bond 
did not influence the reaction and 260 led to the corresponding tetrahedral 
intermediate (entry 2). Remarkably, addition of a secondary organolithium also 
provided stable hemiaminals (entries 3 and 4). However, the tricyclic scaffolds were 
incapable of supporting hemiaminals substituted with tertiary carbon and instead 
ketones 265 and 266 were formed (Table 27, entries 5 and 6).  
 















R2 = Me, sec-Bu
favored when
R2 = t-Bu
(230) R1 = H 261-264 265, 266
(260) R1 = i-Pr
 
entry amide hemiaminal/ 
amino ketone 
R2 reagent yield [%] 
1 230 261 Me MeLi 95 
2 260 262 Me MeLi 92 
3 230 263 sec-Bu sec-BuLi 80 
4 260 264 sec-Bu sec-BuLi 88 
5 230 265 tert-Bu tert-BuLi 90 




The hemiaminals 261-264 exemplify some of the most sterically hindered 
tetrahedral intermediates isolated to date. Although, it is possible that these structures 
exist in equilibrium with the corresponding amino ketones the presence of the 
hemiaminal form is supported by NMR and IR spectra. The major species observed 
by NMR was characterized by the presence of a typical to hemiaminal 13C NMR 
resonance about 86-88 ppm. In addition, the ketone peak was not detected in 13C 
NMR. In only two instances were marginal peaks corresponding to the CO group 
visible in IR spectra (the presence of these peaks could also suggest that the 
hemiaminal and the amino ketone exist in a dynamic equilibrium).291 Although, in 
theory, equilibrium between hemiaminal and amino ketone was also possible in the 
transannular amino-tert-butylketones 265 and 266, in these cases only carbonyl peaks 
were observed. Overall, these results indicate that the steric contribution can override 
the inherent stability of tetrahedral intermediates provided by the scaffolding effects. 
We also determined that the tricyclic amide 260 affords a clean addition product in 
reaction with TMSCH2Li, indicating that nucleophilic addition reactions to bridged 
amides depend on the degrees of twist of the amide bond (see Table 36 for details).  
To compare the reactivity of distorted and planar amides we subjected 
selected fused amides (obtained as complementary products to the bridged amides in 
the Schmidt reactions) to analogous reactions with organometallic reagents (Scheme 
94). The reaction of planar bicyclic amide 267 with MeLi (3.0 equiv) afforded 
enamine 268 (Scheme 94a, the structure confirmed after reduction to 269, 
stereochemistry not determined). The dehydration292 was not general; for example, 
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addition of n-BuLi to 267 resulted in a complex mixture of products including 
starting material, ketone, enamine, and alcohol. Similarly, the reaction of a tricyclic 
fused amide 270 with MeLi afforded inseparable 3:1:1 mixture of enamine 271, 
ketone 272, and alcohol 273 (Scheme 94b). Subsequent reduction furnished amine 
274 (stereochemistry not determined). Furthermore, we determined that in the case of 
planar amides, the reaction time was longer than with the bridged lactams (for 
example, after 3 h of the reaction with MeLi, bridged 34 >95% conversion vs. fused 
267 ~70% conversion). Overall, these results exemplify the effect of the amide bond 













































Although, the hemiaminal corresponding to 254 (Table 26) was in equilibrium 
favoring the corresponding amino ketone, we hypothesized that the conformation of 
the 9-membered ring should favor the placement of the reactive nitrogen and ketone 
groupings on the same side of the ring. This hypothesis was confirmed when we 
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found that upon treatment of 254 with MeOD-d4, a transannular N
…C=O interaction 
took place (Scheme 95). Thus, the 13C NMR spectrum of 254 in chloroform exhibited 
one set of sharp signals, with a peak at 211 ppm corresponding to the methyl ketone 
carbonyl. Upon dissolution in methanol this signal was no longer present and other 
peaks were significantly broadened. We ascribed this phenomenon to the N…C=O 
interaction affording a pseudo-tetrahedral hemiaminal-type carbon, adopting a 
hybridization state between sp2 and sp3 (254a). Addition of DCl terminated the 
equilibrium, affording 9:1 mixture of protonated amino ketone 254b and hemiaminal 
254c. We determined that a similar interaction does not occur upon dissolution of 254 
in C6D6 and CD3CN. However in DMSO-d6 minor quantities of aminal 254c are 
formed. In addition, when more sterically hindered ketones 256 and 257 were treated 
with MeOD-d4 the transannular effect was not observed, indicating the role of steric 































The observation that N…C=O interaction is favored in polar media is in 
agreement with previous findings.209 This is, however, the first illustration of a 
continuum of change in a single system: from hemiaminal 238 (stable tetrahedral 
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intermediate) to amino ketone 254 (collapsing tetrahedral intermediate) through 
N…C=O interaction (254a, MeOD-d4). This picture also includes a progressive 
change from hemiaminals 261-264 (stable tetrahedral intermediates) to amino ketones 
265 and 266 (unstable tetrahedral intermediates). 
The difference in stability between the hemiaminal collapsing to amino ketone 
254 (Table 26) and the stable hemiaminal 261 (Table 27) could reflect the increased 
scaffolding effect gained by the presence of the additional cyclohexene ring in 261. 
However, it could also arise from a difference in distortion parameters of the two 
parent amides. We previously found that the tricyclic lactam 229 is characterized by 
twist angle τ = 51.5°,54 while a representative bicyclic lactam 35 is slightly less 
distorted, and characterized by τ = 43.2°.226 The influence of distortion parameters on 
the reactivity of bicyclic and tricyclic amides and comparison of their reactivity will 
be discussed in the final part of Chapter 3.   
Overall, these results demonstrate that tetrahedral intermediates formed in the 
addition of nucleophiles to one-carbon medium-bridged twisted amides exhibit 
remarkable proximity-induced stability. One-carbon bridged amides can serve as 
models to delineate the transition from stable tetrahedral intermediates, through 
N…C=O interactions, to unstable tetrahedral intermediates. The comparison of 
reactivity of bridged and planar lactams highlights the role of amide bond geometry 





Corey-Chaykovsky Reaction of Bridged Amides. The epoxide is one of the 
most useful functional groups in organic chemistry.293 Epoxides are essential 
structural motifs in many biologically active natural products. Due to the ease of 
opening, often with high regio- and enantiocontrol, epoxides have been utilized as 
versatile precursors in the synthesis of complex targets.294-298 Given the importance of 
this functional group, numerous researchers have been engaged in the application of 
novel heteroatom substituted variants of traditional epoxides. For example, alkoxy-
substituted epoxides developed by Danishefsky are especially useful as intermediates 
in carbohydrate synthesis.299-301 However, the analogous aminoepoxides have 
received much less attention, primarily since their stability is compromised by the 
nitrogen-assisted ring opening and polymerization.302-307 Very few examples of stable 


























Figure 18. (a) Examples of isolable aminoepoxides. (b) Common decomposition 




One attractive strategy to improve the stability of aminoepoxides is to limit 
the delocalization of nitrogen n electrons into a σ*C-O orbital. This can be achieved by 
incorporating the aminoepoxide into a rigid ring system. Such an approach was 
utilized by Stevens in a seminal examination of aminoepoxides,302-304 in which 
inherent strain of aziridines was exploited to inhibit the epoxide opening (Figure 18a, 
first two examples). However, this method was limited to aminoepoxides containing 
aziridine rings. A different approach would utilize basic scaffolds of bridgehead 
enamines and bridged amides, compounds that feature diminished conjugation 
between the nitrogen and C=C or C=O π systems. However, the oxidation of 
enamines can be complicated by competing N-oxide formation and elimination 
reactions.307 In addition, a very limited number of bridged enamines are known.  
In this context, epoxidation of much more easily-accessible bridged amides 
seemed to be a particularly attractive method, especially since we had already 
demonstrated that one-carbon bridged amides differ markedly in properties from 
planar amides and can undergo reactions more commonly associated with ketones 
rather than amides.308 
Our investigations began with amide 34, readily available from the 
intramolecular Schmidt reaction (Table 28). We found that when 34 was exposed to 
dimethylsulfonium methylide under Corey-Chaykovsky conditions,309-311 the spiro-
epoxyamine 275 was formed in excellent yield (Table 28, entry 2). Very importantly, 
the resulting aminoepoxide was stable to the reaction and chromatographic isolation 
conditions, and could be stored over long periods of time without detectable 
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decomposition. To the best of our knowledge, such a direct amide epoxidation 
reaction is without precedent. This transformation provided further evidence for the 
increased reactivity of the twisted amide carbonyl group, and a consequence of a 
limited overlap of the lone pair of electrons of the amide nitrogen and the carbonyl 
systems. In a similar vein, the decreased nN→σ*C-O delocalization is responsible for 
the stability of the aminoepoxide 275.  
 







Me3S I N Ph
t-Bu
O
0 °C → rt










a See experimental section for details. b Determined by 1H NMR.  
c Isolated yield. nd = not determined. 
 
Interestingly, the epoxidation proved to be very dependent on the 
concentration of the reaction (Table 1, entries 4 and 5). Even slight increases in the 
concentration led to the complete decomposition of the reaction components. In 
entry equiv time conc. conversion yield 
 NaH Me3SI [h] [M]a [%]b [%]c 
1 5.0 2.0 15 0.005 81 nd 






















6 7.0 2.5 18 0.004 >95 73 
7 7.0 2.5 19 0.005 >95 78 
8 7.0 2.5 18 0.003 >95 88 
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addition, monitoring of the reaction by NMR revealed a reaction t1/2 of ~ 5 h.
312 This is 
consistent with the initial fast addition of the methylide to the amide bond. We think 
that the resulting zwitterion exists in the equilibrium with the ring-opened 9-
membered heterocycle, which is destabilized due to a transannular interaction 




























We next examined the scope of this Corey-Chaykovsky reaction by varying 
the substituents and the ring systems of bridged amides (Table 29). Both substitution 
with a heteroatom in the α position and removal of the bulky tert-butyl group also 
permit isolation of spiro-epoxyamines in very good yield (entry 2). Remarkably, even 
the hydrolysis-sensitive α-unsubstitued bridged amide 3 could be used to deliver 
isolable aminoepoxide (entry 3). Although the thiomethyl analogue was incompatible 
with the polar solvent system, resulting in the polymerization of the aminoepoxide 
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product, we found that the use of modified conditions allowed for isolation of the 
sensitive epoxide 241 (entry 4). However, a carbon-higher homologue of 241 ([5.3.1] 
ring system) did not undergo the epoxidation reaction. Tricyclic amides can also be 
employed to access spiro-epoxyamines. Substitution with aromatic rings and 
protected alcohols is tolerated (entry 5 and 6). The double bond is not required for the 
reaction (entry 7). Finally, increased steric hindrance close to the reactive amide bond 
did not have any influence on the facility of aminoepoxide formation (entry 8). 
 
Table 29. Scope of the Corey-Chaykovsky Reaction. 








1 (34), R1 = Ph, R2 = t-Bu 275 (88) 
2 (73), R1 = SPh, R2 = H 276 (81) 
3 (3), R1 = H, R2 = t-Bu 277 (41) 










       
5 (229), R1 = H, R2 = 4-BrC6H4 281 (70) 
6 (279), R1 = H, R2 = (CH2)2OBn 282 (73) 
7 (280), R1 = H, R2 = Ha 283 (77) 
8 (260), R1 = i-Pr, R2 = H 284 (70) 





We have also attempted Corey-Chaykovsky epoxidations using a number of 
other sulfur ylides, including dimethylsulfoxonium methylide,309 diphenylsulfonium 
ethylide,313 diphenylsulfonium cyclopropylide,314 tetrahydrothiophenium 1-
carbomethoxylide315 and benzylide316, 317 under variety of conditions. However, the 
formation of the corresponding epoxyamines were not observed. In most cases, 
analysis of the reaction mixtures indicated only the presence of starting materials, 
although decomposition was also noticed in several instances. In these reactions, the 
addition of ylides to amide carbonyls is complicated by (1) lower nucleophilicity of 
the ylides relative to dimethylsulfonium methylide and (2) their decreased stability.312 
In such cases, the resulting zwitterions may sometimes be formed, however the 
zwitterions revert to the starting materials instead of undergoing the rearrangement to 
spiro-epoxyamines. Alternative routes to aminoepoxides, including addition of 
chloromethyl TMS318 and bromomethyl anions319 to bridged amides were 
unsuccessful. Given the stability of bridged aminoepoxides, epoxidation of now 
easily accessible bridged enamines (see Table 34) could provide an attractive 
alternative.  
As expected, the twist of amide bonds is important for the Corey-Chaykovsky 
reaction. As evidenced by spectroscopic properties, bridged amides having [5.3.1] 
ring are less distorted than amides having [4.3.1] ring system. The behavior of the 
latter scaffolds is consistent with less “amide-like” and greater “ketone-like” nature of 
the carbonyl group (see also Scheme 90).  
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A vital factor allowing for the epoxidation of one-carbon bridged amides is 
their superior hydrolytic stability as compared to other twisted amides, for example 2-
quinuclidone derivatives. Under Corey-Chaykovsky reaction conditions, 
quinuclidone-based twisted amides would be expected to undergo hydrolysis to 
amino acids or collapse after ylide addition. Transannular interactions between amine 
and ketone groups in these systems are much weaker than in 9-membered 
heterocycles, in which the ketone is placed at the carbon adjacent directly to the ring. 
Having established a general route to bridged spiro-epoxyamines, we probed 
the reactivity of this new class of compounds, using epoxide 275 as a test substrate. In 
particular, we were curious whether the reactivity of bridged aminoepoxides would 










































Among the most synthetically useful reactions of epoxides are ring opening 
under acidic, basic and reductive conditions.294 Thus, exposure of 275 to hydrochloric 
acid resulted in the selective epoxide opening at the less substituted carbon, however 
the following collapse of the bicyclic ring system is highly unusual (Scheme 97, 286). 
Treatment with bases led to a 1,2-hydride shift to provide unstable aldehyde 287. We 
think that in this case the epoxide opening is reversible due to a close proximity of the 
alkoxide and the methoxy leaving group, affording the thermodynamically favored 
product. The reduction of 275 resembled the opening under acidic conditions, 
involving the final collapse of the bicyclic aminal 287.  
The bicyclic structure can be retained, for example upon exposure to 
trifluoroacetic acid to give the aminodiol 288 or upon treatment with 
methanol/aqueous acid to furnish the aminohydroxy ether 289. Especially interesting 
is the stability of the latter (characterized by the resonance of the hemiaminal carbon 
at 96.5 ppm in 13C NMR). It suggests that when the XCH2 group (where X is an 
electronegative atom) is added to the bicyclic bridged amides instead of an alkyl 
group (see for example 287 or 255), the resulting hemiaminals do not collapse as 
readily to the corresponding open-form analogues.  
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Furthermore, we determined that aminoepoxides undergo reactions at nitrogen 
with preservation of the epoxide structure as exemplified by N-protonation with 













275 290  
 
The stability of bridged aminoepoxides allowed for a number of thermal 
manipulations to confirm their unusual reactivity profile (Scheme 99). When 275 was 
subjected to KCN, the bridged amide 34 was obtained; the use of NaI under similar 
conditions afforded the bicyclic 291. In addition, when heated to higher temperatures, 
275 underwent a 1,2-hydride shift to provide aldehyde 286 (not shown, PhCH3, 200 
°C, 81%), while exposure to NaN3 resulted in the rearrangement to the primary amide 
292. This reaction proceeds most likely via rearrangement to aldehyde, azide addition 
and Schmidt reaction. The proposed intermediates involved in each of these 



























































Next, we established that bridged spiro-epoxyamines participate in a number 
of Lewis acid-catalyzed reactions not typical to traditional epoxides (Table 30). For 
example, upon exposure of 275 to Et2AlCl or Me2AlCl conversion to aldehyde and 
subsequent alkyl transfer was observed (Table 30, entries 1 and 2). When additives 
such as TMSCN and Et3SiH were utilized, closely-related derivatives were formed 
after the rearrangement to the aldehyde (entries 4 and 5), while acid change to 
MeAlCl2 resulted in the formation of a Friedel-Crafts product (entry 7, Scheme 100). 
In contrast, it is well-precedented that when traditional epoxides are exposed to 












275 293-297  
entry acid/additive R yield 

































a Friedel-Crafts product, see below. b Aldehyde is the  






















Interestingly, although BF3•Et2O is the most common Lewis acid used for the 
transformation of epoxides into carbonyl groups,327-332 and it has even been suggested 
that “no epoxide is insensitive” to this reagent,333 we have determined that bridged 
spiro-epoxyamines are inert to BF3•Et2O (Table 30, entry 8).  
Although the detailed mechanism of the aluminum-promoted rearrangement 
of bridged aminoepoxides is unknown at present, it is tempting to suggest a dual 
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activation mode of aminoepoxides by aluminum334-336 being responsible for their 
unusual reactivity (Scheme 101b). It is also possible that the aluminate complex with 
the acid coordinating to the oxygen and/or nitrogen is formed, and that one of these 
intermediates is prone to the rearrangement (Scheme 101a). Further studies will be 




































In addition, to the above examples we attempted a number of other reactions, 
however the epoxyamine 275 was either unreactive or decomposed under the 
reaction conditions. Selected results are summarized in Table 31. 
 
Table 31. Additional Reactions of Amino-epoxide 275.  
entry reagent conditions result/notes 
1 NaN3 NH4Cl, EtOH/H2O, 6 h, ∆ a 
2 H2O 90 °C, 5 h decomposition
3 KOH DMSO, 90 °C, 20 h decomposition
4 MeONa DMF, 110 °C, 16 h b 
5 thiourea NaHCO3, MeOH, rt, 18 h no reaction 
6 allylamine EtOH, 50 °C, 17 h no reaction 
7 allylamine LiClO4, 120 °C, 21 h decomposition
8 MeI CH2Cl2, 60 °C, 22 h c 
9 MeLi -78 °C → rt, 16 h no reaction 
10 t-BuLi -78 °C → rt, 16 h no reaction  
11 LDA -78 °C → rt, 16 h no reaction  
12 sec-BuLi, sparteine, TMSCl -90 °C, 3 h no reaction 
13 n-BuLi, BF3•Et2O -78 °C → rt, 5 h no reaction  
14 n-BuLi, CuCN -20 °C → rt, 5 h no reaction  
15 LiCH2CO2Li THF, 60 °C, 15 h no reactiond  
16 dimethylmalonate/NaH MeOH, 60 °C, 15 h e 
17 EtMgBr THF, 60 °C, 15 h f 
18 CH3CO2tBu, LDA, Et2AlCl -20 °C → rt, 5 h no reaction  
19 Cp2TiCl2Zn THF, rt, 0.5 h no reaction  
20 AlCl3 rt, 15 h g 
21 TiCl4 rt, 15 h h 
a Traces of the desired azidohydrin. b <10% conversion to the aldehyde. c 
Methylation, followed by ring opening, similar to 285, see the experimental section 
for details. d Partial decomposition was observed. e 50% conversion to aldehyde. f 
70% conversion to aldehyde. g The chlorohydrin was formed. h Complex mixture of 
products, including the aldehyde. 
 
 
In conclusion, we have discovered an unprecedented Corey-Chaykovsky 
reaction that permits the direct epoxidation of twisted amides. This method allows for 
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preparation and isolation of bridged aminoepoxides, compounds which, as correctly 
suggested (and pioneered in reactions with aziridine-derived aminoepoxides) by 
Stevens 40 years ago,302-304 display reactivity divergent from traditional epoxides. The 
generality of this approach was demonstrated by the application to a range of bicyclic 
and tricyclic bridged amide substrates. We expect that spiro-aminoepoxides will find 





 Synthesis and Rearrangement of a Bridged Thioamide. Thioamides often 
appear in biologically active molecules337-342 (Figure 19) and are useful synthetic 
intermediates.187, 343-351 In particular, thioamides as close isosteres of amide bonds, 
have found widespread application in peptidomimetics, drug design and synthesis of 
metal complexes where they often have beneficial effects compared to typical amide 
linkages. Thioamides as more reactive analogues of amide bonds, have been utilized 
extensively in natural product synthesis, conformational control, and preparation of 


































Figure 19. Biologically relevant thioamides.  
  
  Thioamides are also of fundamental theoretical interest. Experimental and 
theoretical studies have shown that in addition to the larger van der Waals radius 
of sulfur, the C=S bond in thioamides is longer than the corresponding C=O bond 
in amides.352 The sulfur atom is a weaker hydrogen-bond acceptor and the N–H 
bond in thioamides is a stronger hydrogen-bond donor than those atoms in the 
corresponding amides.353 Also, the barrier of rotation around the C(S)–N bond in 
thioamides is higher than the barrier of rotation around C(O)–N bond in amides. 
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This difference results from the increased contribution of the dipolar canonical 
structure in thioamides.354-356 Consequently, thioamides exhibit higher preference 
for a planar geometry than amides.  
  Although non-planar lactams, as discussed above, have attracted 
considerable attention, no examples of bridged thioamides have been reported. 
Note, however that due to a large van der Waals radius of sulfur, thioamides have 
been used to increse twist angles of amide bonds by steric repulsion approach.49, 
357, 358 Bridged thioamides would be expected to extend the already unusual 
reactivity profile of bridged lactams. Synthesis of bridged thiolactams is also 
important from theoretical perspective and offers a potential to test bridged 
thioamides in medicinal chemistry as amide bond isosteres. Given our successful 
efforts in exploring the synthesis and reactivity of non-planar bridged lactams, we 
wished to prepare a bridged thiolactam analogue, and investigate its reactivity in 
comparison with bridged amides as well as planar thioamides.  
  Most commonly, the preparation of thioamides involves the thionation of 
amides with two reagents: phosphorus pentasulfide359 and Lawesson’s reagent.360 
Accordingly, our study started with the thionation of the readily available lactam 
34 (Scheme 102). We found that upon exposure of lactam 34 to 0.25 equiv of 
P4S10 and 1.7 equiv of HMDO (Curphey reagent), two compounds were formed in 
very good overall yield. The minor product was identifed as the desired thiolactam 
299, exhibiting lower polarity than the oxygen analogue and characterized by the 
expected spectroscopic properties (more downfield shift in 13C NMR, 225 ppm for 
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thiolactam C=S vs. 184 ppm for lactam C=O, and very similar 1H NMR spectrum 
to the bridged lactam). The major product, however, showed puzzling 
spectroscopic characteristics, and could be identified as the rearranged product 
300 only after conversion to the methylated analogue 300a and X-ray 
crystallographic analysis of this derivative (Scheme 103).361 Contrary to 





















Lawesson's reagent, toluene, 110 °C, 24 h
5% 90%
299:300 = 1:11 (70% conversion) 
 
Scheme 103 





























  The proposed mechanism for the rearrangement of 34 to 300 is presented 
in Scheme 104. We think that 299 is an intermediate in the formation of 300. 
Thus, electrophilic activation of the nitrogen of the bridged thioamide with 
phosphorus pentasulfide can allow for intermolecular attack of sulfur on the C−N 
adjacent to the bridged amide bond. The following nucleophilic displacement by 
the thioamide sulfur and tautomerization provides the final product. Although 
alternative mechanisms can be proposed (for example, the intramolecular attack of 
the thioamide sulfur on the C−N bond or the cleavage of the C−N bond of the 
bridged amide, with the following thionation and reclosure), a number of 
observations supports the pathway in Scheme 104. First, resubjecting thioamide 
299 to the reaction conditions results in conversion to the product 300. Second, 
when 299 is exposed to thermal conditions in the absence of the thionating  
reagent, no reaction occurs. From inspection of molecular models, it seems 
unlikely that the thioamide sulfur can position itself in the backside arrangement 
for the direct SN2 attack necessary for the intramolecular reaction. 
  The observed cleavage of the C−N bond in 299 is closely related to the 
hydrogenolysis reaction of tricyclic and bicyclic bridged lactams, in which 
breaking of C−N bond adjacent to the strained amide bond was observed.31 The 
rearrangement of the thioamide 299 further confirms novel reactivity profile of 






























  We also briefly examined the influence of the reaction conditions on this 
reaction (Table 32). Thus, the shortening of the reaction time does not 
significantly improve the yield of the bridged thiolactam. Interstingly, the use of 
larger excess of thionating agent supresses the formation of the thiolactam. 
HMDO is not necessary for the reaction, however in its absence the yield of 3 is 
decreased. As proposed by Curphey,359 the beneficial effect of the HMDO 
additive is to supress the electrophilicity of the polythiophosphates. Lawesson’s 
reagent can also be utilized; however, the reaction is much slower. 
 
Table 32. Influence of Reaction Conditions on Thionation of 34. 
 
entry reagents conditions 299:300 yield [%] 
1 P10S10/HMDO (0.25/1.7 equiv) toluene, 90 °C, 6 h <5:95 79a 
2 P10S10/HMDO (0.25/1.7 equiv) toluene, 90 °C, 3 h n.a. 13b 
3 P10S10/HMDO (1.3/7.5 equiv) toluene, 90 °C, 15 h <5:95 93a 
4 P10S10/HMDO (1.3/7.5 equiv) toluene, 90 °C, 2 h 1:3 40c 
5 P10S10 (5.0 equiv) toluene, 90 °C, 15 h <5:95 76a 
a Isolated yield of 300; b Isolated yield of 299; c Combined yield; n.a. = not available; 
<5:95 indicates that 299 was not observed by 1H NMR of the crude reaction mixture. 
Note: no conversion was observed at lower temperatures, or in CH2Cl2, THF solvents.  
 
   
167 
 
 In general, the lactam carbonyl group is the most easily thionated of the 
common carbonyl derivatives, while the thionation of ketones is often problematic. 
Thus, it was of interest to compare the reactivity of bridged amides (compounds 
which display properties on the border between amides and ketones) with traditional 
planar amides. We determined that, while the thionation of the bridged amide 34 
proceeded relatively slowly with Lawesson’s reagent, the thionation of the fused 
analogue 27 was rapid (Scheme 105). In addition, no reaction was observed when less 
distorted higher homologues of the amide 34 were used (for example, lactam 93 
having a [5.3.1] ring system and lactam 203 with a [5.2.1] ring system), suggesting 
that the N-activativion is required for the thionation of  bridged amides. As expected, 
the twist of the amide bond is important for the thionation, and in cases where N-
activation cannot occur, steric hindrance around the bridged structure prevents the 
reaction. There are very few examples of thionation of sterically hindred planar 
amides. It is very likely that the direct thionation of bridged amides will be possible 










Toluene, 110 °C, 0.5 h
Lawesson's reagent
93%
27 301  
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 One of the goals of our study was to explore the effect of amide twist on the 
spectroscopic properties. For example, we demonstrated that non-planar amides often 
display spectral features consistent with less “amide-like” and greater “ketone-like” 
nature of the carbonyl group (Table 19).257 As outlined in Table 33, the bridged 
thioamide 299 also follows a similar pattern, with the bridged thiolactam carbonyl 
deshielded by 25 ppm in 13C NMR as compared to the planar fused thioamide 301 
(Table 33, entry 2 and 4). This value is consistent with a decreased conjugation Nlone 
pair–thiocarbonyl grouping and indicates a consderable degree of twist. The difference 
of carbonyl shifts between bridged analogues 34 and 299 is practically midway (41.1 
ppm) between the values for ketones 302 and 303 (55.6 ppm) and fused amides 27 
and 301 (28.1 ppm). Accordingly, we have determined that bridged lactams 
possessing [4.3.1] scaffold lie almost exactly on the keto-amide reactivity border (see 
below for details). 
 
Table 33. Spectroscopic Properties of Bridged and Planar Lactams and Thiolactams 
in Comparison with Structurally-Related Ketones and Thioketones. 
entry compound C=O or C=S 
13C NMR 
[ppm] 




1 34 184.4 1670 - 
2 299 225.5 1491 41.1 
3 27 172.4 1635 - 
4 301 200.5 1470, 1443 28.1 
5 Cycloheptanone (302) 205.8 1702 - 
6 Cycloheptathione (303) 261.4362 - 55.6 





  In summary, a synthesis of the first bridged thiolactam and an unusual 
rearrangement of this compound has been investigated. The rearrangement of the 
bridged thiolactam confirms that C−N bond adjacent to twisted amides can 
undergo interesting strain-activated chemistry. Further work aimed at improving 
the facility of the bridged thioamide formation and at studying its chemical 
behavior is necessary, however these results are the first step towards the use of 
bridegd thioamides in chemistry and biology. 
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 Bridged exocyclic enamine. In an attempt to extend the synthetic utility of 
one-carbon bridged amides we considered olefination of the bridged amide carbonyl. 
Enamines are recognized as valuable synthetic intermediates,363, 364 with Stork 
enamines365 and enamines in organocatalysis366 being some prominent examples. In 
contrast to planar enamines, which due to delocalization of nitrogen lone electrons 
into the alkene  system are nucleophilic at carbon, bridged enamines are expected to 
behave as more or less isolated amino-olefins. For example, Doering367 demonstrated 
that the enamine constrained in [2.3.2] ring exits in the equilibrium with the 
corresponding allylamine (Scheme 106). However, there is very few examples of 
bridged enamines described in literature and most of them are based on quinuclidone 
























Figure 20. Examples of bridged enamines and their derivatives.  
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After some experimentation, we determined that exposure of bridged amide 
34 to Petasis olefination conditions374-378 is a convenient method for preparation of 
the bridged exocycylic enamine 304 (Table 34). Optimization of reaction conditions 
revealed that the enamine decomposes under the reaction conditions (entries 3 and 4). 
The use of pyridine as an additive to suppress the decomposition pathways proved 
beneficial (entry 5). Careful control of the reaction time afforded the desired product 
in very high yield (entry 7). 
 









34 304  








1 5.0 THF 60 12 60 58 
2 10.0 THF 66 24 >95 60b 
3 5.0 PhCH3 80 14 >95 52 
4 5.0 PhCH3 80 24 >95 37 
5 5.0 PhCH3/pyridine 80 12 85 61 
6 5.0 PhCH3/pyridine 105 15 >95 80b 
7 5.0 PhCH3/pyridine 105 10 >95 95b 





Although planar amides undergo Petasis olefination,377 to the best of our 
knowledge this is the first example of a direct olefination of a bridged lactam with a 
metalloorganic reagent. It is particularly noteworthy that the oxatitanacyclobutane 
intermediate does not collapse with the opening to the nine-membered ring system 
(Scheme 107, see also Table 26) and that the bridged enamine was stable to 

































Initial explorations of the reactivity of enamine 304 confirm that this 
compound exhibit properties of an isolated amino-olefin. For example, hydrogenation 
of 304 affords the corresponding methyl analogue 305, however no reaction was 
observed upon reduction under acidic conditions (Scheme 108a). This reactivity 
profile stands in a sharp contrast to the behavior of a bridged endocyclic enamine 
(Scheme 108b),368 which was reduced under protic conditions. These results suggest 













































We expect that the functionalization of the enamine carbon will provide 
access to bridged compounds that are not easily accessible by other methods. For 
example, Heck reaction afforded the phenyl derivative in an unoptimized 21% yield 
(Scheme 108c, olefin geometry not determined). 
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Miscellaneous Reactions (Comparison of Distortion Parameters). As 
mentioned in the introductory chapter, the intramolecular Schmidt reaction provides 
access to tricyclic and bicyclic bridged amides which contain amide bonds from the 
previously unknown distortion range. Table 35 summarizes distortion parameters of 
all bridged amides obtained in the Schmidt reaction that have been amenable for X-
ray crystallography to date. The table also includes the corresponding values for 
representative planar and orthogonal amides, and the structural parameters of the  N-
protonated amide 229. For additional examples of 2-quinuclidone derivatives, see 
Table 1.  
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1 306b 1.418 1.212 49.8 7.1 72.4 
2aa 229c 1.387 1.217 35.9 13.2 51.7 
2b  - - 35.5 13.0 50.8 
3aa 229d 1.387 1.218 36.1 12.8 51.5 
3b  1.383 1.221 35.3 13.1 50.8 
4 35e 1.363 1.234 33.8 16.3 43.2 
5aa 53c 1.374 1.210 48.0 13.2 34.7 
5b  - - 16.6 13.2 50.4 
6 53b 1.375 1.219 43.7 12.4 35.9 
7 307c 1.503 1.192 52.1 1.5 81.9 
8 308f 1.526 1.192 59.5 0.2 90.9 
9 309f,g 1.349 1.193 0.0 0.0 0.0 
10 309ag,h 1.325 1.233 - - 2.5 
aTwo independent molecules in the unit cell. b Ref. 225; c Ref. 189;  
d Ref. 54; e Ref. 226; f Ref. 26; g Calculated; h Ref. 166. 
 
Of this series of bridged amides, the most distorted is amide 306 with a twist 
angle close to the perpendicular amide bond and nitrogen practically pyramidal in 
character (Table 35, entry 1). At present it is unclear whether the increased distortion 
of 306 as compared to the amide 229 (entries 2a-3b) is caused by the saturation of the 
six-membered ring or by the steric repulsion between the amide bond and the p-
bromobenzoyl moiety. The tricyclic amide 229, which seems to be representative for 
the class of tricyclic amides obtained in domino Diels-Alder/Schmidt sequence, is 
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characterized by τ ca. 50° (entries 2a-3b). This is slightly more than the τ of the 
bicyclic 35, which is a good model for the amide bond constrained in a bicyclic 
[4.3.1] ring system (entry 4). Pyramidalization at nitrogen is similar in 229 and 35. 
Interestingly, the distortion parameters of the amide 53 depend on whether its six-
membered ring adopts a boat-like (entries 5a and 6) or a chair-like (entry 5b) 
conformation, and is possibly influenced by crystal packing of 53. 
The N-protonated amide 307 (entry 7) is even more distorted than 306 (entry 
1). Note a dramatic increase in the rotation around the C–N bond (τ moves from 51.5° 
to 81.9°) and the changes in bond lengths upon N-protonation. In 307 the N–C(O) 
bond experiences significant lengthening (by 0.116 Å), while the C=O bond is 
moderately shortened (by 0.026 Å).  
Comparison of structures in Table 35 indicates that the bond lengths display a 
good correlation with distortion parameters of amide bonds. Thus, the N–C(O) bond 
length increases from 1.325Å in planar amide (entry 10) through 1.363 Å and 1.387 
Å (entries 4 and 3a) to 1.418 Å (entry 1) and 1.503 Å (entry 7). The last value 
practically matches the N–C(O) bond length for perfectly perpendicular and 
protonated 2-quinuclidone. On the other hand, the length of the C=O bond shortens 
with the increased distortion of amide bonds. The elongated N–C(O) bond and the 
shortened C=O bond are consistent with the increased twist angle of amide bonds, 
and result from a lower ability of nitrogen to donate its n electrons into π* orbital of 
C=O group.  
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As presented in Table 35 tricyclic bridged amides obtained in the Schmidt 
reaction are slightly more distorted than their bicyclic analogues; importantly, both 
classes of compounds contain half-way rotated amide bonds. This provided us with 
an opportunity to test how the midway rotation of the amide bonds would influence 
the reactivity of amide bonds. In particular, we wished to estimate the border between 
an amide-like and keto amine-like reactivity of amide carbonyl groups. Towards this 
end we performed a number of reactions that are typical to ketones and amines but 




Table 36. Reactions of Bicyclic and Tricyclic Bridged Amides. 
entry lactam conditions result/notes 
1 230 NaN3/H2SO4 no reactiona 
2 230 m-CPBA no reactionb 
3 230 H2O2, Davis oxaziridine no reactionc 
4 34, 230 Ph3PMeBr/KOtBu, 110 °C, 24 h no reactiond 
5 34 n-C6H13N3, PPh3, 110 °C, 24 h no reaction  
6 34 Dimethylmalonate, NaH, 66 °C, 27 h no reaction 
7 34 Ethyl bromoacetate, LHMDS, 66 °C, 24 h no reaction 
8 34, 230 TMSCN, KCN, 18-crown-6, 90 °C, 24 h no reactione 
9 34 Danishefsky’s or Rawal’s diene, 170 °C, 24 hf no reaction  
10 34 C3H5SiMe3, TiCl4, 24 h  no reaction 
11 34 PhCH2NH2, 110 °C, 20 h no reaction  
12 229 PhCH2NH2, 110 °C, 23 h imine 310 
13g 53 (CH2OH)2, , 80 °C, 48 h no reaction 
14g 230 (CH2OH)2, , 80 °C, 48 h ketal 311 
15 34 TMSCH2Li, -78 °C → rt, 3 h no reaction 
16 260 TMSCH2Li, -78 °C → rt, 3 h hemiaminal 312 
17g 229 MeI, 40 °C N-methylation 
18 34 MeI, 160 °Ch N-methylation 
19 230 HCl, p-TsOH N-protonation 
20 3 HCl, p-TsOH hydrolysis 
21 38 HCl, p-TsOH hydrolysisi 
a Schmidt reaction was tried under variety of conditions. b Baeyer-Villiger reaction 
was tried under variety of conditions. c N-oxide formation was attempted under 
variety of conditions. d Wittig reaction was tried, under various conditions. e 
attempted cyanohydrin formation under variety of conditions. f Lewis acid mediated 
hetero Diels-Alder reactions were also tried. g Reference 189. h No reaction at lower 
temperatures. i Starting material was also observed.  
 
 
As expected, the bridged amides were unreactive under some of the reaction 
conditions, indicating that 50° distortion of amide bonds is not sufficient for certain 
carbonyl additions to amide bonds (entries 1-10). However, the half-way rotated 
lactams also provided examples of some unusual reactivity, indicating that the amide 
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bond does not need to be perfectly perpendicular to experience reactions typically 
associated with ketones and amines rather than amides (entries 12, 14, 16-18).  
Very importantly, we found a significant difference in reactivity between 
tricyclic and bicyclic amides, with the tricyclic structures being more reactive than 
bicyclic analogues. Given that the first class of compounds is more distorted, this 
provides the first experimental evidence regarding degrees of the amide bond 
distortion that mark the border between amide-like and ketone-like carbonyl 
reactivity of lactams. Of particular note are reactions with amines (entries 11 and 12), 
alcohols (entries 13 and 14), TMS methylide (entries 15 and 16) and MeI (entries 17 
and 18). In addition, although Kirby demonstrated that perfectly perpendicular 1-aza-
2-adamantanone (τ = 90.5°) undergoes Wittig olefination, twist angle of currently 
investigated amides did not allow for this reaction; only starting amides were re-
isolated (entry 4). 
Overall, these results demonstrate that the lactam twist angle of ca. 50° is 
close to a barrier for carbonyl reactions typically associated with ketones but not 
amides. A similar amide bond distortion range suffices for efficient N-activation of 
amide linkages. We expect that these findings will facilitate the understanding of 
biological and chemical activation of amide bonds.  
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Summary. The reactivity of one-carbon bridged amides has been 
investigated. Examination of the hydrolytic stability of bicyclic and tricyclic bridged 
lactams indicates that one-carbon bridged amides exhibit levels of stability 
unprecedented to other classes of bridged lactams. This property results from a 
unique placement of the amide carbonyl at one-carbon bridge located at the center of 
a medium-sized heterocycle. The stability of one-carbon-bridged amides allows for 
synthetic manipulations not possible with other distorted lactams.  
One-carbon bridged amides undergo facile nucleophilic addition reactions of 
hydrides and metalloorganic reagents. Remarkably, due to the geometrical constraints 
imposed by rigid cyclic structures, some of the hemiaminals are isolable. These 
scaffolds can be used to monitor a transition from stable tetrahedral intermediates to 
unstable species.  
One-carbon bridged amides participate in a direct Corey-Chaykovsky 
epoxidation; the resulting spiro-epoxyamines are chromatographically stable. Of 
particular interest is the chemistry of bridged aminoepoxides, which differ 
significantly from the traditional epoxides.  
Other noteworthy compounds prepared from bridged amides include a bridged 
thioamide and a bridged exocyclic enamine. Furthermore, it has been demonstrated 
that the lactam twist angle of ca. 50° marks a barrier for certain reactions typically 
associated with ketones and amines but not amides. 
The stability and rich chemistry of one-carbon bridged amides bode well for 






General Procedures.  1H and 13C NMR spectra were recorded on a Bruker 
DRX-400 (400 MHz and 100 MHz, respectively) or a Bruker AM-500 (500 MHz and 
125 MHz, respectively) instrument. Unless otherwise noted, all samples were 
dissolved in CDCl3, and the shifts are expressed in parts per million (ppm) relative to 
residual CHCl3 as an internal standard. Abbreviations are: s, singlet; d, doublet; t, 
triplet; q, quartet; br s, broad singlet.  Infrared spectra were recorded on a Perkin-
Elmer 1420 spectrometer or a Nicolet Fourier Transform Infrared spectrometer and 
are expressed in wave numbers (cm-1). Melting points were determined using a 
Thomas-Hoover melting point apparatus and are uncorrected. Low resolution mass 
spectroscopic data (CI, chemical ionization or FAB+, fast atom bombardment) were 
obtained with a Ribermag R10-10 quadrupole instrument. High resolution mass 
spectra were collected using a VG Analytical ZAG double focusing spectrometer.  
All flash chromatography was performed using Fischer Scientific silica gel (230-400 
mesh) with the noted eluent system. Tetrahydrofuran, dichloromethane, and ether 
were purchased from Fisher Scientific and purified using an Innovative Technologies 
solvent purification system. All other solvents were used without further purification 
or drying procedures. Reaction flasks were oven or flame-dried and cooled under 
vacuum then purged with argon; all reactions were conducted under argon or nitrogen 
atmosphere unless otherwise noted. Where indicated, microwave heating was 
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performed in BiotageTM Initiator microwave reactor. All starting material were 
purchased from Aldrich, Lancaster, Fischer, or Strem chemical companies and used 
as received. The following compounds are known: azide 1, fused and bridged lactam 
2 and 3,188 arylketones 6379 and 7, azides 20 and 21, bridged and fused lactams 27, 34, 
28 and 35,188 ethyl 5-tert-butyl-2-oxocyclo hexanecarboxylate 43,380 4-tert-Butyl-2-
(methylthio)cyclohexanone 60,381 azide 72,173 ketone 75,382 2-methylthioketones 86, 
90, 96 and 103,383, 384 N-Allyl-2-nitrobenzenesulfonamide,385 N-(But-3-enyl)-2-
nitrobenzenesulfonamide,386 2-Nitro-N-(pent-4-enyl)benzenesulfonamide,386 
Dimethyl 2-allyl-2-(2-bromoethyl)malonate,387 Methyl allylphenylacetate,388 Phenyl 
allylphenylacetate,389 bridged lactams 229, 230, 53, 231,31 bridged lactam 260,188 
fused lactam 270,31  bridged lactams 279 and 280.31  
2-aryl-tert-butylcyclohexanones were prepared following procedures by 
Hartwig390 and Rawal.391 Ester 43 was prepared following a procedure by Lachia et 
al.392 using diethyl carbonate in 84% yield. Amide 44 was prepared following a 
procedure by Hendi et al.393 2,2-Dimethoxycyclohexanol (precursor to 75) was 
prepared following the method by Zacuto et al.394 2-thiomethylyketones 55, 86, 90,  
96 and 103 were prepared following the method of Trost.395 Dimethyl 2-
allylmalonate, Grubbs 1, Grubbs 2 and Hoveyda-Grubbs 2 were purchased from 
Aldrich and used as received. Fürstner catalyst was purchased from Strem and used as 
received. All nitrobenzenosulfonamides were prepared by method of Cluzeau et al.385 
Phenyl allylphenylacetate was obtained by alkylation of commercially available 
phenyl phenylacetate following a procedure by Molander.396 
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Cation−π control of regiochemistry in Schmidt reaction. 
 
General procedure for Schmidt Reaction. To a solution of azidoketone (1.0 
equiv) in CH2Cl2, Lewis or protic acid was added dropwise at 0 °C, the reaction was 
allowed to slowly warm to rt and was stirred at rt for a specified time. The reaction 
was cooled to 0 °C, quenched with water (10 mL), and extracted with CH2Cl2 (3 x 20 
mL). The organic layer was washed with brine (1 x 20 mL), dried (Na2SO4), and 
concentrated. Flash chromatography afforded the title lactams. Note: typically 
bridged lactams are less polar and more UV active than fused lactams. These 
properties are another consequence of the decreased conjugation of the lone pair of 
electrons at nitrogen with the amide C=O system. 
Optimization of Product Distribution in Schmidt Reaction with Azide 1. 
According to the general procedure azide 1 was reacted with acids specified in Tables 
2-4. The reactions were monitored by TLC, and worked-up after consumption of the 
starting material. Analysis of crude reaction mixtures by 1H NMR indicated ratio of 2 
to 3.  
General procedure for arylation.390 (Synthesis of 2-arylketones 6-12). To a 
100 mL round bottom flask charged with Pd(OAc)2 (0.02 equiv), tBu3P (0.025 equiv), 
NaOtBu (1.5 equiv) and THF (20-40 mL), aryl chloride or bromide (1.0 equiv) and 
tert-butylcyclohexanone (1.1 equiv) were added under argon. The flask was sealed 
and the reaction mixture was heated to 60-65 °C for 18-24 h. The reaction mixture 
was cooled to rt, diluted with ether (200 mL), washed with water (1 x 50 mL) and 
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brine (1 x 50 mL). The aqueous layer was re-extracted with ether (2 x 100 mL). 
Combined organic layers were dried (Na2SO4), and concentrated. Flash 
chromatography afforded the title arylketones. Note: this method did not afford 4-
tert-butyl-2-(4-nitrophenyl)cyclohexanone (8). 8 was prepared following a procedure 
by Rawal et al.391 
General procedure for alkylation with iodo-chloroalkane. (Synthesis of 
chlorides 13-19). To a suspension of NaH (60% dispersion in mineral oil, 1.05-1.10 
equiv) in THF (40 mL), HMPA (1.2 equiv) was added and the reaction mixture was 
stirred at rt for 10 min. After the reaction mixture was cooled to 0 °C, the ketone (1.0 
equiv) was added dropwise in THF (5-10 mL). After stirring for 3 h at rt, the chloro-
iodoalkane (4.0 equiv) was added at rt, and the reaction was stirred for additional 15 -
18 h. The reaction mixture was diluted with ether (200 mL) and quenched with water 
(50 mL). The aqueous layer was extracted with ether (2 x 20 mL), and the combined 
organic layers were washed with water (20 mL) and brine (20 mL). The organic layer 
was dried (Na2SO4) and concentrated. Flash chromatography afforded the title 
products. 
General procedure for SN2 displacement with sodium azide. (Synthesis of 
azides 20-26). Caution! Low molecular weight alkylazides are potential explosion 
hazards and should be used with appropriate caution. To a solution of chloride (1.0 
equiv) in DMF (20-30 mL) NaN3 (5.0 equiv) was added, and the reaction mixture was 
heated at 80° C for 2-3 h. Ether (150 mL) was added, and the mixture was washed 
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with water (4 x 50 mL) and brine (1 x 50 mL). The organic layer was dried (Na2SO4) 






(2R,4S)-4-tert-Butyl-2-(4-nitrophenyl)cyclohexanone (8). PtBu3 (1.0 M in 
toluene, 1.20 mL, 0.06 equiv) was added to a mixture of (4-tert-butylcyclohex-1-
enyloxy)trimethylsilane (4.5 g, 19.9 mmol, 1.0 equiv), 1-bromo-4-nitrobenzene (2.03 
g, 9.9 mmol, 0.5 equiv), Pd2(dba)3 (0.46 g, 0.51 mmol, 0.025 equiv) and Bu3SnF 
(6.15 g, 19.9 mmol, 1.0 equiv) in THF (30 mL) and the resulting mixture was heated 
to reflux for 13 h. The reaction was cooled to rt, diluted with ether (200 mL), tin 
residue was removed by decantation, washed with 1.0 N NaOH (2 x 50 mL), brine (1 
x 50 mL), dried and concentrated. Chromatography (1/15 EtOAc/hexanes) afforded 
the title compound as solid (Mp = 105-106 °C, Rf = 0.43, 1/10 EtOAc/hexanes). 
Yield 61% (2.22 g, 8.1 mmol). 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 9H), 1.59-1.72 
(m, 1H), 1.79 (m, 2H), 2.21-2.35 (m, 2H), 2.48-2.64 (m, 2H), 3.72-3.79 (m, 1H), 7.32 
(d, J = 8.7 Hz, 2H), 8.21 (d, J = 8.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 27.6, 
28.5, 32.6, 36.7, 41.6, 47.3, 56.7, 123.5, 129.8, 146.6, 147.0, 209.1; IR (neat) 2959, 











Prepared according to the general procedure using Pd(OAc)2 (0.0678 g, 0.30 mmol, 
0.02 equiv), tBu3P (0.0762 g, 0.38 mmol, 0.025 equiv), NaOtBu (2.24 g, 22.7 mmol, 
1.5 equiv), 4- 5-bromo-1,2,3-trimethoxybenzene (3.83 g, 15.1 mmol, 1.0 equiv) and 
tert-butylcyclohexanone (2.56 g, 16.6 mmol, 1.1 equiv) in THF (40 mL) at 65 °C for 
18 h. Chromatography (1/5 EtOAc/hexanes) afforded the title compound as oil. Yield 
46% (2.24 g, 7.0 mmol). 1H NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.58-1.83 (m, 
4H), 2.18-2.26 (m, 1H), 2.27-2.35 (m, 1H), 2.46-2.62 (m, 2H), 3.53-3.63 (m, 1H), 
3.86 (s, 3H), 3.88 (s, 6H), 6.36 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 27.7, 28.5, 
32.6, 37.1, 41.7, 47.5, 56.1, 57.4, 60.8, 105.8, 134.8, 136.8, 153.1, 210.5; IR (neat) 
2950, 1705, 1585, 1455, 1240, 1120 cm-1; HRMS calcd for C19H28O4Na (M+ + Na) 







(2R,4S)-4-tert-Butyl-2-(3,4-dimethoxyphenyl)cyclohexanone (10). Prepared 
according to the general procedure using Pd(OAc)2 (0.0420 g, 0.18 mmol, 0.02 
equiv), tBu3P (0.0510 g, 0.23 mmol, 0.025 equiv), NaOtBu (1.35 g, 13.7 mmol, 1.5 
equiv), 4-bromoveratrole (1.33 mL, 9.1 mmol, 1.0 equiv) and tert-
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butylcyclohexanone (1.56 g, 10.0 mmol, 1.1 equiv) in THF (40 mL) at 65 °C for 22 h. 
Chromatography (1/4 EtOAc/hexanes) afforded the title compound as oil (Rf = 0.24, 
1/4 EtOAc/hexanes). Yield 52% (1.38 g, 4.8 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.97 (s, 9H), 1.58-1.69 (m, 1H), 1.70-1.83 (m, 2H), 2.17-2.25 (m, 1H), 2.26-2.34 (m, 
1H), 2.45-2.61 (m, 2H), 3.58 (q, J = 6.9 Hz, 1H), 3.89 (s, 3H), 3.90 (s, 3H), 6.66-6.73 
(m, 2H), 6.87 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 27.7, 28.6, 32.6, 
37.1, 41.7, 47.5, 55.9, 55.9, 56.6, 111.1, 112.1, 120.6, 131.7, 148.0, 148.7, 210.9; IR 
(neat) 2958, 1715, 1518, 1464, 1259, 1231, 1144, 1028 cm-1; HRMS calcd for 








Prepared according to the general procedure using Pd(OAc)2 (0.029 g, 0.13 mmol, 
0.02 equiv), tBu3P (0.036 g, 0.16 mmol, 0.025 equiv), NaOtBu (0.95 g, 9.6 mmol, 1.5 
equiv), 5-chloro-1,3-benzodioxole (0.76 mL, 6.4 mmol, 1.0 equiv) and tert-
butylcyclohexanone (1.09 g, 7.0 mmol, 1.1 equiv) in THF (20 mL) at 65 °C for 22 h. 
Chromatography (1/20 EtOAc/hexanes) afforded the title compound as solid (Mp = 
83-84 °C, Rf = 0.29, 1/10 EtOAc/hexanes). Yield 37% (0.65 g, 2.4 mmol). 1H NMR 
(400 MHz, CDCl3) δ 0.96 (s, 9H), 1.56-1.79 (m, 3H), 2.17-2.32 (m, 2H), 2.44-2.60 
(m, 2H), 3.50-3.58 (m, 1H), 5.97 (s, 2H), 6.60 (dd, J = 1.5, 7.9 Hz, 1H), 6.66 (d, J = 
1.4 Hz, 1H), 6.79 (d, J = 7.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 27.7, 28.5, 
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32.6, 37.1, 41.7, 47.4, 56.6, 101.0, 108.2, 109.2, 121.7, 132.9, 146.5, 147.6, 210.7; IR 
(neat) 2955, 1868, 1715, 1504, 1491, 1443, 1250, 1231, 1040 cm-1; HRMS calcd for 








Prepared according to the general procedure using Pd(OAc)2 (0.082 g, 0.35 mmol, 
0.02 equiv), tBu3P (1.0 M in toluene, 0.44 mL, 0.44 mmol, 0.025 equiv), NaOtBu 
(2.62 g, 26.7 mmol, 1.5 equiv), 1-bromo-3,5-dimethoxybenzene (3.96 g, 17.7 mmol, 
1.0 equiv) and tert-butylcyclohexanone (3.05 g, 19.5 mmol, 1.1 equiv) in THF (30 
mL) at 65 °C for 18 h. Chromatography (1/6 EtOAc/hexanes) afforded the title 
compound as oil (Rf = 0.47, 1/4 EtOAc/hexanes). Yield 62% (3.17 g, 10.9 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.97 (s, 9H), 1.58-1.67 (m, 1H), 1.71-1.86 (m, 2H), 2.16-
2.34 (m, 2H), 2.45-2.59 (m, 2H), 3.554-3.61 (m, 1H), 3.80 (s, 6H), 6.33 (d, J = 2.3 
Hz, 2H), 6.40 (t, J = 2.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 27.7, 28.5, 32.6, 
36.7, 41.7, 47.4, 55.3, 57.2, 98.8, 107.0, 141.5, 160.7, 210.1; IR (neat) 2957, 1713, 
1599, 1462, 1429, 1204, 1151, 1065 cm-1; HRMS calcd for C18H27O3 (M+ + H) 











(15). According to the general procedure, the reaction of NaH (0.35 g, 8.8 mmol, 1.1 
equiv), HMPA (1.70 mL, 9.60 mmol, 1.2 equiv), 8 (2.20 g, 8.0 mmol, 1.0 equiv) and 
1-chloro-3-iodopropane (3.43 mL, 32.0 mmol, 4.0 equiv) in THF (40 mL) for 18 h 
afforded after chromatography (1/15 EtOAc/hexanes) the title compound as solid (Mp 
= 101-102 °C, Rf = 0.37, 1/10 EtOAc/hexanes). Yield 41% (1.17 g, 3.3 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.98 (s, 9H), 1.26-1.38 (m, 1H), 1.56-1.85 (m, 3H), 1.90 
(t, J = 12.5 Hz, 1H), 2.08-2.36 (m, 4H), 2.46-2.56 (m, 1H), 2.59-2.70 (m, 1H), 3.46-
3.58 (m, 2H), 7.46 (d, J = 9.0 Hz, 2H), 8.20 (d, J = 9.0 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 26.8, 26.9, 27.4, 32.5, 32.8, 38.5, 38.8, 41.8, 44.9, 56.4, 123.2, 128.7, 146.6, 
149.7, 212.0; IR (neat) 2961, 2870, 1709, 1597, 1518, 1468, 1348, 1232, 912, 856, 








(22). According to the general procedure the reaction of chloride 15 (0.65 g, 1.85 
mmol, 1.0 equiv), NaN3 (0.60 g, 9.2 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 
2.5 h afforded after chromatography (1/4 EtOAc/hexanes) the title compound as solid 
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(Mp = 94-95 °C, Rf = 0.53, 1/4 EtOAc/hexanes). Yield 88% (0.59 g, 1.63 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.97 (s, 9H), 1.04-1.16 (m, 1H), 1.42-1.54 (m, 1H), 1.56-
1.68 (m, 1H), 1.72-1.81 (m, 1H), 1.90 (t, J = 12.6 Hz, 1H), 2.06-2.26 (m, 4H), 2.50 
(dq, J  = 3.7, 14.5 Hz, 1H), 2.57-2.68 (m, 1H), 3.21-3.29 (m, 2H), 7.45 (d, J = 8.9 Hz, 
2H), 8.19 (d, J = 8.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 23.5, 26.8, 27.4, 32.5, 
32.6, 38.5, 28.7, 41.8, 51.3, 56.5, 123.2, 128.7, 146.5, 149.7, 212.0; IR (neat) 2960, 
2870, 2097, 1709, 1597, 1518, 1348, 856 cm-1; HRMS calcd for C19H27N4O3 (M+ + 










cyclohexanone (16). According to the general procedure, the reaction of NaH (0.30 
g, 7.6 mmol, 1.1 equiv), HMPA (1.45 mL, 8.3 mmol, 1.2 equiv), 9 (2.20 g, 6.9 mmol, 
1.0 equiv) and 1-chloro-3-iodopropane (2.89 mL, 27.5 mmol, 4.0 equiv) in THF (30 
mL) for 22 h afforded after chromatography (1/8 EtOAc/hexanes) the title compound 
as oil (Rf = 0.45, 1/4 EtOAc/hexanes). Yield 40% (1.08 g, 2.7 mmol). 1H NMR (400 
MHz, CDCl3) δ 0.96 (s, 9H), 1.33-1.44 (m, 1H), 1.58-1.75 (m, 3H), 1.93-2.21 (m, 
5H), 2.36-2.56 (m, 2H), 3.43-3.57 (m, 2H), 3.86 (s, 9H), 6.48 (s, 2H); 13C NMR (100 
MHz, CDCl3) δ 25.8, 27.1, 27.3, 32.6, 33.4, 37.8, 38.1, 41.9, 45.4, 55.9, 56.3, 60.8, 
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105.0, 137.0, 137.4, 152.9, 214.1; IR (neat) 2960, 1715, 1590, 1520, 1420, 1255, 










cyclohexanone (23). According to the general procedure, the reaction of chloride 16 
(1.08 g, 2.72 mmol, 1.0 equiv) and NaN3 (0.88 g, 13.6 mmol, 5.0 equiv) in DMF (15 
mL) at 80 °C for 2.5 h afforded after chromatography (1/4 EtOAc/hexanes) the title 
compound as oil. Yield 99% (1.08 g, 2.7 mmol). 1H NMR (400 MHz, CDCl3) δ 0.96 
(s, 9H), 1.11-1.26 (m, 1H), 1.42-1.78 (m, 3H), 1.88-2.12 (m, 5H), 2.37-2.56 (m, 2H), 
3.14-3.32 (m, 2H), 3.84 (s, 9H), 6.46 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 25.6, 
25.6, 27.3, 32.6, 33.4, 37.2, 38.0, 41.9, 51.7, 55.9, 56.3, 60.8, 104.9, 137.0, 137.3, 
152.9, 214.2; IR (neat) 2960, 2100, 1715, 1595, 1520, 1420, 1255, 1140, 1020 cm-1; 









cyclohexanone (17). According to the general procedure, the reaction of NaH (0.176 
g, 4.0 mmol, 1.1 equiv), HMPA (0.83 mL, 4.8 mmol, 1.2 equiv), 10 (1.16 g, 4.0 
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mmol, 1.0 equiv) and 1-chloro-3-iodopropane (1.89 mL, 17.6 mmol, 4.0 equiv) in 
THF (30 mL) for 17 h afforded after chromatography (1/8 EtOAc/hexanes) the title 
compound as oil (Rf = 0.41, 1/4 EtOAc/hexanes). Yield 45% (0.66 g, 1.8 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.97 (s, 9H), 1.30-1.42 (m, 1H), 1.58-1.73 (m, 3H), 1.94-
2.21 (m, 5H), 2.42-2.54 (m, 2H), 3.41-3.53 (m, 2H), 3.89 (s, 6H), 6.78-6.86 (m, 3H); 
13C NMR (100 MHz, CDCl3) δ 25.9, 27.1, 27.3, 32.6, 33.3, 37.3, 38.0, 41.9, 45.4, 
55.3, 55.8, 56.0, 110.7, 111.2, 119.4, 134.2, 147.8, 148.6, 214.3; IR (neat) 2957, 
1707, 1518, 1464, 1256, 1150, 1028 cm-1; HRMS calcd for C21H32ClO3 (M+ + H) 









cyclohexanone (24). According to the general procedure, the reaction of chloride 17 
(0.57 g, 1.55 mmol, 1.0 equiv) and NaN3 (0.50 g, 7.76 mmol, 5.0 equiv) in DMF (20 
mL) at 80 °C for 2.5 h afforded after chromatography (1/4 EtOAc/hexanes) the title 
compound as oil (Rf = 0.39, 1/4 EtOAc/hexanes). Yield 87% (0.49 g, 1.30 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.11-1.22 (m, 1H), 1.42-1.52 (m, 1H), 1.58-
1.69 (m, 2H), 1.92-2.12 (m, 5H), 2.42-2.53 (m, 2H), 3.16-3.27 (m, 2H), 3.88 (s, 6H), 
6.77-6.86 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 23.6, 25.8, 27.3, 32.6, 33.3, 36.9, 
37.9, 41.9, 51.7, 55.4, 55.8, 56.0, 110.7, 111.2, 119.3, 134.1, 147.9, 148.6, 214.4; IR 
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(neat) 2957, 2868, 2097, 1709, 1518, 1464, 1258, 1150, 1028 cm-1; HRMS calcd for 









cyclohexanone (18). According to the general procedure, the reaction of NaH (0.096 
g, 2.4 mmol, 1.1 equiv), HMPA (0.46 mL, 2.65 mmol, 1.2 equiv), 1l (0.60 g, 2.2 
mmol, 1.0 equiv) and 1-chloro-3-iodopropane (0.94 mL, 8.8 mmol, 4.0 equiv) in THF 
(20 mL) for 17 h afforded after chromatography (1/20 EtOAc/hexanes) the title 
compound as oil (Rf = 0.32, 1/10 EtOAc/hexanes). Yield 37% (0.28 g, 0.81 mmol). 
1H NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.33-1.41 (m, 1H), 1.58-1.72 (m, 3H), 
1.91-2.17 (m, 5H), 2.49 (t, J = 7.5 Hz, 2H), 3.42-3.53 (m, 2H), 5.97 (s, 2H), 6.71-
.6.82 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 26.2, 27.1, 27.3, 32.6, 33.3, 37.6, 38.0, 
41.8, 45.3, 55.5, 101.1, 107.8, 108.4, 120.3, 136.6, 146.2, 147.7, 214.0; IR (neat) 
2959, 1709, 1504, 1489, 1433, 1240, 1040 cm-1; HRMS calcd for C20H31ClO3N (M+ 











cyclohexanone (25). According to the general procedure, the reaction of chloride 18 
(0.20 g, 0.57 mmol, 1.0 equiv) and NaN3 (0.19 g, 2.85 mmol, 5.0 equiv) in DMF (20 
mL) at 80 °C for 2.5 h afforded after chromatography (1/4 EtOAc/hexanes) the title 
compound as oil (Rf = 0.30, 1/10 EtOAc/hexanes). Yield 86% (0.18 g, 0.49 mmol). 
1H NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.11-1.23 (m, 1H), 1.43-1.52 (m, 1H), 
1.60-1.68 (m, 2H), 1.92-2.12 (m, 5H), 2.43-2.52 (m, 2H), 3.18-3.32 (m, 2H), 5.96 (s, 
2H), 6.70-6.80 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 23.5, 26.1, 27.3, 32.6, 33.2, 
37.4, 38.0, 41.8, 51.6, 55.6, 101.1, 107.9, 108.3, 120.2, 135.6, 146.2, 147.7, 214.0; IR 
(neat) 2959, 2097, 1709, 1489, 1204 cm-1; HRMS calcd for C20H31N4O3 (M+ + NH4) 









cyclohexanone (19). According to the general procedure, the reaction of NaH (0.46 
g, 11.4 mmol, 1.1 equiv), HMPA (2.17 mL, 12.4 mmol, 1.2 equiv), 12 (3.0 g, 10.3 
mmol, 1.0 equiv) and 1-chloro-3-iodopropane (4.4 mL, 41.2 mmol, 4.0 equiv) in THF 
(40 mL) for 14 h afforded after chromatography (1/33 EtOAc/hexanes) the title 
compound as oil (Rf = 0.32, 1/10 EtOAc/hexanes). Yield 43% (1.64 g, 4.5 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.95 (s, 9H), 1.33-1.45 (m, 1H), 1.56-1.72 (m, 3H), 1.96-
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2.21 (m, 5H), 2.41-2.54 (m, 2H), 3.42-3.54 (m, 2H), 3.80 (s, 6H), 6.38 (t, J = 2.1 Hz, 
1H), 6.44 (d, J = 2.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 25.8, 27.2, 27.3, 32.6, 
33.3, 37.1, 38.0, 41.8, 45.4, 55.3, 55.9, 98.1, 106.0, 144.3, 160.6, 213.9; IR (neat) 
2957, 1709, 1595, 1456, 1423, 1205, 1157, 1065 cm-1; HRMS calcd for C21H32ClO3 









cyclohexanone (26). According to the general procedure, the reaction of chloride 19 
(1.42 g, 3.9 mmol, 1.0 equiv) and NaN3 (1.26 g, 19.3 mmol, 5.0 equiv) in DMF (20 
mL) at 80 °C for 2.5 h afforded after chromatography (1/4 EtOAc/hexanes) the title 
compound as oil (Rf = 0.26, 1/10 EtOAc/hexanes). Yield 89% (1.28 g, 3.4 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.95 (s, 9H), 1.17-1.28 (m, 1H), 1.42-1.70 (m, 3H), 1.88-
2.12 (m, 5H), 2.38-2.56 (m, 2H), 3.16-3.38 (m, 2H), 3.79 (s, 6H), 6.34 (t, J = 2.1 Hz, 
1H), 6.42 (d, J = 2.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 23.6, 25.7, 27.3, 32.6, 
33.2, 36.8, 37.9, 41.8, 51.7, 55.3, 55.9, 98.0, 106.0, 144.3, 160.6, 214.0; IR (neat) 
2957, 2097, 1709, 1595, 1456, 1205, 1157, 1064 cm-1; HRMS calcd for C21H35N4O3 




Optimization of Product Distribution in Schmidt Reaction with Azide 20. 
According to the general procedure azide 20 was reacted with acids specified in Table 
6. The reactions were monitored by TLC, and worked-up after consumption of the 
starting material. Analysis of crude reaction mixtures by 1H NMR indicated ratio of 










one (27) and (4R,6R)-4-tert-Butyl-6-phenyl-1-azabicyclo[4.3.1]decan-10-one (34). 
According to the general procedure, the reaction of azide 20 (0.0904 g, 0.29 mmol, 
1.0 equiv) and MeAlCl2 (1.0 M in hexanes, 0.43 mL, 1.5 equiv) in CH2Cl2 (5.4 mL, 
0.05 M) for 24 h afforded after chromatography 1/3 hexanes/EtOAc-EtOAc lactam 27 
(0.0185 g, 0.065 mmol, yield 22%) as oil (Rf = 0.40, 1/1 EtOAc/hexanes) and lactam 
34 (0.0502 g, 0.0176 mmol, yield 61%) as oil (Rf = 0.70, 1/1 EtOAc/hexanes). 
Analysis of the crude reaction mixture by 1H NMR indicated 26:74 ratio of 27 to 34. 













azepin-5(6H)-one (28) and (4R,6R)-4-tert-Butyl-6-(4-methoxyphenyl)-1-
azabicyclo[4.3.1]decan-10-one (35). According to the general procedure, the 
reaction of azide 21 (0.0841 g, 0.25 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in 
hexanes, 0.37 mL, 1.5 equiv) in CH2Cl2 (4.5 mL, 0.05 M) for 24 h afforded after 
chromatography 1/2 hexanes/EtOAc-EtOAc lactam 28 (0.0090 g, 0.028 mmol, yield 
11%) as oil and lactam 35 (0.0556 g, 0.0177 mmol, yield 71%) as white solid (Mp  = 
135-136 °C), recrystallization from EtOAc afforded crystals suitable for X-ray 
analysis. Analysis of the crude reaction mixture by 1H NMR indicated 12:88 ratio of 











azepin-5(6H)-one (29) and (4R,6R)-4-tert-Butyl-6-(4-nitrophenyl)-1-
azabicyclo[4.3.1]decan-10-one (36). According to the general procedure, the 
reaction of azide 22 (0.0872 g, 0.24 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in 
hexanes, 0.37 mL, 1.5 equiv) in CH2Cl2 (4.4 mL, 0.05 M) for 24 h afforded after 
chromatography 1/2 hexanes/EtOAc-EtOAc lactam 29 (0.0301 g, 0.091 mmol, yield 
38%) as white solid (Mp  = 177-178 °C,  Rf = 0.53, 1/1 EtOAc/hexanes) and lactam 
36 (0.0312 g, 0.095 mmol, yield 39%, Rf = 0.84, 1/1 EtOAc/hexanes) as white solid 
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(Mp  = 135-136 °C). Analysis of the crude reaction mixture by 1H NMR indicated 
51:49 ratio of 29 to 36. Compound 29: 1H NMR (400 MHz, CDCl3) δ 0.93 (s, 9H), 
1.24-1.43 (m, 3H), 1.49-1.56 (m, 1H), 1.74-1.81 (m, 1H), 1.88-1.95 (m, 1H), 2.07 (dt, 
J = 6.0, 12.8 Hz, 1H), 2.12-2.26 (m, 2H), 2.34 (dd, J = 4.3, 12.6 Hz, 1H), 2.53 (d, J = 
13.9 Hz, 1H), 3.64-3.77 (m, 2H), 7.40 (d, J = 8.8 Hz, 2H), 8.22 (d, J = 8.9 Hz, 2H);  
13C NMR (100 MHz, CDCl3) δ 19.7, 24.5, 27.0, 32.7, 33.0, 39.0, 41.4, 43.2, 47.6, 
68.5, 123.9, 126.0, 147.0, 154.7, 172.2; IR (neat) 2961, 2870, 1636, 1597, 1518, 
1452, 1421, 1348, 731 cm-1; HRMS calcd for C19H27N2O3 (M+ + H) 331.2022, found 
333.2008. Compound 36: 1H NMR (400 MHz, CDCl3) δ 0.99 (s, 9H), 1.53-1.72 (m, 
2H), 1.81-2.04 (m, 6H), 2.56 (d, J = 11.7 Hz, 1H), 2.62-2.72 (m, 1H), 3.40 (m, 1H), 
3.74 (d, J = 10.2 Hz, 1H), 3.93 (dd, J = 5.9, 13.4 Hz, 1H), 7.52 (d, J = 6.8 Hz, 2H), 
8.21 (d, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 22.3, 25.9, 28.0, 34.1, 37.0, 
43.0, 44.2, 50.1, 54.6, 56.3, 123.8, 127.3, 146.3, 154.8, 183.1; IR (neat) 2957, 2876, 
1666, 1603, 1518, 1348, 1317, 1186, 1177, 732 cm-1; HRMS calcd for C19H27N2O3 















[1,2-a]azepin-5(6H)-one (30) and (4R,6R)-4-tert-Butyl-6-(3,4,5-
trimethoxyphenyl)-1-azabicyclo[4.3.1]decan-10-one (37). According to the general 
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procedure, the reaction of azide 23 (0.0779 g, 0.19 mmol, 1.0 equiv) and MeAlCl2 
(1.0 M in hexanes, 0.29 mL, 1.5 equiv) in CH2Cl2 (3.6 mL, 0.05 M) for 24 h afforded 
after chromatography 1/1 hexanes/EtOAc-EtOAc lactam 30 (0.0136 g, 0.036 mmol, 
yield 19%) as oil (Rf = 0.28, 1/1 EtOAc/hexanes) and lactam 37 (0.0473 g, 0.126 
mmol, yield 66%, Rf = 0.53, 1/1 EtOAc/hexanes) as solid (Mp  = 158-159 °C). 
Analysis of the crude reaction mixture by 1H NMR indicated 21:79 ratio of 30 to 37. 
Compound 30: 1H NMR (400 MHz, CDCl3) δ 0.93 (s, 9H), 1.22-1.52 (m, 3H), 1.58 
(t, J = 13.2 Hz, 1H), 1.66-1.78 (m, 1H), 1.86-1.97 (m, 1H), 2.05-2.19 (m, 2H), 2.21-
2.36 (m, 2H), 2.42 (d, J = 14.0 Hz, 1H), 3.58-3.74 (m, 2H), 3.86 (s, 9H), 6.37 (d, J = 
3.1 Hz, 2H);  13C NMR (100 MHz, CDCl3) δ 19.8, 24.7, 27.1, 32.7, 32.9, 39.2, 41.6, 
43.0, 47.6, 56.3, 60.8, 68.8, 102.2, 136.9, 143.0, 153.2, 172.4; IR (neat) 2960, 1630, 
1580, 1500, 1445, 1405, 1325, 1235, 1120 cm-1; HRMS calcd for C22H34NO4 (M+ + 
H) 376.2488, found 376.2477. Compound 37: 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 
9H), 1.50 (m, 1H), 1.54-1.63 (m, 1H), 1.85-1.97 (m, 5H), 2.07 (m, 1H), 2.49 (d, J = 
11.9 Hz, 1H), 2.59-2.67 (m, 1H), 3.30-3.38 (m, 1H). 3.70 (d, J = 11.0 Hz, 1H), 3.83 
(d, J = 4.0 Hz, 3H), 3.87 (d, J = 3.8 Hz, 6H), 3.90-3.97 (m, 1H), 6.55 (d, J = 3.8 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 22.5, 25.9, 28.0, 34.1, 37.6, 43.1, 44.3, 50.3, 
54.6, 56.2, 56.4, 60.8, 103.7, 136.6, 143.4, 153.1, 184.2; IR (neat) 2950, 1660, 1580, 
















[1,2-a]azepin-5(6H)-one (21) and (4R,6R)-4-tert-Butyl-6-(3,4-dimethoxyphenyl)-
1-azabicyclo[4.3.1]decan-10-one (38). According to the general procedure, the 
reaction of azide 24 (0.0849 g, 0.23 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in 
hexanes, 0.34 mL, 1.5 equiv) in CH2Cl2 (4.2 mL, 0.05 M) for 24 h afforded after 
chromatography 1/2 hexanes/EtOAc-EtOAc lactam 31 (0.0143 g, 0.041 mmol, yield 
18%) as oil (Rf = 0.27, 1/1 EtOAc/hexanes) and lactam 38 (0.0520 g, 0.150 mmol, 
yield 65%, Rf = 0.55, 1/1 EtOAc/hexanes) as solid (Mp  = 105-106 °C). Analysis of 
the crude reaction mixture by 1H NMR indicated 22:78 ratio of 31 to 38. Compound 
31: 1H NMR (400 MHz, CDCl3) δ 0.91 (s, 9H), 1.29 (m, 2H), 1.42 (q, J = 10.6 Hz, 
1H), 1.55 (q, J = 10.1, 1H), 1.71 (m, 1H), 1.90 (m, 1H), 2.09 (d, J = 6.8 Hz, 2H), 
2.16-2.33 (m, 2H), 2.42 (d, J = 13.8 Hz, 1H), 3.57-3.72 (m, 2H), 3.88 (s, 6H), 6.68-
6.73 (m, 2H), 6.82 (d, J = 8.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 19.7, 24.7, 
27.1, 32.6, 33.0, 39.4, 41.5, 43.0, 47.5, 55.9, 56.1, 68.3, 108.3, 110.8, 117.1, 139.7, 
147.9, 149.0, 172.4; IR (neat) 2955, 1634, 1514, 1450, 1257, 1140 cm-1; HRMS calcd 
for C21H32NO3 (M+ + H) 346.2382, found 346.2397. Compound 38: 1H NMR (400 
MHz, CDCl3) δ 0.98 (s, 9H), 1.47-1.68 (m, 2H), 1.82-2.12 (m, 6H), 2.50 (d, J = 11.9 
Hz, 1H), 2.60-2.68 (m, 1H), 3.36 (m, 1H), 3.71 (dd, J = 3.2, 11.3 Hz, 1H), 3.88 (s, 
3H), 3.89 (s, 3H), 3.95 (m, 1H), 6.84-6.91 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 
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22.6, 26.0, 28.0, 34.1, 37.7, 43.1, 44.5, 50.2, 54.7, 55.9, 55.9, 56.0, 110.2, 111.3, 
117.8, 140.6, 147.5, 148.7, 184.6; IR (neat) 2955, 1666, 1518, 1460, 1252,  1150, 














[1,2-a]azepin-5(6H)-one (32) and (4R,6R)-6-(Benzo[d][1,3]dioxol-5-yl)-4-tert-
butyl-1-azabicyclo[4.3.1]decan-10-one (39). According to the general procedure, the 
reaction of azide 25 (0.1005 g, 0.28 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in 
hexanes, 0.42 mL, 1.5 equiv) in CH2Cl2 (5.2 mL, 0.05 M) for 24 h afforded after 
chromatography 1/2 hexanes/EtOAc lactam 32 (0.0123 g, 0.037 mmol, yield 13%) as 
oil (Rf = 0.56, 1/1 EtOAc/hexanes) and lactam 39 (0.0669 g, 0.203 mmol, yield 72%, 
Rf = 0.81, 1/1 EtOAc/hexanes) as solid (Mp  = 162-163 °C). Analysis of the crude 
reaction mixture by 1H NMR indicated 17:83 ratio of 32 to 39. Compound 32: 1H 
NMR (400 MHz, CDCl3) δ 0.92 (s, 9H), 1.30 (m, 2H), 1.41-1.57 (m, 2H), 1.68-1.75 
(m, 1H), 1.91 (m, 1H), 2.06-2.11 (m, 2H), 2.20 (dt, J = 6.4, 12.9 Hz, 1H), 2.30 (m, 
1H), 2.41 (d, J = 13.8 Hz, 1H), 3.60-3.71 (m, 2H), 5.98 (s, 2H), 6.64 (dd, J = 1.9, 8.1 
Hz, 1H), 6.72 (d, J = 1.8 Hz, 1H), 6.77 (d, J = 8.1 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 19.7, 24.7, 27.1, 32.7, 33.0, 39.5, 41.4, 43.1, 47.5, 68.4, 101.2, 105.7, 107.9, 
117.9, 141.2, 146.4, 148.0, 172.3; IR (neat) 2959, 2870, 1634, 1487, 1440, 1234, 
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1050 cm-1; HRMS calcd for C20H28NO3 (M+ + H) 330.2069, found 330.2065. 
Compound 39: 1H NMR (400 MHz, CDCl3) δ 0.97 (s, 9H), 1.50 (m, 1H), 1.58 (t, J = 
11.5 Hz, 1H), 1.82-2.08 (m, 6H), 2.45 (d, J = 11.8 Hz, 1H), 2.57-2.66 (m, 1H), 3.34 
(m, 1H), 3.69 (dd, J = 3.2, 11.0 Hz, 1H), 3.93 (m, 1H), 5.94 (s, 2H), 6.77-6.85 (m, 
3H); 13C NMR (100 MHz, CDCl3) δ 22.5, 26.0, 28.0, 34.1, 37.7, 43.0, 44.5, 50.2, 
54.7, 56.0, 100.9, 107.2, 108.2, 118.9, 141.8, 145.7, 147.6, 184.4; IR (neat) 2959, 
1666, 1504, 1487, 1240, 1040, 731 cm-1; HRMS calcd for C20H28NO3 (M+ + H) 












[1,2-a]azepin-5(6H)-one (33) and (4R,6R)-4-tert-Butyl-6-(3,5-dimethoxyphenyl)-
1-azabicyclo[4.3.1]decan-10-one (40). According to the general procedure, the 
reaction of azide 26 (0.0802 g, 0.21 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in 
hexanes, 0.32 mL, 1.5 equiv) in CH2Cl2 (4.0 mL, 0.05 M) for 24 h afforded after 
chromatography 1/2 hexanes/EtOAc lactam 33 (0.0185 g, 0.054 mmol, yield 25%) as 
oil (Rf = 0.42, 1/1 EtOAc/hexanes) and lactam 40 (0.0470 g, 0.136 mmol, yield 65%, 
Rf = 0.72, 1/1 EtOAc/hexanes) as solid (Mp = 117-118 °C). Analysis of the crude 
reaction mixture by 1H NMR indicated 27:73 ratio of 33 to 40. Compound 33: 1H 
NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 1.23-1.35 (m, 2H), 1.46 (m, 1H), 1.51-1.58 
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(m, 1H), 1,71 (m, 1H), 1.89 (m, 1H), 2.02-2.18 (m, 2H), 2.21-2.31 (m, 2H), 2.38 (d, J 
= 14.0 Hz, 1H), 3.57-3.71 (m, 2H), 3.79 (s, 6H), 6.32-6.38 (m, 3H); 13C NMR (100 
MHz, CDCl3) δ 19.7, 24.7, 27.1, 32.6, 32.9, 39.1, 41.4, 42.9, 47.5, 55.4, 68.7, 97.8, 
103.6, 149.9, 160.9, 172.3; IR (neat) 2955, 2916, 1634, 1597, 1454, 1421, 1157 cm-1; 
HRMS calcd for C21H32NO3 (M+ + H) 346.2383, found 346.2382. Compound 40: 1H 
NMR (400 MHz, CDCl3) δ 0.97 (s, 9H), 1.49 (m, 1H), 1.61 (t, J = 11.8 Hz, 1H), 
1.81-2.08 (m, 6H), 2.47 (d, J = 12.1 Hz, 1H), 3.34 (t, J = 11.1 Hz, 1H), 3.68 (m, 1H), 
3.80 (s, 6H), 3.89-3.97 (m, 1H), 6.36 (t, J = 2.1 Hz, 1H), 6.51 (d, J = 2.2 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 22.6, 26.0, 28.0, 34.1, 37.5, 43.0, 44.0, 50.2, 54.7, 55.3, 
56.4, 97.8, 104.7, 150.1, 160.7, 184.2; IR (neat) 2957, 1670, 1595, 1456, 1155 cm-1; 
HRMS calcd for C21H32NO3 (M+ + H) 346.2383, found 346.2396. 
.  
Influence of Stoichiometry of Lewis Acid on Product Distribution in 
Cation-π Directed Schmidt Reaction (Table 8). According to the general procedure 
azides were reacted with 1.0, 1.5, 2.0 and 3.0 equiv of MeAlCl2 and 2.0 equiv of 
BF3•CH3CN for 24 h at rt. Aqueous work-up and analysis of the crude reaction 








According to the general procedure, the reaction of NaH (0.0956 g, 2.39 mmol, 1.1 
equiv), HMPA (0.46 mL, 2.60 mmol, 1.2 equiv), 6 (0.50 g, 2.17 mmol, 1.0 equiv) and 
1-chloro-4-iodobutane (1.08 mL, 8.68 mmol, 4.0 equiv) in THF (30 mL) for 20 h 
afforded after chromatography (1/50 EtOAc/hexanes) the title compound as oil (Rf = 
0.51, 1/10 EtOAc/hexanes). Yield 46% (0.322 g, 1.00 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.97 (s, 9H), 0.90-1.04 (m, 1H), 1.34-1.48 (m, 1H), 1.58-1.68 (m, 2H), 1.75 
(p, J = 7.0 Hz, 2H), 1.93-2.18 (m, 5H), 2.50 (m, 2H), 3.42-3.54 (m, 2H), 7.23-7.40 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.1, 26.2, 27.4, 32.6, 32.8, 35.0, 37.4, 38.2, 
41.9, 44.6, 56.2, 126.6, 127.4, 128.2, 142.1, 214.2; IR (neat) 2954, 1710, 1465, 1444, 







According to the general procedure the reaction of chloride 41 (0.296 g, 0.92 mmol, 
1.0 equiv), NaN3 (0.60 g, 9.2 mmol, 10.0 equiv) in DMF (20 mL) at 80 °C for 2.5 h 
afforded after chromatography (1/4 EtOAc/hexanes) the title compound as oil (Rf = 
0.39, 1/10 EtOAc/hexanes). Yield 90% (0.270 g, 0.82 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.88-1.02 (m, 1H), 0.97 (s, 9H), 1.26-1.38 (m, 1H), 1.52-1.69 (m, 4H), 
205 
 
1.93-2.16 (m, 5H), 2.47-2.54 (m 2H), 3.16-3.37 (m, 2H), 7.24-7.40 (m, 5H); 13C 
NMR (100 MHz, CDCl3) δ 21.0, 26.1, 27.3, 29.2, 32.6, 35.4, 37.6, 38.2, 41.9, 51.1, 
56.2, 126.6, 127.4, 128.2, 142.1, 214.2; IR (neat) 2952, 2868, 2094, 1710, 1465, 
1444, 1365, 1257 cm-1; HRMS calcd for C20H30N3O (M+ + H) 328.2389, found 
328.2384. 
Attempted Schmidt Reaction with Azide 42. According to the general 
procedure 42 (0.100 g, 0.30 mmol, 1.0 equiv) was reacted with MeAlCl2 (1.0 M in 
hexanes, 0.61 mL, 0.61 mmol, 2.0 equiv) in CH2Cl2 (5.5 mL, 0.05 M) at rt for 24 h. 
Analysis of the crude reaction mixture by NMR indicated only the presence of 
starting material. Note: the reaction of 42 with TiCl4 (5.0 equiv, toluene, 105 °C, 18 
h) or Sc(OTf)3 (0.5 equiv, H2O, 180 °C, 3 h)397 did not afford the desired lactams; 
only starting material and decomposition products were observed when crude reaction 







5-tert-Butyl-N-butyl-2-oxocyclohexanecarboxamide (44). The compound 
was prepared following a procedure by Hendi et al.393 To a solution of LDA prepared 
from diisopropylamine (4.8 mL, 34.0 mmol, 1.05 equiv) and n-BuLi (1.55 M in 
hexanes, 20.9 mL, 32.4 mmol, 1.0 equiv) in Et2O (80 mL) at -78 °C for 15 min, 4-
tert-butylcyclohexanone (5.05 g, 32.4 mmol, 1.0 equiv) was added in Et2O (20 mL) at 
-78 °C, and the stirring was continued for 20 min. butyl isocyanate (3.65 mL, 32.4 
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mmol, 1.0 equiv) was added in Et2O (10 mL) at -78 °C. After the reaction mixture 
was stirred at -78 °C for 2 h, the reaction was allowed to slowly warm up to rt. After 
the reaction was stirred for the next 2 h, the reaction was quenched with sat. NH4Cl 
(50 mL). The aqueous layer was extracted with ether (3 x 100 mL), combined organic 
layers were washed with brine (1 x 100 mL), dried and concentrated. 
Chromatography (1/4 EtOAc/hexanes) afforded the title compound as solid (Mp = 83 
-84 °C). Yield 67% (5.49 g, 21.7 mmol). The compound exists as a mixture of keto-
enol tautomers and amide rotamers. 1H NMR (400 MHz, CDCl3) δ 0.81-0.95 (m, 
12H), 1.16-1.65 (m, 8H), 1.83 (t, J = 11.8 Hz, 1H), 1.92-2.12 (m, 1H), 2.24 (d, J = 7.5 
Hz, 1H), 2.28-2.58 (m, 1H), 3.08-3.30 (m, 2H), 5.27 (s, 0.5H), 6.05 (s, 0.1H), 7.43 (s, 
0.3H), 14.16 (s, 0.5H); 13C NMR (100 MHz, CDCl3) δ 13.7, 13.7, 13.8, 20.0, 20.1, 
20.1, 23.1, 23.9, 26.2, 27.3, 27.4, 27.5, 27.6, 28.4, 28.9, 30.3, 31.5, 31.5, 31.8, 32.3, 
32.4, 32.4, 32.6, 32.7, 33.4, 38.9, 39.0, 39.1, 39.5, 40.3, 42.0, 42.2, 44.3, 46.7, 54.6, 
55.8, 96.5, 167.5, 169.4, 169.8, 172.6, 211.0, 211.2; IR (neat) 3320, 2940, 2850, 
1705, 1625, 1530, 1355, 1295, 1215 cm-1; HRMS calcd for C15H28O2 (M+ + H) 







carboxylate (45). According to the general procedure, the reaction of NaH (0.039 g, 
0.97 mmol, 1.1 equiv), HMPA (0.19 mL, 1.06 mmol, 1.2 equiv), 43 (0.20 g, 0.88 
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mmol, 1.0 equiv) and 1-chloro-3-iodopropane (0.38 mL, 3.52 mmol, 4.0 equiv) in 
THF (15 mL) for 24 h afforded after chromatography (1/50 EtOAc/hexanes) the title 
compound as oil. Yield 62% (0.165 g, 0.55 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.93 (d, J = 2.9 Hz, 9H), 1.27 (dt, J = 3.0, 7.1 Hz, 3H), 1.46-1.68 (m, 3H), 1.81-2.17 
(m, 6H), 2.36-2.52 (m, 2H), 3.47-3.62 (m, 2H), 4.13-4.26 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 14.1, 26.5, 27.4, 27.5, 30.3, 32.5, 33.7, 38.4, 41.5, 45.1, 60.4, 61.2, 
172.3, 209.3; IR (neat) 2940, 1720, 1700, 1440, 1355, 1240 cm-1; HRMS calcd for 







(47). According to the general procedure, the reaction of chloride 45 (0.100 g, 0.33 
mmol, 1.0 equiv) and NaN3 (0.11 g, 1.65 mmol, 5.0 equiv) in DMF (5 mL) at 80 °C 
for 2.5 h afforded after chromatography (1/10 EtOAc/hexanes) the title compound as 
oil. Yield 81% (0.083 g, 0.27 mmol). 1H NMR (400 MHz, CDCl3) δ 0.93 (d, J = 1.5 
Hz, 9H), 1.22-1.32 (dt, J = 2.0, 7.2 Hz, 3H), 1.37-1.76 (m, 4H), 1.82-2.18 (m, 5H), 
2.44 (s, 2H), 3.24-3.38 (m, 2H), 4.13-4.26 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
14.1, 24.0, 26.4, 27.4, 30.1, 32.5, 33.7, 38.4, 41.6, 51.5, 60.5, 61.2, 172.2, 209.3; IR 
(neat) 2940, 2080, 1720, 1700, 1440, 1360, 1240, 1180 cm-1; HRMS calcd for 










carboxamide (46). To a suspension of NaH (0.103 g, 2.56 mmol, 1.1 equiv) in THF 
(15 mL), amide 44 (0.59 g, 2.33 mmol, 1.0 equiv) was added in THF (5.0 mL) 
dropwise at 0 °C, and the reaction mixture was stirred at rt for 40 min. 1-chloro-3-
iodopropane (0.38 mL, 3.50 mmol, 1.5 equiv) was added neat and the reaction was 
stirred at rt for 9 h. Work-up analogous to the described above followed by 
chromatography (1/6 EtOAc/hexanes) afforded the title compound as oil. Yield 47% 
(0.363 g, 1.10 mmol). 1H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 0.80-1.05 
(m, 12H), 1.05-1.18 (m, 0.5H), 1.22-1.58 (m, 6H), 1.59-1.78 (m, 3.5H), 1.92-2.22 (m, 
2.5H), 2.32-2.71 (m, 2.5H), 3.09-3.59 (m 4H), 5.83 (s, 0.25H), 8.29 (s, 0.5H); 13C 
NMR (100 MHz, CDCl3) (mixture of rotamers) δ 13.6, 13.7, 20.0, 20.1, 26.7, 27.1, 
27.3, 27.4, 27.7, 31.4, 31.5, 32.4, 33.4, 34.3, 35.0, 36.9, 39.0, 39.5, 40.6, 41.3, 43.1, 
44.6, 45.1, 57.0, 59.9, 169.3, 171.9, 212.4, 215.6; IR (neat) 3330, 2940, 1680, 1635, 












carboxamide (48). According to the general procedure, the reaction of chloride 46 
(0.280 g, 0.85 mmol, 1.0 equiv) and NaN3 (0.28 g, 4.2 mmol, 5.0 equiv) in DMF (10 
mL) at 80 °C for 2 h afforded after chromatography (1/4 EtOAc/hexanes) the title 
compound as oil. Yield 98% (0.281 g, 0.83 mmol). 1H NMR (400 MHz, CDCl3) δ 
(mixture of rotamers) 0.81-0.97 (m, 12H), 1.03-1.16 (m, 0.5H), 1.22-1.74 (m, 9.5H), 
1.81-2.10 (m, 2.5H), 2.30-2.65 (m, 2.5H), 3.11-3.25 (m, 4H), 5.74 (s, 0.25H), 8.00 (s, 
0.5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 13.7, 13.7, 20.0, 20.2, 
23.8, 24.2, 26.6, 27.2, 27.4, 27.4, 31.4, 31.5, 32.5, 33.4, 34.2, 34.5, 34.8, 37.0, 39.1, 
39.6, 40.6, 41.5, 43.1, 45.1, 51.1, 51.6, 57.1, 60.0, 60.1, 169.2, 171.9, 212.7, 215.8; 
IR (neat) 3330, 2070, 1675, 1625, 1510, 1450, 1350, 1240 cm-1; HRMS calcd for 






carboxylate (49). According to the general procedure, the reaction of azide 47 (0.180 
g, 0.58 mmol, 1.0 equiv) and MeAlCl2 (1.0 M in hexanes, 1.32 mL, 2.2 equiv, added 
in two portions at the beginning of the reaction and after 2 h) in CH2Cl2 (10.0 mL, 
0.05 M) for 6 h afforded after chromatography (100% EtOAc) lactam 49 (0.131 g, 
0.47 mmol, yield 80%) as oil. Analysis of the crude reaction mixture by NMR did not 
indicate the formation of bridged isomer. 1H NMR (400 MHz, CDCl3) δ 0.88 (s, 9H), 
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1.16-1.43 (m, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.61-1.76 (m, 2H), 1.78-1.93 (m, 3H), 
2.10 (d, J = 14.4 Hz, 1H),  2.27-2.48 (m, 3H), 3.50-3.66 (m, 2H), 4.16-4.26 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 14.2, 20.3, 24.3, 26.9, 32.6, 32.6, 33.6, 39.3, 40.6, 
47.2, 61.6, 68.4, 171.8, 174.5; IR (neat) 2950, 1720, 1635, 1440, 1410, 1360, 1250, 
1110 cm-1; HRMS calcd for C16H28NO3 (M+ + H) 282.2069, found 282.2076.  
Note: the Schmidt reaction of azide 47 (0.089 g, 0.29 mmol, 1.0 equiv) and 
TfOH (0.13 mL, 1.44 mmol, 5.0 equiv) in CH2Cl2 (10 mL) for 1 h at rt afforded 49 in 
92% yield (0.077 g, 0.27 mmol). The Schmidt reaction of azide 47 (0.081 g, 0.26 
mmol, 1.0 equiv) in TFA (3.0 mL, excess) for 2 h at rt afforded 49 in 88% yield 
(0.064 g, 0.23 mmol). The Schmidt reaction of azide 47 (0.103 g, 0.33 mmol, 1.0 
equiv) and BF3•OEt2 (0.046 mL, 0.37 mmol, 1.1 equiv) in CH2Cl2 (10 mL) for 5 h at 
rt afforded 49 in 78% yield (0.072 g, 0.26 mmol); Analysis of crude reaction mixtures 











9a-carboxamide (50) and (4R,6R)-4-tert-Butyl-N-butyl-10-oxo-1-azabicyclo[4.3.1] 
decane-6-carboxamide (51). According to the general procedure, the reaction of 
azide 48 (0.16 g, 0.47 mmol, 1.0 equiv) and TfOH (0.21 mL, 5.0 equiv) in CH2Cl2 
(10.0 mL, 0.05 M) for 23 h afforded after chromatography (100% EtOAc-10% 
MeOH/CH2Cl2) lactam 50 (eluting with EtOAc, 0.077 g, 0.25 mmol, yield 52%) as 
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oil and lactam 51 (eluting with MeOH/CH2Cl2, 0.0192 g, 0.062 mmol, yield 13%) as 
oil. Compound 50: 1H NMR (400 MHz, CDCl3) (mixture of rotamers, major rotamer) 
δ 0.88 (s, 9H), 0.93 (t, J = 7.3 Hz, 3H), 1.02-1.11 (m, 1H), 1.29-1.44 (m, 3H), 1.45-
1.53 (m, 2H), 1.57-1.69 (m, 2H), 1.78-1.91 (m, 3H), 2.25 (d, J = 14.9 Hz, 1H), 2.29-
2.41 (m, 2H), 2.45 (dd, J = 6.2, 6.3 Hz, 1H), 3.18-3.39 (m, 2H), 3.50-3.59 (m, 1H), 
3.61-3.68 (m, 1H), 6.53 (s, 1H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers, 
major rotamer) δ 13.7, 20.1, 20.4, 24.5, 26.9, 31.7, 32.7, 32.9, 33.9, 39.3, 39.5, 40.9, 
48.1, 70.3, 172.9, 174.4; IR (neat) 3330, 1950, 1650, 1615, 1520, 1440, 1415, 1360, 
1170 cm-1; HRMS calcd for C18H33N2O2 (M+ + H) 309.2542, found 309.2552. 
Compound 51: 1H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 0.76-1.00 (m, 
12H), 1.15-1.49 (m, 6H), 1.71-2.05 (m, 3H), 2.16-2.34 (m, 2H), 2.39-2.83 (m, 3H), 
3.14-3.40 (m, 3H), 3.69-3.79 (m, 1H), 3.92-4.02 (m, 1H), 5.31 (s, 1H); 13C NMR (100 
MHz, CDCl3) (mixture of rotamers) δ 13.7, 20.0, 23.3, 26.9, 27.2, 27.5, 27.7, 27.8, 
30.0, 20.9, 31.6, 31.7, 32.3, 32.5, 34.6, 37.9, 38.3, 39.2, 39.4, 39.6, 42.7, 44.8, 58.9, 
59.2, 61.2, 62.0, 172.0, 172.9, 179.2, 180.5; IR (neat) 3320, 2940, 1645, 1625, 1520, 
1455, 1145, 1100 cm-1; HRMS calcd for C18H33N2O2 (M+ + H) 309.2542, found 
309.2558. Note: the reaction of 48 (0.323 g, 0.96 mmol) and MeAlCl2 (1.0 M in 
hexanes, 1.44 mL, 1.5 equiv) in CH2Cl2 (15 mL, 0.06 M) for 5 h at rt afforded 50 in 
77% yield (0.237 g, 0.74 mmol). Analysis of crude reaction mixtures by NMR did not 
indicate formation of the bridged isomer 51. 
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2-(3′-Chloropropyl)-2-(methylthio)cyclohexanone (56). To a suspension of 
potassium hydride (0.56 g, 14.1 mmol, 2.5 equiv) in 15 mL of THF was added 2-
(methylthio)cyclohexanone 55395 (0.81 g, 5.6 mmol, 1.0 equiv) dropwise in 5 mL of 
THF at room temperature and the resulting solution was stirred for 10 min. 1-Chloro-
3-iodopropanone (1.80 mL, 16.8 mmol, 3.0 equiv) was added in one portion and the 
solution was stirred for 48 h at room temperature followed by reflux for 30 min. The 
reaction was cooled to room temperature, diluted with ether (20 mL) and quenched 
with saturated NaHCO3 (10 mL). The aqueous layer was extracted with ether (2 x 20 
mL), and the combined organic layers were washed with water (20 mL) and brine (20 
mL). The organic layer was dried (Na2SO4) and concentrated. Chromatography (4% 
EtOAc/hexanes) afforded the title compound as a colorless oil (Rf = 0.46, 10% 
EtOAc/hexanes). Yield 47% (0.579 g, 2.63 mmol). Note: the crude reaction mixture 
is unstable and must be chromatographed immediately after work-up. The title 
compound is unstable at room temperature. 1H NMR (400 MHz, CDCl3) δ 1.55-2.07 
(complex, 13H), 2.21 (dddd, J = 2.0, 2.2, 4.2, 15.2 Hz, 1H), 3.10 (dt, J = 6.0, 14.9 Hz, 
1H), 3.50-3.61 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 10.9, 20.9, 26.4, 26.9, 30.6, 
36.2, 36.8, 45.4, 56.1, 206.6; IR (neat) 2937, 2862, 1697, 1445, 1124 cm-1; HRMS 






2-(3′-Azidopropyl)-2-(methylthio)cyclohexanone (57). Caution! Low 
molecular weight alkylazides are potential explosion hazards and should be used with 
appropriate caution. 2-(3′-Chloropropyl)-2-(methylthio)cyclohexanone 56 (0.52 g, 
2.4 mmol, 1.0 equiv) and NaN3 (0.77 g, 11.8 mmol, 5.0 equiv) were combined in 
DMF (20 mL), and the mixture was heated to 80 °C for 2 h. Ether (150 mL) was 
added, and the mixture was washed with water (4 x 50 mL) and brine (1 x 50 mL). 
The organic layer was dried (Na2SO4) and concentrated. Flash chromatography (3% 
EtOAc/hexanes) afforded the compound as yellowish oil (Rf = 0.41, 10% 
EtOAc/hexanes). Yield 82% (0.449 g, 1.98 mmol). Note: the title compound is 
unstable at room temperature. 1H NMR (400 MHz, CDCl3) δ 1.49-1.91 (complex, 
10H), 1.92-2.10 (m, 3H), 2.24 (dddd, J = 2.0, 2.2, 4.2, 15.2 Hz, 1H), 3.13 (dt, J = 6.0, 
14.7 Hz, 1H), 3.33 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 10.9, 20.9, 23.1, 26.4, 
30.4, 36.2, 36.9, 51.7, 56.2, 206.7; IR (neat) 2937, 2862, 2095, 1697, 1448, 1257, 








6-(Methylthio)-1-azabicyclo[4.3.1]decan-10-one (58) and 9a-
(Methylthio)hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (59). To a solution of 
azide 57 (0.0910 g, 0.40 mmol, 1.0 equiv) in CH2Cl2 (8.0 mL, 0.05 M) was added 
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TfOH (0.18 mL, 2.0 mmol, 5.0 equiv) in one portion at 0 °C and the resulting 
solution was stirred at 0° C for 2.5 min. The reaction was quenched with saturated 
NaHCO3 (10 mL), and extracted with CH2Cl2 (3 x 20 mL). The organic layer was 
washed with brine (1 x 20 mL), dried (Na2SO4), and concentrated. Analysis of the 
crude reaction mixture by 1H NMR indicated 80:20 ratio of 58 to 59. Flash 
chromatography (1/2 EtOAc/hexanes, followed by EtOAc) afforded compound 58 as 
a pale yellow oil (Rf = 0.57, 1/1 EtOAc/hexanes), yield 65% (0.0525 g, 0.26 mmol) 
and compound 59 as a colorless oil (Rf = 0.31, 1/1 EtOAc/hexanes), yield 15% 
(0.0120 g, 0.06 mmol). Compound 58: 1H NMR (400 MHz, CDCl3) δ 1.53-1.79 
(complex, 4H), 1.80-1.99 (complex, 4H), 2.05-2.14 (complex, 4H), 2.22-2.29 (m, 
1H), 2.80-2.86 (m, 1H), 3.18-3.24 (m, 1H), 3.43 (dt, J =2.8, 12.0 Hz, 1H), 3.86-3.94 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 12.8, 22.5, 24.3, 26.5, 36.4, 40.1, 47.9, 50.6, 
57.0, 182.4; IR (neat) 2927, 2860, 1686, 1445, 1173 cm-1; HRMS calcd for 
C10H18NOS (M+ + H) 200.1109, found 200.1107. Compound 59: 1H NMR (400 MHz, 
CDCl3) δ 1.45-1.57 (m, 1H), 1.62-1.90 (complex, 4H), 1.97-2.14 (complex, 6H), 
2.16-2.23 (m, 1H), 2.41-2.47 (m, 1H), 2.50-2.56 (m, 1H), 3.20 (dt, J = 2.2, 13.8 Hz, 
1H), 3.48-3.57 (m, 1H), 3.68-3.75 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 13.2, 
21.1, 23.7, 24.9, 37.2, 39.3, 43.1, 49.6, 72.7, 174.7; IR (neat) 2926, 1632, 1429, 1406 















and (2R,4S)-4-tert-Butyl-2-(3-chloropropyl)-2-(methylthio)cyclohexanone (62). 
According to the procedure for 56 the reaction of 60381 (2.05g, 10.3 mmol, 1.0 equiv), 
KH (1.03 g, 25.7 mmol, 2.5 equiv) and 1-chloro-3-iodopropane (3.31 mL, 30.8 mmol, 
3.0 equiv) in THF (30 mL) at rt for 48 h, followed by reflux for 0.5 h afforded after 
chromatography (1/50 EtOAc/hexanes) 61 as colorless oil (Rf = 0.57, 1/10 
EtOAc/hexanes), yield ca. 6% (0.174 g, 0.63 mmol), and 62 as colorless oil (Rf = 
0.51, 1/10 EtOAc/hexanes), yield ca. 6%, purity ca. 80% (0.190 g, 0.68 mmol). 
Compound 61: 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 1.32 (m, 1H), 1.60 (t, J = 
13.6 Hz, 1H), 1.68-1.78 (m, 2H), 1.81-1.97 (m, 3H), 1.89 (s, 3H), 1.98-2.08 (m, 2H), 
2.24-2.33 (m, 1H), 2.80-2.88 (m, 1H), 3.59 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
11.8, 24.6, 27.1, 27.1, 29.3, 32.6, 36.1, 36.2, 42.7, 45.2, 55.6, 208.1; IR (neat) 3453, 
2959, 1700, 1441, 1368, 1229 cm-1; HRMS calcd for C14H26ClOS (M+ + H) 
277.1393, found 277.1379. Compound 62: 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 
9H), 1.31-1.46 (m, 1H), 1.55-2.06 (m, 8H), 1.81 (s, 3H), 2.22-2.29 (m, 1H), 3.08-3.18 
(m, 1H), 3.51-3.63 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 11.1, 27.0, 27.3, 27.5, 
30.9, 32.2, 36.6, 37.3, 41.6, 45.3, 55.4, 206.6; IR (neat) 2917, 1698, 1437, 1420, 









According to the general procedure the reaction of 61 (0.16 g, 0.58 mmol, 1.0 equiv) 
and NaN3 (0.19 g, 2.90 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2 h afforded 
after chromatography (1/20 EtOAc/hexanes) the title compound as colorless oil (Rf = 
0.41, 1/10 EtOAc/hexanes). Yield 63% (0.104 g, 0.37 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.89 (s, 9H), 1.38 (m, 1H), 1.54-1.78 (m, 5H), 1.88 (s, 3H), 1.84-1.92 (m, 
2H), 1.99-2.06 (m, 1H), 2.21-2.30 (m, 1H), 2.78-2.88 (m, 1H), 3.34 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 11.8, 23.4, 24.5, 27.1, 29.1, 32.6, 36.1, 36.1, 42.8, 51.6, 
55.5, 208.0; IR (neat) 3439, 2959, 2095, 1704, 1368, 1256 cm-1; HRMS calcd for 







According to the general procedure the reaction of 62 (0.15 g, 0.54 mmol, 1.0 equiv) 
and NaN3 (0.17 g, 2.70 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2 h afforded 
after chromatography (1/50 EtOAc/hexanes) the title compound as colorless oil (Rf = 
0.42, 1/10 EtOAc/hexanes). Yield 76% (0.117 g, 0.41 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.91 (s, 9H), 1.35 (m, 1H), 1.48-1.66 (m, 3H), 1.69-1.77 (m, 1H), 1.81 (s, 
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3H), 1.82-1.98 (m, 2H), 2.00-2.08 (m, 2H), 2.22-2.30 (m, 1H), 3.13 (dt, J = 5.8, 15.0 
Hz, 1H), 3.26-3.40 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 11.1, 23.2, 27.3, 27.5, 
30.6, 32.2, 36.6, 37.2, 41.6, 51.8, 55.5, 206.5; IR (neat) 2959, 2095, 1698, 1468, 








According to the procedure for 57, the reaction of 63 (0.0344, 0.12 mmol, 1.0 equiv, 
single diastereoisomer) and TfOH (0.055 mL, 0.61 mmol, 5.0 equiv) in CH2Cl2 (2.4 
mL, 0.05 M) for 60 s at 0 °C afforded after chromatography (1/3 EtOAc/hexanes) the 
title compound as white solid (Mp = 141 °C, Rf = 0.70, 1/1 EtOAc/hexanes). Yield 
74% (0.0226 g, 0.09 mmol). 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 1.42 (m, 
2H), 1.62-1.84 (m, 3H), 1.86-1.93 (m, 1H), 2.02-2.15 (m, 2H), 2.22 (s, 3H), 2.43 (m, 
1H), 2.58 (m, 1H), 3.23 (dt, J = 3.3, 11.4 Hz, 1H), 3.56-3.61 (m, 1H), 3.85 (dd, J = 
5.8, 13.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 12.8, 23.4, 26.3, 27.8, 33.9, 36.5, 
43.4, 45.6, 50.0, 54.7, 57.9, 182.6; IR (neat) 2952, 2916, 1680, 1465, 1236 cm-1; 
HRMS calcd for C14H26NOS (M+ + H) 256.1735, found 256.1734. The analysis of the 
above crude reaction mixture by 1H NMR indicated 86:7:7 ratio of 65:66:67. 66 and 
67 were not isolated. The Schmidt reaction of 63 (0.0303 g, 0.11 mmol, 1.0 equiv) 
carried out with BF3•Et2O (1.04 M, 0.31 mL, 3.0 equiv) in CH2Cl2 (2.1 mL, 0.05 M), 
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at rt for 2 h afforded the title compound in 69% yield (0.0187 g, 0.073 mmol). The 







t -Bu SMe  
8-tert-Butyl-9a-(methylthio)hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-
one (66) and 8-tert-Butyl-2,3,7,8-tetrahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(67). According to the procedure for 57, the reaction of 64 (0.0356, 0.13 mmol, 1.0 
equiv, single diastereoisomer) and TfOH (0.055 mL, 0.63 mmol, 5.0 equiv) in CH2Cl2 
(2.5 mL, 0.05 M) for 60 s at 0 °C, afforded after chromatography (1/4-1/1 
EtOAc/hexanes) 66 (mixture of diastereoisomers, resulting from acid-promoted 
elimination-addition) as oil (Rf = 0.15, 1/4 EtOAc/hexanes), yield 57% (0.0184 g, 
0.072 mmol) and 67 as oil (Rf = 0.31, 1/4 EtOAc/hexanes), yield 18% (0.0047 g, 
0.023 mmol). Analysis of the crude reaction mixture by TLC and NMR did not 
indicate the formation of the bridged lactam. Note: compound 66 is very unstable; 
decomposition was observed during solvent removal, at rt over time, and during 
chromatography on SiO2. Compound 66 (major isomer): 1H NMR (400 MHz, CDCl3) 
δ 0.92 (s, 9H), 1.36 (m, 2H), 1.80-2.28 (m, 5H), 2.01 (s, 3H), 2.28 (m, 1H), 2.40-2.48 
(m, 1H), 2.53-2.62 (m, 1H), 3.16 (m, 1H), 3.46-3.54 (m, 1H), 3.68-3.78 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 13.4, 21.0, 24.6, 27.7, 33.1, 36.5, 40.9, 43.5, 45.6, 49.4, 
72.5, 174.6; IR (neat) 2956, 2918, 1635, 1413, 1365, 1226, 1194, 1107 cm-1; HRMS 
calcd for C14H25NOSNa (M+ + Na) 278.1555, found 278.1523. Compound 67: 1H 
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NMR (400 MHz, CDCl3) δ 0.93 (s, 9H), 1.67 (m, 1H), 1.77-1.89 (m, 2H), 1.98-2.13 
(m, 2H), 2.41-2.51 (m, 2H), 2.54-2.72 (m, 2H), 3.58-3.66 (m, 1H), 3.68-3.76 (m, 1H), 
5.00 (d, J = 1.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 21.5, 23.8, 27.7, 33.6, 34.2, 
36.3, 48.3, 50.2, 107.0, 137.9, 173.6; IR (neat) 3382, 2917, 2847, 1650, 1576, 1542, 
1385, 1123 cm-1; HRMS calcd for C13H21NONa (M+ + Na) 230.1521, found 
230.1507. Interestingly, the analogous amide 59, which differs only by the lack of the 
t-butyl substituent was found to be much more stable. The elimination was not 








Note: the azide 72 is known.173 There is an error in this reference; the single 
isomer obtained in the original report was incorrectly assigned as 74 (compound 25 in 
this reference). We now reassign the major product as 73 due to the IR and 13C NMR 
signatures of the carbonyl group in this molecule (1680 cm-1 and 181.9 ppm, 
respectively). In addition, we have been able to isolate legitimate 73 in the repeated 
reaction as shown below.  
6-(Phenylthio)-1-azabicyclo[4.3.1]decan-10-one (73) and 9a-(Phenylthio) 
hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (74). According to the general, the 
reaction of 72 (0.102 g, 0.35 mmol, 1.0 equiv) and TfOH (0.16 mL, 1.76 mmol, 5.0 
equiv) in CH2Cl2 (7.0 mL, 0.05 M) for 2.5 min at 0 °C afforded after chromatography 
(1/2 EtOAc/hexanes) 73 as oil (Rf = 0.62, 1/1 EtOAc/hexanes), yield 35% (0.0322 g, 
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0.12 mmol), and 74 as oil (Rf = 0.38, 1/1 EtOAc/hexanes), yield 32% (0.0288 g, 0.11 
mmol). Compound 73: 1H NMR (400 MHz, CDCl3) δ 1.34-1.48 (m, 1H), 1.62-1.69 
(m, 2H), 1.78-1.88 (m, 3H), 1.93-2.06 (m, 3H), 2.37 (dd, J = 6.3, 14.4 Hz, 1H), 2.78 
(dt, J = 5.6, 13.7, 1H), 3.24-3.38 (m, 2H), 3.94 (dt, J = 6.4, 13.8 Hz, 1H), 7.28-7.34 
(m, 3H), 7.60-7.64 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 22.6, 23.6, 25.7, 36.3, 
41.4, 49.7, 50.1, 61.5, 128.4, 128.7, 133.0, 135.9, 181.9; IR (neat) 2920, 1680 cm-1; 
HRMS calcd for C15H20NOS (M+ + H) 262.1266, found 262.1262. Compound 74: 1H 
NMR (400 MHz, CDCl3) δ 1.47-1.68 (m, 3H), 1.71-1.84 (m, 2H), 1.88-1.98 (m, 1H), 
1.99-2.06 (m, 1H), 2.20-2.32 (m, 2H), 2.37-2.45(m, 1H), 2.60 (dd, J = 5.7, 14.0 Hz, 
1H), 3.27 (t, J = 13.8 Hz, 1H), 3.45-3.56 (m, 2H), 7.32-7.43 (m, 3H), 7.48-7.51 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 20.4, 23.7, 24.9, 37.2, 40.9, 44.0, 49.6, 77.0, 
129.1, 129.3, 132.1, 136.8, 174.6; IR (neat) 2930, 1625, 1430, 1395, 1190 cm-1; 





6-Allyl-6-methoxy-1,4-dioxaspiro[4.5]decane (76). A solution of ketone 
75382 (5.35 g, 31.8 mmol, 1.0 equiv), ethylene glycol (3.7 mL, 63.7 mmol, 2.0 equiv), 
pTsOH (0.30 g, 1.60 mmol, 0.05 equiv) and benzene (20 mL) was heated under 
Dean-Stark trap for 15 h. The reaction mixture was cooled to rt, washed with sat. 
NaHCO3 (1 x 20 mL), dried over Na2SO4 and concentrated. Chromatography (1/10 
Et2O/Hexanes) afforded the title compound as oil (Rf = 0.25, 1/3 Et2O/hexanes). 
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Yield 44% (2.95 g, 13.9 mmol). 1H NMR (400 MHz, CDCl3) δ 1.37-1.62 (m, 6H), 
1.78-1.88 (m, 2H), 2.23 (ddt, J = 1.2, 7.4, 15.3 Hz, 1H), 2.56 (ddt, J = 1.4, 6.8, 15.2 
Hz, 1H), 3.32 (s, 3H), 3.92 (m, 4H), 3.88-4.02 (m, 2H), 5.87-5.99 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 20.3, 23.0, 31.1, 31.9, 34.8, 50.1, 64.3, 65.0, 79.2, 111.4, 116.0, 
135.0; IR (neat) 2937, 2882, 1180, 1088 cm-1; HRMS calcd for C12H20O3Na (M+ + 





3-(6-Methoxy-1,4-dioxaspiro[4.5]decan-6-yl)propan-1-ol (77). To a 
solution of 76 (2.27 g, 10.7 mmol, 1.0 equiv) in THF (40 mL), BH3 (2.0 M, THF, 8.1 
mL, 16.1 mmol, 1.5 equiv) was added dropwise at 0 °C. After stirring for 30 min at rt, 
H2O (7.1 mL), followed by NaOH (3.0 M, H2O, 11.6 mL) and H2O2 (30%, 7.8 mL) 
were added at 0 °C. After stirring for 2 h at rt, the reaction mixture was extracted with 
EtOAc (3 x 100 mL), dried (Na2SO4) and concentrated. Chromatography (1/1 
EtOAc/hexanes) afforded the title compound as oil (Rf = 0.30, 1/1 EtOAc/hexanes). 
Yield 60% (1.49 g, 6.5 mmol). 1H NMR (400 MHz, CDCl3) δ 1.35 (m, 1H), 1.41-
1.66 (m, 8H), 1.73-1.86 (m, 3H), 2.11 (br, 1H), 3.28 (s, 3H), 3.60 (m, 2H), 3.86-3.97 
(m, 4H); 13C NMR (100 MHz, CDCl3) δ 20.5, 22.9, 26.0, 26.5, 31.2, 32.1, 50.4, 63.6, 
64.3, 65.0, 79.0, 111.8; IR (neat) 3404, 2949, 1180, 1086, 955 cm-1; HRMS calcd for 






6-(3-Azidopropyl)-6-methoxy-1,4-dioxaspiro[4.5]decane (78). To a solution 
of 77 (1.10 g, 4.8 mmol, 1.0 equiv) in CH2Cl2 (20 mL), Et3N (1.0 mL, 7.2 mmol, 1.5 
equiv), followed by MsCl (0.56 mL, 7.2 mmol, 1.5 equiv) were added at 0 °C. After 
stirring for 1 h at rt, the reaction was quenched with sat. NaHCO3 (20 mL), extracted 
with CH2Cl2 (3 x 50 mL), washed with brine (1 x 20 mL), dried and concentrated. To 
the solution of the crude mesylate (4.8 mmol, 1.0 equiv) in DMF (20 mL), NaN3 
(1.56 g, 24.0 mmol, 5.0 equiv) was added and the reaction was stirred at 80 °C for 2 
h. Ether (150 mL) was added, and the mixture was washed with water (4 x 50 mL) 
and brine (1 x 50 mL). The organic layer was dried (Na2SO4) and concentrated. 
Caution! An explosion occurred during solvent removal under reduced pressure; the 
title compound was used in the next step without further purification, and it was not 
concentrated to dryness. (Rf = 0.57, 1/4 EtOAc/hexanes). 1H NMR (400 MHz, 
CDCl3) δ 1.32-1.58 (m, 6H), 1.61-1.69 (m, 2H), 1.72-1.86 (m, 3H), 3.26 (m, 4H), 
3.86-3.96 (m, 4H), 4.50 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.4, 22.9, 22.9, 
27.1, 30.9, 32.1, 50.1, 52.3, 64.2, 64.9, 78.8, 111.6; IR (neat) 2953, 2095, 1178, 1086 








2-(3-Azidopropyl)-2-methoxycyclohexanone (79). To a solution of crude 78 
(4.5 mmol, 1.0 equiv) in CH3CN/H2O (98%, 10 mL), LiBF4 (1.0 M, CH3CN, 4.5 mL, 
1.0 equiv) was added at rt, and the resulting mixture was stirred at rt for 7 days. 
Workup with H2O/Et2O, followed by chromatography (1/4 EtOAc/hexanes) afforded 
the title compound as oil (Rf = 0.50, 1/4 EtOAc/hexanes). Yield 65% (three steps) 
(0.62 g, 2.9 mmol). 1H NMR (400 MHz, CDCl3) δ 1.48-1.78 (m, 6H), 1.89-2.04 (m, 
3H), 2.14-2.22 (m, 1H), 2.27-2.34 (m, 1H), 2.66-2.75 (m, 1H), 3.17 (s, 3H), 3.29-3.38 
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.7, 22.1, 27.8, 28.0, 37.0, 39.4, 50.7, 51.7, 
82.1, 212.5; IR (neat) 2942, 2097, 1717, 1457, 1258, 1073 cm-1; HRMS calcd for 













pyrrolo[1,2-a]azepin-5(6H)-one (81) and Azecane-2,7-dione (82). According to the 
general procedure, the reaction of 79 (0.0827 g, 0.39 mmol, 1.0 equiv) and TfOH 
(0.18 mL, 1.96 mmol, 5.0 equiv) in CH2Cl2 (7.6 mL, 0.05 M) for 1 min at 0 °C 
afforded after purification by PTLC (EtOAc) 80 as oil (Rf = 0.49, EtOAc/hexanes), 
yield 23% (0.0167 g, 0.091 mmol), 81 as oil (Rf = 0.52, EtOAc), yield 23% (0.0136 
g, 0.090 mmol), and 82 as oil (Rf = 0.39, EtOAc), yield 29% (0.0189 g, 0.11 mmol). 
Compound 80: 1H NMR (400 MHz, CDCl3) δ 1.56-2.01 (m, 10H), 2.26-2.33 (m, 1H), 
2.69-2.78 (m, 1H), 3.28 (dt, J = 2.9, 11.4 Hz, 1H), 3.39 (s, 3H), 3.87-3.97 (m, 1H); 
224 
 
13C NMR (100 MHz, CDCl3) δ 22.1, 22.4, 25.0, 32.2, 41.4, 49.1, 50.5, 51.9, 83.7, 
183.0; IR (neat) 2931, 1682, 1445, 1177 cm-1; HRMS calcd for C10H18NO2 (M+ + H) 
184.1338, found 184.1327. Compound 81: 1H NMR (400 MHz, CDCl3) δ 1.80-1.92 
(m, 4H), 2.22-2.31 (m, 2H), 2.51-2.58 (m, 2H), 2.59-2.65 (m, 2H), 3.70 (t, J = 7.2 Hz, 
2H), 4.91 (t, J = 4.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 21.2, 21.4, 29.0, 34.5, 
37.8, 49.0, 104.3, 137.1, 173.0; IR (neat) 2927, 1647, 1396, 1223 cm-1; HRMS calcd 
for C9H14NO (M+ + H) 152.1075, found 152.1066. Compound 82: 1H NMR (400 
MHz, CDCl3) δ (mixture of ketone and enol tautomers) 1.47-2.25 (m, 10H), 2.49 (dd, 
J = 6.9, 14.0 Hz, 1H), 2.87 (t, J = 13.7 Hz, 1H), 3.17 (br, 1H), 3.31-3.42 (m, 1H), 
3.77-3.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ketone peaks) 22.2, 24.3, 27.6, 
36.9, 39.5, 41.0, 41.5, 173.9, 215.1; IR (neat) 3350, 2932, 1701, 1616, 1456, 1437, 






2-(3-Azidopropyl)-2-(methylsulfonyl)cyclohexanone (83). To a solution of 
57 (0.0549 g, 0.24 mmol, 1.0 equiv) in CH2Cl2 (4.0 mL) mCPBA (77%, 0.11 g, 0.48 
mmol, 2.0 equiv) was added at 0 °C. After stirring at 0 °C for 1 h, the reaction 
mixture was washed with saturated NaHCO3 (5 x 10 mL), brine (1 x 10 mL), dried 
and concentrated. Chromatography (1/1 EtOAc/hexanes) afforded the title compound 
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as oil (Rf = 0.75, 1/1 EtOAc/hexanes). Yield 78% (0.0486 g, 0.19 mmol). 1H NMR 
(400 MHz, CDCl3) δ 1.54 (m, 1H), 1.61-1.80 (m, 3H), 1.84-2.08 (m, 3H), 2.09-2.22 
(m, 2H), 2.53 (dt, J = 4.5, 16.7 Hz, 1H), 2.63-2.72 (m, 1H), 2.80 (m, 1H), 2.89 (s, 
3H), 3.27-3.40 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 21.2, 23.6, 24.5, 28.5, 30.4, 
37.2, 40.8, 51.2, 74.3, 206.6; IR (neat) 2947, 2098, 1701, 1298, 1126 cm-1; HRMS 








6-(Methylsulfonyl)-1-azabicyclo[4.3.1]decan-10-one (84) and 9a-
(Methylsulfonyl)hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (85). According 
to the general procedure, the reaction of 83 (0.0990 g, 0.38 mmol, 1.0 equiv) and 
TfOH (0.17 mL, 1.91 mmol, 5.0 equiv) in CH2Cl2 (7.5 mL, 0.05 M) for 30 s at 0 °C 
afforded after purification by PTLC (EtOAc) 84 as oil (Rf = 0.46, EtOAc), yield 48% 
(0.0418 g, 0.18 mmol), and 85 as oil (Rf = 0.21, EtOAc), yield ca. 13% (0.0117 g, 
0.051 mmol). Note: compound 85 is very unstable; decomposition was observed 
during solvent removal, at rt over short periods of time, and during chromatography 
on SiO2. Despite numerous attempts to obtain analytically pure 85, samples of 85 
were always contaminated by elimination side products. Compound 84: 1H NMR 
(400 MHz, CDCl3) δ 1.70-2.03 (m, 7H), 2.06-2.11 (m, 1H), 2.44 (dd, J = 8.4, 14.9 
Hz, 1H), 2.75-2.83 (m, 1H), 2.87-2.96 (m, 1H), 3.19 (s, 3H), 3.31-3.46 (m, 2H), 3.92-
4.02 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.8, 24.1, 26.0, 28.6, 34.5, 38.4, 48.3, 
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50.6, 72.3, 177.7; IR (neat) 3416, 1666, 1288, 1134 cm-1; HRMS calcd for 
C10H17NO3SNa (M+ + Na) 254.0827, found 254.0830. Compound 85: 1H NMR (400 
MHz, CDCl3) δ 1.50-2.45 (m, 8H), 2.64 (ddd, J = 2.0, 7.8, 15.0 Hz, 1H), 2.75 (d, J = 
13.6 Hz, 1H), 2.78-2.92 (m, 2H), 2.82 (s, 3H), 3.82-3.95 (m, 1H), 4.10 (ddt, J = 1.9, 
9.6, 16.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 22.2, 26.6, 30.7, 36.0, 36.3, 37.4, 
48.1, 58.6, 89.4, 172.6 ; IR (neat) 2930, 1651, 1454, 1296, 1130 cm-1; HRMS calcd 






2-(3-Chloropropyl)-2-(methylthio)cyclopentanone (87). According to the 
procedure for 56, the reaction of 86 (1.0 g, 7.7 mmol, 1.0 equiv), KH (0.77 g, 19.2 
mmol, 2.5 equiv), and 1-chloro-3-iodopropane (2.50 mL, 23.1 mmol, 3.0 equiv) in 
THF (20 mL) for 48 h at rt, followed by reflux for 30 min, afforded after 
chromatography (1/20 EtOAc/hexanes, followed by 1/10 Et2O/cyclohexanes) 87 as 
oil (Rf = 0.41, 1/10 EtOAc/hexanes), yield 37% (0.59 g, 2.9 mmol). Note: the crude 
reaction mixture is unstable and must be chromatographed immediately after work-
up. The title compound is unstable at room temperature. 1H NMR (400 MHz, CDCl3) 
δ 1.47-1.58 (m, 1H), 1.66-1.77 (m, 1H), 1.84-2.21 (m, 7H), 1.91 (s, 3H), 2.59-2.69 
(m, 1H), 3.51-3.63 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 10.7, 18.2, 27.8, 28.4, 
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35.2, 35.4, 45.1, 54.8, 210.3; IR (neat) 2958, 1720, 1445, 1161 cm-1; HRMS calcd for 






2-(3-Azidopropyl)-2-(methylthio)cyclopentanone (88). According to the 
general procedure, The reaction of 87 (0.32 g, 1.55 mmol, 1.0 equiv) and NaN3 (0.54 
g, 8.30 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2.5 h, afforded after 
chromatography (1/4 Et2O/hexanes, followed by 1/20 EtOAc/hexanes) the title 
compound as oil (Rf = 0.33, 1/10 EtOAc/hexanes), yield 77% (0.26 g, 1.23 mmol). 
Note: the title compound is unstable at room temperature, and it decomposes slowly 
at -20 °C. 1H NMR (400 MHz, CDCl3) δ 1.42-1.56 (m, 2H), 1.81-2.20 (m, 7H), 1.90 
(s, 3H), 2.58-2.68 (m, 1H), 3.27-3.39 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 10.7, 
18.1, 24.1, 28.2, 35.1, 35.4, 51.5, 54.9, 210.3; IR (neat) 2953, 2097, 1722, 1259, 1163 





8a-(Methylthio)hexahydroindolizin-5(1H)-one (89). According to the 
general procedure, the reaction of 88 (0.0404 g, 0.19 mmol, 1.0 equiv) and TfOH 
(0.085 mL, 0.95 mmol, 5.0 equiv) in CH2Cl2 (3.8 mL, 0.05 M) at 0 °C for 60 s 
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afforded after purification by PTLC (EtOAc) the title compound as oil (Rf = 0.30, 1/1 
EtOAc/hexanes), yield 43% (0.0151 g, 0.082 mmol). Note: the title compound is very 
unstable; decomposition was observed during solvent removal (temp. must be kept 
below 35 °C to prevent significant decomposition), at rt over short periods of time, 
and during chromatography on SiO2. 1H NMR (500 MHz, CDCl3) δ 1.54-1.62 (m, 
2H), 1.71-1.87 (m, 2H), 1.88-1.96 (m, 1H), 2.00 (s, 3H), 2.22-2.38 (m, 4H), 2.42-2.54 
(m, 1H), 3.43-3.51 (m, 1H), 3.68-3.74 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 14.2, 
17.8, 20.7, 30.5, 33.6, 39.6, 45.1, 73.7, 169.6; IR (neat) 2953, 2918, 1643, 1437, 
1400, 1340, 1184 cm-1; HRMS calcd for C9H16NOS (M+ + H) 186.0953, found 
186.0941. Reactions of 88 with BF3•Et2O (2.0 equiv, rt, 15 h) and TiCl4 (2.0 equiv, rt, 
2 h) afforded 89 in 40% and 48% yields, respectively. Analysis of crude reaction 





2-(3-Chloropropyl)-2-(methylthio)cycloheptanone (91). According to the 
procedure for 56, the reaction of 90 (1.0 g, 6.3 mmol, 1.0 equiv), KH (0.63 g, 15.8 
mmol, 2.5 equiv), and 1-chloro-3-iodopropane (2.03 mL, 18.9 mmol, 3.0 equiv) in 
THF (20 mL) for 48 h at rt, followed by reflux for 30 min, afforded after 
chromatography (1/25 EtOAc/hexanes) 90 as oil (Rf = 0.48, 1/10 EtOAc/hexanes), 
yield 64% (0.95 g, 4.0  mmol). Note: the crude reaction mixture is unstable and must 
be chromatographed immediately after work-up. The title compound is unstable at 
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room temperature. 1H NMR (400 MHz, CDCl3) δ 1.12-1.23 (m, 1H), 1.35 (q, J = 8.7 
Hz, 2H), 1.42-1.52 (m, 1H), 1.54-1.63 (m, 1H), 1.77 (s, 3H), 1.71-1.94 (m, 5H), 1.96-
2.07 (m, 2H), 2.33 (q, J = 7.6 Hz, 1H), 3.07 (dt, J = 2.6, 11.8 Hz, 1H), 3.51-3.59 (m, 
2H) ; 13C NMR (100 MHz, CDCl3) δ 11.8, 24.5, 25.9, 26.3, 27.2, 30.2, 32.1, 38.9, 
45.3, 57.7, 206.0; IR (neat) 2926, 1686, 1460, 1443, 1155 cm-1; HRMS calcd for 





2-(3-Azidopropyl)-2-(methylthio)cycloheptanone (92). According to the 
general procedure, the reaction of 91 (0.85 g, 3.8 mmol, 1.0 equiv) and NaN3 (1.25 g, 
19.2 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2.5 h, afforded after 
chromatography (1/20 EtOAc/hexanes) the title compound as oil (Rf = 0.46, 1/10 
EtOAc/hexanes), yield 85% (0.74 g, 3.1 mmol). 1H NMR (400 MHz, CDCl3) δ 1.10-
1.21 (m, 1H), 1.35 (q, J = 9.9 Hz, 2H), 1.44-1.60 (m, 3H), 1.75 (s, 3H), 1.64-2.04 (m, 
6H), 2.32 (q, J = 7.4 Hz, 1H), 3.01-3.10 (m, 1H), 3.25-3.37 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 11.8, 23.2, 24.5, 25.7, 26.3, 30.2, 32.1, 38.9, 51.6, 57.7, 206.1; IR 
(neat) 2926, 2858, 2097, 1686, 1456, 1259, 1155 cm-1; HRMS calcd for C11H19N3OS 
















Azacycloundecane-2,8-dione (94), and 3-(1-(Methylthio)-2-
oxocycloheptyl)propanal (95). According to the general procedure, the reaction of 
92 (0.0435 g, 0.18 mmol, 1.0 equiv) and TfOH (0.080 mL, 0.90 mmol, 5.0 equiv) in 
CH2Cl2 (3.6 mL, 0.05 M) at 0 °C for 30 min afforded after purification by 
chromatography (1/2 EtOAc/hexanes) 93 as oil (Rf = 0.44, 1/1 EtOAc/hexanes), yield 
62% (0.0237 g, 0.11 mmol), 94 as oil (Rf = 0.10 1/1 EtOAc/hexanes), yield 11% 
(0.0038 g, 0.021 mmol), and 95 as oil (Rf = 0.84 1/1 EtOAc/hexanes), yield 20% 
(0.0075 g, 0.035 mmol). Compound 93: 1H NMR (400 MHz, CDCl3) δ 1.44-1.55 (m, 
2H), 1.65-1.77 (m, 3H), 1.86-2.21 (m, 6H), 2.18 (s, 3H), 2.25-2.32 (m, 1H), 2.74 (dd, 
J = 4.5, 13.5 Hz, 1H), 3.21-3.28 (m, 1H), 3.61 (dt, J = 3.2, 11.9 Hz, 1H), 4.60 (dt, J = 
3.6, 13.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 12.8, 22.6, 24.8, 24.8, 32.2, 34.8, 
48.3, 48.8, 50.0, 54.3, 178.1; IR (neat) 2925, 2856, 1650, 1488, 1444, 1351, 1193 cm-
1; HRMS calcd for C11H20NOS (M+ + H) 214.1266, found 214.1264. Compound 94: 
1H NMR (400 MHz, CDCl3) δ 1.46-1.54 (m, 2H), 1.62-1.71 (m, 4H), 1.96-2.11 (m, 
4H), 2.38-2.49 (m, 4H), 3.41 (q, J = 6.0 Hz, 2H), 5.46 (br, 1H); 13C NMR (100 MHz, 
CDCl3) δ 23.4, 23.4, 24.1, 26.6, 38.8, 39.4, 40.2, 42.7, 174.1, 213.6; IR (neat) 3314, 
2930, 1699, 1635, 1551, 1439, 1408, 1211, 1124 cm-1; HRMS calcd for C10H18NO2 
(M+ + H) 184.1338, found 184.1331. Compound 95: 1H NMR (400 MHz, CDCl3) δ 
1.15-1.25 (m, 1H), 1.33-1.42 (m, 1H), 1.45-1.54 (m, 1H), 1.77 (s, 3H), 1.72-2.01 (m, 
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6H), 2.25-2.42 (m, 2H), 2.46-2.56 (m, 1H), 2.57-2.68 (m, 1H), 3.09 (t, J = 12.1 Hz, 
1H), 9.84 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 11.8, 20.9, 24.5, 26.4, 30.2, 32.2, 
38.8, 39.0, 57.8, 201.5, 206.0; IR (neat) 2926, 2856, 2721, 1722, 1688, 1456, 1443, 
1155 cm-1; HRMS calcd for C11H19O2S (M+ + H) 215.1106, found 215.1103. 
Reactions of 92 with BF3•Et2O (3.0 equiv, rt, 48 h) and TiCl4 (3.0 equiv, reflux, 24 h) 





2-(3-Chloropropyl)-2-(methylthio)cyclooctanone (97). According to the 
procedure for 56, the reaction of 96 (1.0 g, 5.8 mmol, 1.0 equiv), KH (0.58 g, 14.5 
mmol, 2.5 equiv), and 3-chloro-1-iodopropane (1.87 mL, 17.4 mmol, 3.0 equiv) in 
THF (35 mL) for 48 h at rt, followed by reflux for 30 min, afforded after 
chromatography (1/40 EtOAc/hexanes) 97 as oil (Rf = 0.54, 1/10 EtOAc/hexanes), 
yield 75% (1.09 g, 4.4  mmol). 1H NMR (400 MHz, CDCl3) δ 0.81-0.93 (m, 1H), 
1.18-1.29 (m, 1H), 1.39-1.50 (m, 1H), 1.55-2.06 (m, 10H), 1.73 (s, 3H), 2.15-2.24 (m, 
2H), 3.14 (dt, J = 3.2, 13.1 Hz, 1H), 3.61 (t, J = 6.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 11.1, 23.9, 24.6, 25.2, 26.0, 27.1, 28.7, 30.7, 36.4, 45.4, 58.1, 209.2; IR 
(neat) 2938, 1694, 1447, 1318, 1231, 1125 cm-1; HRMS calcd for C12H21ClOSNa (M+ 






2-(3-Azidopropyl)-2-(methylthio)cyclooctanone (98). According to the 
general procedure, the reaction of 97 (1.08 g, 4.4 mmol, 1.0 equiv) and NaN3 (1.42 g, 
21.8 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2 h, afforded after 
chromatography (1/30 EtOAc/hexanes) the title compound as oil (Rf = 0.41, 1/10 
EtOAc/hexanes), yield 90% (1.0 g, 3.9 mmol). 1H NMR (400 MHz, CDCl3) δ 0.77-
0.88 (m, 1H), 1.21 (q, J = 12.4 Hz, 1H), 1.38-1.93 (m, 11H), 1.68 (s, 3H), 2.11-2.21 
(m, 2H), 3.11 (dt, J = 1.7, 12.2 Hz, 1H), 3.34 (t, J = 5.8 Hz, 2H); 13C NMR (100 
MHz, CDCl3) δ 11.0, 23.2, 23.5, 24.5, 25.2, 26.0, 28.6, 30.6, 36.4, 51.7, 58.1, 209.2; 
IR (neat) 2929, 2094, 2682, 1467, 1446, 1259, 1116 cm-1; HRMS calcd for 





3-(1-(Methylthio)-2-oxocyclooctyl)propanal (99). According to the general 
procedure, the reaction of 98 (0.159 g, 0.62 mmol, 1.0 equiv) and TfOH (0.28 mL, 
3.1 mmol, 5.0 equiv) in CH2Cl2 (12.2 mL, 0.05 M) at 0 °C for 1 h, followed by rt for 
30 min afforded after purification by chromatography (1/4 EtOAc/hexanes) the title 
compound as oil as oil (Rf = 0.48, 1/4 EtOAc/hexanes). Yield 30% (0.0412 g, 0.18 
mmol). Note: the title compound is unstable; facile decomposition was observed at rt. 
1H NMR (400 MHz, CDCl3) δ 0.81-0.93 (m, 1H), 1.19-1.30 (m, 1H), 1.40-1.94 (m, 
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8H), 1.70 (s, 3H), 2.16-2.46 (m, 4H), 2.62-2.71 (m, 1H), 3.14 (dt, J = 3.0, 12.6 Hz, 
1H), 9.85 (d, J = 1.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 11.1, 19.3, 24.4, 25.2, 
26.0, 28.7, 30.6, 36.5, 38.7, 58.0, 201.6, 209.2; IR (neat) 2928, 2722, 1723, 1682, 
1468, 1447, 1117, 1083 cm-1; HRMS calcd for C12H20O2SNa (M+ +Na) 251.1082, 
found 251.1083. Note: no conversion was observed in reactions of 98 with BF3•Et2O, 
TiCl4 and TFA at temperatures ranging from rt to 45 °C by analysis of crude reaction 





2-(4-Chlorobutyl)-2-(methylthio)cyclohexanone (100). According to the 
procedure for 56, the reaction of 55 (0.50 g, 3.5 mmol, 1.0 equiv), KH (0.15 g, 3.8 
mmol, 1.1 equiv), and 4-chloro-1-iodopropane (1.30 mL, 10.4 mmol, 3.0 equiv) in 
THF (20 mL) for 48 h at rt, followed by reflux for 30 min, afforded after 
chromatography (1/40 EtOAc/hexanes) 100 as oil (Rf = 0.44, 1/10 EtOAc/hexanes), 
yield 67% (0.54 g, 2.3  mmol). 1H NMR (400 MHz, CDCl3) δ 1.30-1.42 (m, 1H), 
1.52-1.89 (m, 8H), 1.80 (s, 3H), 1.92-2.11 (m, 3H), 2.18-2.27 (m, 1H), 3.12 (dt, J = 
5.8, 14.3 Hz, 1H), 3.57 (t, J = 6.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 11.0, 20.7, 
21.0, 26.4, 32.3, 32.9, 36.1, 36.9, 44.9, 56.4, 206.8; IR (neat) 2937, 2862, 1693, 1446, 







2-(4-Azidobutyl)-2-(methylthio)cyclohexanone (101). According to the 
general procedure, the reaction of 100 (0.51 g, 2.2 mmol, 1.0 equiv) and NaN3 (0.71 
g, 10.9 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2 h, afforded after 
chromatography (1/20 EtOAc/hexanes) the title compound as oil (Rf = 0.47, 1/10 
EtOAc/hexanes), yield 86% (0.45 g, 1.9 mmol). 1H NMR (400 MHz, CDCl3) δ 1.22-
1.34 (m, 1H), 1.42-1.87 (m, 8H), 1.77 (s, 3H), 1.92-2.08 (m, 3H), 2.16-2.24 (m, 1H), 
3.09 (dt, J = 6.2, 14.0 Hz, 1H), 3.29 (t, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) 
δ 10.9, 20.6, 21.0, 26.3, 29.2, 32.7, 36.1, 36.9, 51.3, 56.4, 206.7; IR (neat) 2941, 
2864, 2092, 1693, 1446, 1273, 1255, 1122 cm-1; HRMS calcd for C11H19N3OSNa (M+ 





4-(1-(Methylthio)-2-oxocyclohexyl)butanal (102). According to the general 
procedure, the reaction of 101 (0.0769 g, 0.32 mmol, 1.0 equiv) and TfOH (0.14 mL, 
1.6 mmol, 5.0 equiv) in CH2Cl2 (6.4 mL, 0.05 M) at 0 °C for 1.5 h afforded after 
purification by chromatography (1/4 EtOAc/hexanes) the title compound as oil as oil 
(Rf = 0.19, 1/10 EtOAc/hexanes). Yield 53% (0.0359 g, 0.17 mmol). Note: the title 
compound is unstable; rapid decomposition was observed at rt. 1H NMR (400 MHz, 
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CDCl3) δ 1.47-1.89 (m, 7H), 1.80 (s, 3H), 1.94-2.12 (m, 3H), 2.18-2.27 (m, 1H), 2.50 
(t, J = 6.6 Hz, 2H), 3.12 (dt, J = 6.0, 14.7 Hz, 1H), 9.79 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 11.0, 16.1, 21.0, 26.4, 32.6, 36.0, 36.9, 44.0, 56.4, 202.1, 206.7; IR (neat) 
2928, 2863, 2724, 1720, 1694, 1447, 1420, 1227, 1125 cm-1; HRMS calcd for 
C11H19O2S (M+ +H) 215.1106, found 215.1105. No conversion or decomposition was 
observed in reactions of 101 with BF3•Et2O or TiCl4 at temperatures ranging from rt 






(104). According to the procedure for 56, the reaction of 103 (1.0 g, 5.2 mmol, 1.0 
equiv), KH (0.52 g, 13.0 mmol, 2.5 equiv), and 3-chloro-1-iodopropane (1.70 mL, 
15.6 mmol, 3.0 equiv) in THF (35 mL) for 48 h at rt, followed by reflux for 30 min, 
afforded after chromatography (1/40 EtOAc/hexanes) 104 as oil (Rf = 0.61, 1/10 
EtOAc/hexanes), yield 55% (0.76 g, 2.8  mmol). 1H NMR (400 MHz, CDCl3) δ 1.76-
1.88 (m, 1H), 1.92 (s, 3H), 1.94-2.06 (m, 2H), 2.12-2.25 (m, 2H), 2.33 (dt, J = 4.8, 
13.0 Hz, 1H), 2.83 (dq, J = 2.4, 17.2 Hz, 1H), 3.32 (m, 1H), 3.57-3.69 (m, 2H), 7.21 
(d, J = 7.6 Hz, 1H), 7.34 (t, J = 7.6 Hz, 1H), 7.48 (dt, J = 1.4, 7.4 Hz, 1H), 8.14 (dd, J 
= 1.2, 7.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 10.2, 25.3, 27.2, 30.9, 32.3, 45.3, 
52.8, 126.8, 128.5, 128.5, 130.8, 133.1, 142.2, 190.7; IR (neat) 2920, 1670, 1601, 
1454, 1429, 1292, 1231 cm-1; HRMS calcd for C14H18ClOS (M+ +H) 269.0767, found 
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269.0747. Note: the reaction of 103 with 1.1 equiv of KH instead of 2.5 equiv 






According to the general procedure, the reaction of 104 (0.71 g, 2.7 mmol, 1.0 equiv) 
and NaN3 (0.86 g, 13.3 mmol, 5.0 equiv) in DMF (20 mL) at 80 °C for 2 h, afforded 
after chromatography (1/30 EtOAc/hexanes) the title compound as oil (Rf = 0.56, 
1/10 EtOAc/hexanes), yield 67% (0.49 g, 1.8 mmol). 1H NMR (400 MHz, CDCl3) δ 
1.53-1.66 (m, 1H), 1.75-1.97 (m, 2H), 1.91 (s, 3H), 2.06 (dt, J = 3.9, 12.2 Hz, 1H), 
2.17-2.25 (m, 1H), 2.34 (dt, J = 4.9, 13.7 Hz, 1H), 2.84 (dq, J = 2.1, 17.2 Hz, 1H), 
3.26-3.45 (m, 3H), 7.22 (d, J = 7.6 Hz, 1H), 7.34 (t, J = 7.6 Hz, 1H), 7.48 (t, J = 8.3 
Hz, 1H), 8.14 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 10.2, 23.5, 25.3, 
30.6, 32.3, 51.7, 52.9, 126.8, 128.4, 128.5, 130.8, 133.1, 142.2, 190.7; IR (neat) 2094, 
1666, 1600, 1454, 1351, 1292, 1234 cm-1; HRMS calcd for C14H17N3OSNa (M+ +Na) 







and 2,3-dihydro-1H-benzo[e]pyrrolo[1,2-a]azepin-5(10H)-one (107). According to 
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the general procedure, the reaction of 105 (0.1249 g, 0.45 mmol, 1.0 equiv) and TfOH 
(0.20 mL, 2.3 mmol, 5.0 equiv) in CH2Cl2 (9.0 mL, 0.05 M) at 0 °C for 0.5 h afforded 
after purification by chromatography (1/10 EtOAc/hexanes) 106 as oil (Rf = 0.38, 1/4 
EtOAc/hexanes), yield 10% (0.0116 g, 0.05 mmol) and 107 as oil (Rf = 0.29, 1/4 
EtOAc/hexanes), yield 14% (0.0124 g, 0.06 mmol). Compound 106: 1H NMR (400 
MHz, CDCl3) δ 1.82 (s, 3H), 2.04-2.15 (m, 2H), 2.20 (dt, J = 4.9, 13.7 Hz, 1H), 2.32 
(m, 1H), 2.40-2.62 (m, 2H), 2.72-2.79 (m, 1H), 3.23 (m, 1H), 7.13 (d, J = 7.2 Hz, 
1H), 7.26 (t, J = 7.5 Hz, 1H), 7.40 (t, J = 7.4 Hz, 1H), 8.05 (d, J = 7.9 Hz, 1H), 9.78 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 10.3, 25.3, 25.7, 32.3, 38.7, 52.8, 126.9, 
128.5, 128, 5, 130.8, 133.3, 142.2, 190.8, 201.4; IR (neat) 2922, 1665, 1601, 1454, 
1429, 1298, 1235, 1129 cm-1; HRMS calcd for C14H16O2SNa (M+ +Na) 271.0769, 
found 271.0777. Compound 107: 1H NMR (400 MHz, CDCl3) δ 1.88 (m, 2H), 2.38 
(t, J = 7.3 Hz, 2H), 3.13 (d, J = 6.8 Hz, 2H), 3.87 (t, J = 7.3 Hz, 2H), 5.23 (t, J = 6.8 
Hz, 1H), 7.02 (d, J = 7.5 Hz, 1H), 7.23 (dt, J = 1.0, 7.7 Hz, 1H), 7.34 (dt, J = 1.4, 7.4 
Hz, 1H), 7.86 (dd, J = 1.2, 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 21.0, 31.1, 
31.8, 48.8, 106.0, 126.4, 126.7, 130.9, 132.0, 133.5, 140.9, 142.0, 168.4; IR (neat) 
2924, 1626, 1572, 1454, 1377, 1352, 1221, 1154 cm-1; HRMS calcd for C13H14NO 
(M+ +H) 200.1075, found 200.1075. Note: <20% conversion was observed when the 
reaction was carried out with TfOH (5.0 equiv) for 60 s at 0 °C. No conversion was 
observed in reactions of 105 with BF3•Et2O or TiCl4 at temperatures ranging from rt 







2-(4-azidobutyl)-2-(methylsulfonyl)cyclohexanone (108). According to the 
procedure for 83, the reaction of 101 (0.0623 g, 0.26 mmol, 1.0 equiv) and mCPBA 
(77%, 0.12 g, 0.53 mmol, 2.50 equiv) in CH2Cl2 (10 mL) at 0 °C for 1 h, afforded 
after purification by chromatography (1/4 EtOAc/hexanes) the title compound as oil 
(Rf = 0.70, 1/1 EtOAc/hexanes). Yield 76% (0.0536 g, 0.20 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.24-1.36 (m, 1H), 1.42-1.83 (m, 6H), 1.93-2.22 (m, 4H), 2.53 (dt, J 
= 4.7, 16.6 Hz, 1H), 2.64-2.73 (m, 1H), 2.80 (m, 1H), 2.88 (s, 3H), 3.31 (t, J = 6.6 
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 21.3, 21.4, 24.4, 28.3, 29.2, 32.8, 37.1, 40.9, 
50.9, 74.6, 206.8; IR (neat) 2945, 2097, 1703, 1298, 1126 cm-1; HRMS calcd for 
C11H19N3O3SNa (M+ + Na) 296.1045, found 296.1034. Note: only decomposition was 







(1-(3-azidopropyl)-2-oxocyclohexyl)dimethylsulfonium iodide (109). To a 
solution of 57 (0.0492 g, 0.22 mmol, 1.0 equiv) in CH2Cl2 (10 mL) MeI (0.14 mL, 2.2 
mmol, 10 equiv) was added, followed by AgBF4 (0.0440 g, 0.22 mmol, 1.0 equiv) at 
rt and the resulting mixture was stirred at rt for 24 h. TLC analysis showed presence 
of starting material, 10 more equiv of MeI and 1.0 equiv of AgBF4 were added and 
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stirring was continued for 2 h at rt. The reaction mixture was filtered and 
concentrated to afford the title compound which was used in the next step without 
further purification. Yield 27% (0.0218 g, 0.06 mmol). 1H NMR (400 MHz, CDCl3) δ 
1.63-1.75 (m, 2H), 1.98-2.38 (m, 7H), 2.62-2.85 (m, 3H), 2.81 (s, 3H), 2.85 (s, 3H), 
3.38-3.58 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 17.9, 21.1, 21.2, 23.1, 25.9, 29.1, 
30.9, 39.3, 49.9, 74.6, 206.2; HRMS calcd for C11H20N3O3S (M+ + H) 242.1327, 
found 242.1328. Note: only decomposition was observed in the reaction of 109 with 








n = 2  
7-(Methylsulfinyl)-1-azabicyclo[5.3.1]undecan-11-one (110). To a solution 
of 93 (0.0248 g, 0.12 mmol) in CH2Cl2 (10 mL) mCPBA (77%, 0.0261 g, 0.12 mmol, 
1.0 equiv) in CH2Cl2 (3.0 mL) was added at 0 °C. After stirring for 1 h at 0 °C, the 
reaction mixture was washed with sat. NaHCO3 (2 x 10 mL), brine (1 x 10 mL), 
dried, concentrated and purified by chromatography (EtOAc) to give the title 
compound as oil as oil (Rf = 0.61, EtOAc). Yield 72% (0.0196 g, 0.09 mmol). 1H 
NMR (400 MHz, CDCl3) (mixture of diastereoisomers) δ 1.47-2.25 (m, 21H), 2.25-
2.32 (m, 1H), 2.40 (s, 3H), 2.44 (s, 3H), 2.71-2.93 (m, 4H), 3.25-3.35 (m, 2H), 3.61-
3.76 (m, 2H), 4.52-4.71 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 22.2, 23.1, 23.6, 
23.9, 24.3, 24.3, 24.6, 25.0, 31.8, 32.2, 32.4, 33.8, 41.9, 47.1, 47.8, 48.2, 49.6, 49.7, 
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66.0, 67.7, 175.0, 176.8; IR (neat) 2930, 1636, 1447, 1289, 1277, 1210, 1026 cm-1; 









n = 1  
6-(Methylsulfonyl)-1-azabicyclo[4.3.1]decan-10-one (111). According to 
the procedure for 110 the reaction of 58 (0.0220 g, 0.11 mmol, 1.0 equiv) and 
mCPBA (0.0490 g, 0.22 mmol, 2.0 equiv) in CH2Cl2 (4.0 mL) at 0 °C for 1.5 h, 
afforded after purification by chromatography (EtOAc) the title compound. Yield 






n = 2 
1-Azabicyclo[5.3.1]undecan-11-one (112). To a solution of 93 (0.0328 g, 
0.15 mmol, 1.0 equiv) in dioxane (10 mL) Raney Ni (ca. 0.200 g) was added and the 
reaction mixture was heated to reflux for 1 h. The reaction mixture was cooled to rt, 
filtered through a cotton pad and concentrated. Known amount of benzene was added 
as the internal standard, and the reaction was analyzed by 1H NMR. Yield 86%. 
Purification by PLTC (EtOAc) afforded the title compound as oil (Rf = 0.40-0.55, 
EtOAc). Yield 43% (0.0110 g, 0.066 mmol). Note: the compound is unstable on 
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silica. 1H NMR (400 MHz, CDCl3) δ 1.44-1.57 (m, 3H), 1.61-.89 (m, 6H), 1.92-2.14 
(m, 2H), 2.18-2.26 (m, 1H), 2.69-2.82 (m, 2H), 3.18-3.26 (m, 1H), 3.66 (dt, J = 2.7, 
11.8 Hz, 1H), 4.58 (dt, J = 3.8, 13.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 22.4, 
23.5, 25.3, 26.4, 32.3, 41.9, 41.9, 48.0, 49.6, 181.2; IR (neat) 2931, 2856, 1627, 1492, 
1446, 1357, 1284, 1203, 1188, 1172 cm-1; HRMS calcd for C10H18NO (M+ + H) 







n = 2  
7-(Chloromethylthio)-1-azabicyclo[5.3.1]undecan-11-one (113). To a 
solution of 93 (0.0323 g, 0.15 mmol) in CCl4 (10 mL) N–Chlorosuccinimide (0.0227 
g, 0.17 mmol, 1.1 equiv) was added at rt and the reaction mixture was stirred at rt for 
2 h. The reaction mixture was filtered, concentrated and purified by chromatography 
(1/2 EtOAc/hexanes) to afford the title compound as oil (Rf = 0.60, 1/1 
EtOAc/hexanes). Yield 58% (0.0220 g, 0.09 mmol). 1H NMR (400 MHz, CDCl3) δ 
1.1.48-1.60 (m, 2H), 1,72-1.84 (m, 2H), 1.84-2.06 (m, 4H), 2.15 (m, 2H), 2.38 (m, 
2H), 2.79 (dd, J = 4.6, 13.5 Hz, 1H), 3.27-3.39 (m, 1H), 3.65 (dt, J = 4.2, 11.5 Hz, 
1H), 4.63 (dt, J = 3.6, 13.0 Hz, 1H), 4.92 (d, J = 12.6 Hz, 1H), 5.45 (d, J = 12.6 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 21.7, 24.7, 24.7, 32.4, 34.5, 48.7, 48.7, 48.9, 
49.9, 55.9, 177.7; IR (neat) 2930, 2854, 1640, 1445, 1434, 1354, 1333, 1208, 1198, 






n = 2 
1-Azabicyclo[5.3.1]undec-6-en-11-one (114). A solution of 110 (0.0174 g, 
0.076 mmol, 1.0 equiv) in toluene (10 mL) was heated to reflux for 72 h. The reaction 
mixture was cooled to rt and concentrated. Purification by chromatography (1/2 
EtOAc/hexanes-EtOAc) afforded the title compound as oil (Rf = 0.70, EtOAc). Yield 
36% (0.0045 g, 0.027 mmol). Monitoring of the reaction by NMR showed that only 
one of the diasteroisomeric sulfoxides underwent efficient elimination. 1H NMR (400 
MHz, CDCl3) δ 1.08-1.20 (m, 1H), 1.56-1.92 (m, 4H), 2.04-2.17 (m, 3H), 2.25-2.32 
(m, 1H), 2.81 (t, J = 12.1 Hz, 1H), 2.87-2.99 (m, 2H), 3.16-3.23 (m, 1H), 4.33 (t, J = 
14.1 Hz, 1H), 6.17 (t, J = 4.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 23.2, 25.6, 
30.5, 35.1, 36.6, 46.6, 56.1, 125.0, 141.8, 184.7; IR (neat) 2921, 2847, 1684, 1638, 
1468, 1443, 1397, 1352, 1314, 1165, 1027 cm-1; HRMS calcd for C10H16NO (M+ + 
H) 166.1232, found 166.1232. Note: a similar reaction of the phenyl sulfoxide 
prepared from 73 under thermal conditions led only to decomposition products, 
suggesting that [5.3.1] scaffold is the lower limit for a reasonable stability of 









(4R,6S)-4-tert-butyl-1-azabicyclo[4.3.1]decan-10-one (115). According to 
the procedure for 112, the reaction of 65 (0.0203 g, 0.08 mmol, 1.0 equiv) and Raney 
Ni (ca. 0.200 g) in dioxane (10 mL) at reflux for 1 h, afforded 1.3 to 1.0 mixture of 
cis (bottom) and trans (top) isomers. Purification by PTLC (1/3 EtOAc/hexanes) 
allowed for isolation of 115 as film in 19% yield (0.0031 g, 0.0015 mmol). Cis 
isomer decomposed during purification. Note: the compound is unstable on silica. 1H 
NMR (400 MHz, CDCl3) δ 0.92 (s, 9H), 1.12-1.18 (m, 2H), 1.60-1.72 (m, 4H), 1.88-
1.93 (m, 1H), 2.12-2.73 (m, 2H), 2.74 (q, J = 6.6 Hz, 1H), 3.00-3.08 (m, 2H), 3.45-
3.53 (m, 1H), 3.81-3.88 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 21.3, 27.6, 28.1, 
29.7, 32.6, 33.9, 44.0, 45.3, 46.6, 52.4, 188.9; IR (neat) 2949, 2926, 1699, 1462, 
1394, 1365, 1165 cm-1; HRMS calcd for C13H24NO (M+ + H) 210.1858, found 
210.1842. 
 
NMR study with azides 57, 61 and 62. General Procedure: NMR tube was 
charged with azide (1.0 equiv), CD2Cl2 and benzene as the internal standard. 
Reference spectrum was recorded, cap was removed, the tube was flushed argon, 
BF3•Et2O (3.0 equiv) was added at rt, the tube was flushed with argon and sealed. 
The reaction was monitored by NMR. After 24 h at rt the septum was removed and 
0.20 mL of D2O was added at rt. The tube was gently shaken and analyzed by NMR.   
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Reaction of azide 57: According to the general procedure, the reaction of 57 
(0.0117 g, 0.052 mmol, 1.0 equiv), CD2Cl2 (0.70 mL) and BF3•Et2O (0.98 M in 
CD2Cl2, 0.15 mL, 0.16 mmol, 3.0 equiv) for 24 h afforded 58 in 64% yield.  
Reaction of azide 61: According to the general procedure, the reaction of 61 
(0.0107 g, 0.038 mmol, 1.0 equiv), CD2Cl2 (0.70 mL) and BF3•Et2O (0.94 M in 
CD2Cl2, 0.12 mL, 0.11 mmol, 3.0 equiv) for 24 h afforded 65 in 84% yield.  
Reaction of azide 62: According to the general procedure, the reaction of 62 
(0.01114 g, 0.040 mmol, 1.0 equiv), CD2Cl2 (0.70 mL) and BF3•Et2O (1.0 M in 




Transannular cyclization strategy 
 
General procedure for hydrolysis of bridged amides: To a solution of 
amide (1.0 equiv) in MeOH (10 mL), HCl (4.0 M in dioxanes, 1.0 mL) was added at 
rt (pH = 1), and the reaction mixture was stirred at rt for appropriate time. The 
reaction was quenched with sat. NH4Cl (10 mL), extracted with CH2Cl2 (3 x 50 mL), 
dried, and concentrated. Chromatography provided the title amino esters. Note: minor 
quantities (<10%) of some of the esters close spontaneously to bridged amides when 
put under high vacuum. This process can be easily monitored by TLC (Rf of bridged 









(7R)-Methyl 7-tert-butyl-5-phenylazonane-5-carboxylate (116). According 
to the general procedure, the reaction of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) 
and HCl (4.0 M in dioxanes, 1.0 mL) in MeOH (10 mL) for 24 h at rt, afforded after 
chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title product as oil (Rf = 0.32, 
NH4OH/MeOH/CH2Cl2), yield 89% (0.0151 g, 0.048 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.41 (s, 9H), 1.23-1.37 (m, 1H), 1.39-1.46 (m, 1H), 1.51-1.71 (m, 2H), 
1.77-1.93 (m, 2H), 2.14-2.25 (m, 2H), 2.73-2.82 (m, 2H), 2.82-2.96 (m, 3H), 3.67 (s, 
3H), 7.18-7.36 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.7, 25.4, 27.3, 32.8, 34.0, 
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35.3, 37.7, 43.1, 46.3, 52.1, 55.2, 126.8, 126.9, 128.3, 144.8, 177.6; IR (neat) 2949, 
2870, 1728, 1668, 1479, 1446, 1366, 1244, 1200, 1186, 1078, 910 cm-1; HRMS calcd 
for C20H32NO2 (M+ + H) 318.2433, found 318.2424. Note: about 6% of the product 









(7R)-Methyl 7-tert-butylazonane-5-carboxylate (117). According to the 
general procedure, the reaction of amide 3 (0.0250 g, 0.12 mmol, 1.0 equiv) and HCl 
(4.0 M in dioxanes, 1.5 mL) in MeOH (10 mL) for 13 h at rt, afforded after 
chromatography (1/15/85 NH4OH/MeOH/CH2Cl2) the title product as oil (Rf = 0.26, 
NH4OH/MeOH/CH2Cl2), yield 77% (0.0221 g, 0.092 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.89 (s, 9H), 1.13-1.23 (m, 1H), 1.43-1.62 (m, 3H), 1.66-1.96 (m, 4H), 
1.98-2.08 (m, 1H), 2.68-2.88 (m, 5H), 3.67 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
21.8, 24.7, 27.5, 27.6, 31.3, 32.3, 42.6, 43.9, 44.8, 48.3, 51.5, 177.6; IR (neat) 2947, 
2868, 1734, 1684, 1475, 1435, 1366, 1161 cm-1; HRMS calcd for C14H28NO2 (M+ + 
H) 242.2120, found 242.2094. Note: the compound was contaminated by <5% of the 








Methyl 5-(phenylthio)azonane-5-carboxylate (118). According to the 
general procedure, the reaction of amide 73 (0.0151 g, 0.058 mmol, 1.0 equiv) and 
HCl (4.0 M in dioxanes, 1.5 mL) in MeOH (10 mL) for 8 h at rt, afforded after 
chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title product as oil (Rf = 0.39, 
NH4OH/MeOH/CH2Cl2), yield 84% (0.0143 g, 0.049 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.44-1.56 (m, 3H), 1.57-1.66 (m, 1H), 1.73-1.92 (m, 3H), 1.96-2.06 (m, 
2H), 2.13-2.22 (m, 1H), 2.69-2.78 (m, 1H), 2.79-2.89 (m, 3H), 3.08 (br, 1H), 3.69 (s, 
3H), 7.27-7.47 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 18.6, 21.3, 26.4, 27.2, 28.1, 
41.8, 47.4, 52.0, 60.2, 128.7, 129.4, 131.0, 136.8, 173.9; IR (neat) 2943, 2918, 2849, 
1724, 1580, 1472, 1437, 1364, 1248, 1194, 1144, 1087, 1040 cm-1; HRMS calcd for 
C16H24NO2S (M+ + H) 294.1528, found 294.1521. Note: the spontaneous closure was 








(7R)-Ethyl 7-tert-butyl-5-phenylazonane-5-carboxylate (119). According to 
the general procedure, the reaction of amide 34 (0.0250 g, 0.088 mmol, 1.0 equiv) 
and HCl (4.0 M in dioxanes, 1.5 mL) in EtOH (10 mL) for 24 h at rt, afforded after 
chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title product as oil (Rf = 0.31, 
NH4OH/MeOH/CH2Cl2), yield 95% (0.0276 g, 0.083 mmol). 1H NMR (400 MHz, 
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CDCl3) δ 0.41 (s, 9H), 1.18 (dt, J = 0.8, 7.1 Hz, 3H), 1.24-1.36 (m, 1H), 1.37-1.44 
(m, 1H), 1.53-1.70 (m, 2H), 1.73-1.91 (m, 2H), 2.12-2.25 (m, 2H), 2.50 (br, 1H), 
1.67-2.94 (m, 5H), 4.02-4.12 (m, 1H), 4.18-4.28 (m, 1H), 7.17-7.32 (m, 5H); 13C 
NMR (100 MHz, CDCl3) δ 14.2, 21.9, 25.3, 27.3, 33.0, 34.0, 35.3, 37.7, 43.2, 46.4, 
55.1, 60.6, 126.6, 127.0, 128.2, 145.0, 177.1; IR (neat) 3375, 2951, 2870, 1724, 1599, 
1580, 1478, 1447, 1366, 1242, 1168, 1078, 911, 860 cm-1; HRMS calcd for 
C21H33NO2Na (M+ + Na) 354.2409, found 354.2434. Note: the spontaneous closure 








(7R)-Isopropyl 7-tert-butyl-5-phenylazonane-5-carboxylate (120). 
According to the general procedure, the reaction of amide 34 (0.0202 g, 0.071 mmol, 
1.0 equiv) and HCl (4.0 M in dioxanes, 5.0 mL) in iPrOH (10 mL) for 24 h at rt, 
afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title product as 
oil (Rf = 0.21, NH4OH/MeOH/CH2Cl2), yield 37% (0.0091 g, 0.026 mmol). 1H NMR 
(400 MHz, CDCl3) δ 0.41 (s, 9H), 0.86-0.99 (m, 1H), 1.08 (d, J = 6.2 Hz, 3H), 1.20 
(d, J = 6.3 Hz, 3H), 1.24-1.38 (m, 1H), 1.39-1.46 (m, 1H), 1.54-1.72 (m, 2H), 1.78-
1.88 (m, 1H), 2.12-2.22 (m, 2H), 2.68-2.98 (m, 5H), 5.02-5.11 (m, 1H), 7.16-7.31 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ 21.3, 21.6, 21.7, 25.2, 27.3, 32.6, 34.0, 35.1, 
37.6, 42.9, 46.2, 55.0, 67.7, 126.5, 127.0, 128.1, 145.0, 176.4; IR (neat) 3380, 2955, 
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2916, 1849, 1719, 1576, 1539, 1418, 1385, 1244, 1109 cm-1; HRMS calcd for 











(4R)-4-tert-Butyl-6-carboxy-6-phenylazonanium chloride (121). To a 
solution of amide 34 (0.015 g, 0.053 mmol, 1.0 equiv) in THF (3 mL), HCl (6.0 M in 
H2O, 3 mL) was added, and the resulting mixture was stirred at rt for 1.5 h. The 
solvent was removed to afford the corresponding amino acid (0.0167 g, 0.049 mmol, 
93% yield), which was used in the next step without further purification. 1H NMR 
(400 MHz, DMSO-d6) δ 0.35 (s, 9H), 1.22-1.50 (m, 2H), 1.61-2.03 (m, 5H), 2.09-
2.20 (m, 1H), 2.34-2.43 (m, 1H), 2.97-3.06 (m, 2H), 3.09-3.26 (m, 2H), 7.18-7.36 (m, 
5H), 8.65 (s, 1H), 9.54 (s, 1H), 12.6 (s, 1H); 13C NMR (125 MHz, DMSO-d6) δ 18.4, 
25.7, 26.7, 28.4, 33.9, 34.6, 37.7, 41.1, 44.2, 53.8, 126.7, 126.7, 128.1, 177.0; HRMS 










(4R)-4-tert-Butyl-6-carboxyazonanium chloride (122). According to the 
procedure described above, the reaction of amide 3 (0.025 g, 0.12 mmol, 1.0 equiv), 
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HCl (6.0 M in H2O, 3 mL) in THF (3 mL) for 1.5 h at rt afforded the title amino acid 
(0.031 g, 0.12 mmol, 98% yield), which was used in the next step without further 
purification. Spectroscopic properties matched those previously described.54 
 
General procedure for closure to the twisted amides: To a flask charged 
with aminoester (1.0 equiv) and toluene (5-10 mL), DBU (10 equiv) was added and 
the reaction mixture was heated to reflux until TLC analysis indicated full conversion 
to the bridged amide. Typically, 1 h for methyl esters. Solvent removal, followed by 






Lactam 34. According to the general procedure, the reaction of aminomethyl 
ester (0.0278 g, 0.09 mmol, 1.0 equiv) and DBU (0.14 mL, 0.90 mmol, 10 equiv) in 
toluene (5 mL) for 1 h, afforded after chromatography (1/2 EtOAc/hexanes) the title 
amide in 92% yield (0.0230 g, 0.081 mmol). Spectroscopic properties matched those 
previously described. Note: refluxing the aminomethylester in toluene under Dean-
Stark trap for 24 h w/o DBU did not lead to any conversion to the bridged amide. 
Heating the aminoester at 120 °C under vacuum (5 h, no solvent) led to ca. 50% 
conversion along with decomposition products. Putting the aminomethylester under 
vacuum for 24 h at rt led to 11% conversion to amide. In addition, leaving the 
251 
 
aminoester in a flask open to air for 2 weeks led to ca. 80% conversion to 34, after 4 





Lactam 3. According to the general procedure, the reaction of aminomethyl 
ester (0.020 g, 0.083 mmol, 1.0 equiv) and DBU (0.13 mL, 0.83 mmol, 10 equiv) in 
toluene (5 mL) for 1 h, afforded after chromatography (1/1 EtOAc/hexanes) the title 
amide in 48% yield (0.0083 g, 0.040 mmol). Spectroscopic properties matched those 
previously described. Note: lower yield in this case is caused by instability of 3 on 






Lactam 73. According to the general procedure, the reaction of aminomethyl 
ester (0.012 g, 0.041 mmol, 1.0 equiv) and DBU (0.06 mL, 0.41 mmol, 10 equiv) in 
toluene (5 mL) for 1 h, afforded after chromatography (1/1 EtOAc/hexanes) the title 
amide in 84% yield (0.0089 g, 0.034 mmol). Spectroscopic properties matched those 








Lactam 34 (From ethyl ester). According to the general procedure, the 
reaction of aminoethyl ester (0.025 g, 0.076 mmol, 1.0 equiv) and DBU (0.12 mL, 
0.76 mmol, 10 equiv) in toluene (10 mL) for 18 h, afforded after chromatography (1/2 
EtOAc/hexanes) the title amide in 85% yield (0.0183 g, 0.064 mmol). Note: the 
reaction is slower than with the methyl ester. Spectroscopic properties matched those 






Amide 34 (From ispropyl ester). According to the general procedure, the 
reaction of aminoisopropyl ester (0.0062 g, 0.018 mmol, 1.0 equiv) and DBU (0.03 
mL, 0.18 mmol, 10 equiv) in toluene (10 mL) for 7 days, afforded after 
chromatography (1/2 EtOAc/hexanes) the title amide in 49% yield (0.0025 g, 0.009 
mmol). Note:  1H NMR indicated 75% conversion. Spectroscopic properties matched 






Amide 34 (From carboxylic acid). To a solution of amino acid (0.015 g, 
0.044 mmol, 1.0 equiv) in DMSO (5 mL), DCC (1.0 M in CH2Cl2, 0.44 mL, 0.44 
mmol, 10 equiv), followed by DMAP (0.054 g, 0.44 mmol, 10 equiv) was added and 
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the resulting mixture was stirred at rt for 20 h. The reaction was quenched with water 
(10 mL), diluted with ether (100 mL), washed with water (4 x 20 mL), brine (1 x 20 
mL), dried and concentrated. Chromatography (1/3 EtOAc/hexanes) afforded the title 
amide in 79% yield (0.0099 g, 0.035 mmol). Spectroscopic properties matched those 






Amide 3 (From carboxylic acid). According to the procedure described 
above, the reaction of amino acid (0.031 g, 0.12 mmol, 1.0 equiv), DCC (1.0 M in 
CH2Cl2, 1.2 mL, 1.2 mmol, 10 equiv), and DMAP (0.15 g, 1.2 mmol, 10 equiv) in 
DMSO (5 mL) at rt for 20 h, afforded after chromatography (1/1 EtOAc/hexanes) the 
title amide in 59% yield (0.0083 g, 0.040 mmol). Spectroscopic properties matched 
those previously described. Note: lower yield in this case is caused by instability of 3 





1-tert-Butyl 2-methyl 2-(3-chloropropyl)pyrrolidine-1,2-dicarboxylate 
(124). To a solution of LDA, prepared from nBuLi (2.3 M in hexanes, 2.44 mL, 5.6 
mmol, 1.3 equiv) and diisopropylamine (0.86 mL, 6.04 mmol, 1.4 equiv) in THF (20 
mL) at -78 °C for 20 min, 123 (1.0 g, 4.3 mmol, 1.0 equiv) in THF (10 mL) was 
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added dropwise at -78 °C. After 20 min 1-chloro-3-iodopropane (0.92 mL, 8.6 mmol, 
2.0 equiv) was added, and the dry ice-acetone ice bath was removed. After stirring at 
rt for 19 h, the reaction mixture was quenched with NH4Cl (20 mL), extracted with 
ether (3 x 100 mL), dried and concentrated. Chromatography (1/6 EtOAc/hexanes) 
afforded the title compound as oil (Rf = 0.31, 1/4 EtOAc/hexanes). Yield 62% (1.07 
g, 3.5 mmol). 1H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 1.39 (s, 5.7H), 
1.42 (s, 3.3H), 1.64-2.14 (m, 7H), 2.29 (dt, J = 4.6, 13.9 Hz, 1H), 3.33-3.42 (m, 1H), 
3.44-3.75 (m, 4H), 3.68 (s, 1.1 H), 3.69 (s, 1.9H); 13C NMR (100 MHz, CDCl3) 
(mixture of rotamers) δ 22.7, 23.1, 27.1, 27.6, 28.3, 28.4, 32.0, 32.8, 36.2, 37.5, 45.2, 
48.5, 48.6, 52.1, 67.0, 67.6, 79.6, 80.2, 153.7, 154.1, 174.8, 175.1; IR (neat) 2974, 
2918, 1742, 1697, 1391, 1366, 1163, 1132 cm-1; HRMS calcd for C14H24ClNO4Na 





Methyl hexahydro-1H-pyrrolizine-7a-carboxylate (125). To a solution of 
124 (0.567 g, 1.85 mmol, 1.0 equiv) in MeOH (15 mL), TMSCl (1.18 mL, 9.26 
mmol, 5.0 equiv) was added dropwise at rt, and the reaction mixture was stirred at rt 
for 24 h. The reaction was quenched with sat. NaHCO3 (10 mL) until pH >8, diluted 
with CH2Cl2 (50 mL), extracted with CH2Cl2 (3 x 50 mL), dried, concentrated and 
purified by chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) to afford the title 
compound as oil (Rf = 0.61, 1/10/90 NH4OH/MeOH/CH2Cl2). Yield 89% (0.28 g, 
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1.65 mmol). The compound is known.119 Described above method for its preparation 




4-Allyl-7a-(methoxycarbonyl)octahydropyrrolizinium iodide (126). To a 
solution of amine 125 (0.0750 g, 0.44 g, 1.0 mmol) in CH2Cl2 (10 mL), allyliodide 
(0.21 mL, 2.22 mmol, 5.0 equiv) was added and the resulting mixture was stirred at rt 
for 22 h. Solvent removal afforded the title compound as oil. Yield 98% (0.145 g, 
0.43 mmol. 1H NMR (400 MHz, CDCl3) δ 2.18-2.48 (m, 6H), 2.52-2.68 (m, 2H), 
3.73-3.93 (m, 4H), 3.81 (s, 3H), 4.02 (d, J = 6.8 Hz, 2H), 5.60 (d, J = 10.0 Hz, 1H), 
5.75 (d, J = 16.8 Hz, 1H), 5.92-6.04 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.5, 
33.7, 54.5, 62.0, 63.0, 86.7, 125.6, 129.2, 168.4; IR (neat) 2953, 2916, 2189, 1740, 
1456, 1435, 1283, 1234, 1136, 1038, 920, 731 cm-1; HRMS calcd for C12H20NO2 




Me I  
7a-(Methoxycarbonyl)-4-methyloctahydropyrrolizinium iodide (126a). To 
a solution of amine 125 (0.10 g, 0.59 g, 1.0 mmol) in CH2Cl2 (10 mL), methyliodide 
(0.37 mL, 5.9 mmol, 10.0 equiv) was added and the resulting mixture was stirred at rt 
for 21 h. Solvent removal afforded the title compound as solid (mp. = 121-2 °C, Rf = 
0.67, 1/10/90 NH3/MeOH/CH2Cl2). Yield 99% (0.18 g, 0.58 mmol). 1H NMR (400 
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MHz, CDCl3) δ 1.92-2.08 (m, 2H), 2.09-2.24 (m, 4H), 2.29-2.42 (m, 2H), 3.06 (s, 
3H), 3.58 (s, 3H), 3.59-3.68 (m, 2H), 3.82-3.92 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 21.2, 33.0, 48.7, 54.3, 65.8, 86.2, 168.0; IR (neat) 3477, 2953, 2189, 1738, 
1470, 1454, 1286, 1229, 1138, 1011, 920, 731 cm-1; HRMS calcd for C10H18NO2 





4-Allyloctahydropyrrolizinium-7a-carboxylate (127). To a solution of 126 
(0.048 g, 0.14 mmol, 1.0 equiv) in THF (10 mL), NaOMe (0.081 g, 1.42 mmol, 10.0 
equiv) was added, and the resulting mixture was heated at reflux for 30 min. Solvent 
removal and purification by chromatography (1/25/75 NH3/MeOH/CH2Cl2) afforded 
the title compound as oil (Rf = 0.42, 1/20/80 NH3/MeOH/CH2Cl2). Yield 59% 
(0.0161 g, 0.083 mmol). 1H NMR (400 MHz, CDCl3) δ 2.08-2.22 (m, 4H), 2.24-2.36 
(m, 2H), 2.84-2.92 (m, 2H), 3.28-3.42 (m, 2H), 3.82-3.98 (m, 2H), 4.20 (d, J = 7.2 
Hz, 2H), 5.57-5.69 (m, 2H), 5.90-6.04 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.4, 
34.2, 61.0, 61.5, 90.4, 126.8, 127.5, 169.6; IR (neat) 3437, 1620, 1462, 1383, 1360, 
1013, 955 cm-1; HRMS calcd for C11H18NO2 (M+) 196.1338, found 196.1317.  
Note: the reaction of 126 (0.0568 g, 0.16 mmol, 1.0 equiv) and NaN3 (0.0547 
g, 0.81 mmol, 5.0 equiv) in THF (5 mL) for 30 h at reflux afforded 127 in 49% yield 
(0.0153 g, 0.08 mmol); the reaction of 126 (0.0705 g, 0.21 mmol, 1.0 equiv) and 
EtONa (0.147 g, 2.1 mmol, 10.0 equiv) in THF (10 mL) for 72 h at reflux afforded 
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127 in 55% yield (0.0224 g, 0.11 mmol). To further confirm the structure of 127, the 
methyl analogue 126a (0.0455 g, 0.15 mmol, 1.0 equiv) was subjected to the reaction 
with MeONa (0.083 g, 1.46 mmol, 10.0 equiv) in THF (10 mL) for 30 min at reflux. 
Interestingly, in this case, purification by chromatography led only to decomposition, 
however solvent removal afforded 127a. A number of other reaction conditions were 
also tried (for example, reduction with NH3/Na, Zn/AcOH, NaCNBH3, SmI2) but did 






4-Methyloctahydropyrrolizinium-7a-carboxylate (127a). 1H NMR (400 
MHz, DMSO-d6) δ 1.91-2.11 (m, 4H), 2.38-2.52 (m, 4H), 3.06 (s, 3H), 3.60 (t, J =7.3 
Hz, 4H); 13C NMR (100 MHz, DMSO-d6) δ 21.0, 33.8, 47.1, 64.3, 88.1, 170.2; 








1-Allyl 2-methyl 2-(3-chloropropyl)pyrrolidine-1,2-dicarboxylate (128). 
To a solution of amine 125 (0.0744 g, 0.44 mmol, 1.0 equiv) in toluene (10 mL), allyl 
chloroformate (0.14 mL, 1.32 mmol, 3.0 equiv) was added at rt, and the resulting 
mixture was stirred at 100 °C for 30 min. Solvent removal, followed by 
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chromatography (1/3 EtOAc/hexanes) afforded the title compound as oil (Rf = 0.35, 
1/4 EtOAc/hexanes). Yield 91% (0.117 g, 0.40 mmol). 1H NMR (400 MHz, CDCl3) 
(mixture of rotamers) δ 1.56-2.34 (m, 9H), 3.40-3.56 (m, 3H), 3.64, 3.67 (s, 3H), 
4.43-4.58 (m, 2H), 5.12-5.29 (m, 2H), 5.75-5.94 (m, 1H); 13C NMR (100 MHz, 
CDCl3) (mixture of rotamers) δ 22.6, 23.1, 27.1, 27.4, 31.7, 32.7, 36.1, 37.4, 45.0, 
48.3, 49.1, 52.4, 65.6, 66.0, 67.3, 68.1, 117.0, 117.7, 132.5, 132.9, 154.3, 174.4, 
174.7; IR (neat) 2953, 2880, 1742, 1703, 1400, 1339, 1271, 1169, 1127, 995 cm-1; 








1-Benzyl 2-methyl 2-(3-chloropropyl)pyrrolidine-1,2-dicarboxylate (129). 
According to the above procedure, the reaction of 125 (0.0603 g, 0.36 mmol) and 
benzyl chloroformate (0.16 mL, 1.07 mmol, 3.0 equiv) in toluene (10 mL) at 100 °C 
for 30 min afforded after chromatography (1/4 EtOAc/hexanes) afforded the title 
compound as oil (Rf = 0.27, 1/4 EtOAc/hexanes). Yield 89% (0.109 g, 0.32 mmol). 
1H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 1.57-2.41 (m, 8H), 3.28-3.59 
(m, 4H), 3.69 (m, 3H), 5.04-5.18 9m, 2H), 7.28-7.38 (m, 5H); 13C NMR (100 MHz, 
CDCl3) (mixture of rotamers) δ 22.7, 23.2, 27.2, 27.5, 31.8, 32.7, 36.1, 37.5, 44.9, 
45.1, 48.4, 49.2, 52.2, 52.4, 66.7, 67.1, 67.3, 68.2, 127.6, 127.9, 127.9, 128.4, 128.4, 
128.5, 136.2, 136.9, 154.4, 154.5, 174.4, 174.6; IR (neat) 2953, 2880, 1740, 1703, 
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1406, 1356, 1213, 1169, 1127 cm-1; HRMS calcd for C17H23ClNO4 (M+ + H) 









dicarboxylate (130). According to the above procedure, the reaction of 125 (0.040 g, 
0.24 mmol) and 4-nitrophenyl chloroformate (0.13 g, 0.62 mmol, 2.6 equiv) in 
toluene (10 mL) at rt for 4 h afforded after chromatography (1/4 EtOAc/hexanes) 
afforded the title compound as oil (Rf = 0.76, 1/1 EtOAc/hexanes). Yield 76% 
(0.0677 g, 0.18 mmol). 1H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 1.71-
2.52 (m, 8H), 3.42-3.98 (m, 4H), 3.78, 3.85 (s, 3H), 7.26-7.38 (m, 2H), 8.23-8.33 (m, 
2H), 7.28-7.38 (m, 5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 22.7, 
23.1, 27.2, 27.5, 31.5, 32.8, 36.1, 37.6, 44.8, 49.1, 49.6, 52.8, 52.9 68.4, 69.0, 121.9, 
122.2, 122.3, 125.1, 125.2, 125.2, 144.8, 144.9, 151.6, 153.0, 156.0, 156.1, 171.4, 
173.6; IR (neat) 2953, 2916, 1728, 1521, 1385, 1344, 1223, 1204, 1111 cm-1; HRMS 












1-Benzyl 5-methyl azocane-1,5-dicarboxylate (131) and 1-Benzyl 2-methyl 
2-propylpyrrolidine-1,2-dicarboxylate (131a). To a solution of 125 (0.165 g, 0.98 
mmol, 1.0 equiv) in THF (10 mL) at -78 °C, benzyl chloroformate (0.84 mL, 5.6 
mmol, 5.7 equiv) was added dropwise. After stirring for 4 h at -78 °C, NaCNBH3 
(0.216 g, 3.4 mmol, 3.5 equiv) in THF (5 mL) was added dropwise, the reaction 
mixture was warmed slowly to rt, and stirred overnight. The reaction mixture was 
concentrated, the residue taken in CH2Cl2 (20 mL), washed with NaOH (1.0 M, 1 x 
10 mL), brine (1 x 10 mL), dried and concentrated. Chromatography (1/10-1/4 
EtOAc/hexanes) afforded 131a as oil (Rf = 0.32, 1/4 EtOAc/hexanes), yield 33% 
(0.0982 g, 0.32 mmol), and 131 as oil (Rf = 0.25, 1/4 EtOAc/hexanes), yield 26% 
(0.0775 g, 0.25 mmol). Compound 131: 1H NMR (400 MHz, CDCl3) δ 1.56-2.01 (m, 
8H), 2.49-2.58 (m, 1H), 3.13-3.21 (m, 2H), 3.63-3.78 (m, 2H), 3.68 (s, 3H), 7.30-7.41 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 24.6, 25.7, 27.2, 27.9, 43.1, 47.2, 48.1, 51.7, 
67.0, 127.0, 127.5, 127.8, 127.9, 128.5, 137.0, 156.0, 177.1; IR (neat) 2947, 2862, 
1732, 1697, 1477, 1454, 1420, 1354, 1221, 1144, 1051 cm-1; HRMS calcd for 
C17H24ClNO4 (M+ + H) 306.1705, found 306.1702. Compound 131a: 1H NMR (400 
MHz, CDCl3) (mixture of rotamers) δ 0.88, 0.95 (t, J = 7.3 Hz, 3H), 1.11-1.46 (m, 
2H), 1.78-1.98 (m, 3H), 2.04-2.18 (m, 2.5H), 2.31 (td, J = 4.7, 13.6 Hz, 0.5H), 3.49, 
3.70 (s, 3H), 3.41-3.52 (m, 1H), 3.70-3.84 (m, 1H), 5.06-5.20 (m, 2H), 77.27-7.38 (m, 
5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 14.3, 14.3, 16.7, 16.9, 
22.8, 23.3, 36.1, 37.2, 37.5, 48.4, 49.3, 52.1, 52.3, 66.6, 67.0, 67.8, 68.6, 127.6, 127.8, 
128.0, 128.2, 128.4, 128.4, 136.5, 137.0, 154.3, 154.5, 175.0, 175.2; IR (neat) 2959, 
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2874, 1742, 1705, 1454, 1408, 1356, 1169, 1130, 1097, 912, 743 cm-1; HRMS calcd 





Methyl azocane-5-carboxylate (132). To a solution of 131 (0.130 g, 0.42 
mmol, 1.0 equiv) in MeOH (5 mL), Pd/C (5%, 0.18 g) was added, and the resulting 
solution was stirred under a balloon of H2 at rt for 1 h. Filtration through Celite, 
followed by chromatography (1/5/95 NH3/MeOH/CH2Cl2) afforded the title 
compound as oil (Rf = 0.19, 1/10/90 NH3/MeOH/CH2Cl2). Yield 71% (0.0511 g, 0.30 
mmol). 1H NMR (400 MHz, CDCl3) δ 1.51-1.62 (m, 2H), 1.72-1.86 (m, 4H), 1.93-
2.02 (m, 2H), 2.76-2.85 (m, 3H), 2.87-2.98 (m, 2H), 3.68 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 27.3, 27.4, 44.0, 48.4, 51.5, 177.6; IR (neat) 2916, 2849, 1732, 1576, 
1541, 1472, 1435, 1385, 1298, 1159, 1090 cm-1; HRMS calcd for C9H18NO2 (M+ + 
H) 172.1338, found 172.1324. Note: attempted transannular closure of 132 in a 





Diethyl 2-(3-(tert-butyldimethylsilyloxy)propyl)malonate (133). To a 
suspension of NaH (60% in mineral oil, 0.42 g, 10.5 mmol, 1.4 equiv) in DMF (8 
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mL) diethyl malonate (1.60 mL, 10.5 mmol, 1.4 equiv) was added at 0 °C. After the 
reaction mixture was stirred at rt for 30 min, 3-bromopropoxy-tert-
butyldimethylsilane (1.82 mL, 7.6 mmol, 1.0 equiv) was added in THF (16 mL) at 0 
°C. The resulting mixture was stirred at 55 °C for 72 h, cooled to rt, quenched with 
sat. NH4Cl (20 mL), extracted with ether (3 x 50 mL), washed with water (1 x 50 
mL), brine (1 x 50 mL), dried and concentrated under reduced pressure. 
Chromatography (1/20 EtOAc/hexanes) afforded the title compound as oil (Rf = 0.36, 
1/10 EtOAc/hexanes). Yield 92% (2.31 g, 7.0 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.00 (s, 6H), 0.85 (s, 9H), 1.23 (t, J = 7.1 Hz, 6H), 1.46-1.57 (m, 2H), 1.87-1.97 (m, 
2H), 3.33 (t, J = 7.6 Hz, 1H), 3.60 (t, J = 6.2 Hz, 2H), 4.15 (qd, J = 1.0, 7.2 Hz, 4H); 
13C NMR (100 MHz, CDCl3) δ -5.4, 14.0, 18.2, 25.3, 25.9, 30.3, 51.6, 61.2, 62.4, 
169.4; IR (neat) 2955, 2930, 2859, 1753, 1736, 1471, 1370, 1254, 1098, 1032, 837 





malonate (134). To a suspension of NaH (60% in mineral oil, 0.318 g, 8.0 mmol, 1.2 
equiv) in THF (5 mL), a solution of malonate (2.2 g, 6.6 mmol, 1.0 equiv) in THF (10 
mL) was added dropwise at 0 °C. After the reaction mixture was stirred for 30 min at 
rt, 1-chloro-3-iodopropane (1.42 mL, 13.2 mmol, 2.0 equiv) was added at 0 °C, the 
resulting mixture was stirred at rt for 30 min, followed by reflux for 30 min. The 
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reaction was cooled to rt, quenched with sat. NH4Cl (20 mL), extracted with ether (3 
x 50 mL), washed with water (1 x 50 mL), brine (1 x 50 mL), dried and concentrated 
under reduced pressure. Chromatography (1/10 EtOAc/hexanes) afforded the title 
compound as oil (Rf = 0.36, 1/10 EtOAc/hexanes). Yield 74% (2.0 g, 4.9 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.06 (s, 6H), 0.91 (s, 9H), 1.27 (td, J = 1.1, 7.1 Hz, 6H), 
1.36-1.46 (m, 2H), 1.64-1.75 (m, 2H), 1.91-1.98 (m, 2H), 2.01-2.08 (m, 2H), 3.54 (t, 
J = 6.5 Hz, 2H), 3.62 (t, J = 6.2 Hz, 2H), 4.20 (q, J = 7.0 Hz, 4H); 13C NMR (100 
MHz, CDCl3) δ -5.3, 14.1, 18.3, 25.9, 27.4, 27.5, 28.9, 29.8, 44.8, 56.8, 61.3, 62.9, 
171.5; IR (neat) 2955, 2930, 2857, 1732, 1472, 1464, 1256, 1194, 1098, 1032, 837 




Diethyl 2-(3-chloropropyl)-2-(3-hydroxypropyl)malonate (135). To a 
solution of ether (0.33 g, 0.80 mmol, 1.0 equiv) in CH3CN (3 mL) HF•CH3CN 
(prepared in a separate vial from 0.2 mL of HF and 1.8 mL of CH3CN) was added 
dropwise at 0 °C. After stirring for 20 min at 0 °C, the reaction was carefully 
quenched with sat. NaHCO3, extracted with ether (3 x 50 mL), washed with brine (1 x 
50 mL), dried and concentrated. The product was used in the next step without further 
purification. Analytical sample was obtained by chromatography (1/1 
EtOAc/hexanes) afforded the title compound as oil (Rf = 0.40, 1/1 EtOAc/hexanes). 
1H NMR (400 MHz, CDCl3) δ 1.27 (t, J = 7.1 Hz, 6H), 1.43-1.56 (m, 2H), 1.67-1.77 
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(m, 2H), 1.95-2.12 (m, 4H), 3.55 (t, J = 6.5 Hz, 2H), 3.64-3.69 (m, 2H), 4.21 (q, J = 
7.1 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 14.1, 27.4, 27.5, 28.9, 30.1, 44.8, 56.8, 
61.4, 62.7, 171.4; IR (neat) 3380, 2916, 1728, 1539, 1385, 1300, 1256, 1184, 1049, 





malonate (136). To a 25 ml round-bottom flask charged with alcohol (0.235 g, 0.80 
mmol, 1.0 equiv), 2-nitrobenzenesulfonamide (0.51 g, 2.5 mmol, 3.1 equiv), 
triphenylphosphine (0.37 g, 1.4 mmol, 1.75 equiv) toluene (5 mL) and THF (1 mL), 
DIAD (0.28 mL, 1.36 mmol, 1.70 equiv) was added dropwise at 0 °C, and the 
resulting mixture was stirred at rt for 2.5 h. After the solvent was removed under 
reduced pressure, chromatography (1/5 EtOAc/hexanes) afforded the title compound 
as oil (Rf = 0.59, 1/1 EtOAc/hexanes). Yield 70% (2 steps, 0.27 g, 0.57 mmol).1H 
NMR (400 MHz, CDCl3) δ 1.21 (t, J = 7.1 Hz, 6H), 1.39-1.51 (m, 2H), 1.55-1.67 (m, 
2H), 1.80-1.88 (m, 2H), 1.88-1.96 (m, 2H), 3.08 (q, J = 6.0 Hz, 2H), 3.48 (t, J = 6.1 
Hz, 2H), 4.14 (q, J = 6.9 Hz, 4H), 5.44 (t, J = 5.4 Hz, 1H), 7.70-7.76 (m, 2H), 7.79-
7.85 (m, 1H), 8.05-8.12 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 24.6, 27.4, 
29.7, 30.2, 43.8, 44.8, 56.6, 61.4, 125.4, 131.0, 132.9, 133.5, 133.7, 148.0, 171.0; IR 
(neat) 3337, 2957, 2917, 1727, 1542, 1366, 1257, 1167, 1094, 1030 cm-1; HRMS 






malonate (137). A solution of amine (0.0464 g, 0.10 mmol, 1.0 equiv) and LiBr (0.30 
g, 3.4 mmol, 35 equiv) in 2-butenone (4 mL) was heated to reflux for 18 h. The 
reaction was cooled to rt, quenched with water (20 mL), extracted with ether (3 x 50 
mL), washed with sat. sodium thiosulfate (1 x 20 mL), brine (1 x 20 mL), dried and 
concentrated to afford the title compound as oil (Rf = 0.60, 1/1 EtOAc/hexanes), 
which was used in the next step without further purification. Yield 97% (0.0493 g, 
0.094 mmol). 1H NMR (400 MHz, CDCl3) δ 1.26 (t, J = 7.1 Hz, 6H), 1.44-1.54 (m, 
2H), 1.68-1.77 (m, 2H), 1.85-1.92 (m, 2H), 1.94-2.01 (m, 2H), 3.08-3.16 (m, 2H), 
3.33-3.42 (m, 2H), 4.22 (q, J = 7.1 Hz, 4H), 5.40 (t, J = 5.9 Hz, 1H), 7.73-7.79 (m, 
2H), 7.85-7.90 (m, 1H), 8.10-8.15 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 
24.7, 27.5, 29.8, 31.5, 33.3, 43.8, 56.6, 61.5, 125.4, 131.1, 132.8, 133.6, 133.7, 148.1, 
171.0; IR (neat) 3331, 2978, 2919, 1726, 1542, 1366, 1345, 1300, 1248, 1167, 1094, 








Diethyl 1-(2-nitrophenylsulfonyl)azocane-5,5-dicarboxylate (138) and 
Diethyl 2-allyl-2-(3-(2-nitrophenylsulfonamido)propyl)malonate (138a). To a 
stirred solution of Cs2CO3 (0.14 g, 0.43 mmol, 4.9 equiv) and nBu4NI (0.065 g, 0.17 
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mmol, 2.0 equiv) in CH3CN (5 mL) at 60 °C, a solution of amine (0.045 g, 0.086 
mmol, 1.0 equiv) in CH3CN (5 mL) was added via syringe pump over 2 h. The 
reaction mixture was stirred at 60 °C for additional 2 h, cooled to rt, poured into 
water (50 mL), extracted with ether (3 x 50 mL), washed with brine (1 x 50 mL), 
dried and concentrated. Chromatography (1/4 EtOAc/hexanes) afforded 138 as oil 
(more polar compound) in 40% yield (0.0151 g, 0.034 mmol) and 138a as oil (less 
polar compound) in 34% yield (0.0128 g, 0.029 mmol). Compound 138. 1H NMR 
(400 MHz, CDCl3) δ 1.26 (td, J = 1.6, 7.0 Hz, 6H), 1.75-1.84 (m, 4H), 2.24-2.32 (m, 
4H), 3.36 (t, J = 5.8 Hz, 4H), 4.21 (qd, J = 1.6, 7.1 Hz, 4H), 7.61-7.66 (m, 1H), 7.67-
7.75 (m, 2H), 7.94-7.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 24.1, 28.0, 
50.2, 57.2, 61.4, 124.1, 130.7, 131.5, 132.9, 133.4, 148.2, 171.8; IR (neat) 2916, 
2849, 1724, 1576, 1541, 1385, 1092, 1078 cm-1; HRMS calcd for C19H26N2O8SNa 
(M+ + Na) 465.1308, found 465.1303. Compound 138a. 1H NMR (400 MHz, CDCl3) 
δ 1.26 (t, J = 7.1 Hz, 6H), 1.46-1.55 (m, 2H), 1.82-1.89 (m, 2H), 2.61 (d, J = 7.4 Hz, 
2H), 3.10 (q, J = 6.8 Hz, 2H), 4.19 (qd, J = 1.2, 7.1 Hz, 4H), 5.09 (d, J = 11.8 Hz, 
2H), 5.34 (t, J = 5.6 Hz, 1H), 5.53-5.67 (m, 1H), 7.73-7.79 (m, 2H), 7.86-7.92 (m, 
1H), 8.12-8.17 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 24.6, 29.4, 37.3, 43.9, 
56.9, 61.4, 119.3, 125.5, 131.1, 132.1, 132.8, 133.6, 133.6, 148.1, 170.9; IR (neat) 
3337, 2924, 1729, 1542, 1366, 1345, 1190, 1167, 1032 cm-1; HRMS calcd for 









Diethyl azocane-5,5-dicarboxylate (139). To a solution of nosylamine 
(0.0117 g, 0.028 mmol, 1.0 equiv) and Cs2CO3 (0.0259 g, 0.08 mmol, 3.0 equiv) in 
CH3CN (4 mL), PhSH (0.006 g, 0.05 mmol, 2.0 equiv) was added, and the resulting 
mixture was stirred at 55 °C for 30 min. Solvent removal, followed by 
chromatography (1/10/90 NH3/MeOH/CH2Cl2) afforded the title compound as oil (Rf 
= 0.38, 1/10/90 NH3/MeOH/CH2Cl2). Yield 78% (0.0052 g, 0.020 mmol). 1H NMR 
(400 MHz, CDCl3) δ 1.26 (t, J = 7.1 Hz, 6H), 1.56-1.65 (m, 4H), 2.14 (br, 1H), 2.21-
2.28 (m, 4H), 2.84 (t, J = 6.2 Hz, 4H), 4.19 (q, J = 7.1 Hz, 4H); 13C NMR (100 MHz, 
CDCl3) δ 14.1, 24.8, 28.2, 48.9, 57.6, 61.1, 172.4; IR (neat) 3380, 2916, 1726, 1576, 
1541, 1472, 1385, 1227, 1186, 1094, 1080 cm-1; HRMS calcd for C13H24NO4 (M+ + 
H) 258.1705, found 258.1704. Note: deprotection of 138 (0.0104 g, 0.024 mmol, 1.0 
equiv) with thioglycolic acid (0.09 mL, 1.2 mmol, 50 equiv) and LiOH (0.058 g, 2.4 
mmol, 100 equiv) in DMF (5 mL) at rt for 1 h afforded 1:3 mixture of amine 139 and 





Diethyl azocane-1,5-dicarboxylate (140). According to the procedure 
described above, the reaction of amine 139 (0.005 g, 0.02 mmol, 1.0 equiv) and DBU 
(0.03 mL, 0.20 mmol, 10.0 equiv) in toluene (10 mL) at reflux for 24 h afforded after 
chromatography (1/1 EtOAc/hexanes) the title product as oil (Rf = 0.76, 1/1 
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EtOAc/hexanes). Yield 62% (0.0031 g, 0.012 mmol). 1H NMR (400 MHz, CDCl3) 
δ 1.22-1.32 (m, 6H), 1.66-1.88 (m, 6H), 1.90-1.98 (m, 2H), 2.46-2.54 (m, 1H), 3.08-
3.18 (m, 2H), 3.57-3.65 (m, 1H), 3.67-3.76 (m, 1H), 4.09-4.21 (m, 4H); 13C NMR 
(100 MHz, CDCl3) δ 14.3, 14.8, 24.7, 25.7, 27.3, 28.0, 43.3, 47.1, 47.9, 60.3, 61.1, 
156.3, 176.8; IR (neat) 2916, 1730, 1697, 1541, 1474, 1420, 1385, 1221, 1177, 1146 







(141). To a solution of the malonate (0.0172 g, 0.039 mmol, 1.0 equiv) in THF (2.5 
mL), LiOH (0.0374 g, 1.6 mmol, 40 equiv) in H2O (2.5 mL) was added at rt, and the 
resulting mixture was stirred at rt for 24 h. The solution was acidified to pH = 2 with 
sat. KHSO4, extracted with EtOAc (3 x 50 mL), washed with brine (1 x 50 mL), dried 
and concentrated to provide the title compound as oil (0.0154 g, 0.037 mmol, 96% 
yield), which was used in the next step without further purification. 1H NMR (400 
MHz, CDCl3) δ 1.29 (t, J = 7.1 Hz, 3H), 1.76-1.91 (m, 4H), 2.31 (t, J = 5.6 Hz, 4H), 
3.28-3.44 (m, 4H), 4.24 (q, J = 7.1 Hz, 2H), 7.61-7.66 (m, 1H), 7.67-7.74 (m, 2H), 
7.93-7.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 24.1, 28.0, 50.1, 57.2, 61.9, 
124.2, 130.7, 131.6, 132.8, 133.5, 148.2, 171.4, 177.0; IR (neat) 3368, 2916, 2849, 
1731, 1717, 1700, 1576, 1542, 1385, 1374, 1165, 1077 cm-1; HRMS calcd for 
C17H22N2O8SNa (M+ + Na) 437.0995, found 437.0993. Note: the selectivity in 
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hydrolysis using excess of base is without precedent and likely results from the steric 






dicarboxylate (142). To a solution of acid (0.0143 g, 0.035 mmol, 1.0 equiv) and 
pentafluorophenol (0.0096 g, 0.052 mmol, 1.5 equiv) in CH2Cl2 (4 mL), EDC (0.0168 
g, 0.088 mmol, 2.5 equiv) was added at rt, and the resulting mixture was stirred at rt 
for 30 min. The reaction was quenched with sat. NH4Cl (10 mL), extracted with ether 
(3 x 30 mL), washed with brine (1 x 30 mL), dried and concentrated. 
Chromatography (1/2 EtOAc/hexanes) afforded the title product as oil (Rf = 0.68, 1/1 
EtOAc/hexanes). Yield 75% (0.0153 g, 0.026 mmol).1H NMR (400 MHz, CDCl3) 
δ 1.32 (t, J = 7.2 Hz, 3H), 1.83-1.92 (m, 4H), 2.44 (t, J = 5.7 Hz, 4H), 3.34-3.46 (m, 
4H), 4.29 (q, J = 7.1 Hz, 2H), 7.63-7.68 (m, 1H), 7.69-7.75 (m, 2H), 7.96-8.02 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 13.9, 23.8, 28.2, 50.0, 57.5, 62.3, 124.2, 130.8, 
131.6, 132.7, 133.5, 137.0, 138.9, 140.1, 142.0, 148.2, 168.2, 170.2; IR (neat) 2917, 
2849, 1785, 1736, 1541, 1522, 1374, 1349, 1161, 1109, 995 cm-1; HRMS calcd for 






Ethyl 5-(tert-butyldimethylsilyloxy)-2-phenylpentanoate (143). To a 
solution of HMPA (1.0 mL, 6.1 mmol, 2.0 equiv) in THF (10 mL), LHMDS (1.0 M 
in THF, 3.35 mL, 3.35 mmol, 1.1 equiv) was added at rt, and the reaction mixture 
was cooled to -78 °C. Phenyl ethyl acetate (0.49 mL, 3.05 mmol, 1.0 equiv) was 
added in THF (5 mL), and the reaction mixture was stirred at -78 °C for 1 h. (3-
Bromopropoxy)-tert-butyldimethylsilane (1.09 mL, 4.6 mmol, 1.5 equiv) was added 
dropwise, the reaction mixture was allowed to slowly warm to rt, and stirred at rt 
overnight. The reaction was quenched with sat. NH4Cl (30 mL), extracted with ether 
(4 x 50 mL), washed with brine (1 x 50 mL), dried and concentrated. 
Chromatography (1/40 EtOAc/hexanes) afforded the title product as oil (Rf = 0.33, 
1/20 EtOAc/hexanes). Yield 89% (0.91 g, 2.7 mmol). 1H NMR (400 MHz, CDCl3) 
δ 0.05 (s, 6H), 0.91 (s, 9H), 1.23 (t, J = 7.1 Hz, 3H), 1.42-1.58 (m, 2H), 1.82-1.92 (m, 
1H), 2.09-2.19 (m, 1H), 3.57 (t, J = 7.8 Hz, 1H), 3.62 (td, J = 1.8, 6.4 Hz, 2H), 4.08-
4.19 (m, 2H), 7.18-7.35 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 14.2, 18.4, 
26.0, 29.9, 30.7, 51.5, 60.7, 62.8, 127.1, 128.0, 128.6, 139.3, 174.1; IR (neat) 2955, 
2930, 2857, 1734, 1472, 1254, 1159, 1098, 837 cm-1; HRMS calcd for C19H32O3SiNa 





phenylpentanoate (144). To a solution of ester (0.56 g, 1.67 mmol, 1.0 equiv) in 
271 
 
THF (10 mL) and HMPA (1.5 mL), LDA (0.60 M, 3.87 mL, 2.34 mmol, 1.4 equiv; 
freshly prepared from 1.1 equiv of DIPA and 1.0 equiv of nBuLi in THF) was added 
at -78 °C. After the reaction mixture was stirred for 1 h at -78 °C, 1-chloro-3-
iodopropane (0.54 mL, 5.0 mmol, 3.0 equiv) was added, the reaction mixture was 
allowed to warm up rt and stirred for next 15 h. NH4Cl (30 mL), extracted with ether 
(4 x 50 mL), washed with brine (1 x 50 mL), dried and concentrated. 
Chromatography (1/33 EtOAc/hexanes) afforded the title product as oil (Rf = 0.45, 
1/10 EtOAc/hexanes). Yield 91% (0.63 g, 1.5 mmol). 1H NMR (400 MHz, CDCl3) 
δ 0.06 (s, 6H), 0.91 (s, 9H), 1.20 (t, J = 7.1 Hz, 3H), 1.32-1.42 (m, 2H), 1.53-1.65 (m, 
2H), 1.99-2.22 (m, 4H), 3.51 (t, J = 6.5 Hz, 2H), 3.62 (t, J = 6.2 Hz, 2H), 4.15 (q, J = 
7.1 Hz, 2H), 7.22-7.38 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 14.1, 18.3, 26.0, 
27.5, 27.6, 30.9, 32.4, 45.3, 53.1, 60.8, 63.2, 126.4, 126.8, 128.4, 142.3, 175.5; IR 
(neat) 2955, 2930, 2857, 1728, 1472, 1252, 1196, 1098, 1032, 837 cm-1; HRMS calcd 




Ethyl 5-chloro-2-(3-hydroxypropyl)-2-phenylpentanoate (145). According 
to the procedure described for 135, the reaction of 144 (0.63 g, 1.5 mmol, 1.0 equiv) 
and HF•CH3CN (prepared from 0.5 mL of HF and 2.5 mL of CH3CN) in 5 mL of 
CH3CN for 20 min at 0 °C, afforded after chromatography (1/1 EtOAc/hexanes) the 
title compound as oil (Rf = 0.65, 1/1 EtOAc/hexanes). Yield 93% (0.42 g, 1.4 mmol). 
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1H NMR (400 MHz, CDCl3) δ 1.21 (t, J = 7.1 Hz, 3H), 1.32-1.49 (m, 2H), 1.52-1.68 
(m, 3H), 2.03-2.25 (m, 4H), 3.52 (t, J = 6.4 Hz, 2H), 3.62 (dt, J = 1.5, 6.2 Hz, 2H), 
4.16 (q, J = 7.1 Hz, 2H), 7.22-7.36 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 14.1, 
27.5, 27.6, 31.1, 32.4, 45.3, 53.2, 60.9, 63.0, 126.4, 126.9, 128.4, 142.1, 175.5; IR 
(neat) 3400, 2917, 2849, 1725, 1576, 1539, 1386, 1235, 1094, 1059, 1032 cm-1; 





phenylpentanoate (146). According to the procedure described for 136, 145 (0.20 g, 
0.67 mmol, 1.0 equiv) was reacted with DBAD (0.268 g, 1.14 mmol, 1.7 equiv), 
triphenylphosphine (0.31 g, 1.17 mmol, 1.75 equiv) and nosylamine (0.424 g, 2.1 
mmol, 3.1 equiv) in THF/toluene (1 mL/5 mL) for 3 h. HCl (4.0 M in dioxane, 3.0 
mL) was added and the reaction was stirred at rt for 1 h. The reaction was diluted 
with ether (10 mL), washed with aq. HCl (4.0 M, 2 x 10 mL), water (1 x 20 mL), 
brine (1 x 20 mL), dried and concentrated. Chromatography (1/3 EtOAc/hexanes) 
afforded the title compound as oil (Rf = 0.60, 1/1 EtOAc/hexanes). Yield 68% (0.22 
g, 0.46 mmol). 1H NMR (400 MHz, CDCl3) δ 1.20 (t, J = 7.1 Hz, 3H), 1.29-1.41 (m, 
2H), 1.46-1.64 (m, 2H), 1.96-2.18 (m, 4H), 3.05-3.16 (m, 2H), 3.50 (t, J = 6.3 Hz, 
2H), 4.09-4.19 (m, 2H), 5.31 (t, J = 5.7 Hz, 1H), 7.14-7.36 (m, 5H), 7.70-7.78 (m, 
2H), 7.82-7.91 (m, 1H), 8.07-8.13 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 
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24.7, 27.6, 32.2, 32.5, 44.1, 45.2, 53.2, 61.1, 125.4, 126.3, 127.0, 128.5, 131.0, 132.8, 
133.6, 133.7, 141.6, 148.0, 175.0; IR (neat) 3339, 2916, 2849, 1719, 1576, 1541, 
1385, 1366, 1165, 1090 cm-1; HRMS calcd for C22H27ClN2O6SNa (M+ + Na) 





phenylpentanoate (147). According to the procedure described for 137, the reaction 
of chloride 146 (0.0761 g, 0.16 mmol, 1.0 equiv) and LiBr (0.48 g, 5.5 mmol, 35 
equiv) in butanone (4 mL) at reflux for 15 h afforded the title product as oil. Yield 
96% (0.0797 g, 0.15 mmol). 1H NMR (400 MHz, CDCl3) δ 1.20 (dt, J = 0.8, 7.2 Hz, 
3H), 1.31-1.44 (m, 2H), 1.56-1.73 (m, 2H), 2,01 (t, J = 8.0 Hz, 2H), 2.08-2.18 (m, 
2H), 3.03-3.14 (m, 2H), 3.36 (t, J = 6.4 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 5.32 (t, J = 
6.0 Hz, 1H), 7.14-7.35 (m, 5H), 7.73-7.82 (m, 2H), 7.83-7.89 (m, 1H), 8.08-8.13 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 24.7, 27.7, 32.2, 33.7, 33.9, 44.1, 53.2, 
61.1, 125.4, 126.3, 127.0, 128.5, 131.0, 132.8, 133.6, 133.6, 141.6, 148.0, 175.0; IR 
(neat) 3345, 2917, 2849, 1719, 1576, 1542, 1418, 1365m 1165, 1092, 913 cm-1; 










Ethyl 1-(2-nitrophenylsulfonyl)-5-phenylazocane-5-carboxylate (148) and 
Ethyl 2-(3-(2-nitrophenylsulfonamido)propyl)-2-phenylpent-4-enoate (149). 
According to the procedure described for 137, the reaction of 147 (0.0731 g, 0.14 
mmol, 1.0 equiv), Cs2CO3 (0.22 g, 0.68 mmol, 4.9 equiv) and nBu4NI (0.10 g, 0.28 
mmol, 2.0 equiv) in CH3CN (10 and 5 mL) at 60 °C for 4 h (syringe pump addition 
for 1.5 h) afforded after chromatography (1/4 EtOAc/hexanes) compound 148 as oil 
(Rf = 0.59, 1/1 EtOAc/hexanes) in 29% yield (0.0178 g, 0.040 mmol) and compound 
149 as oil (Rf = 0.71, 1/1 EtOAc/hexanes) in 39% yield (0.0240 g, 0.054 
mmol).Compound 148: 1H NMR (400 MHz, CDCl3) δ 1.19 (t, J = 7.1 Hz, 3H), 1.64-
1.75 (m, 2H), 1.77-1.88 (m, 2H), 2.30-2.39 (m, 2H), 2.42-2.51 (m, 2H), 3.18-3.27 (m, 
2H), 3.52-3.61 (m, 2H), 4.14 (q, J = 7.1 Hz, 2H), 7.22-7.38 (m, 5H), 7.62-7.66 (m, 
1H), 7.68-7.74 (m, 2H), 7.94-7.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 
24.2, 30.6, 50.2, 53.8, 61.0, 124.2, 126.3, 126.9, 128.5, 130.6, 131.5, 133.0, 133.4, 
143.4, 148.2, 175.7; IR (neat) 2917, 2849, 1717, 1541, 1374, 1161, 1125, 1092 cm-1; 
HRMS calcd for C22H27N2O6S (M+ + H) 447.1590, found 447.1595. Compound 149: 
1H NMR (400 MHz, CDCl3) δ 1.19 (t, J = 7.1 Hz, 3H), 1.26-1.39 (m, 2H), 1.98 (dd, J 
= 5.4, 11.0 Hz, 2H), 2.67-2.74 (m, 1H), 2.79-2.86 (m, 1H), 3.06 (q, J = 6.6 Hz, 2H), 
4.07-4.21 (m, 2H), 5.04-5.11 (m, 2H), 5.25 (t, J = 5.7 Hz, 1H), 5.46-5.58 (m, 1H), 
7.16-7.35 (m, 5H), 7.71-7.77 (m, 2H), 7.84-7.88 (m, 1H), 8.08-8.12 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 14.1, 24.2, 31.8, 39.2, 44.1, 53.2, 61.0, 118.6, 125.4, 
126.3, 126.9, 128.5, 131.1, 132.8, 133.3, 133.5, 133.7, 141.6, 148.1, 174.9; IR (neat) 
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3343, 2979, 2934, 1723, 1541, 1445, 1364, 1345, 1210, 1167, 1127, 1030 cm-1; 






Ethyl 5-phenylazocane-5-carboxylate (150). According to the procedure for 
139, the reaction of 148 (0.0115 g, 0.026 mmol, 1.0 equiv), Cs2CO3 (0.025 g, 0.78 
mmol, 3.0 equiv) and PhSH (0.006 g, 0.05 mmol, 2.0 equiv) in CH3CN (5 mL) at 55 
°C for 30 min, afforded after chromatography (1/10/90 NH3/MeOH/CH2Cl2) the title 
compound as film (Rf = 0.24, 1/10/90 NH3/MeOH/CH2Cl2). Yield 89% (0.0060 g, 
0.023 mmol). 1H NMR (400 MHz, CDCl3) δ 1.19 (t, J = 7.1 Hz, 3H), 1.55-1.72 (m, 
4H), 2.26-2.39 (m, 2H), 2.42-2.51 (m, 2H), 2.82-2.99 (m, 4H), 3.07 (br, 1H), 4.14 (q, 
J = 7.1 Hz, 2H), 7.22-7.41 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 14.1, 24.7, 30.8, 
49.0, 54.1, 60.8, 126.4, 126.6, 128.4, 144.1, 176.1; IR (neat) 3368, 2917, 1721, 1542, 
1385, 1212, 1183, 1113, 1082 cm-1; HRMS calcd for C16H24NO4 (M+ + H) 262.1807, 
found 262.1792. Note: deprotection of 148 (0.0042 g, 0.01 mmol, 1.0 equiv) with 
thioglycolic acid (0.03 mL, 0.5 mmol, 50 equiv) and LiOH (0.023 g, 0.9 mmol, 100 
equiv) in DMF (5 mL) at rt for 1 h afforded 150 in 53% yield (0.0013 g, 0.005 
mmol). Note: attempted transannular closure (DBU, toluene, 110 °C, 24 h) led to no 








1-(2-Nitrophenylsulfonyl)-5-phenylazocane-5-carboxylic acid (151). A 
mixture of ester (0.0303 g, 0.068 mmol, 1.0 equiv) and LiOH (0.163 g, 6.8 mmol, 100 
equiv) in dioxane/water (6 mL/3 mL) was refluxed for 48 h. The reaction was cooled 
to rt, quenched with 10% KHSO4 (until pH = 2), extracted with ether (3 x 50 mL), 
washed with water (1 x 20 mL), brine (1 x 20 mL), dried and concentrated to afford 
the title product as oil (Rf = 0.26, 1/1 EtOAc/hexanes), which was used in the next 
step without further purification. Yield 91% (0.0259 g, 0.062 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.70-1.88 (m, 4H), 2.29-2.41 (m, 2H), 2.46-2.58 (m, 2H), 3.22-3.32 
(m, 2H), 3.48-3.58 (m, 2H), 7.24-7.46 (m, 5H), 7.58-7.66 (m, 1H), 7.68-7.73 (m, 2H), 
7.93-7.99 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 24.2, 30.3, 50.2, 53.6, 124.2, 
126.6, 127.3, 128.7, 130.6, 131.6, 133.0, 133.4, 142.2, 148.2, 181.4; IR (neat) 3416, 
2916, 1698, 1542, 1374, 1343, 1162, 1127, 913, 734 cm-1; HRMS calcd for 






carboxylate (152). According to the procedure described for 142, the reaction of acid 
(0.0240 g, 0.057 mmol, 1.0 equiv), EDC (0.0165 g, 0.086 mmol, 1.5 equiv) and 
pentafluorophenol (0.0262 g, 0.14 mmol, 2.5 equiv) in CH2Cl2 at rt for 30 min, 
afforded after chromatography (1/2 EtOAc/hexanes) the title compound as oil (Rf = 
0.74, 1/1 EtOAc/hexanes).Yield 72% (0.0241 g, 0.041 mmol). 1H NMR (400 MHz, 
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CDCl3) δ 1.73-1.86 (m, 2H), 1.87-1.98 (m, 2H), 2.44-2.66 (m, 4H), 3.18-3.28 (m, 
2H), 3.64-3.72 (m, 2H), 7.31-7.47 (m, 5H), 7.64-7.68 (m, 1H), 7.70-7.76 (m, 2H), 
7.97-8.01 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.9, 30.9, 50.1, 54.7, 124.2, 
126.3, 127.7, 128.9, 130.7, 131.6, 132.8, 133.5, 136.7, 139.1, 139.9, 141.5, 142.3, 
148.2, 172.4; IR (neat) 2917, 2849, 1771, 1542, 1520, 1385, 1100, 996 cm-1; HRMS 






5-Phenyl-1-azabicyclo[3.3.1]nonan-9-one (153). According to the previously 
described procedure, 152 (0.0155 g, 0.27 mmol, 1.0 equiv) was reacted with Cs2CO3 
(0.0259 g, 0.80 mmol, 3.0 equiv) and PhSH (0.006 g, 0.05 mmol, 2.0 equiv) in 
CH3CN (5 mL) at 55 °C for 30 min. Solvent was removed under reduced pressure, 
and the reaction was analyzed by 1H NMR. Yield 57% (vs. 2-
nitrophenylphenylsulfide). Note: the compound is unstable, rapid decomposition is 
observed in CDCl3. Attempted purification led only to the decomposition products. 
1H NMR (400 MHz, CDCl3) (aromatic peaks not resolved) δ 1.55-1.65 (m, 2H), 2.24-
2.36 (m, 2H), 2.37-2.43 (m, 4H), 3.36-3.45 (m, 2H), 3.48-3.57 (m, 2H); 13C NMR 
(100 MHz, CDCl3) (aromatic peaks not resolved) δ 22.3, 40.8, 52.8, 57.0, 199.5; IR 
(neat) 2919, 2849, 1730.5, 1621, 1518, 1439, 1337, 1304, 1250, 1136 cm-1; HRMS 
calcd for C14H18NO (M+ + H) 216.1388, found 216.1391. The structure was 
confirmed by COSY, NOESY, HMBC and HSQC experiments. Note: attempted 
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deprotection of 152 with thioglycolic acid and LiOH in DMF led only to 




Ethyl 6-(tert-butyldimethylsilyloxy)-2-phenylhexanoate (154). According 
to the procedure described for 143, the reaction of phenyl ethyl acetate (0.49 mL, 3.05 
mmol, 1.0 equiv), LiHMDS (1.0 M in THF, 3.36 mL, 3.36 mmol, 1.1 equiv), HMPA 
(1.06 mL, 6.1 mmol, 2.0 equiv) and tert-Butyl(4-iodobutoxy)dimethylsilane (1.25 
mL, 4.57 mmol, 1.5 equiv) in THF (15 mL) for 18 h, afforded after chromatography 
(1/40 EtOAc/hexanes) the title product as oil (Rf = 0.54, 1/10 EtOAc/hexanes). Yield 
69% (0.74 g, 2.1 mmol). 1H NMR (400 MHz, CDCl3) δ 0.05 (s, 6H), 0.90 (s, 9H), 
1.23 (t, J = 7.1 Hz, 3H), 1.28-1.40 (m, 2H), 1.50-1.61 (m, 2H), 1.77-1.86 (m, 1H), 
2.06-2.16 (m, 1H), 3.56 (t, J = 7.7 Hz, 1H), 3.60 (t, J = 6.5 Hz, 2H), 4.06-4.22 (m, 
2H), 7.24-7.36 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 14.2, 18.3, 23.9, 26.0, 
32.6, 33.5, 51.8, 60.6, 62.9, 127.1, 127.9, 128.6, 139.3, 174.1; IR (neat) 2928, 1732, 









(155). According to the procedure described for 144, the reaction of ester 154 (0.62 g, 
1.76 mmol, 1.0 equiv), LDA (0.94 M in THF, 2.61 mL, 2.46 mmol, 1.4 equiv), 1-
bromo-2-chloroethane (0.31 mL, 3.52 mmol, 2.0 equiv), 1-iodo-2-chloroethane (0.51 
mL, 5.29 mmol, 3.0 equiv) and HMPA (1.5 mL) in THF for 18 h, afforded after 
chromatography (1/50 EtOAc/hexanes) the title compound as oil (Rf = 0.48, 1/10 
EtOAc/hexanes). Yield 43% (0.125 g, 0.30 mmol, out of theoretical 0.7 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.05 (s, 6H), 0.090 (s, 9H), 1.22 (t, J = 7.1 Hz, 3H), 1.17-
1.38 (m, 2H), 1.51-1.61 (m, 2H), 1.98-2.16 (m, 2H), 2.42-2.61 (m, 2H), 3.23-3.31 (m, 
1H), 3.33-3.41 (m, 1H), 3.62 (t, J = 6.3 Hz, 2H), 4.14-4.22 (m, 2H), 7.24-7.38 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 14.1, 18.3, 20.8, 26.0, 33.2, 35.3, 38.5, 
40.6, 53.7, 61.0, 62.7, 126.3, 127.1, 128.6, 141.5, 174.8; IR (neat) 2955, 2930, 2731, 
1337, 1388, 1256, 1104, 836 cm-1; HRMS calcd for C22H37ClO3SiNa (M+ + Na) 





Ethyl 2-(2-chloroethyl)-6-hydroxy-2-phenylhexanoate (156). According to 
the procedure described earlier, the reaction of 155 (0.121 g, 0.29 mmol, 1.0 equiv) 
and HF•CH3CN (prepared from 0.5 mL of HF and 2.5 mL of CH3CN) in 5.0 mL of 
CH3CN at 0 °C for 20 min, afforded after chromatography (1/2 EtOAc/hexanes) the 
title compound as oil (Rf = 0.32, 1/2 EtOAc/hexanes). Yield 74% (0.0638 g, 0.21 
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mmol). 1H NMR (400 MHz, CDCl3) δ 1.22 (td, J = 2.0, 7.1 Hz, 3H), 1.26-1.37 (m, 
2H), 1.53-1.63 (m, 2H), 1.97-2.19 (m, 2H), 3.21-3.31 (m, 1H), 3.34-3.41 (m, 1H), 
3.63 (td, J = 1.8, 6.4 Hz, 2H), 4.14-4.26 (m, 2H), 7.24-7.45 (m, 5H); 13C NMR (100 
MHz, CDCl3) δ 14.1, 20.7, 32.9, 35.4, 38.5, 40.6, 53.7, 61.1, 62.4, 126.2, 127.1, 
128.6, 141.3, 174.8; IR (neat) 3430, 2938, 1725, 1651, 1447, 1233, 1175, 1032 cm-1; 






(157). According to the procedure described for 146, the reaction of 156 (0.0601 g, 
0.20 mmol, 1.0 equiv), nosylamine (0.127 g, 0.62 mmol, 3.1 equiv), 
triphenylphosphine (0.0927 g, 0.35 mmol, 1.75 equiv) and DBAD (0.0820 g, 0.34 
mmol, 1.70 equiv) in THF/toluene (1 mL/5 mL) for 3.5 h, followed by treatment with 
HCl (4.0 M in dioxane, 1.0 mL) for 1 h, afforded after chromatography (1/4 
EtOAc/hexanes) the title compound as oil (Rf = 0.60, 1/1 EtOAc/hexanes). Yield 80% 
(0.0772 g, 0.16 mmol). 1H NMR (400 MHz, CDCl3) δ 1.21 (t, J = 7.1 Hz, 3H), 1.06-
1.31 (m, 2H), 1.51-1.59 (m, 2H), 1.91-2.06 (m, 2H), 2.33-2.54 (m, 2H), 3.04-3.16 (m, 
2H), 3.18-3.26 (m, 1H), 3.32-3.39 (m, 1H), 4.17 (q, J = 7.1 Hz, 2H), 5.33 (t, J = 5.8 
Hz, 1H), 7.16-7.36 (m, 5H), 7.72-7.78 (m, 2H), 7.84-7.89 (m, 1H), 8.10-8.16 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 14.1, 21.5, 30.0, 35.2, 38.5, 40.5, 43.5, 53.6, 61.2, 
125.5, 126.2, 127.2, 127.8, 128.7, 131.0, 132.9, 133.7, 141.0, 148.0, 174.6; IR (neat) 
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3350, 2917, 1723, 1542, 1366, 1342, 1165, 1092 cm-1; HRMS calcd for 
C22H27ClN2O6SNa (M+ + Na) 505.1176, found 505.1169. Note: attempted chloride 
displacement of 157 with LiBr according to previously utilized conditions led to no 
conversion. Under more forcing conditions (200 equiv of LiBr, 31 h, reflux) lactone 




6-(tert-Butyldimethylsilyloxy)-2-phenylhexanenitrile (160). According to 
the procedure described for 154, benzyl cyanide (0.50 g, 4.3 mmol, 1.0 equiv) was 
reacted with LHMDS (1.0 M in THF, 4.73 mL, 4.73 mmol, 1.1 equiv), HMPA (1.50 
mL, 8.6 mmol, 2.0 equiv) and tert-Butyl(4-iodobutoxy)dimethylsilane (1.41 mL, 5.2 
mmol, 1.2 equiv) in THF (20 mL) to afford after chromatography (1/30-1/10 
EtOAc/hexanes) the title compound as oil (Rf = 0.68, 1/10 EtOAc/hexanes). Yield 
60% (0.79 g, 2.6 mmol). 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 6H), 0.90 (s, 9H), 
1.46-1.66 (m, 4H), 1.86-2.02 (m, 2H), 3.58-3.67 (m, 2H), 3.77-3.84 (m, 1H), 7.26-
7.44 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 23.5, 26.0, 32.0, 35.7, 37.4, 
62.6, 120.9, 127.3, 128.0, 129.1, 136.0; IR (neat) 2951, 2930, 2856, 2241, 1495, 
1472, 1454, 1256, 1099, 835 cm-1; HRMS calcd for C18H29NOSiNa (M+ + Na) 









(161). According to the procedure described for 155, the reaction of 160 (0.70 g, 2.3 
mmol, 1.0 equiv), LDA (0.75 M in THF, 4.3 mL, 3.2 mmol, 1.4 equiv), HMPA (3 
mL) and 1-bromo-2-chloroethane (1.0 mL, 11.5 mmol, 5.0 equiv) in THF (25 mL) for 
15 h afforded after chromatography (1/100-1/20 EtOAc/hexanes) the title compound 
as oil (Rf = 0.67, 1/10 EtOAc/hexanes). Yield 88% (0.74 g, 2.0 mmol). 1H NMR (400 
MHz, CDCl3) δ 0.00 (s, 6H), 0.86 (s, 9H), 1.16-1.28 (m, 1H), 1.42-1.58 (m, 3H), 
1.91-2.12 (m, 2H), 2.34-2.45 (m, 1H), 2.46-2.57 (m, 1H), 3.14-3.24 (m, 1H), 3.51-
3.62 (m, 3H), 7.31-7.49 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 21.6, 
25.9, 32.3, 39.6, 41.1, 43.4, 47.1, 62.5, 121.4, 125.7, 128.2, 129.3, 136.8; IR (neat) 
2952, 2928, 2235, 1492, 1459, 1255, 1101, 834 cm-1; HRMS calcd for 






(162). According to the procedure described earlier, the reaction of chloride (0.16 g, 
0.44 mmol, 1.0 equiv) and NaN3 (0.29 g, 4.4 mmol, 10.0 equiv) in DMF (20 mL) at 
90 °C for 6 h afforded the title product as oil which was used in the next step without 
further purification. Yield 86% (0.14 g, 0.38 mmol). 1H NMR (400 MHz, CDCl3) 
283 
 
δ 0.00 (s, 3H), 0.02 (s, 3H), 0.86 (s, 9H), 1.16-1.26 (m, 1H), 1.44-1.61 (m, 3H), 1.91-
2.12 (m, 2H), 2.14-2.24 (m, 1H), 2.27-2.36 (m, 1H), 3.06-3.16 (m, 1H), 3.34-3.44 (m, 
1H), 3.49-3.64 (m, 2H), 7.28-7.49 (m, 5H); 13C NMR (100 MHz, CDCl3) δ -5.3, 18.3, 
21.7, 25.9, 32.3, 39.5, 41.2, 46.3, 47.6, 62.5, 121.5, 125.7, 128.2, 129.2, 137.0; IR 
(neat) 2953, 2928, 2857, 2100, 1458, 1256, 1102, 912, 837 cm-1; HRMS calcd for 






sulfonamide (164). To a solution of azide 163 (0.14 g, 0.38 mmol, 1.0 equiv) in 
EtOAc (3 mL), Pd/C (5%, 0.028 g) was added and the resulting mixture was stirred 
under H2 balloon at rt for 6 h. The reaction mixture was filtered through celite and 
concentrated. The crude amine was taken in CH2Cl2 (10 mL), Hünig base (0.060 g, 
0.46 mmol, 1.2 equiv), followed by nosyl chloride (0.0868 g, 0.38 mmol, 1.0 equiv) 
in CH2Cl2 (2 mL) were added and the resulting mixture was stirred at rt for 2 h. The 
reaction was quenched with water (1 x 20 mL), extracted with EtOAc (3 x 50 mL), 
washed with brine (1 x 20 mL), dried and concentrated. Chromatography (1/4 
EtOAc/hexanes) afforded the title product as oil (Rf = 0.81, 1/1 EtOAc/hexanes). 
Yield 74% (0.15 g, 0.28 mmol). 1H NMR (400 MHz, CDCl3) δ 0.00 (s, 3H), 0.00 (s, 
3H), 0.84 (s, 9H), 1.10-1.22 (m, 1H), 1.38-1.57 (m, 3H), 1.88-2.06 (m, 2H), 2.26-2.40 
(m, 2H), 2.84-2.93 (m, 1H), 3.17-3.27 (m, 1H), 3.47-3.59 (m, 2H), 5.37 (t, J = 6.0 Hz, 
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1H), 7.31-7.45 (m, 5H), 7.67-7.76 (m, 2H), 7.82-7.86 (m, 1H), 7.95-7.99 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ -5.3, 18.2, 21.6, 25.9, 32.3, 40.3, 40.7, 41.3, 46.4, 62.5, 
121.5, 125.5, 125.7, 128.2, 129.3, 131.1, 132.9, 133.1, 133.8, 136.9, 148.0; IR (neat) 
3342, 2953, 2928, 2856, 2235, 1541, 1350, 1254, 1169, 1095, 837 cm-1; HRMS calcd 






According to procedure described for 156, the reaction of 163 (0.0490 g, 0.092 
mmol) and HF•CH3CN (prepared from 0.3 mL of HF and 1.9 mL of CH3CN) in 5 mL 
of CH3CN at 0 °C for 20 min afforded after chromatography (1/2 EtOAc/hexanes) the 
title compound as oil (Rf = 0.23, 1/1 EtOAc/hexanes). Yield 96% (0.0369 g, 0.088 
mmol). 1H NMR (400 MHz, CDCl3) δ 1.12-1.25 (m, 1H), 1.42-1.62 (m, 3H), 1.91-
2.06 (m, 2H), 2.27-2.41 (m, 2H), 2.84-2.93 (m, 1H), 3.16-3.26 (m, 1H), 3.58 (t, J = 
6.0 Hz, 2H), 5.41 (t, J = 6.0 Hz, 1H), 7.34-7.45 (m, 5H), 7.68-7.76 (m, 2H), 7.82-7.87 
(m, 1H), 7.95-7.99 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.5, 32.2, 40.3, 40.6, 
41.1, 46.4, 62.3, 121.5, 125.5, 125.7, 128.3, 129.3, 131.1, 132.9, 133.1, 133.7, 136.8, 
148.0; IR (neat) 3537, 3342, 2935, 2868, 2237, 1541, 1361, 1344, 1167, 1126, 1074, 









According to the procedure described earlier, the reaction of 164 (0.0549 g, 0.13 
mmol, 1.0 equiv), triphenylphosphine (0.104 g, 0.39 mmol, 3.0 equiv) and DBAD 
(0.0917 g, 0.39 mmol, 3.0 equiv) in THF/toluene (2 mL/10 mL) at rt for 4 h afforded 
after chromatography (1/4 EtOAc/hexanes) the title compound as oil (Rf = 0.67, 1/1 
EtOAc/hexanes). Yield 42% (0.0217 g, 0.054 mmol). 1H NMR (400 MHz, CDCl3) 
δ 1.39-1.55 (m, 2H), 1.92-2.11 (m, 3H), 2.31-2.44 (m, 2H), 2.66-2.74 (m, 1H), 3.14-
3.22 (m, 1H), 3.28 (dt, J = 5.4, 14.6 Hz, 1H), 3.70 (dt, J = 5.2, 14.7 Hz, 1H), 3.76-
3.83 (m, 1H), 7.33-7.58 (m, 5H), 7.62-7.65 (m, 1H), 7.69-7.77 (m, 2H), 7.92-7.96 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 23.3, 29.0, 34.9, 38.9, 45.5, 46.1, 48.9, 122.8, 
124.2, 125.9, 128.1, 129.1, 130.9, 131.4, 131.5, 133.7, 140.8, 148.5; IR (neat) 2929, 
2869, 2234, 1544, 1370, 1347, 1168, 913 cm-1; HRMS calcd for C20H21N3O4SNa (M+ 
+ Na) 422.1150, found 422.1137. Note: the yield and purity of the product was found 
to decrease upon scale-up. Attempted manipulations of the nitrile including 








Dimethyl 2-allyl-2-(3-iodopropyl)malonate (168). To a suspension of 
sodium hydride (60%, suspension in mineral oil) (0.111 g, 2.78 mmol, 1.1 equiv) in 
10 mL of THF at 0° C was added dimethyl 2-allylmalonate (0.434 g, 2.52 mmol, 1.0 
equiv) dropwise in 10 mL of THF and the resulting solution was stirred at rt for 30 
min. 1,3-diiodopropane (1.15 mL, 10.1 mmol, 4.0 equiv) was added in one portion at 
0 °C and the resulting solution was stirred for 30 min at room temperature followed 
by heating to 60-65 °C for 1 h. The reaction was cooled to room temperature, diluted 
with ether (20 mL) and quenched with brine (10 mL). The aqueous layer was 
extracted with ether (3 x 50 mL), and the combined organic layers were washed brine 
(20 mL). The organic layer was dried (Na2SO4) and concentrated. Chromatography 
(3-5% EtOAc/hexanes) afforded the title compound as a colorless oil (Rf = 0.30, 10% 
EtOAc/hexanes). Yield 71% (0.609 g, 1.79 mmol). 1H NMR (400 MHz, CDCl3) δ 
1.72-1.80 (m, 2H), 1.96-2.02 (m, 2H), 2.64-2.68 (m, 2H), 3.17 (t, J = 6.8, 2H), 3.75 
(s, 6H), 5.11-5.17 (m, 1H), 5.60-5.71 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 5.6, 
28.3, 33.5, 37.4, 52.5, 57.0, 119.4, 132.0, 171.3; IR (neat) 2950, 1731, 1435, 1221 






malonate (169). To a solution of iodide 168 (0.381 g, 1.12 mmol, 1.0 equiv) in DMF 
(12.0 mL) was added Et3N (0.31 mL, 2.24 mmol, 2.0 equiv), followed by allylamine 
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(0.43 mL, 5.61 mmol, 5.0 equiv) under Ar. The septum was sealed with Teflon tape, 
Ar atmosphere was removed, and the reaction mixture was heated at 60 °C for 30 
min. The reaction was cooled to room temperature, diluted with ether (20 mL), 
quenched with water (10 mL), and extracted with ether (3 x 50 mL). The organic 
layer was washed with water (4 x 50 mL), and brine (1 x 50 mL), dried (Na2SO4), and 
concentrated. The resulting amine was used in the next step w/o further purification.  
To a solution the crude amine (1.12 mmol) in DCM (20 mL), Et3N (0.23 mL, 
1.68 mmol, 1.5 equiv) was added, followed by TsCl (0.265 g, 1.34 mmol, 1.2 equiv). 
The reaction mixture was stirred for 19 h at rt. The solvent was removed under 
reduced pressure, and the reaction mixture was purified directly by flash 
chromatography (1/6-1/4 EtOAc/hexanes) to afford the title compound 169 as a light 
oil (Rf = 0.25, 1/4 EtOAc/hexanes), yield 75% for two steps (0.353 g, 0.83 mmol). 1H 
NMR (400 MHz, CDCl3) δ 1.40-1.48 (m, 2H), 1.78-1.84 (m, 2H), 2.44 (s, 3H), 2.62 
(d, J = 7.4 Hz, 2H), 3.10 (t, J = 7.4 Hz, 2H), 3.72 (s, 6H), 3.79 (d, J = 6.5 Hz, 2H), 
5.06-5.19 (m, 4H), 5.55-5.67 (m, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.69 (d, J = 8.1 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 21.5, 23.0, 29.6, 37.4, 47.2, 50.7, 52.4, 57.3, 
118.9, 119.1, 127.2, 129.7, 132.2, 133.2, 136.9, 143.2, 171.4; IR (neat) 2951, 2926, 










(170). To a solution of the crude amine obtained as described above (0.60 mmol) in 
DCM (15 mL), Et3N (0.12 mL, 0.90 mmol, 1.5 equiv) was added, followed by Boc2O 
(0.16 g, 0.72 mmol, 1.2 equiv). The reaction mixture was stirred for 20 h at rt. The 
solvent was removed under reduced pressure, and the reaction mixture was purified 
directly by flash chromatography (1/8-1/4 EtOAc/hexanes) to afford the title 
compound 170 as colorless oil (Rf = 0.43, 1/4 EtOAc/hexanes), yield 59% for two 
steps (0.13 g, 0.35 mmol). 1H NMR (400 MHz, CDCl3) δ 1.37-1.52 (m, 2H), 1.47 (s, 
9H), 1.82-1.88 (m, 2H), 2.66 (d, J = 7.4 Hz, 2H), 3.17-3.25 (m, 2H), 3.73 (s, 6H), 
3.75-3.85 (m, 2H), 5.07-5.16 (m, 4H), 5.57-5.69 (m, 1H), 7.71-5.83 (m, 1H); 13C 
NMR (100 MHz, CDCl3) (mixture of rotamers) δ 22.8, 23.1, 28.4, 29.7, 37.2, 46.5, 
49.4, 52.4, 57.3, 79.5, 116.4, 119.1, 132.3, 134.3, 155.4, 171.5; IR (neat) 2976, 1735, 
1695, 1410, 1244, 1207, 1149 cm-1; HRMS calcd for C19H31NO6Na (M+ + Na) 






(171). To a solution of the crude amine obtained as described above (0.60 mmol) in 
DCM (15 mL), Et3N (0.12 mL, 0.90 mmol, 1.5 equiv) was added, followed by CBzCl 
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(0.10 mL, 0.72 mmol, 1.2 equiv). The reaction mixture was stirred for 5 h at rt. The 
solvent was removed under reduced pressure, and the reaction mixture was purified 
directly by flash chromatography (1/4 EtOAc/hexanes) to afford the title compound 
171 as colorless oil (Rf = 0.35, 1/4 EtOAc/hexanes), yield 69% for two steps (0.165 g, 
0.41 mmol). 1H NMR (400 MHz, CDCl3) δ 1.47 (br, 2H), 1.85 (br, 2H), 2.63 (br, 
2H), 3.25 (br, 2H), 3.70 (s, 6H), 3.90 (br, 2H), 4.98-5.22 (br, 4H), 5.15 (s, 2H), 5.52-
5.86 (m, 2H), 7.29-7.40 (m, 5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) 
δ 22.6, 23.1, 29.6, 37.3, 46.4, 47.0, 49.5, 50.0, 52.4, 57.3, 67.2, 116.6, 117.1, 119.1, 
127.9, 128.5, 132.2, 133.8, 136.8, 156.0, 171.5; IR (neat) 2951, 1734, 1699, 1238, 






(172). To a round bottom flask charged with N-allyl-2-nitrobenzenesulfonamide1 
(0.0475 g, 0.20 mmol, 1.0 equiv), K2CO3 (0.060 g, 0.43 mmol, 2.2 equiv) and DMF 
(12 mL), iodide 168 (0.100 g, 0.29 mmol, 1.5 equiv) was added as a solution in DMF 
(3 mL) at rt, and the reaction mixture was heated at 60 °C for 30 min. The reaction 
was cooled to room temperature, diluted with ether (20 mL), quenched with water (10 
mL), and extracted with ether (3 x 30 mL). The organic layer was washed with water 
(4 x 20 mL), and brine (1 x 20 mL), dried (Na2SO4), and concentrated. 
Chromatography (1/2 EtOAc/hexanes) afforded the title compound as a colorless oil 
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(Rf = 0.56, 1/1 EtOAc/hexanes). Yield 90% (0.0801 g, 0.18 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.42-1.52 (m, 2H), 1.74-1.80 (m, 2H), 2.61 (d, J = 7.4 Hz, 2H), 3.29 
(t, J = 7.4 Hz, 2H), 3.72 (s, 6H), 3.94 (d, J = 6.4 Hz, 2H), 5.06-5.13 (m, 2H), 5.18-
5.26 (m, 2H), 5.54-5.76 (m, 2H), 7.63-7.75 (m, 3H), 8.03-8.07 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 22.5, 29.5, 37.5, 46.7, 49.8, 52.4, 57.2, 119.2, 119.4, 124.2, 
131.0, 131.7, 132.2, 132.7, 133.5, 133.7, 148.0, 171.3; IR (neat) 2952, 1732, 1543, 








dicarboxylate (173). Table 15, entry 1. To a 25 ml round-bottom flask charged with 
olefin and solvent (c = 0.003 M), 50 mol% of Grubbs 1 catalyst was added as solid 
under nitrogen. The reaction was stirred at 40 °C for 16 h. The reaction was cooled to 
rt, 50 mol% of Grubbs 1 catalyst was added, and stirring at 40 °C was continued for 
next 10 h. The reaction was cooled to rt, solvent was removed under reduced 
pressure. Known amount of nitromethane was added as the internal standard, and the 
reaction was analyzed by 1H NMR. Purification by flash chromatography afforded the 
title product. 1H NMR (400 MHz, CDCl3) δ 1.72 (s, 2H), 2.15 (s, 2H), 2.45 (s, 3H), 
2.7-3.2 (br s, 2H), 3.17 (s, 2H), 3.66 (s, 2H), 3.76 (s, 6H), 5.49 (q, J = 10.4 Hz, 1H), 
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5.81 (m, 1H), 7.33 (d, J = 8.0 Hz), 7.71 (d, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3) 
δ 21.5, 23.9, 27.8, 30.3, 46.5, 50.8, 52.7, 56.7, 127.3, 128.4, 129.5, 129.7, 135.3, 
143.4, 171.6; IR (neat) 2952, 2926, 1733, 1339, 1210, 1160, 1090 cm-1; HRMS calcd 
for C19H26NO6SNa (M+ + Na) 418.1300, found 418.1296. 
Optimization of RCM reaction, representative entries from Table 15. 
Entry 2 and 3. To a 25 ml round-bottom flask charged with olefin and solvent (c = 
0.003 M), Fürstner catalyst was added in one portion as solid under nitrogen. The 
reaction was stirred at rt (entry 2) or 40 °C (entry 3) for specified period of time. 
Solvent was removed under reduced pressure. Known amount of nitromethane was 
added as the internal standard, and the reaction was analyzed by 1H NMR.  
Entry 4 and 5. To a 25 ml round-bottom flask charged with olefin. Grubbs 2 
catalyst followed by solvent (c = 0.003 M) was added as solid under nitrogen. The 
reaction was stirred at 40 °C (entry 4) or 80 °C (entry 5) for specified period of time. 
Solvent was removed under reduced pressure. Known amount of nitromethane was 
added as the internal standard, and the reaction was analyzed by 1H NMR.  
Entry 7. To a 25 ml round-bottom flask charged with olefin. Grubbs 2 catalyst 
followed by solvent (c = 0.003 M) was added as solid under nitrogen. Ti(OiPr)4 (5 
equiv) was added and the reaction was stirred at 80 °C for specified period of time. 
Solvent was removed under reduced pressure. Known amount of nitromethane was 
added as the internal standard, and the reaction was analyzed by 1H NMR.  
Entry 6 and 10. A 25 ml round-bottom flask charged with olefin and solvent 
(c = 0.003 M) was heated to 80 °C for 30-45 min. Grubbs 2 (entry 6) or Hoveyda-
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Grubbs 2 catalyst (entry 10) was added in DCE and the reaction was stirred at 80 °C 
for specified period of time. Solvent was removed under reduced pressure. Known 
amount of nitromethane was added as the internal standard, and the reaction was 
analyzed by 1H NMR.  
Entry 13. A 25 ml round-bottom flask charged with olefin (0.0150 g, 0.036 
mmol, 1.0 equiv)  and solvent (c = 0.003 M) was heated to 80 °C for 15 min. 
Hoveyda-Grubbs 2 catalyst was added in DCE. Argon was bubbled through the 
reaction while it was stirred at 80 °C for specified period of time. Solvent was 
removed under reduced pressure. Purification of the residue by flash chromatography 
(1/7-1/4 EtOAc/Hexanes) afforded the title compound in 87% yield (0.0122 g, 0.031 
mmol).  
Entry 14. A 25 ml round-bottom flask charged with olefin (0.0144 g, 0.034 
mmol, 1.0 equiv) and solvent (c = 0.003 M) was sealed with a septum under argon 
and heated to 80 °C for 15 min. Hoveyda-Grubbs 2 catalyst was added in DCE. The 
reaction was stirred at 80 °C for 8 h. A needle was inserted once every hour to open 
the reaction to air and release ethylene. Solvent was removed under reduced pressure. 
Purification of the residue by flash chromatography (1/7-1/4 EtOAc/Hexanes) 










5,5(2H)-dicarboxylate (176). A 100 ml round-bottom flask charged with olefin 172 
(0.0610 g, 0.134 mmol, 1.0 equiv)  and DCE (45 mL, c = 0.003 M) was heated to 80 
°C for 15 min. Hoveyda-Grubbs 2 catalyst (0.0042 g, 0.0067 mmol, 0.05 equiv) was 
added in DCE (1.0 mL). Argon was bubbled through the reaction while it was stirred 
at 80 °C for 16 h. Solvent was removed under reduced pressure. Purification of the 
residue by flash chromatography (1/7-1/1 EtOAc/Hexanes) afforded the title 
compound as an oil (Rf = 0.33, 1/1 EtOAc/hexanes). Yield 93% (0.0532 g, 0.125 
mmol). 1H NMR (400 MHz, CDCl3) δ 1.75 (s, 2H), 2.16 (s, 2H), 2.94 (s, 2H), 3.39 (t, 
J = 6.0 Hz, 2H), 3.76 (s, 6H), 3.85 (d, J = 7.0 Hz, 2H), 5.51-5.59 (m, 1H), 5.86-5.94 
(m, 1H), 7.60-7.64 (m, 1H), 7.67-7.75 (m, 2H), 7.96-7.99 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 23.6, 27.1, 30.4, 46.2, 50.9, 52.7, 56.6, 124.1, 129.0, 129.7, 130.7, 
131.5, 132.0, 133.6, 148.5, 171.5; IR (neat) 2952, 2924, 1732, 1541, 1373, 1346, 








tricarboxylate (174). According to the procedure for 176, the reaction of 170 (0.0840 
g, 0.23, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0071 g, 0.011 mmol, 0.05 
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equiv) in DCE (57 mL = 0.004 M) at 80 °C for 17 h afforded after chromatography 
(1/7-1/5 EtOAc/hexanes) the title compound as a colorless oil (Rf = 0.33, 1/4 
EtOAc/hexanes). Yield 85% (0.0662 g, 0.194 mmol). 1H NMR (400 MHz, CDCl3) δ 
1.49 (s, 9H), 1.6-2.2 (m, 4H), 2.5-3.0 (m, 2H), 3.37 (s, 2H), 3.75 (s, 6H), 3.75-4.05 
(m, 2H), 5.27-5.42 (m, 1H), 5.83-5.92 (m, 1H); 13C NMR (100 MHz, CDCl3) 
(mixture of rotamers) δ 21.8, 23.1, 26.9, 27.7, 28.5, 28.5, 29.7, 30.4, 30.5, 46.6, 47.8, 
49.9, 50.8, 52.6, 52.6, 57.0, 57.3, 79.6, 79.8, 125.9, 126.6, 130.9, 131.2, 155.5, 171.7; 
IR (neat) 2952, 1733, 1693, 1456, 1411, 1395, 1125, 1170 cm-1; HRMS calcd for 







tricarboxylate (175). According to the procedure for Table 1, entry 14, the reaction 
of 171 (0.0170 g, 0.042, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0013 g, 0.0021 
mmol, 0.05 equiv) in DCE (15 mL = 0.003 M) at 80 °C for 8 h afforded after 
chromatography (1/7-1/5 EtOAc/hexanes) the title compound as a colorless oil (Rf = 
0.68, 1/1 EtOAc/hexanes). Yield 89% (0.0141 g, 0.038 mmol). 1H NMR (400 MHz, 
CDCl3) δ 2.11 (s, 2H), 2.79 (s, 2H), 3.42 (t, J = 6.0 Hz, 2H), 3.76 (s, 6H), 3.85 (s, 
2H), 3.92 (d, J = 6.2 Hz, 2H), 5.35-5.44 (m, 1H), 5.88-6.01 (m, 1H), 7.31-7.42 (m, 
5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 21.8, 23.0, 26.6, 27.1, 
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30.7, 30.8, 46.0, 47.3, 50.0, 50.3, 52.6, 52.7, 56.9, 57.0, 67.1, 67.3, 127.0, 127.4, 
127.8, 127.9, 128.0, 128.5, 130.5, 130.7, 136.7, 136.9, 155.8, 156.3, 171.6; IR (neat) 
2950, 1731, 1699, 1417, 1251, 1230, 1214, 1089 cm-1; HRMS calcd for C20H26NO6 






Dimethyl 1-tosylazonane-5,5-dicarboxylate (177). To a solution of 173 
(0.0069 g, 0.0175 mmol, 1.0 equiv) in EtOAc (3 mL), Pd/C (5%), ca. 10 mg was 
added, and the reaction was stirred under H2 balloon at rt for 20 h. Filtration through 
celite pad, followed by chromatography (1/2 EtOAc/hexanes) afforded the title 
compound as oil (Rf = 0.63, 1/1 EtOAc/hexanes). Yield 96% (0.0067 g, 0.0169 
mmol). 1H NMR (400 MHz, CDCl3) δ 1.65 (m, 4H), 1.79 (m, 2H), 2.14 (t, J = 6.4 Hz, 
2H), 2.31 (t, J = 5.9 Hz, 2H), 2.45 (s, 3H), 2.99-3.05 (m, 4H), 3.73 (s, 6H), 7.33 (d, J 
= 8.1 Hz, 2H), 7.69 (d, J = 8.1 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 18.4, 21.2, 
21.5, 26.4, 26.7, 28.0, 45.9, 50.4, 52.5, 57.5, 127.5, 129.6, 134.5, 143.3, 172.3; IR 
(neat) 2952, 2916, 1730, 1338, 1207, 1159, 912, 742 cm-1; HRMS calcd for 
C19H28NO6S (M+ + H) 398.1637, found 398.1636. Note: DEPT, COSY and HSQC in 








Methyl 10-oxo-1-azabicyclo[4.3.1]dec-3-ene-6-carboxylate (178). To a 
solution of 176 (0.0206 g, 0.0484 mmol, 1.0 equiv) and Cs2CO3 (0.088 g, 0.27 mmol, 
5.5 equiv) in CH3CN (5 mL), thiophenol (0.0297 g, 0.27 mmol, 5.5 equiv) was added, 
and the resulting mixture was heated at 55-60 °C for 2.5 h. Solvent was removed 
under reduced pressure, and the reaction was analyzed by 1H NMR Yield 89% (vs. 2-
nitrophenylphenylsulfide). Purification by PTLC (1:1 EtOAc/hexanes) afforded the 
title compound as oil (Rf = 0.57, 1/1 EtOAc/hexanes). Yield 54% (0.0055 g, 0.0263 
mmol). Note: the compound is unstable on silica. 1H NMR (400 MHz, CDCl3) δ 1.78-
1.88 (m, 2H), 1.93-2.02 (m, 1H), 2.32-2.40 (m, 1H), 2.50-2.56 (m, 1H), 3.03-3.11 (m, 
1H), 3.19 (m, 1H), 3.29-3.37 (m, 1H), 3.41-3.48 (m, 1H), 3.80 (s, 3H), 3.40-3.48 (m, 
1H), 5.55-5.62 (m, 1H), 5.67-5.74 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.2, 
34.2, 35.4, 50.4, 52.7, 54.9, 59.5, 126.6, 126.7, 172.8, 181.9; IR (neat) 2916, 1739, 
1683, 1458, 1437, 1242, 1182, 1116 cm-1; HRMS calcd for C11H15NO3Na (M+ + Na) 






Methyl 10-oxo-1-azabicyclo[4.3.1]decane-6-carboxylate (179). A 10 mL 
round-bottom flask charged with 174 (0.0245 g, 0.072 mmol, 1.0 equiv), EtOAc (5 
mL) and Pd/C (5%, ca. 50 mg) was stirred under H2 balloon for 22 h at rt. The 
reaction mixture was filtered through a pad of celite and concentrated. The residue 
was taken in 8 mL of DCM and 3 mL of TFA was added at rt After stirring for 2 h at 
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rt, the solvent was removed under reduced pressure, CH3CN was added, followed by 
Cs2CO3 (0.47 g, 1.44 mmol, 20 equiv), and the reaction mixture was stirred at 60 °C 
for 3 h. Solvent removal, followed by chromatography (1/2-1/1 EtOAc/hexanes) 
afforded the title compound as oil (Rf = 0.72, 1/1 EtOAc/hexanes). Yield 73% 
(0.0111 g, 0.053 mmol). Note: in contrast to 178, the compound is stable on silica. 1H 
NMR (400 MHz, CDCl3) δ 1.64-1.97 (m, 8H), 2.41-2.55 (m, 2H), 2.77-2.84 (m, 1H), 
3.30-3.37 (m, 1H), 3.44 (dt, J = 4.0, 11.2 Hz, 1H), 3.79 (s, 3H), 3.90 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 21.6, 23.7, 26.3, 32.4, 35.4, 49.1, 50.2, 52.5, 58.6, 173.3, 
181.0; IR (neat) 2945, 1737, 1680, 1444, 1255, 1240, 1176 cm-1; HRMS calcd for 







 Methyl 3-butyl-2-oxopiperidine-3-carboxylate (180). A 10 mL round-
bottom flask charged with 175 (0.0140 g, 0.0373 mmol, 1.0 equiv), MeOH (5 mL) 
and Pd/C (5%, ca. 30 mg) was stirred under H2 balloon for 24 h at rt. The reaction 
mixture was filtered through a pad of celite and concentrated. Purification by 
chromatography (EtOAc-1/4 MeOH/EtOAc) afforded the title compound as oil (Rf = 
0.37, EtOAc). Yield 63% (0.0050 g, 0.024 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.92 (t, J = 7.0 Hz, 3H), 1.14-1.39 (m, 4H), 1.79-2.04 (m, 5H), 2.19-2.27 (m, 1H), 
3.36 (m, 2H), 3.76 (s, 3H), 5.83 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 19.8, 
23.1, 26.7, 29.5, 35.4, 42.5, 52.6, 54.0, 170.9, 173.5; IR (neat) 3209, 2954, 1734, 
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1668, 1558, 1489, 1456, 1197 cm-1; HRMS calcd for C11H20NO3 (M+ + Na) 





Dimethyl 1-(2-nitrophenylsulfonyl)azonane-5,5-dicarboxylate (181). To a 
solution of 176 (0.018 g, 0.042 mmol, 1.0 equiv) in THF (5 mL), Rh(PPh3)3Cl  
(0.0195 g, 0.021 mmol, 0.5 equiv) was added under nitrogen. The flask was 
evacuated (3 x), H2 atmosphere was established, H2 was bubbled through the solution 
for ca. 30 s, and the reaction was stirred under H2 balloon for 16 h. Solvent was 
removed under reduced pressure, and the residue was purified by chromatography 
(1/2-1/1 EtOAc/hexanes) to afford the title compound as oil (Rf = 0.37, 1/1 
EtOAc/hexanes). Yield 60% (0.0108 g, 0.025 mmol). Note: traces of the aniline were 
detected by MS. 1H NMR (400 MHz, CDCl3) δ 1.58-1.67 (m, 2H), 1.68-1.76 (m, 2H), 
1.78-1.86 (m, 2H), 2.16 (t, J = 6.4 Hz, 2H), 2.32 (t, J = 6.1 Hz, 2H), 3.24-3.32 (m, 
4H), 3.73 (s, 6H), 7.57-7.62 (m, 1H), 7.66-7.76 (m, 2H), 7.91-7.5 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 18.8, 21.5, 26.7, 26.9, 27.8, 46.7, 51.0, 52.6, 57.5, 123.9, 130.7, 
131.1, 131.3, 133.6, 149.0, 172.2; IR (neat) 2952, 2918, 1728, 1543, 1373, 1346, 









Methyl 10-oxo-1-azabicyclo[4.3.1]decane-6-carboxylate (179). From 181. 
According to the general procedure, the reaction of 181 (0.0081 g, 0.019 mmol, 1.0 
equiv), Cs2CO3 (0.062 g, 0.19 mmol, 10 equiv) and PhSH (0.0104 g, 0.095 mmol, 5.0 
equiv) in CH3CN (6 mL) at 60 °C for 2 h afforded after chromatography (1/4-1/1 
EtOAc/hexanes) the title compound in 78% yield (0.0031 g, 0.015mmol). 







(183). According to the procedure for 172, the reaction of N-allyl-2-
nitrobenzenesulfonamide (0.11 g, 0.45 mmol, 1.0 equiv), K2CO3 (0.138 g, 0.99 mmol, 
2.2 equiv) and dimethyl 2-allyl-2-(2-bromoethyl)malonate (0.25 g, 0.91 mmol, 2.0 
equiv) in DMF (15 mL) at 80 °C for 7 h afforded after chromatography (1/4-1/2 
EtOAc/hexanes) the title compound as a colorless oil (Rf = 0.66, 1/1 EtOAc/hexanes). 
Yield 70% (0.139 g, 0.32 mmol). 1H NMR (400 MHz, CDCl3) δ 2.09-2.16 (m, 2H), 
2.64 (d, J = 7.4 Hz, 2H), 3.25-3.32 (m, 2H), 3.74 (s, 6H), 3.97 (d, J = 6.4 Hz, 2H), 
5.09-5.32 (m, 4H), 5.55-5.75 (m, 2H), 7.62-7.74 (m, 3H), 8.00-8.05 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 30.8, 37.6, 42.6, 50.1, 52.6, 56.1, 119.6, 119.7, 125.0, 
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130.9, 131.7, 131.8, 132.5, 133.5, 133.6, 148.0, 170.9; IR (neat) 2952, 1732, 1545, 








malonate (184). According to the procedure for 172, the reaction of N-(but-3-enyl)-
2-nitrobenzenesulfonamide (0.16 g, 0.62 mmol, 1.0 equiv), K2CO3 (0.22 g, 1.6 mmol, 
2.5 equiv) and dimethyl 2-allyl-2-(2-bromoethyl)malonate (0.52 g, 1.9 mmol, 3.0 
equiv) in DMF (15 mL) at 80 °C for 13 h afforded after chromatography (1/4-1/3-1/1 
EtOAc/hexanes) the title compound as a colorless oil (Rf = 0.77, 1/1 EtOAc/hexanes). 
Yield 75% (0.21 g, 0.46 mmol). 1H NMR (400 MHz, CDCl3) δ 2.10-2.16 (m, 2H), 
2.28-2.36 (m, 2H), 2.66 (d, J = 7.4 Hz, 2H), 3.30-3.37 (m, 2H), 3.37-3.42 (m, 2H), 
3.76 (s, 6H), 5.02-5.18 (m, 4H), 5.58-5.77 (m, 2H), 7.61-7.74 (m, 3H), 7.99-8.04 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 31.4, 32.6, 38.0, 43.2, 47.0, 52.7, 56.1, 117.5, 
119.7, 124.2, 130.8, 131.6, 131.9, 133.4, 133.6, 134.2, 148.0, 170.9; IR (neat) 2952, 
1732, 1545, 1373, 1350, 1222, 1161 cm-1; HRMS calcd for C20H27N2O8S (M+ + H) 









malonate (185). According to the procedure for 172, the reaction of 2-nitro-N-(pent-
4-enyl)benzenesulfonamide (0.114 g, 0.42 mmol, 1.0 equiv), K2CO3 (0.147 g, 1.05 
mmol, 2.5 equiv) and dimethyl 2-allyl-2-(2-bromoethyl)malonate (0.35 g, 1.25 mmol, 
3.0 equiv) in DMF (15 mL) at 80 °C for 13 h afforded after chromatography (1/4-1/2 
EtOAc/hexanes) the title compound as a colorless oil (Rf = 0.14, 1/4 EtOAc/hexanes). 
Yield 68% (0.133 g, 0.28 mmol). 1H NMR (400 MHz, CDCl3) δ 1.61-1.69 (m, 2H), 
2.01-2.08 (m, 2H), 2.09-2.16 (m, 2H), 2.66 (d, J = 7.4 Hz, 2H), 3.27-3.35 (m, 4H), 
3.76 (s, 6H), 4.97-5.05 (m, 2H), 5.09-5.18 (m, 2H), 5.57-5.68 (m, 2H), 5.70-5.81 (m, 
2H), 7.60-7.73 (m, 3H), 7.98-8.02 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 27.2, 
30.6, 31.5, 37.9, 43.2, 47.3, 52.7, 56.1, 115.5, 119.7, 124.2, 130.8, 131.6, 131.9, 
133.4, 133.5, 137.2, 148.1, 170.9; IR (neat) 2952, 1732, 1545, 1373, 1350, 1219, 






malonate (186). According to the procedure for 172, the reaction of N-(but-3-enyl)-
2-nitrobenzenesulfonamide (0.165 g, 0.64 mmol, 1.0 equiv), K2CO3 (0.197 g, 1.41 
mmol, 2.2 equiv) and iodide 168 (0.33 g, 0.97 mmol, 1.5 equiv) in DMF (20 mL) at 
60 °C for 60 min afforded after chromatography (1/4-1/2 EtOAc/hexanes) the title 
compound as a colorless oil (Rf = 0.63, 1/1 EtOAc/hexanes). Yield 95% (0.284 g, 
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0.61 mmol). 1H NMR (400 MHz, CDCl3) δ 1.44-1.54 (m, 2H), 1.76-1.82 (m, 2H), 
2.24-2.33 (m, 2H), 2.62 (d, J = 7.4 Hz, 2H), 3.28-3.39 (m, 4H), 3.72 (s, 6H), 5.00-
5.13 (m, 4H), 5.54-5.76 (m, 2H), 7.63-7.74 (m, 3H), 8.00-8.04 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 22.8, 29.6, 32.5, 37.6, 46.5, 47.1, 52.5, 57.2, 117.5, 119.3, 
124.2, 130.8, 131.6, 132.1, 133.4, 133.6, 134.1, 148.0, 171.3; IR (neat) 2952, 1732, 
1545, 1373, 1346, 1215, 1159 cm-1; HRMS calcd for C21H29N2O8S (M+ + H) 




Dimethyl 2-allyl-2-(4-iodobutyl)malonate (187). According to the procedure 
for 168, the reaction of sodium hydride (60%, suspension in mineral oil) (0.26 g, 6.4 
mmol, 1.1 equiv), dimethyl 2-allylmalonate (1.0 g, 5.8 mmol, 1.0 equiv), and 1,4-
diiodopropane (2.3  mL, 17.4 mmol, 3.0 equiv) in THF (20 mL) afforded after 
chromatography (2-5% EtOAc/hexanes) the title compound as a colorless oil (Rf = 
0.42, 10% EtOAc/hexanes). Yield 75% (1.54 g, 4.4 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.22-1.37 (m, 2H), 1.78-1.92 (m, 4H), 2.67 (d, J = 7.4 Hz, 2H), 3.19 (t, J = 
6.9 Hz, 2H), 3.74 (s, 6H), 5.08-55.14 (m, 2H), 5.57-5.69 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 6.3, 24.8, 31.1, 33.3, 37.1, 52.5, 57.4, 119.2, 132.3, 171.6; IR (neat) 









(188). According to the procedure for 172, the reaction of N-allyl-2-
nitrobenzenesulfonamide (0.173 g, 0.72 mmol, 1.0 equiv), K2CO3 (0.22 g, 1.57 mmol, 
2.2 equiv) and iodide 187 (0.38 g, 1.07 mmol, 1.5 equiv) in DMF (15 mL) at 60 °C 
for 60 min afforded after chromatography (1/4-1/2 EtOAc/hexanes) the title 
compound as a colorless oil (Rf = 0.72, 1/1 EtOAc/hexanes). Yield 88% (0.295 g, 
0.63 mmol). 1H NMR (400 MHz, CDCl3) δ 1.05-1.15 (m, 2H), 1.52 (p, J = 7.5 Hz, 
2H), 1.78-1.87 (m, 2H), 2.58 (d, J = 7.4 Hz, 2H), 3.28 (t, J = 7.5 Hz, 2H), 3.71 (s, 
6H), 3.92 (d, J = 6.2 Hz, 2H), 5.04-5.27 (m, 4H), 5.54-5.76 (m, 2H), 7.62-7.75 (m, 
3H), 8.01-8.06 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.1, 27.9, 32.1, 37.1, 46.6, 
49.7, 52.4, 57.5, 119.0, 119.2, 124.3, 130.9, 131.6, 132.3, 132.8, 133.5, 133.7, 147.9, 
171.5; IR (neat) 2952, 1732, 1543, 1373, 1352, 1211, 1161 cm-1; HRMS calcd for 




Methyl 2-allyl-6-chloro-2-phenylhexanoate (191). To solution of LDA 
prepared from diisopropylamine (0.37 mL, 2.62 mmol, 1.15 equiv) and n-
butyllithium (2.3 M in hexanes) (1.09 mL, 2.50 mmol, 1.10 equiv) in THF (10 mL), 
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HMPA (1.0 mL) was added dropwise at -78 °C. After stirring for 30 min at -78 °C 
methyl allylphenylacetate 189 in THF (5 mL) was added dropwise. After next 45 min 
at -78 °C, 1-chloro-4-iodobutane (0.42 mL, 3.4 mmol, 1.5 equiv) was added dropwise, 
and after 15 min the reaction mixture was allowed to warm to room temperature. 
After stirring for additional 3 h, the reaction was quenched with brine (10 mL). The 
aqueous layer was extracted with ether (3 x 50 mL), and the combined organic layers 
were washed brine (20 mL). The organic layer was dried (Na2SO4) and concentrated. 
Chromatography (1-2-5% EtOAc/hexanes) afforded the title compound as a colorless 
oil (Rf = 0.47, 10% EtOAc/hexanes). Yield 84% (0.534 g, 1.90 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.23-1.33 (m, 2H), 1.78 (p, J = 7.5 Hz, 2H), 1.98-2.08 (m, 2H), 2.84 
(dq, J = 7.7, 14 Hz, 2H), 3.52 (dt, J = 1.5, 6.6 Hz, 2H), 3.68 (s, 3H), 5.05-5.15 (m, 
2H), 5.49-5.61 (m, 1H), 7.24-7.38 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.2, 
32.9, 33.7, 39.1, 44.6, 52.1, 53.7, 118.5, 126.3, 126.9, 128.4, 133.5, 142.0, 175.8; IR 
(neat) 2951, 1730, 1496, 1446, 1271, 1217, 1155 cm-1; HRMS calcd for 






(193). To a round bottom flask charged with N-allyl-2-nitrobenzenesulfonamide 
(0.215 g, 0.89 mmol, 1.0 equiv), K2CO3 (0.273 g, 1.96 mmol, 2.2 equiv), NaI (0.67g, 
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4.5 mmol, 5 equiv) and DMF (10 mL), chloride 191 (0.50 g, 1.78 mmol, 2.0 equiv) 
was added as a solution in DMF (5 mL) at rt, and the reaction mixture was heated at 
80 °C for 14 h. The reaction was cooled to room temperature, diluted with ether (20 
mL), quenched with water (10 mL), and extracted with ether (3 x 50 mL). The 
organic layer was washed with water (4 x 50 mL), and brine (1 x 50 mL), dried 
(Na2SO4), and concentrated. Chromatography (1/4-1/3 EtOAc/hexanes) afforded the 
title compound as a yellow oil (Rf = 0.76, 1/1 EtOAc/hexanes). Yield 72% (0.313 g, 
0.64 mmol). 1H NMR (400 MHz, CDCl3) δ 0.96-1.06 (m, 2H), 1.44-1.56 (m, 2H), 
1.90-1.99 (m, 2H), 2.74 (dq, J = 6.8, 14 Hz, 2H), 3.24 (d, J = 7.7 Hz, 2H), 3.65 (s, 
3H), 3.91 (d, J = 6.2 Hz, 2H), 5.02-5.09 (m, 2H), 5.19 (dt, J = 1.2, 10.0 Hz, 2H), 
5.44-5.56 (m, 1H), 5.63-5.75 (m, 1H), 7.19-7.38 (m, 5H), 7.62-7.73 (m, 3H), 8.00-
8.04 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.0, 28.1, 34.1, 39.2, 46.8, 49.7, 52.1, 
53.7, 118.4, 119.1, 124.2, 126.3, 126.9, 128.4, 130.9, 131.6, 132.8, 133.4, 133.5, 
133.8, 141.9, 147.9, 175.8; IR (neat) 2949, 1728, 1545, 1371, 1352, 1163 cm-1; 




Phenyl 2-allyl-6-chloro-2-phenylhexanoate (192). According to the 
procedure for 191, the reaction of LDA (prepared from diisopropylamine (0.27 mL, 
1.91 mmol, 1.15 equiv) and n-butyllithium (2.3 M in hexanes) (0.79 mL, 1.83 mmol, 
1.10 equiv) in THF (10 mL)), HMPA (1.0 mL), phenyl allylphenylacetate 190 (0.42 
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g, 1.66 mmol, 1.0 equiv), and 1-chloro-4-iodobutane (0.31 mL, 2.5 mmol, 1.5 equiv) 
afforded after chromatography (hexanes-1-2-5% EtOAc/hexanes) the title compound 
as a colorless oil (Rf = 0.35, 10% EtOAc/hexanes). The compound was contaminated 
with inseparable impurity (ca. 10-15% by 1H NMR). Yield (corrected by impurity) 
69% (0.39 g, 1.14 mmol). 1H NMR (400 MHz, CDCl3) δ 1.33-1.52 (m, 2H), 1.83 (p, 
J = 7.0 Hz, 2H), 2.07-2.24 (m, 2H), 2.97 (dq, J = 6.6, 14.1 Hz, 2H), 3.52-3.62 (m, 
2H), 5.18-5.24 (m, 2H), 5.63-5.74 (m, 1H), 6.94-6.99 (m, 2H), 7.19-7.24 (m, 1H), 
7.29-7.45 (m, 7H); 13C NMR (100 MHz, CDCl3) δ 21.3, 32.9, 33.6, 39.0, 44.7, 53.8, 
118.9, 121.4, 125.8, 126.4, 127.1, 128.6, 129.4, 133.1, 141.6, 150.8, 174.0; IR (neat) 
2952, 1749, 1593, 1492, 11.92, 1161 cm-1; HRMS calcd for C21H23ClO2Na (M+ + Na) 






(194). According to the procedure for 193, the reaction of N-allyl-2-
nitrobenzenesulfonamide (0.109 g, 0.45 mmol, 1.0 equiv), K2CO3 (0.138 g, 0.99 
mmol, 2.2 equiv), NaI (0.34 g, 2.3 mmol, 5 equiv) and chloride 192 (0.39 g, 1.14 
mmol, 2.5 equiv) in DMF (15 mL) at 80 °C for 14 h afforded after chromatography 
(1/5-1/4 EtOAc/hexanes) the title compound as oil (Rf = 0.74, 1/1 EtOAc/hexanes). 
Yield 65% (0.161 g, 0.29 mmol). 1H NMR (400 MHz, CDCl3) δ 1.10- 1.20 (m, 2H), 
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1.51-1.62 (m, 2H), 2.02-2.16 (m, 2H), 2.89 (dq, J = 6.6, 14.0 Hz, 2H), 3.28 (t, J = 7.6 
Hz, 2H), 3.92 (d, J = 6.3 Hz, 2H), 5.12- 5.25 (m, 4H), 5.58-5.76 (m, 2H), 6.92-6.97 
(m, 2H), 7.19-7.24 (m, 1H), 7.28-7.43 (m, 7H), 7.60-7.71 (m, 3H), 8.01-8.05 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 21.1, 28.2, 34.1, 39.0, 46.7, 49.8, 53.8, 118.9, 119.1, 
121.3, 124.2, 125.8, 126.4, 127.1, 128.6, 129.4, 130.9, 131.6, 132.8, 133.1, 133.4, 
133.7, 141.5, 147.9, 150.8, 173.9; IR (neat) 2935, 1747, 1543, 1371, 1352, 1161, 






4,4(5H)-dicarboxylate (195). According to the procedure for Table 1, entry 14, the 
reaction of 183 (0.0689 g, 0.157 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 
(0.0049 g, 0.0080 mmol, 0.05 equiv) in DCE (53 mL = 0.003 M) at 80 °C for 2.5 h 
(needle was inserted every 15-30 min) afforded after chromatography (1/7-1/1 
EtOAc/hexanes) the title compound as white solid (Mp = 158 °C; Rf = 0.43, 1/1 
EtOAc/hexanes). Yield 90% (0.0583 g, 0.142 mmol). 1H NMR (400 MHz, CDCl3) δ 
2.36 (m, 2H), 3.03 (d, J = 7.6 Hz, 2H), 3.55 (m, 2H), 3.76 (s, 6H), 4.00 (d, J = 4.1 Hz, 
2H), 5.72-5.86 (m, 2H), 7.62-7.75 (m, 3H), 7.98-8.04 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 28.7, 31.1, 45.3, 46.8, 52.9, 57.5, 124.2, 127.6, 129.2, 131.1, 131.7, 132.6, 
133.6, 148.0, 171.2; IR (neat) 2954, 1732, 1541, 1373, 1346, 1221, 1163, 1130 cm-1; 







4,4(5H)-dicarboxylate (196. According to the procedure for 195, the reaction of 184 
(0.0663 g, 0.146 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0046 g, 0.0073 
mmol, 0.05 equiv) in DCE (50 mL = 0.003 M) at 80 °C for 2.5 h (needle was inserted 
every 15-30 min) afforded after chromatography (1/7-1/1 EtOAc/hexanes) the title 
compound as yellowish foam (Rf = 0.47, 1/1 EtOAc/hexanes). Yield 94% (0.0586 g, 
0.138 mmol). 1H NMR (400 MHz, CDCl3) δ 2.24 (t, J = 5.7 Hz, 2H), 2.52 (s, 2H), 
3.04 (d, J = 8.4 Hz, 2H), 3.25 (s, 2H), 3.34 (s, 2H), 3.80 (s, 6H), 5.47-5.56 (m, 1H), 
5.84-5.92 (m, 1H), 7.58-7.62 (m, 1H), 7.67-7.75 (m, 2H), 7.88-7.93 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 27.8, 29.8, 31.9, 46.1, 49.2, 52.9, 56.6, 124.0, 128.3, 
130.7, 131.1, 131.4, 131.4, 133.6, 148.7, 171.2; IR (neat) 2952, 1733, 1542, 1456, 
1437, 1373, 1350, 1221, 1167 cm-1; HRMS calcd for C18H23N2O8S (M+ + H) 






5,5(6H)-dicarboxylate (197). According to the procedure for 195, the reaction of 186 
(0.0578 g, 0.123 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0039 g, 0.0062 
mmol, 0.05 equiv) in DCE (42 mL = 0.003 M) at 80 °C for 2 h afforded after 
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chromatography (1/7-1/1 EtOAc/hexanes) the title compound (5:1 mixture of Z/E 
isomers) as oil (Rf = 0.43, 1/1 EtOAc/hexanes). Yield 90% (0.0495 g, 0.110 mmol). 
1H NMR (400 MHz, CDCl3) (mixture of Z/E isomers) δ 1.45-1.80 (m, 2.7H), 1.90-
2.50 (m, 3.9H), 2.62 (s, 1.3H), 3.00 (m, 4.5H), 3.75 (s, 8.2H), 3.93 (s, 1.1H), 5.42-
5.51 (m, 1H, Z isomer), 5.50-5.61 (m, 1H, E isomer), 5.65-5.70 (m, 1H, E isomer), 
5.71-5.79 (m, 1H, Z isomer), 7.58-7.64 (m, 1.07H), 7.65-7.73 (m, 2.36H), 7.86-7.93 
(m, 1.18H); 13C NMR (100 MHz, CDCl3) (Z isomer) δ 22.9, 25.6, 28.4, 28.7, 49.1, 
49.8, 52.6, 55.7, 124.1, 125.7, 127.8, 130.2, 131.1, 131.5, 133.4, 148.3, 171.8; IR 
(neat) 2952, 1730, 1543, 1437, 1373, 1344, 1273, 1257, 1209, 1141 cm-1; HRMS 






4,4(1H)-dicarboxylate (198). A 100 ml round-bottom flask charged with olefin 185 
(0.0587 g, 0.125 mmol, 1.0 equiv) and DCE (62 mL, c = 0.003 M) was heated to 80 
°C for 15 min open to air. Hoveyda-Grubbs 2 catalyst (0.0039 g, 0.0063 mmol, 0.05 
equiv) was added in DCE (0.5 mL) at 80 °C. After stirring for 1.5 h at 80 °C, the 
solvent was removed under reduced pressure. Purification of the residue by flash 
chromatography (1/7-1/4-/1/2 EtOAc/Hexanes) afforded the title compound as oil (Rf 
= 0.47, 1/1 EtOAc/hexanes). Yield 92% (0.0508 g, 0.116 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.80-2.40 (m, 4.6H), 2.50-2.85 (m, 2H), 3.10 (m, 3.5H), 3.25-3.65 (m, 
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1.9H), 3.80 (s, 6H), 5.27-5.35 (m, 1H), 5.54-5.63 (m, 1H), 7.56-7.61 (m, 1H), 7.67-
7.76 (m, 2H), 7.89-7.92 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.6, 27.1, 27.1, 
30.0, 44.5, 46.7, 52.9, 56.5, 123.9, 126.0, 130.0, 131.0, 131.2, 132.2, 133.8, 148.9, 
171.3; IR (neat) 2952, 1732, 1545, 1460, 1373, 1357, 1222, 1172, 1126 cm-1; HRMS 






6,6(5H)-dicarboxylate (199). According to the procedure for 195, the reaction of 188 
(0.0587 g, 0.125 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0039 g, 0.0063 
mmol, 0.05 equiv) in DCE (42 mL = 0.003 M) at 80 °C for 3 h afforded after 
chromatography (1/7-1/3-1/1 EtOAc/hexanes) the title compound as oil (Rf = 0.71, 
1/1 EtOAc/hexanes). Yield 79% (0.0435 g, 0.099 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.43 (s, 3H), 1.76 (s, 1H), 1.92 (s, 1H), 2.03 (s, 1H), 2.57 (m, 1H), 3.17 (m, 
1H), 3.30 (m, 1H), 3.52 (m, 1H), 3.76 (s, 6H), 4.05 (m, 1H), 2.29 (m, 1H), 5.53-5.69 
(m, 2H), 7.64-7.75 (m, 3H), 8.06-8.11 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.0, 
27.6, 28.6, 28.7, 41.6, 44.9, 52.8, 55.8, 124.3, 127.2, 131.2, 131.3, 131.7, 133.2, 
133.5, 148.0, 171.2, 171.7; IR (neat) 2952, 1730, 1543, 1437, 1371, 1340, 1161 cm-1; 








octahydroazecine-6-carboxylate (200). According to the procedure for 195, the 
reaction of 193 (0.0678 g, 0.148 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 
(0.0046 g, 0.0074 mmol, 0.05 equiv) in DCE (60 mL = 0.003 M) at 80 °C for 5 h 
afforded after chromatography (1/7-1/3 EtOAc/hexanes) the title compound as oil (Rf 
= 0.68, 1/1 EtOAc/hexanes). Yield 76% (0.0482 g, 0.112 mmol). 1H NMR (400 MHz, 
CDCl3) (mixture of rotamers) δ 1.21 (m, 0.9H), 1.36 (m, 0.5H), 1.43-1.66 (m, 1.1H), 
1.78-2.06 (m, 2.1H), 2.15-2.33 (m, 1.1H), 2.50 (dd, J = 3.4, 14.0 Hz, 0.6H), 2.94-3.02 
(m, 0.4H), 3.17 (t, J = 12.5 Hz, 0.5H), 3.31-3.44 (m, 1.6H), 3.48-3.70 (m, 1.2H), 3.67 
(s, 3H), 3.94-4.10 (m, 1H), 4.31-4.42 (m, 1H), 5.34 (dt, J = 4.6, 11.8 Hz, 0.6H), 5.47 
(dt, J = 4.6, 11.6 Hz, 0.6H), 5.60 (dt, J = 4.7, 11.6 Hz, 0.4H), 5.81 (dt, J = 4.6, 12.1 
Hz, 0.4H), 7.25-7.40 (m, 6H), 7.64-7.75 (m, 3H), 8.06-8.13 (m, 1H); 13C NMR (100 
MHz, CDCl3) (mixture of rotamers) δ 18.9, 19.6, 28.8, 29.1, 29.3, 30.0, 30.4, 33.0, 
41.9, 45.2, 52.1, 52.2, 52.3, 52.5, 124.3, 126.0, 126.1, 126.3, 126.3, 127.2, 128.6, 
131.3, 131.6, 132.6, 133.2, 133.3, 133.5, 140.8, 142.2, 148.0, 175.6, 175.7; IR (neat) 
2951, 1726, 1543, 1371, 1354, 1340, 1219, 1161 cm-1; HRMS calcd for 








octahydroazecine-6-carboxylate (201). According to the procedure for 198, the 
reaction of 194 (0.0397 g, 0.0723 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 
(0.0023 g, 0.0036 mmol, 0.05 equiv) in DCE (61 mL = 0.0012 M) at 80 °C for 13 h 
afforded after chromatography (1/7-1/41/2 EtOAc/hexanes) the title compound as oil 
(Rf = 0.50, 1/2 EtOAc/hexanes). Yield 60% (0.0227 g, 0.044 mmol). 1H NMR (400 
MHz, CDCl3) (mixture of rotamers) δ 1.25-1.45 (m, 1H), 1.55 (m, 1H), 1.70-1.95 (m, 
2H), 2.09 (m, 1H), 2.39 (m, 1H), 2.57 (dd, J = 3.6, 13.7 Hz, 0.6H), 3.11-319 (m, 
0.4H), 3.26-3.49 (m, 2H), 3.52-3.58 (m, 0.4H), 3.62-3.70 (m, 0.6H), 3.99 (dd, J = 4.8, 
14.2 Hz, 0.6H), 4.06-4.13 (m, 0.4H), 4,40 (m, 1H), 5.40 (dd, J = 4.8, 12.0 Hz, 0.6H), 
5.52 (dd, J = 4.9, 11.4 Hz, 0.6H), 5.69 (dd, J = 4.6, 11.2 Hz, 0.4H),  5.95-6.03 (m, 
0.4H), 6.93 (t, J = 8.2 Hz, 2H), 7.22 (t, J = 7.5 Hz, 1H), 7.30-7.52 (m, 7H), 7.64-7.76 
(m, 3H), 8.08-8.14 (m, 1H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 
18.9, 19.7, 28.7, 29.1, 29.3, 29.7, 30.0, 30.4, 33.0, 41.9, 42.0, 45.2, 52.4, 52.6, 121.3, 
124.3, 125.9, 126.1, 126.3, 126.8, 127.4, 128.8, 129.4, 131.3, 131.7, 132.4, 132.9, 
133.1, 133.5, 140.3, 141.7, 148.0, 150.8, 173.7; IR (neat) 2916, 1745, 1542, 1371, 









Methyl 9-oxo-1-azabicyclo[4.2.1]non-3-ene-6-carboxylate (202). According 
to the procedure for 178, the reaction of 195 (0.0190 g, 0.046 mmol, 1.0 equiv), 
Cs2CO3 (0.15 g, 0.46 mmol, 10 equiv), PhSH (0.0254 g, 0.23 mmol, 5.0 equiv) in 
CH3CN (5 mL) at 60 °C for 2 h afforded the title compound in 92 % yield (1H NMR, 
vs. 2-nitrophenylphenylsulfide) and in 75% yield (0.0067 g, 0.034 mmol) after 
purification by PTLC (1:1 EtOAc/hexanes) (Rf = 0.57, 1/1 EtOAc/hexanes). 1H NMR 
(400 MHz, CDCl3) δ 2.03 (dd, J = 7.9, 12.5 Hz, 1H), 2.16-2.24 (m, 1H), 2.60-2.70 
(m, 1H), 2.92-3.01 (m, 1H), 3.08-3.18 (m, 1H), 3.32-3.39 (m, 1H), 3.53 (t, J = 9.4 Hz, 
1H), 3.81 (s, 3H), 4.24-4.33 (m, 1H), 5.38 (dp, J = 3.0, 12.7 Hz, 1H), 5.63-5.71 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 29.8, 32.1, 46.8, 52.1, 52.7, 57.1, 122.6, 127.6, 
171.1, 183.8; IR (neat) 2952, 1739, 1720, 1437, 1242, 1197, 1134 cm-1; HRMS calcd 






Methyl 10-oxo-1-azabicyclo[5.2.1]dec-4-ene-7-carboxylate (203). 
According to the procedure for 178, the reaction of 196 (0.0213 g, 0.050 mmol, 1.0 
equiv), Cs2CO3 (0.16 g, 0.50 mmol, 10 equiv), PhSH (0.0275 g, 0.25 mmol, 5.0 
equiv) in CH3CN (5 mL) at 60 °C for 13 h afforded the title compound after 
chromatography (1/2-1/1 EtOAc/hexanes) as oil (Rf = 0.39, 1/1 EtOAc/hexanes). 
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Yield 85% (0.00890 g, 0.043 mmol). 1H NMR (400 MHz, CDCl3) δ 1.94-2.02 (m, 
1H), 2,12 (ddd, J = 2.4, 8.0, 10.5 Hz, 1H), 2.50-2.77 (m, 3H), 2.96 (dd, J = 6.0, 14.3 
Hz, 1H), 3.04-3.14 (m, 1H), 3.57-3.67 (m, 2H), 3.73-3.81 (m, 4H), 5.77-5.93 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 24.5, 26.5, 33.8, 43.4, 49.8, 52.6, 60.1, 129.1, 132.7, 
171.3, 180.2; IR (neat) 2949, 1737, 1697, 1456, 1400, 1251, 1194 cm-1; HRMS calcd 








Dimethyl 1,2,3,4,9,10-hexahydroazecine-5,5(6H)-dicarboxylate (204A). 
According to the procedure for 178, the reaction of 197 (0.104 g, 0.24 mmol, 1.0 
equiv), Cs2CO3 (0.78 g, 2.4 mmol, 10 equiv), PhSH (0.13 g, 1.2 mmol, 5.0 equiv) in 
CH3CN (12 mL) at 60 °C for 30 min afforded the title compound (5:1 mixture of Z/E 
isomers) after chromatography (0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil 
(Rf = 0.19, 1/9/90 NH4OH/MeOH/DCM). Yield 99% (0.0614 g, 0.24 mmol). 1H 
NMR (400 MHz, CDCl3) (5:1 mixture of Z/E isomers) δ 1.50 (m, 2H), 2.00 (m, 2H), 
2.11 (s, 1H), 2.52-2.59 (m, 1H), 2.80 (m, 4H), 2.97-3.19 (m, 2H), 3.76 (s, 6H), 5.38-
5.48 (m, 1H, Z isomer), 5.56-5.65 (m, 1H), 5.75 (dt, J = 7.3, 21.5 Hz, 1H, E isomer); 
13C NMR (100 MHz, CDCl3) (Z isomer) δ 23.9, 25.4, 27.8, 29.7, 46.3, 46.9, 52.6, 
56.4, 126.7, 131.4, 171.9; IR (neat) 2951, 1732, 1437, 1269, 1248, 1205, 1180, 1138 
cm-1; HRMS calcd for C13H21NO4Na (M+ + Na) 278.1368, found 278.1369. 
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Methyl 11-oxo-1-azabicyclo[5.3.1]undec-4-ene-7-carboxylate (204). 10 mL 
MW vial (Biotage) was charged with amine 204A (0.0198 g, 0.078 mmol, 1.0 equiv), 
toluene (3.0 mL), and DBU (0.12 g, 0.78 mmol, 10 equiv). The vial was sealed with 
metal septum, placed in an oil bath preheated to 200 °C and stirred for 3 h. The 
reaction was cooled to rt, solvent was removed under vacuum and the residue was 
purified by chromatography (1/1 EtOAc/hexanes) to afford the title compound as oil 
(Rf = 0.67, 1/1 EtOAc/hexanes). Yield 65% (0.0093 g, 0.042 mmol out of possible 
0.065 mmol). 1H NMR (400 MHz, CDCl3) δ 1.84-1.96 (m, 3H), 2.04-2.12 (m, 1H), 
2.21-2.26 (m, 1H), 2.50-2.66 (m, 2H), 2.75-2.86 (m, 2H), 3.24-3.31 (m, 1H), 3.54-
3.61 (m, 1H), 3.78 (s, 3H), 4.05 (dt, J = 4.6, 13.4 Hz, 1H), 5.80-5.96 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 21.8, 24.5, 29.9, 36.4, 46.9, 50.4, 52.3, 60.7, 129.8, 132.3, 
173.1, 177.3; IR (neat) 2928, 1739, 1653, 1452, 1329, 1248, 1192, 1118 cm-1; HRMS 
calcd for C12H18NO3 (M+ + H) 224.1287, found 224.1279. In addition, 









(205A). According to the procedure for 204A, the reaction of 198 (0.0329 g, 0.075 
mmol, 1.0 equiv), Cs2CO3 (0.24 g, 0.75 mmol, 10 equiv), PhSH (0.041 g, 0.37 mmol, 
5.0 equiv) in CH3CN (6 mL) at 60 °C for 1 h afforded the title compound after 
chromatography (0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil (Rf = 0.64, 
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1/9/90 NH4OH/MeOH/DCM). Yield 98% (0.0187 g, 0.073 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.35-1.60 (m, 2H), 1.72-1.88 (m, 2H), 2.23 (t, J = 12.5, 1H), 2.44 (m, 
2H), 2.56-2.68 (m, 2H), 2.77 (m, 2H), 3.75 (s, 6H), 3.98 (t, J = 13.4 Hz, 1H), 5.19-
5.26 (m, 1H), 5.41-5.51 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.2, 26.2, 27.2, 
31.4, 41.7, 44.9, 52.5, 58.1, 126.2, 131.2, 172.1, 172.7; IR (neat) 3352, 2918, 1732, 
1437, 1228, 1182, 1126 cm-1; HRMS calcd for C13H22NO4 (M+ + H) 256.1549, found 
256.1545. 
Methyl 11-oxo-1-azabicyclo[6.2.1]undec-5-ene-8-carboxylate (205). 
According to the procedure for 204, the reaction of 205A (0.0100 g, 0.0392 mmol, 
1.0 equiv) and DBU (0.12 g, 0.78 mmol, 20 equiv) in toluene (3.0 mL) at 180 °C for 
12 h afforded the title compound after chromatography (1/1 EtOAc/hexanes) as oil 
(Rf = 0.33, 1/1 EtOAc/hexanes). Yield 44% (0.0038 g, 0.017 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.81-2.03 (m, 3H), 2.11 (ddd, J = 1.4, 8.6, 13.1 Hz, 1H), 2.18-2.31 
(m, 1H), 2.45-2.55 (m, 1H), 2.61-2.69 (m, 1H), 2.85-2.92 (m, 2H), 3.22 (dt, J = 1.4, 
9.2 Hz, 1H), 3.50 (q, J = 8.6 Hz, 1H), 3.79 (s, 3H), 3.22 (dt, J = 6.1, 13.6 Hz, 1H), 
5.57-5.68 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 24.1, 24.4, 29.0, 32.5, 41.8, 45.7, 
52.7, 55.4, 122.2, 138.6, 172.4, 177.1; IR (neat) 2925, 1735, 1685, 1456, 1431, 1257, 










(206A). According to the procedure for 204A, the reaction of 199 (0.0444 g, 0.10 
mmol, 1.0 equiv), Cs2CO3 (0.32 g, 1.0 mmol, 10 equiv), PhSH (0.056 g, 0.50 mmol, 
5.0 equiv) in CH3CN (6 mL) at 60 °C for 45 min afforded the title compound after 
chromatography (0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil (Rf = 0.44, 
1/9/90 NH4OH/MeOH/DCM). Yield 99% (0.027 g, 0.10 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.33-1.58 (m, 3H), 1.64 (m, 1H), 1.96 (m, 3H), 2.50 (s, 1H), 2.71 (s, 1H), 
2.95 (s, 1H), 3.18-3.42 (m, 2H), 3.76 (s, 6H), 3.84 (m, 1H), 5.40-5.48 (m, 1H), 5.60-
5.68 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.8, 26.7, 29.1, 29.3, 40.3, 44.7, 52.5, 
56.4, 127.8, 132.2, 172.1; IR (neat) 2951, 1732, 1456, 1435, 1286, 1203, 1178 cm-1; 
HRMS calcd for C13H21NO4Na (M+ + Na) 278.1368, found 278.1363. Note: 
attempted heating of 206A with various bases at temperatures ranging from 110-220 










(207A). According to the procedure for 204A, the reaction of 200 (0.0277 g, 0.064 
mmol, 1.0 equiv), Cs2CO3 (0.21 g, 0.64 mmol, 10 equiv), PhSH (0.0354 g, 0.32 
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mmol, 5.0 equiv) in CH3CN (6 mL) at 60 °C for 1 h afforded the title compound after 
chromatography (0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil (Rf = 0.46, 
1/9/90 NH4OH/MeOH/DCM). Yield 98% (0.0154 g, 0.063 mmol). 1H NMR (400 
MHz, CDCl3) (mixture of rotamers) δ 1.22-1.42 (m, 1H), 1.45-1.82 (m, 3H), 1.98-
2.22 (m, 3H), 2.42 (dd, J = 4.0, 14.0 Hz, 0.5H), 2.64-2.78 (m, 1H), 2.86 (m, 0.5H), 
3.05 (q, J = 11.5 Hz, 1H), 3.22-3.38 (m, 1.5H), 3.47 (t, J = 13.4, 0.6H), 3.67 (s, 3H), 
3.91 (t, J = 10.7 Hz, 0.9H), 5.06-5.19 (m, 0.6H), 5.48-5.72 (m, 1.4H), 7.23-7.41 (m, 
5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 19.9, 20.7, 28.0, 29.5, 
29.7, 29.9, 30.4, 33.4, 40.5, 45.0, 52.1, 52.3, 52.8, 125.9, 126.2, 126.4, 126.8, 128.2, 
128.4, 129.0, 129.7, 131.2, 131.6, 141.7, 142.9, 176.2; IR (neat) 2945, 2917, 1727, 
1446, 1433, 1221, 1180, 1138 cm-1; HRMS calcd for C17H24NO2 (M+ + H) 274.1807, 
found 274.1816. 
6-Phenyl-1-azabicyclo[4.4.1]undec-3-en-11-one (207). From 207A. 
According to the procedure for 204, the reaction of 207A (0.0042 g, 0.0171 mmol, 
1.0 equiv) and DBU (0.052 g, 0.34 mmol, 20 equiv) in toluene (3.0 mL) at 220 °C for 
10 h afforded the title compound after chromatography (1/2 EtOAc/hexanes) as a 
white film (Rf = 0.39, 1/1 EtOAc/hexanes). Yield 34% (0.0014 g, 0.0058 mmol). 1H 
NMR (400 MHz, CDCl3) δ 1.75-1.89 (m, 2H), 1.92-2.03 (m, 3H), 2.16 (dd, J = 7.7, 
14.4 Hz, 1H), 2.22-2.29 (m, 1H), 2.76-2.85 (m, 1H), 3.02-3.11 (m, 1H), 3.66-3.71 (m, 
1H), 3.85-3.99 (m, 2H), 5.88-5.96 (m, 1H), 6.12-6.22 (m, 1H), 7.21-7.36 (m, 5H); 13C 
NMR (100 MHz, CDCl3) δ 23.6, 25.2, 33.3, 39.4, 49.7, 51.7, 63.8, 126.4, 126.9, 
128.0, 128.3, 133.0, 146.0, 186.2; IR (neat) 2924, 2854, 1653, 1444, 1290, 1236, 
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1186, 1149 cm-1; HRMS calcd for C16H20NO (M+ + H) 242.1545, found 242.1546. 
Note: no conversion was observed at temperatures lower than 220 °C. 
6-Phenyl-1-azabicyclo[4.4.1]undec-3-en-11-one (207). From 3k. To a 
solution of 201 (0.0187 g, 0.0359 mmol, 1.0 equiv) and Cs2CO3 (0.12 g, 0.35 mmol, 
10 equiv) in CH3CN (6 mL), thiophenol (0.0197 g, 0.18 mmol, 5 equiv) was added, 
and the resulting mixture was heated at 60 °C for 2 h. Solvent was removed under 
reduced pressure, the residue was taken in toluene (10 mL), and DBU (0.10 mL, 0.70 
mmol, 20 equiv) was added. The reaction mixture was heated at 110 °C for 16 h, 
solvent was removed under reduced pressure, and the residue was purified by 
chromatography (1/6-1/4 EtOAc/hexanes) to give the title compound. Yield 86% 






Lactam 204. One-pot RCM/Deprotection/Cyclization. A 100 ml round-bottom 
flask charged with olefin 186 (0.0418 g, 0.092 mmol, 1.0 equiv) and DCE (46 mL, c 
= 0.002 M) was heated to 80 °C for 15 min open to air. Hoveyda-Grubbs 2 catalyst 
(0.0029 g, 0.0046 mmol, 0.05 equiv) was added in DCE (1 mL) at 80 °C. After 
stirring for 1.5 h at 80 °C, the solvent was removed under reduced pressure. The 
residue was taken in CH3CN (12 mL), Cs2CO3 (0.47 g, 1.4 mmol, 15 equiv) followed 
by PhSH (0.10 g, 0.92 mmol, 10 equiv) was added, and the resulting mixture was 
heated at 80 °C for 3 h. Solvent was removed under reduced pressure, the residue was 
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purified by chromatography to give 204 (0.0128 g, 0.061 mmol) in 67% yield. 






hexanoate (208). According to the procedure described earlier, the reaction of N-
(but-3-enyl)-2-nitrobenzenesulfonamide (0.128 g, 0.50 mmol, 1.0 equiv), K2CO3 
(0.54 g, 1.1 mmol, 2.2 equiv), NaI (0.38 g, 2.5 mmol, 5 equiv) and chloride 192 (0.43 
g, 1.25 mmol, 2.5 equiv) in DMF (15 mL) at 80 °C for 14 h afforded after 
chromatography (1/5-1/4 EtOAc/hexanes) the title compound as oil (Rf = 0.45, 1/1 
EtOAc/hexanes). The compound was contaminated with ~5% of nosylamine. Yield 
(corrected for impurity) 54% (0.151 g, 0.27 mmol). 1H NMR (400 MHz, CDCl3) 
δ 1.11-1.22 (m, 2H), 1.47-1.62 (m, 2H), 2.03-2.17 (m, 2H), 2.26-2.34 (m, 2H), 2.81-
2.99 (m, 2H), 3.24-3.38 (m, 4H), 5.02-5.21 (m, 4H), 5.60-5.75 (m, 2H), 6.93-6.98 (m, 
2H), 7.18-7.43 (m, 8H), 7.58-7.69 (m, 3H), 7.96-8.03 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 21.2, 28.5, 32.7, 34.2, 39.0, 46.5, 47.1, 53.8, 117.4, 118.9, 121.3, 124.2, 
125.8, 126.4, 127.1, 128.6, 129.4, 130.7, 131.5, 133.1, 133.4, 133.7, 134.2, 141.5, 
148.0, 150.8, 173.8; IR (neat) 2941, 1747, 1542, 1371, 1346, 1161, 1124 cm-1; HRMS 








carboxylate (209). According to the procedure for 198, the reaction of 208 (0.0447 g, 
0.079 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0025 g, 0.0040 mmol, 0.05 
equiv) in DCE (52 mL = 0.0015 M) at 80 °C for 2.5 h afforded after chromatography 
(1/7-1/4-1/3-1/2 EtOAc/hexanes) the title compound as oil (Rf = 0.23, 1/2 
EtOAc/hexanes). Yield 79% (0.0329 g, 0.062 mmol). 1H NMR (400 MHz, CDCl3) 
(mixture of rotamers) δ 1.55-2.07 (m, 3.4H), 2.12-2.85 (m, 5H), 2.92-3.11 (m, 1.8H), 
3.12-3.28 (m, 2H), 3.38-3.67 (m, 1.8H), 4.86-4.99 (m, 0.4H), 5.46-5.73 (m, 1.3H), 
6.04-6.14 (m, 0.3H), 6.96 (d, J = 7.6 Hz, 1.4H), 7.05 (d, J = 7.6 Hz, 0.6H), 7.18-7.25 
(m, 1H), 7.26-7.47 (m, 7H), 7.52-7.77 (m, 3H), 7.94-8.02 (m, 1H); 13C NMR (100 
MHz, CDCl3) (mixture of rotamers) δ 20.9, 22.4, 27.7, 28.3, 28.7, 29.7, 31.7, 33.0, 
34.1, 36.1, 45.1, 50.9, 51.5, 52.9, 53.5, 55.7, 121.3, 121.6, 123.8, 123.9, 125.6, 125.7, 
125.8, 126.3, 126.8, 127.0, 127.0, 128.6, 128.7, 128.7, 129.3, 129.4, 130.8, 130.9, 
131.3, 131.3, 131.7, 131.9, 133.4, 133.6, 148.7, 149.0, 150.9, 173.3, 174.2; IR (neat) 
2924, 1747, 1545, 1492, 1373, 1348, 1167 cm-1; HRMS calcd for C29H30N2O6SNa 








(Z)-phenyl 6-phenylazacycloundec-8-ene-6-carboxylate (210A). According 
to the procedure for 204A, the reaction of 209 (0.0115 g, 0.21 mmol, 1.0 equiv), 
Cs2CO3 (0.069 g, 0.21 mmol, 10 equiv), PhSH (0.012 g, 0.11 mmol, 5.0 equiv) in 
CH3CN (6 mL) at 60 °C for 60 min afforded the title compound after chromatography 
(0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil (Rf = 0.30, 1/9/90 
NH4OH/MeOH/DCM). Yield 80% (0.0059 g, 0.017 mmol). Note: due to small 
quantity of the material, and the unproductive cyclization pathway, the compound 
was characterized only by 1H NMR and HRMS. 1H NMR (400 MHz, CDCl3) 
(mixture of rotamers) δ 1.38-1.85 (m, 3.8H), 1.88-2.42 (m, 3.6H), 2.48-3.18 (m, 7H), 
3.42 (m, 0.6H), 4.90 (m, 0.4H), 5.43-5.78 (m, 1.4H), 5.92-6.02 (m, 0.2H), 6.95 (m, 
1.5H), 7.02 (d, J = 7.8 Hz, 0.5H), 7.20 (m, 1H), 7.28-7.52 (m, 7H); HRMS calcd for 
C\23H28NO2 (M+ + H) 350.2120, found 350.2118. Note: attempted heating of 210A 
with various amounts of DBU at temperatures ranging from 110-220 °C led to no 





Dimethyl 2-allyl-2-((2-nitrophenylsulfonamido)methyl)malonate (210). 
According to the procedure by Fuller et al.,398 the reaction of dimethyl 2-
allylmalonate (1.0 g, 5.8 mmol, 1.0 equiv), NaH (60% dispersion in mineral oil, 0.26 
g, 6.4 mmol, 1.1 equiv), and N-bromomethylphthalimide (1.44 g, 5.8 mmol, 1.0 
equiv) in THF (15 mL) for 5 h afforded after aqueous work-up the crude dimethyl 2-
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allyl-2-((1,3-dioxoisoindolin-2-yl)methyl)malonate as a white solid that was used in 
the next step without further purification. Yield 94% (1.81 g, 5.5 mmol).  
In a 25 ml round bottom flask, hydrazine (0.154 g, 3.0 mmol, 1.1 equiv) was 
added to a solution of the crude phthalimide (0.91 g, 2.74 mmol, 1.0 equiv) in EtOH 
(10 mL). The reaction mixture was heated to reflux for 21 h, cooled to rt, quenched 
with 0.90 mL conc. HCl, filtered through a pad of celite, and concentrated under 
reduced pressure providing crude amine which was used without further purification.  
The crude amine was taken in 20 mL of DCM, pyridine (2.2 mL, 27.4 mmol, 
10.0 equiv), followed by NsCl (0.94 g, 4.1 mmol, 1.5 equiv) was added, and the 
resulting reaction mixture was stirred at rt for 12 h. The reaction was quenched with 
water (30 mL), extracted with ether (3 x 50 mL), dried over Na2SO4, and 
concentrated. Chromatography (1/4=1/2 EtOAc/hexanes) afforded the title compound 
as oil (Rf = 0.70, 1/1 EtOAc/hexanes). Yield 13% (0.133 g, 0.36 mmol). 1H NMR 
(400 MHz, CDCl3) δ 2.77 (d, J = 7.4 Hz, 2H), 3.50 (d, J = 6.1 Hz, 2H), 3.77 (s, 6H), 
5.13-5.24 (m, 2H), 5.62-5.73 (m, 1H), 6.02 (s, 1H), 7.73-7.80 (m, 2H), 7.86-7.92 (m, 
1H), 8.11-8.16 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 136.7, 45.8, 53.0, 58.0, 
120.5, 125.5, 131.0, 131.2, 132.9, 133.5, 133.7, 148.1, 169.9; IR (neat) 3329, 2954, 
1732, 1541, 1440, 1359, 1228, 1170 cm-1; HRMS calcd for C15H19N2O8S (M+ + H) 
387.0862, found 387.0864. Note: ethylmethylmalonate was obtained as the major 
product in the above reaction (in 3.3 to 1.0 ratio of the major product to 210), most 
likely resulting from transesterification with EtOH during hydrazine deprotection. No 








malonate (211). To a round bottom flask charged with amine 210 (0.0272 g, 0.070 
mmol, 1.0 equiv), K2CO3 (0.049 g, 0.35 mmol, 5.0 equiv), and DMF (6 mL), 4-
bromobut-1-ene (0.10 g, 0.70 mmol, 10 equiv) was added, and the reaction mixture 
was heated at 80 °C for 16 h. The reaction was cooled to room temperature, diluted 
with ether (20 mL), quenched with water (10 mL), and extracted with ether (3 x 50 
mL). The organic layer was washed with water (4 x 50 mL), and brine (1 x 50 mL), 
dried (Na2SO4), and concentrated. Preparative thin-layer chromatography (1/2 
EtOAc/hexanes) afforded the title compound as oil (Rf = 0.44, 1/2 EtOAc/hexanes). 
Yield 38% (0.0116 g, 0.026 mmol). 1H NMR (400 MHz, CDCl3) δ 2.13-2.22 (m, 
2H), 2.76 (d, J = 7.3 Hz, 2H), 3.31 (m, 2H), 3.76 (s, 6H), 4.04 (s, 2H), 4.91-4.98 (m, 
2H), 5.08-5.18 (m, 2H), 5.48-5.60 (m, 1H), 5.74-5.86 (m, 1H), 7.64-7.76 (m, 3H), 
8.03-8.06 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 31.1, 37.3, 47.3, 50.1, 52.8, 58.7, 
117.3, 119.4, 124.3, 131.2, 131.7, 132.1, 133.3, 133.8, 133.8, 148.2, 170.3; IR (neat) 
2924, 1732, 1545, 1439, 1371, 1167 cm-1; HRMS calcd for C19H25N2O8SNa (M+ + 









3,3(4H)-dicarboxylate (212). According to the procedure for 209, the reaction of 211 
(0.0085 g, 0.0193 mmol, 1.0 equiv) and Hoveyda-Grubbs catalyst 2 (0.0006 g, 0.0010 
mmol, 0.05 equiv) in DCE (13 mL = 0.0015 M) at 80 °C for 1 h afforded after 
purification by preparative thin-layer chromatography (1/1 EtOAc/hexanes) the title 
compound as oil (Rf = 0.66, 1/1 EtOAc/hexanes). Yield 77% (0.0061 g, 0.015 mmol). 
1H NMR (400 MHz, CDCl3) δ 2.44 (m, 2H), 2.92 (d, J = 8.5 Hz, 2H), 3.22-3.45 (m, 
2H), 3.81 (s, 6H), 3.87 (m, 2H), 5.53 (q, J = 8.6 Hz, 1H), 5.90-5.98 (m, 1H), 7.62-
7.65 (m, 1H), 7.68-7.76 (m, 2H), 7.94-7.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
28.7, 29.0, 53.0, 53.0, 53.7, 60.1, 124.2, 127.4, 131.1, 131.5, 131.8, 131.9, 133.8, 
148.5, 170.2; IR (neat) 2920, 1732, 1545, 1452, 1439, 1354, 1242, 1165 cm-1; HRMS 





(Z)-Dimethyl 1,2,7,8-tetrahydroazocine-3,3(4H)-dicarboxylate (212A). 
According to the procedure for 204A, the reaction of 212 (0.0055 g, 0.0133 mmol, 
1.0 equiv), Cs2CO3 (0.044 g, 0.13 mmol, 10 equiv), PhSH (0.0075 g, 0.067 mmol, 5.0 
equiv) in CH3CN (5 mL) at 60 °C for 30 min afforded the title compound after 
chromatography (0/0/100-1/4/95-1/9/90 NH4OH/MeOH/DCM) as oil (Rf = 0.46, 
1/9/90 NH4OH/MeOH/DCM). Yield 93% (0.0028 g, 0.0123 mmol). 1H NMR (400 
MHz, CDCl3) δ 2.23 (q, J = 7.2 Hz, 2H), 2.83 (m, 4H), 3.26 (m, 2H), 3.75 (2, 6H), 
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5.62-5.71 (m, 1H), 5.88-5.95 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 29.3, 30.2, 
50.2, 51.9, 52.5, 61.7, 127.4, 132.9, 171.5; IR (neat) 2925, 1730, 1554, 1450, 1437, 
1242, 1099 cm-1; HRMS calcd for C11H18NO4SNa (M+ + Na) 228.1236, found 
228.1237. Note: attempted heating of 212A with various amounts of DBU at 
temperatures ranging from 110-220 °C led only to decomposition products. 
 
General procedure for hydrogenation of bridged amides: To a solution of 
twisted amides in MeOH (5 mL), Pd/C (5%), ca. 30-40 mg was added, and the 
reaction was stirred under H2 balloon at rt. Filtration through cotton or celite pad, 









Methyl 10-oxo-1-azabicyclo[4.3.1]decane-6-carboxylate (179) and Methyl 
3-butyl-2-oxopiperidine-3-carboxylate (180). According to the general procedure, 
the reaction of 178 (0.0042 g, 0.0020 mmol, 1.0 equiv) and Pd/C (5%) (ca. 25 mg) in 
MeOH (4 mL) for 22 h at rt afforded 1:3 mixture of 179 and 180 (0.0040 g, 0.0190 












6-Phenyl-1-azabicyclo[4.4.1]undecan-11-one (214) and 3-Butyl-3-
phenylazepan-2-one (213). According to the general procedure, the reaction of 207 
(0.0105 g, 0.0044 mmol, 1.0 equiv) and Pd/C (5%) (ca. 40 mg) in MeOH (6 mL) for 
18 h at rt afforded 1.1:1.0 mixture of 214 and 213 (0.0057 g, 0.0240 mmol). Yield 
54%. Further purification by PTLC (1/1 EtOAc/hexanes) afforded analytical samples 
of 214 and 213. Compound 214. 1H NMR (400 MHz, CDCl3) δ 1.73-1.93 (m, 8H), 
1.95-2.04 (m, 2H), 2.17-2.25 (m, 2H), 3.10-3.18 (m, 2H), 3.54 (ddd, J = 3.8, 6.4, 10.0 
Hz, 2H), 7.21-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 23.2, 25.5, 35.5, 50.3, 
59.9, 126.1, 127.3, 127.9, 145.0, 186.3; IR (neat) 2951, 2910, 1643, 1492, 1437, 
1413, 1302, 1219 cm-1; HRMS calcd for C16H21NONa (M+ + Na) 266.1521, found 
266.1523. Compound 213: 1H NMR (400 MHz, CDCl3) δ 0.82 (t, J = 7.3 Hz, 3H), 
1.03-1.13 (m, 1H), 1.17-1.32 (m, 3H), 1.36-1.46 (m, 1H), 1.62-1.98 (m, 6H), 2.31 (dt, 
J = 2.5, 14.0 Hz, 1H), 2.62-2.72 (m, 1H), 2.80-2.88 (m, 1H), 5.93 (s, 1H), 7.21-7.39 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 14.1, 23.3, 24.8, 27.4, 29.0, 33.0, 41.8, 44.9, 
53.9, 126.2, 127.2, 128.4, 141.2, 179.4; IR (neat) 3284, 3219, 2929, 2858, 1654, 







Methyl 9-oxo-1-azabicyclo[4.2.1]nonane-6-carboxylate (215). According to 
the general procedure, the reaction of 202 (0.0042 g, 0.022 mmol, 1.0 equiv) and 
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Pd/C (5%) (ca. 30 mg) in MeOH (5 mL) for 18 h at rt afforded 215 (0.0031 g, 0.016 
mmol). Yield 74%. (Rf = 0.39, 1/1 EtOAc/hexanes) 1H NMR (400 MHz, CDCl3) δ 
1.71-1.92 (m, 4H), 2.02 (ddd, J = 1.3, 8.6, 9.9 Hz, 1H), 2.34 (m, 1H), 2.57-2.67 (m, 
1H), 2.77-2.85 (m, 1H), 3.17-3.26 (m, 1H), 3.58 (t, J = 9.6 Hz, 1H), 3.68-3.78 (m, 
2H), 3.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 23.9, 24.3, 28.6, 32.4, 47.1, 48.6, 
52.6, 57.1, 171.7, 183.4; IR (neat) 2924, 1739, 1716, 1458, 1437, 1282, 1186, 1123 






Methyl 10-oxo-1-azabicyclo[5.2.1]decane-7-carboxylate (216). According 
to the general procedure, the reaction of 203 (0.0070 g, 0.033 mmol, 1.0 equiv) and 
Pd/C (5%) (ca. 40 mg) in MeOH (5 mL) for 18 h at rt afforded 216 (0.0050 g, 0.024 
mmol). Yield 72%. (Rf = 0.39, 1/1 EtOAc/hexanes) 1H NMR (400 MHz, CDCl3) 
δ 1.36-1.55 (m, 2H), 1.68-1.84 (m, 2H), 1.96-2.15 (m, 4H), 2.42-2.52 (m, 1H), 2.62-
2.71 (m, 1H), 2.93 (dd, J = 5.4, 13.8 Hz, 1H), 3.44 (dt, J = 1.6, 10.3 Hz, 1H), 3.66 (q, 
J = 9.0 Hz, 1H), 3.78 (s, 3H), 4.18 (dt, J = 4.8, 13.2 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 23.3, 24.5, 26.3, 31.8, 41.7, 44.0, 44.9, 52.5, 54.8, 172.4, 180.1; IR (neat) 
2931, 1739, 1693, 1435, 1418, 1271, 1248, 1195 cm-1; HRMS calcd for C11H18NO3 








Methyl 11-oxo-1-azabicyclo[5.3.1]undecane-7-carboxylate (217). 
According to the general procedure, the reaction of 204 (0.0089 g, 0.040 mmol, 1.0 
equiv) and Pd/C (5%) (ca. 50 mg) in MeOH (5 mL) for 24 h at rt afforded 217 
(0.0071 g, 0.032 mmol). Yield 79%. (Rf = 0.32, 1/1 EtOAc/hexanes) 1H NMR (400 
MHz, CDCl3) δ 1.40-1.59 (m, 2H), 1.70-1.83 (m, 3H), 1.88-2.16 (m, 6H), 2.43 (t, J = 
12.4 Hz, 1H), 2.75 (dd, J = 4.8, 13.6 Hz, 1H), 3.27-3.33 (m, 1H), 3.68 (dt, J = 3.2, 
11.7 Hz, 1H), 3.75 (s, 3H), 4.62 (dt, J = 4.0, 13.3 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 21.8, 23.2, 24.8, 31.0, 32.4, 43.7, 48.2, 49.3, 52.2, 54.5, 174.1, 176.6; IR 
(neat) 2929, 1743, 1647, 1491, 1444, 1244, 1192, 1122 cm-1; HRMS calcd for 






Methyl 11-oxo-1-azabicyclo[6.2.1]undecane-8-carboxylate (218). 
According to the general procedure, the reaction of 205 (0.0056 g, 0.025 mmol, 1.0 
equiv) and Pd/C (5%) (ca. 40 mg) in MeOH (5 mL) for 16 h at rt afforded 218 
(0.0050 g, 0.022 mmol). Yield 89%. (Rf = 0.33, 1/1 EtOAc/hexanes) 1H NMR (400 
MHz, CDCl3) δ 1.11-1.21 (m, 1H), 1.26-1.38 (m, 1H), 1.42-1.52 (m, 1H), 1.71-1.90 
(m, 6H), 2.02 (ddd, J = 2.1, 9.1, 13.3 Hz, 1H), 2.20 (t, J = 11.5 Hz, 1H), 2.67-2.77 
(m, 1H), 2.86-2.93 (m, 1H), 3.45 (dt, J = 2.0, 10.6 Hz, 1H), 3.74 (q, J = 9.2 Hz, 1H), 
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3.78 (s, 3H), 3.94-4.02 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.5, 23.6, 25.9, 
26.0, 27.5, 36.4, 43.3, 46.2, 52.5, 55.3, 172.9, 173.4; IR (neat) 2924, 1737, 1685, 







Lactam 214. Hydrogenation in the presence of Willkinson’s catalyst. To a 
solution of 207 (0.0074 g, 0.031 mmol, 1.0 equiv) in THF (5 mL), Rh(PPh3)3Cl  
(0.0284 g, 0.031 mmol, 1.0 equiv) was added under nitrogen. H2 atmosphere was 
established, H2 was bubbled through the solution for ca. 30 s, and the reaction was 
stirred under H2 balloon for 19 h. Solvent was removed under reduced pressure, and 
the residue was purified by chromatography to give the title compound 214 (0.0065 g, 














1-Allyl 3-ethyl 2-oxopiperidine-1,3-dicarboxylate (220). Prepared from 
Ethyl 2-oxo-3-piperidine carboxylate and allyl chloroformate. A solution of 
piperidone (0.0496 g, 0.29 mmol, 1.0 equiv) and allyl chloroformate (0.15 mL, 1.45 
mmol, 5.0 equiv) in toluene (10 mL) was heated at 105 °C for 6 h. Solvent removal, 
followed by chromatography (1/4 EtOAc/hexanes) afforded the title compound as 
film (Rf = 0.65, 1/1 EtOAc/hexanes). Yield 87% (0.0645 g, 0.25 mmol). 1H NMR 
(400 MHz, CDCl3) δ 1.31 (t, J = 7.1 Hz, 3H), 1.81-1.91 (m, 1H), 1.96-2.06 (m, 1H), 
2.09-2.18 (m, 1H), 2.19-2.28 (m, 1H), 3.53-3.58 (m, 1H), 3.77-3.82 (m, 2H), 4.20-
4.29 (m, 2H), 4.77 (dt, J = 1.3, 5.6 Hz, 2H), 5.26-5.32 (m, 1H), 5.42-5.48 (m, 1H), 
5.91-6.03 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 20.9, 24.1, 46.1, 51.5, 61.7, 
67.7, 118.9, 131.4, 153.9, 167.5, 169.7; IR (neat) 2980, 2916, 1777, 1716, 1373, 








1-Allyl 3-ethyl 3-hydroxy-2-oxopiperidine-1,3-dicarboxylate (221). To a 
solution of 220 (0.0311 g, 0.12 mmol, 1.0 equiv) in CH3CN (12 mL, degassed by 
passing argon for 1 h), Mn(OAc)3 (0.10 g, 0.36 mmol, 3.0 equiv) was added as a 
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powder at rt, and the resulting mixture was stirred at 80 °C for 24 h. The reaction was 
cooled to rt, divided between water (20 mL) and ether (20 mL), extracted with ether 
(3 x 50 mL), washed with brine (20 mL), dried and concentrated. Analysis of the 
crude reaction mixture by NMR did not indicate the presence of the desired lactam. 
Chromatography (1/1 EtOAc/hexanes) afforded the title product as oil (Rf = 0.55, 1/1 
EtOAc/hexanes) contaminated with ~15% of unidentified inseparable impurity. Yield 
37% (0.012 g, 0.044 mmol). 1H NMR (400 MHz, CDCl3) δ 1.31 (t, J = 7.1 Hz, 3H), 
1.98-2.08 (m, 3H), 2.41-2.53 (m, 1H), 3.70-3.77 (m, 1H), 3.91-3.98 (m, 1H), 4.21 (s, 
1H), 4.29 (q, J = 7.2 Hz, 2H), 4.78 (d, J = 5.4 Hz, 2H), 5.27-5.35 (m, 1H), 5.40-5.48 
(m, 1H), 5.88-6.03 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 19.3, 31.4, 46.5, 
62.8, 68.0, 76.9, 119.1, 131.2, 153.6, 170.1, 170.8; IR (neat) 3450, 2917, 2949, 1775, 
1731, 1540, 1385, 1260, 1025 cm-1; HRMS calcd for C12H18NO6 (M+ + H) 272.1134, 
found 272.1138. Note: prolonged reaction time or alternative conditions for 






(Z)-Ethyl 1-(hex-3-enyl)-2-oxopiperidine-3-carboxylate (222). Prepared by 
a sequential N-alkylation and C-acylation. To a suspension of NaH (60% in mineral 
oil, 0.70 g, 17.4 mmol, 1.5 equiv) in THF/HMPA (30 mL/ 3.05 mL, 17.4 mmol, 1.5 
equiv), 2-piperidinone (1.08 mL, 11.6 mmol, 1.0 equiv) was added at 0 °C, and the 
resulting mixture was stirred at rt for 30 min. (Z)-1-iodo-3-hexane (3.18 g, 15.1 
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mmol, 1.3 mmol) was added at rt, and the resulting solution was heated to reflux for 
24 h. The reaction was quenched with sat. NH4Cl (20 mL), extracted with 1:1 
ether/EtOAc (3 x 100 mL), washed with brine (1 x 20 mL), dried and concentrated. 
Chromatography (1/2 EtOAc/hexanes) afforded the alkylated 2-piperidone as oil (Rf 
= 0.42, EtOAc). Yield 18% (0.37 g, 2.0 mmol). 1H NMR (400 MHz, CDCl3) δ 0.97 
(t, J = 7.5 Hz, 3H), 1.72-1.83 (m, 4H), 2.01-2.11 (m, 2H), 2.26-2.42 (m, 4H), 3.25-
3.41 (m, 4H), 5.26-5.36 (m, 1H), 5.41-5.51 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
14.4, 20.6, 21.4, 23.3, 25.2, 32.6, 47.2, 48.3, 125.3, 133.9, 169.6; IR (neat) 2957, 
2934, 1626, 1497, 1354, 1179 cm-1; HRMS calcd for C11H19NONa (M+ + Na) 
204.1364, found 204.1369.  
To a stirred solution of the alkylated lactam (0.37 g, 2.04 mmol, 1.0 equiv) in 
THF (15 mL), LHMDS (1.0 M in THF, 9.0 mL, 9.0 mmol, 4.4 equiv) was added at -
78 °C. After 1 h ethyl chloroformate (0.37 g, 3.3 mmol, 1.6 equiv) was added at -78 
°C in THF (5 mL). The resulting solution was stirred at -78 °C for 4 h, warmed 
slowly to rt and quenched with sat. NH4Cl (10 mL) after the next 3 h. The reaction 
was extracted with 1:1 ether/EtOAc (3 x 50 mL), washed with brine (1 x 30 mL), 
dried and concentrated. Chromatography (1/3-1/2 EtOAc/hexanes) afforded the title 
product as oil (Rf = 0.72, EtOAc). Yield 44% (0.23 g, 0.91 mmol). 1H NMR (400 
MHz, CDCl3) δ 0.92-1.00 (m, 3H), 1.24-1.32 (m, 3H), 1.71-1.82 (m, 1H), 1.91-2.20 
(m, 5H), 2.27-2.38 (m, 2H), 3.26-3.47 (m, 5H), 4.15-4.26 (m, 2H), 5.26-5.36 (m, 1H), 
5.42-5.52 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 14.3, 20.6, 21.2, 25.1, 25.1, 
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47.5, 48.1, 49.2, 61.2, 125.0, 134.1, 165.6, 171.2; IR (neat) 2916, 1736, 1648, 1466, 






(Z)-Ethyl 1-(hex-3-enyl)-3-hydroxy-2-oxopiperidine-3-carboxylate (223). 
According to the procedure described earlier, the reaction of 222 (0.0261 g, 0.10 
mmol, 1.0 equiv) and Mn(OAc)3 (0.0855 g, 0.31 mmol, 3.0 equiv) in degassed 
CH3CN (10 mL) at 80 °C for 24 h, afforded after chromatography (1/1 
EtOAc/hexanes) the title compound as oil (Rf = 0.7, EtOAc). Yield 57% (0.0154 g, 
0.057 mmol). 1H NMR (400 MHz, CDCl3) δ 0.99 (td, J = 0.7, 7.5 Hz, 3H), 1.31 (td, J 
= 0.8, 8.0 Hz, 3H), 1.95-2.15 (m, 5H), 2.29-3.38 (m, 3H), 3.31-3.51 (m, 4H), 4.09 (s, 
1H), 4.27 (q, J = 7.2 Hz, 2H), 5.28-5.37 (m, 1H), 5.44-5.54 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 14.1, 14.3, 19.1, 20.6, 24.9, 31.7, 47.8, 48.3, 62.3, 74.9, 124.7, 134.3, 
168.1, 172.3; IR (neat) 3381, 2961, 2932, 2919, 1734, 1648, 1254, 1131, 1029 cm-1; 
HRMS calcd for C14H23NO4Na (M+ + Na) 292.1525, found 292.1520. Note: use of 
EtOAc instead of CH3CN led to 50% conversion after 24 h at reflux, use of AcOH 
instead of CH3CN afforded the title compound in 65% yield after 24 h at 80 °C, use 
of Cu(OAc)2 as an additive (1.0 equiv) in AcOH for 24 at 80 °C afforded the title 
compound in 39% yield. Analysis of crude reaction mixtures did not indicate the 








Ethyl 2-oxo-1-(pent-4-enyl)piperidine-3-carboxylate  (224). Prepared in a 
sequence analogous to 222. To a solution of NaHMDS (1.0 M in THF, 10.0 mL, 10.0 
mmol, 1.0 equiv) in THF (5 mL), 2-piperidinone (1.02 g, 10.0 mmol, 1.0 equiv) was 
added at rt. The resulting solution was stirred at rt for 30 min, and 5-bromo-1-pentene 
(1.14 mL, 9.1 mmol, 0.91 equiv) was added at rt. The resulting mixture was stirred at 
60 °C for 18 h, cooled to rt and quenched with sat. NH4Cl/conc. HCl mixture (10 mL/ 
0.5 mL) The organic layer was washed with aq. HCl (1.0 M, 10 mL), the aq. Layers 
were extracted with EtOAc (2 x 25 mL), washed with brine (1 x 20 mL), dried and 
concentrated. Chromatography (EtOAc) afforded the title compound as oil (Rf = 0.56, 
EtOAc). Yield 84% (1.28 g, 7.7 mmol). 1H NMR (400 MHz, CDCl3) δ 1.48-1.59 (m, 
2H), 1.63-1.74 (m, 4H), 1.92-1.99 (m, 2H), 2.22-2.28 (m, 2H), 3.14-3.20 (m, 2H), 
3.22-3.28 (m, 2H), 4.82-4.96 (m, 2H), 5.65-5.77 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 21.3, 23.2, 26.1, 31.0, 32.3, 46.6, 47.8, 114.7, 137.8, 169.4; IR (neat) 2938, 
1620, 1499, 1356, 1292, 1191 cm-1; HRMS calcd for C10H17NONa (M+ + Na) 
190.1208, found 190.1203. Note: these conditions were found to be superior to the 
alkylation method used for the synthesis of 222.  
According to the procedure described for the preparation of 222, the reaction 
of alkylated 2-piperidone (0.49 g. 2.94 mmol, 1.0 equiv), LHMDS (1.0 M in THF, 
12.9 mL, 12.9 mmol, 4.4 equiv) and ethyl chloroformate (0.53 g, 4.7 mmol, 1.6 
equiv), after chromatography (40% EtOAc/hexanes) afforded the title product as oil 
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(Rf = 0.19, 1/2 EtOAc/hexanes). Yield 62% (0.43 g, 1.8 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.26 (t, J = 7.1 Hz, 3H), 1.61-1.69 (m, 2H), 1.71-1.82 (m, 1H), 1.89-2.16 
(m, 5H), 3.22-3.44 (m, 5H), 4.11-4.25 (m, 2H), 4.91-5.03 (m, 2H), 5.74-5.85 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 14.1, 21.1, 25.1, 26.1, 30.9, 47.0, 47.7, 49.2, 61.2, 
114.9, 137.9, 165.6, 171.2; IR (neat) 2918, 2849, 1736, 1642, 1493, 1372, 1179, 1162 






Ethyl 3-hydroxy-2-oxo-1-(pent-4-enyl)piperidine-3-carboxylate (225). 
According to the procedure described earlier, the reaction of 224 (0.0489 g, 0.20 
mmol, 1.0 equiv) and Mn(OAc)3 (0.17 g, 0.61 mmol, 3.0 equiv) in degassed CH3CN 
(20 mL) at 80 °C for 24 h, afforded the title compound as oil (Rf = 0.32, 1/1 
EtOAc/hexanes). Yield 78% (0.0398 g, 0.16 mmol). 1H NMR (400 MHz, CDCl3) 
δ 1.23-1.33 (m, 3H), 1.61-1.73 (m, 2H), 1.93-2.15 (m, 6H), 2.25-2.36 (m, 1H), 3.22-
3.47 (m, 3H), 3.49-3.59 (m, 1H), 4.25 (q, J = 7.1 Hz, 2H), 4.94-5.08 (m, 2H), 5.75-
5.89 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0, 29.1, 26.0, 30.8, 31.8, 47.3, 47.9, 
62.2, 75.0, 115.2, 137.6, 168.3, 172.3; IR (neat) 3466, 2930, 2866, 1734, 1638, 1449, 
1254, 1200, 1026 cm-1; HRMS calcd for C13H21NO4Na (M+ + Na) 278.1368, found 








Ethyl 5-(2-oxoazepan-1-yl)pentanoate (226). According to the procedure 
described for alkylation of 2-piperidone,399 the reaction of ε-caprolactam (1.17 g, 10.0 
mmol, 1.0 equiv), NaHMDS (1.0 M in THF, 10.0 mL, 1.0 equiv) and 
ethylbromovalerate (1.49 mL, 9.1 mmol, 9.1 equiv) in THF (5 mL) at 60 °C for 18 h, 
afforded after chromatography (1/2 EtOAc/hexanes) the title compound as oil (Rf = 
0.51, EtOAc). Yield 73% (1.60 g, 6.6 mmol). 1H NMR (400 MHz, CDCl3) δ 1.24 (t, J 
= 7.2 Hz, 3H), 1.48-1.76 (m, 10H), 2.32 (t, J = 7.0 Hz, 2H), 2.47-2.52 (m, 2H), 3.29-
3.34 (m, 2H), 3.36 (t, J = 7.2 Hz, 2H), 4.10 (q, J = 7.2 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 14.2, 22.2, 23.4, 27.5, 28.7, 30.0, 33.9, 37.3, 47.7, 49.6, 60.3, 173.5, 175.7; 
IR (neat) 2930, 2859, 1732, 1644, 1634, 1445, 1372, 1198 cm-1; HRMS calcd for 







Ethyl 5-(3-chloro-2-oxoazepan-1-yl)pentanoate (227). To a solution of 
amide 226 (0.115 g, 0.48 mmol, 1.0 equiv) in THF (9.6 mL), LDA (0.63 M in THF, 
1.65 mL, 1.05 mmol, 2.2 equiv, freshly prepared from 1.1 equiv of DIPA and 1.0 
equiv of nBuLi) was added at -78 °C as rapidly as possible. After 5 min CuCl2 (0.2 M 
in DMF, 5.25 mL, 2.2 equiv) was added at -78 °C as rapidly as possible. After 5 min, 
the dry ice-acetone bath was removed and the reaction was stirred for an additional 45 
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min. The reaction was quenched with sat. NH4Cl (10 mL), extracted with EtOAc (3 x 
50 mL), washed with brine (1x 50 mL), dried and concentrated. The analysis of the 
crude reaction mixture by NMR indicated complex mixture of products, including 
227 and 226 in ca. 1:1 ratio as major products. The bridged lactam was not detected. 
Chromatography (1/1 EtOAc/hexanes) afforded the title product as oil. Yield 19% 
(0.0209 g, 0.076 mmol). 1H NMR (400 MHz, CDCl3) δ 1.32 (t, J = 7.1 Hz, 3H), 1.58-
1.78 (m, 8H), 1.88-2.09 (m, 2H), 2.47-2.57 (m, 2H), 3.29-3.51 (m, 4H), 4.24 (q, J = 
7.2 Hz, 2H), 4.35 (dd, J = 5.6, 8.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 
23.4, 24.6, 28.7, 30.0, 32.0, 37.3, 47.0, 49.5, 57.2, 62.1, 169.6, 175.9; IR (neat) 2930, 
2855, 1742, 1636, 1445, 1180 cm-1; HRMS calcd for C13H22ClNO3Na (M+ + Na) 
298.1186, found 298.1186. Note: attempted Dieckmann condensation of 226 
according to procedure by Arata et al. for an analogous amido-ester146 using 1.5 equiv 
of NaH in refluxing xylenes afforded the corresponding amido-acid in 14% yield. The 






Ethyl 6-(2-oxoazepan-1-yl)hexanoate (228). According to the procedure 
described above, the reaction of ε-caprolactam (1.17 g, 10.0 mmol, 1.0 equiv), 
NaHMDS (1.0 M in THF, 10.0 mL, 1.0 equiv) and ethyl 6-bromohexanoate (1.63 
mL, 9.1 mmol, 9.1 equiv) in THF (10 mL) at 60 °C for 18 h, afforded after 
chromatography (EtOAc) the title compound as oil (Rf = 0.52, EtOAc). Yield 58% 
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(1.35 g, 5.3 mmol). 1H NMR (400 MHz, CDCl3) δ 1.19 (t, J = 7.1 Hz, 3H), 1.22-1.32 
(m, 2H), 1.41-1.52 (m, 2H), 1.54-1.71 (m, 8H), 2.23 (t, J = 7.5 Hz, 2H), 2.42-2.48 (m, 
2H), 3.24-3.34 (m, 4H), 4.07 (q, J = 7.1 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
14.2, 23.4, 24.7, 26.4, 27.8, 28.7, 30.0, 34.2, 37.3, 47.9, 49.5, 60.1, 173.6, 175.5; IR 
(neat) 2930, 2859, 1732, 1636, 1447, 1374, 1198 cm-1; HRMS calcd for C14H26NO3 
(M+ + H) 256.1913, found 256.1935. Note: attempted oxidative cyclization according 
to the procedure described for 226 afforded a complex mixture of products. The 
bridged lactam was not detected in the crude reaction mixture. 
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General Procedure for Extraction Studies of Lactam 229 (Table 20). 
Lactam 229 was dissolved in a specified amount of CH3CN at room temperature. 
After addition of water, aqueous HCl, or aqueous NaOH the reaction mixture was 
vigorously stirred under conditions specified in Table 1 and Schemes B1-B6. 
Reactions were cooled to room temperature (if necessary) and extracted with EtOAc 
(4 x 10 mL). Combined organic layers were washed with water (1 x 10 mL), brine (1 
x 10 mL), dried (Na2SO4), and concentrated to afford the title compound. For entries 
4-6 (Table 20) the reactions were neutralized with saturated NaHCO3 before 
extraction with EtOAc. 
Recovery of Lactam 229 from H2O/CH3CN Mixture. According to the 
general procedure, lactam 229 (40.0 mg, 0.116 mmol) was dissolved in 6.0 mL of 
CH3CN and 1.5 mL of H2O was added. After stirring at room temperature for 20 h the 
reaction mixture was extracted with EtOAc (4 x 10 mL), combined organic layers 
were washed with water (1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and 
concentrated to afford 34.9 mg (0.101 mmol) of the title compound. Yield 87%. 
Recovery of Lactam 229 from aq NaOH/CH3CN Mixture. According to 
the general procedure, lactam 229 (40.3 mg, 0.116 mmol) was dissolved in 6.0 mL of 
CH3CN. 0.5 mL of H2O was added, followed by 0.25 mL of 1.0 N NaOH. After 
stirring at room temperature for 20 h the reaction mixture was extracted with EtOAc 
(4 x 10 mL), combined organic layers were washed with water (1 x 10 mL), brine (1 
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x 10 mL), dried (Na2SO4), and concentrated to afford 37.8 mg (0.109 mmol) of the 
title compound. Yield 94%.  
Recovery of Lactam 229 from aq NaOH/CH3CN Mixture under Reflux. 
According to the general procedure, lactam 229 (25.6 mg, 0.074 mmol) was dissolved 
in 6.0 mL of CH3CN, and 0.25 mL of 1.0 N NaOH was added. After stirring at room 
temperature for 30 min, the reaction was refluxed for 22 h. The reaction was cooled 
to room temperature, extracted with EtOAc (4 x 10 mL), combined organic layers 
were washed with water (1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and 
concentrated to afford 20.6 mg (0.060 mmol) of the title compound. Yield 81%.  
Recovery of Lactam 229 from aq HCl/CH3CN Mixture. According to the 
general procedure, lactam 229 (41.7 mg, 0.121 mmol) was dissolved in 6.0 mL of 
CH3CN, and 0.5 mL of H2O was added followed by 0.25 mL of 1.0 N HCl. After 
stirring at room temperature for 20 h, reaction mixture was basified with saturated 
NaHCO3, extracted with EtOAc (4 x 10 mL), combined organic layers were washed 
with water (1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and concentrated to 
afford 34.3 mg (0.099 mmol) of the title compound. Yield 82%. Note: it was also 
found that the title compound could be recovered from acidic solutions by simple 
extraction with EtOAc, without prior basification with NaHCO3. 
Recovery of Lactam 229 from aq HCl/CH3CN Mixture, 8 Days. According 
to the general procedure, lactam 229 (27.0 mg, 0.078 mmol) was dissolved in 5.0 mL 
of CH3CN. 0.5 mL of H2O was added followed by 0.20 mL of 1.0 N HCl. After 
stirring at room temperature for 8 days (187 h), the reaction mixture was basified with 
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saturated NaHCO3, extracted with EtOAc (4 x 10 mL), combined organic layers were 
washed with water (1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and concentrated 
to afford 23.5 mg (0.068 mmol) of the title compound. Yield 87%.  
Conversion of Lactam 229 to Compound 232. According to the general 
procedure, lactam 229 (19.2 mg, 0.056 mmol) was dissolved in 6.0 mL of CH3CN, 
and 0.25 mL of 1.0 N HCl was added. After stirring at room temperature for 30 min, 
the reaction was refluxed for 23 h. The reaction was cooled to room temperature, 
basified with saturated NaHCO3, extracted with EtOAc (4 x 10 mL), combined 
organic layers were washed with water (1 x 10 mL), brine (1 x 10 mL), dried 
(Na2SO4), and concentrated. Flash chromatography (1/4 EtOAc/hexanes) afforded 
compound 232 as a colorless film, yield 95% (19.1 mg, 0.53 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.41-1.53 (m, 2H), 1.65-1.77 (m, 2H), 1.81-2.05 (m, 3H), 2.21-2.36 
(br, 1H), 2.52 (dd, J = 4.8, 11.9 Hz, 1H), 2.79-2.84 (m, 1H), 3.06 (dd, J = 1.4, 10.0 
Hz, 1H), 3.16 (dt, J = 3.6, 12.1 Hz, 1H), 3.24-3.29 (m, 1H), 3.51-3.58 (m, 1H), 3.60-
3.67 (m, 1H), 5.56-5.59 (m, 1H), 6.04-6.09 (m, 1H), 6.26-6.34 (br, 1H), 7.01 (d, J = 
8.3 Hz, 2H), 7.46 (d, J = 8.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 25.3, 29.1, 
29.8, 33.7, 36.5, 40.4, 44.3, 46.1, 48.8, 119.6, 128.7, 128.9, 130.5, 130.6, 141.4, 
171.3; IR (neat) 3223, 3135, 2995, 2890, 1630, 1455, 795, 705 cm-1; HRMS calcd for 
C18H23BrNO2 (M+ + H) 364.0912, found 364.0910.  
General Procedure for NMR Studies of Lactam 229. An NMR tube was 
charged with a solution of lactam 229 in THF-d8. To this was added D2O, DCl (1.0 N 
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in D2O) or NaOD (1.0 N in D2O) in one portion. The tube was well shaken and 
transferred to the probe of NMR spectrometer operating at ambient temperature. 
NMR Study of Lactam 229 Dissolved in 1:1 D2O/THF-d8. According to the 
general procedure, lactam 229 (10.0 mg, 0.029 mmol) was dissolved in 0.30 mL of 
THF-d8 and transferred to an NMR tube. To this 0.30 mL of D2O was added, the tube 
was well shaken and NMR spectra were recorded. The tube was left at ambient 
temperature for seven days and the spectra were taken again.  
NMR Study of Lactam 229 Dissolved 1:6 DCl (1.0 N in D2O)/THF-d8. 
According to the general procedure, lactam 229 (10.0 mg, 0.029 mmol) was dissolved 
in 0.50 mL of THF-d8 and transferred to an NMR tube. To this 0.080 mL of DCl (1.0 
N in D2O) was added, the tube was well shaken and NMR spectra were recorded. The 
tube was left at ambient temperature for seven days and the spectra were taken again.  
NMR Study of Lactam 229 Dissolved 1:6 NaOD (1.0 N in D2O)/THF-d8. 
According to the general procedure, lactam 229 (10.0 mg, 0.029 mmol) was dissolved 
in 0.50 mL of THF-d8 and transferred to an NMR tube. To this 0.080 mL of NaOD 
(1.0 N in D2O) was added, the tube was well shaken and NMR spectra were recorded. 












Synthesis of Amino Acid 237 under Acidic Conditions. 10 mL round 
bottom flask was charged with lactam 3 (20.0 mg, 0.096 mmol, 1.0 equiv) and HCl 
(1.0 N in H2O) (1.0 mL, 1.0 mmol, 11.1 equiv). The flask was gently stirred for 15 
min. The solvent was evaporated and the flask was left under vacuum overnight to 
give the title compound as a white solid. Recrystallization from water afforded 
crystals suitable for x-ray analysis. Yield: quantitative (25.0 mg, 0.095 mmol). Mp = 
156-158 °C; 1H NMR (400 MHz, D2O) δ 0.90 (s, 9H), 1.32-1.36 (m, 1H), 1.42-1.53 
(m, 2H), 1.76-2.12 (complex, 6H), 2.51-2.62 (m, 1H), 3.07-3.17 (m, 2H), 3.26-3.36 
(m, 2H); 13C NMR (100 MHz, D2O) δ 17.3, 22.2, 26.0, 26.3, 26.5, 33.7, 40.5, 41.8, 
43.8, 46.2, 180.3; IR (KBr) 3430, 3120, 3030, 2950, 1715, 1575, 1155 cm-1; HRMS 








Synthesis of Amino Acid 237 under Basic Conditions. 10 mL round bottom 
flask was charged with lactam 3 (20.0 mg, 0.096 mmol, 1.0 equiv) and NaOH (1.0 N 
in H2O) (0.10 mL, 0.096 mmol, 1.0 equiv). The flask was stirred for 3 h. The solvent 
was evaporated and the flask was left under vacuum overnight to give the title 
compound as a white solid. Yield: quantitative (24.0 mg, 0.096 mmol). Mp > 300 °C; 
1H NMR (400 MHz, D2O) δ 0.87 (s, 9H), 1.18-1.42 (m, 3H), 1.46-1.57 (m, 1H), 1.64-
1.92 (m, 5H), 2.22-2.35 (m, 1H), 2.66-2.79 (m, 2H), 2.81-2.96 (m, 2H); 13C NMR 
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(100 MHz, D2O) δ 20.2, 24.9, 26.6, 27.7, 28.7, 33.5, 41.2, 42.0, 46.6, 48.2, 186.3; IR 
(KBr) 3370, 2880, 1525, 1375 cm-1; HRMS calcd for C13H26NO2 (M+ + H) 228.1963, 
found 228.1958. 
Procedure for Determining Stability of Compound 3 in 1:1 D2O/THF-d8 
Mixture. Lactam 3 (20.0 mg, 0.096 mmol) was dissolved in 0.30 mL of THF-d8 and 
transferred to NMR tube. To this 0.30 mL of D2O was added in one portion, the tube 
was well shaken and transferred to the probe of NMR spectrometer operating at 
ambient temperature. The ratio of 3 to the product amino acid 237 was determined by 
the integral values of 1H NMR spectra.  
 
General Procedure for Extraction Studies of Bicyclic Lactams (Table 23). 
Bicyclic lactam was dissolved in a specified amount of CH3CN at room temperature  
or placed in a round bottom flask (10 mL). To this buffer (pH 4.0, Fluka 82566 or pH 
10.0, Fluka 82575) was added, and the reaction mixture was vigorously stirred under 
conditions specified in Table 23. Reactions were extracted with EtOAc (4 x 10 mL). 
Combined organic layers were washed with water (1 x 10 mL), brine (1 x 10 mL), 
dried (Na2SO4), and concentrated to afford the title compounds.  
Stability of Compound 35 in 1:1 D2O/THF-d8 Mixture. Lactam 35 was 
dissolved in 0.30 mL of THF-d8 and transferred to NMR tube. To this 0.30 mL of 
D2O was added in one portion, the tube was well shaken and transferred to the probe 
of NMR spectrometer operating at ambient temperature. The amino acid was not 
observed by 1H NMR. 
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Recovery of Lactam 34 from Buffer (pH 4)/CH3CN Mixture. According to 
the general procedure, lactam 34 (11.5 mg, 0.040 mmol) was dissolved in 0.20 mL of 
CH3CN. 2.0 mL of buffer (pH 4) was added, and the reaction mixture was vigorously 
stirred for 2 h. The reaction mixture was extracted with EtOAc (4 x 10 mL), 
combined organic layers were washed with water (1 x 10 mL), brine (1 x 10 mL), 
dried (Na2SO4), and concentrated to afford the 10.7 mg (0.038 mmol) of the title 
compound. Yield 93%.  
Recovery of Lactam 34 from Buffer (pH 10)/CH3CN Mixture. According 
to the general procedure, lactam 34 (12.2 mg, 0.043 mmol) was dissolved in 0.20 mL 
of CH3CN. 2.0 mL of buffer (pH 10) was added, and the reaction mixture was 
vigorously stirred for 2 h. The reaction mixture was extracted with EtOAc (4 x 10 
mL), combined organic layers were washed with water (1 x 10 mL), brine (1 x 10 
mL), dried (Na2SO4), and concentrated to afford the 12.1 mg (0.043 mmol) of the title 
compound. Yield 99%.  
Recovery of Lactam 58 from Buffer (pH 4). According to the general 
procedure, lactam 58 (11.1 mg, 0.056 mmol) was dissolved in 2.0 mL of buffer (pH 
4), and the reaction mixture was vigorously stirred for 2 h. The reaction mixture was 
extracted with EtOAc (4 x 10 mL), combined organic layers were washed with water 
(1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and concentrated to afford the 11.0 
mg (0.055 mmol) of the title compound. Yield 99%.  
Recovery of Lactam 58 from Buffer (pH 10). According to the general 
procedure, lactam 58 (10.8 mg, 0.054 mmol) was dissolved in 2.0 mL of buffer (pH 
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10), and the reaction mixture was vigorously stirred for 2 h. The reaction mixture was 
extracted with EtOAc (4 x 10 mL), combined organic layers were washed with water 
(1 x 10 mL), brine (1 x 10 mL), dried (Na2SO4), and concentrated to afford the 10.4 
mg (0.052 mmol) of the title compound. Yield 96%.  
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Proximity Effects in Nucleophilic Addition Reactions 
 
General procedure for reduction with NaBH4: To a solution of amide (1.0 
equiv) in EtOH, NaBH4 (3.0 equiv) was added at rt, and the reaction mixture was 
stirred at rt for 20-24 h. The reaction was quenched with sat. NH4Cl (5 mL), extracted 
with CH2Cl2 (3 x 50 mL), washed with brine (1 x 10 ml) and dried. Chromatography 








According to the general procedure, the reaction of amide 34 (0.0250 g, 0.088 mmol, 
1.0 equiv) and NaBH4 (0.010 g, 0.26 mmol, 3.0 equiv) in EtOH (5.0 mL) for 21 h at 
rt afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title 
compound as oil (Rf = 0.43, 1/10/90 NH4OH/MeOH/CH2Cl2). Yield 90% (0.02228 g, 
0.079 mmol), 80:20 mixture of inseparable diastereoisomers. 1H NMR (400 MHz, 
CDCl3) (major isomer) δ 0.87 (s, 9H), 1.38-1.61 (m, 3H), 1.73-1.92 (m, 3H), 1.99-
2.21 (m, 2H), 2.43-2.53 (m, 2H), 2.65 (dt, J = 5.0, 13.4 Hz, 1H), 3.48 (dt, J = 3.9, 
13.5 Hz, 1H), 3.63-3.70 (m, 1H), 5.13 (s, 1H), 7.16-7.42 (m, 5H); (minor isomer, 
diagnostic peaks) δ 0.95 (s, 9H), 2.93 (d, J = 7.9 Hz, 1H), 4.95 (s, 1H); 13C NMR 
(100 MHz, CDCl3) (major isomer) δ 21.3, 27.5, 29.9, 30.8, 33.8, 42.8, 45.2, 47.1, 
47.5, 53.1, 83.5, 125.4, 125.5, 128.2, 150.6; (minor isomer, diagnostic peaks) δ 21.4, 
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27.8, 29.4, 34.0, 38.0, 38.1, 43.4, 46.2, 50.2, 51.9, 88.3, 126.0, 128.0, 151.2; IR (neat) 
3400, 2057, 2957, 2941, 2866, 1468, 1445, 1366, 733, 696 cm-1; HRMS calcd for 









(239). According to the general procedure, the reaction of amide 35 (0.0335 g, 0.11 
mmol, 1.0 equiv) and NaBH4 (0.0121 g, 0.32 mmol, 3.0 equiv) in EtOH (5.0 mL) for 
20 h at rt afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title 
compound as oil (Rf = 0.40, 1/10/90 NH4OH/MeOH/CH2Cl2). Yield 91% (0.0318 g, 
0.10 mmol), 77:23 mixture of inseparable diastereoisomers. 1H NMR (400 MHz, 
CDCl3) (major isomer) δ 0.86 (s, 9H), 1.38-1.58 (m, 3H), 1.73-1.95 (m, 3H), 1.98-
2.21 (m, 2H), 2.37-2.53 (m, 2H), 2.64 (dt, J = 5.0, 12.8 Hz, 1H), 3.47 (dt, J = 4.1, 
13.8 Hz, 1H), 3.62-3.73 (m, 1H), 3.81 (s, 3H), 5.08 s, 1H), 6.88 (d, J = 8.9 Hz, 2H), 
7.30 (d, J = 8.9 Hz, 2H); (minor isomer, diagnostic peaks) δ 0.94 (s, 9H), 2.93 (d, J = 
7.1 Hz, 1H), 4.91 (s, 1H), 7.52 (d, J = 8.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) 
(major isomer) δ 21.2, 27.5, 30.0, 30.7, 33.8, 42.2, 45.1, 47.2, 47.5, 53.1, 55.2, 83.5, 
113.3, 126.4, 142.7, 157.2; (minor isomer, diagnostic peaks) δ 27.8, 34.0, 38.1, 38.3, 
42.8, 46.2, 50.4, 51.9, 88.6, 113.3, 127.1, 142.7; IR (neat) 3440, 2955, 2988, 1610, 
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10-ol (240). According to the general procedure, the reaction of amide 40 (0.0571 g, 
0.17 mmol, 1.0 equiv) and NaBH4 (0.0188 g, 0.50 mmol, 3.0 equiv) in EtOH (5.0 
mL) for 18 h at rt afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) 
the title compound as oil (Rf = 0.53, 1/10/90 NH4OH/MeOH/CH2Cl2). Yield 95% 
(0.0561 g, 0.16 mmol), 77:23 mixture of inseparable diastereoisomers. 1H NMR (400 
MHz, CDCl3) (major isomer) δ 0.86 (s, 9H), 1.38-1.60 (m, 3H), 1.71-1.91 (m, 3H), 
1.93-2.22 (m, 2H), 2.36-2.52 (m, 2H), 2.64 (dt, J = 5.0, 12.6 Hz, 1H), 3.48 (dt, J = 
4.1, 13.8 Hz, 1H), 3.59-3.69 (m, 1H), 3.82 (s, 9H), 5.05 (s, 1H), 6.32 (t, J = 2.0 Hz, 
1H), 6.54 (d, J = 2.2 Hz, 2H); (minor isomer, diagnostic peaks) δ 0.94 (s, 9H), 1.66 
(m, 2H), 2.92 (d, J = 7.2 Hz, 2H), 4.90 (s, 1H), 6.81 (d, J = 2.2 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) (major isomer) δ 21.3, 27.5, 30.0, 30.7, 33.8, 43.0, 45.0, 46.7, 
47.4, 52.9, 55.2, 83.5, 96.8, 104.5, 153.3, 160.5; (minor isomer, diagnostic peaks) δ 
21.3, 27.8, 29.2, 34.0, 38.0, 43.7, 46.1, 50.3, 51.8, 55.2, 88.2, 97.0, 105.1, 153.9, 
160.3; IR (neat) 3400, 3088, 2955, 2868, 1595, 1456, 1308, 1204, 1151, 1069, 910, 











decan-10-ol (241). According to the general procedure, the reaction of amide 39 
(0.0335 g, 0.10 mmol, 1.0 equiv) and NaBH4 (0.0116 g, 0.30 mmol, 3.0 equiv) in 
EtOH (5.0 mL) for 18 h at rt afforded after chromatography (1/10/90 
NH4OH/MeOH/CH2Cl2) the title compound as oil (Rf = 0.79, 1/10/90 
NH4OH/MeOH/CH2Cl2). Yield 94% (0.0313 g, 0.094 mmol), 78:22 mixture of 
inseparable diastereoisomers. 1H NMR (400 MHz, CDCl3) (major isomer) δ 0.86 (s, 
9H), 1.37-1.50 (m, 2H), 1.51-1.59 (m, 1H), 1.71-1.81 (m, 2H), 1.86 (d, J = 11.8 Hz, 
1H), 1.93-2.22 (m, 2H), 2.38 (dt, J = 6.5, 12.6 Hz, 1H), 2.49 (dd, J = 4.8, 14.1 Hz, 
1H), 2.64 (dt, J = 4.9, 13.2 Hz, 1H), 3.46 (dt, J = 4.0, 13.7 Hz, 1H), 3.61-3.69 (m, 
1H), 5.03 (s, 1H), 5.94 (s, 2H), 6.73-6.84 (m, 2H), 6.90 (s, 1H); (minor isomer, 
diagnostic peaks) δ 0.94 (s, 9H), 2.92 (d, J = 7.5 Hz, 1H), 4.86 (s, 1H), 5.93 (s, 2H), 
7.06 (d, J = 8.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) (major isomer) δ 21.2, 27.5, 
30.3, 30.7, 33.8, 42.7, 45.0, 47.2, 47.4, 53.0, 83.5, 100.8, 106.4, 107.9, 118.2, 144.9, 
145.1, 147.5; (minor isomer, diagnostic peaks) δ 21.3, 27.8, 30.4, 38.2, 38.5, 43.4, 
46.1, 50.3, 51.8, 88.5, 100.7, 107.3, 107.6, 118.9, 144.9, 145.4, 147.2; IR (neat) 3400, 
2959, 2941, 2868, 1504, 1489, 1234, 1042, 912, 733 cm-1; HRMS calcd for 












(4R,6R)-4-tert-Butyl-1-azabicyclo[4.3.1]decan-10-ol (242) and ((7R)-7-tert-
Butylazonan-5-yl)methanol (243). According to the general procedure, the reaction 
of amide 3 (0.100 g, 0.47 mmol, 1.0 equiv) and NaBH4 (0.0545 g, 1.44 mmol, 3.0 
equiv) in EtOH (20 mL) for 18 h at rt afforded after chromatography (1/20/80 
NH4OH/MeOH/CH2Cl2) 242 as oil (Rf = 0.52, 1/10/90 NH4OH/MeOH/CH2Cl2), 
yield 24% (0.0240 g, 0.11 mmol), 80:20 mixture of inseparable diastereoisomers, and 
243 as oil (Rf = 0.24, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 52% (0.0522 g, 0.25 
mmol), isolated as 77:23 mixture with the ammonium salt. Analysis of the crude 
reaction mixture by 1H NMR indicated 30:70 mixture of 242 to 243. Compound 242: 
1H NMR (400 MHz, CDCl3) (major isomer) δ 0.89 (s, 9H), 0.99 (td, J = 3.5, 14.0 Hz, 
1H), 1.21-1.55 (m, 4H), 1.70-1.88 (m, 2H), 2.05-2.16 (m, 1H), 2.16-2.24 (m, 2H), 
2.57 (dd, J = 4.7, 14.4 Hz, 1H), 2.85 (td, J = 2.8, 14.7 Hz, 1H), 3.03 (dt, J = 3.4, 14.5 
Hz, 1H), 3.44 (td, J = 4.0, 13.8 Hz, 1H), 4.66 (s, 1H); (minor isomer, diagnostic 
peaks) δ 0.90 (s, 9H), 2.38-2.46 (m, 2H), 2.48-2.54 (m, 1H), 4.72 (s, 1H); 13C NMR 
(100 MHz, CDCl3) (major isomer) δ 19.4, 24.3, 27.6, 30.5, 31.9, 33.7, 33.9, 44.7, 
45.8, 54.8, 81.4; (minor isomer, diagnostic peaks) δ 19.3, 24.8, 27.6, 29.8, 33.5, 34.7, 
35.3, 45.3, 48.1, 51.4, 81.2; IR (neat) 3400, 3125, 2937, 1468, 1450, 1366, 1053, 986 
cm-1; HRMS calcd for C13H26NO (M+ + H) 212.2014, found 212.2009. Compound 
243: 1H NMR (400 MHz, CDCl3) δ 0.88 (s, 9H), 1.18-1.80 (m, 9H), 1.81-1.92 (m, 
353 
 
1H), 2.03 (br, 2H), 2.53 (td, J = 3.9, 13.1 Hz, 1H), 2.64-2.78 (m, 2H), 2.82-2.92 (m, 
1H), 3.38-3.53 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 24.3, 26.7, 27.7, 28.5, 32.9, 
34.2, 34.8, 40.6, 42.9, 49.5, 67.5; IR (neat) 3350, 2939, 2866, 1477, 1364, 1140, 1030 
cm-1; HRMS calcd for C13H28NO (M+ + H) 214.2171, found 214.2170. 
 




6-(Methylthio)-1-azabicyclo[4.3.1]decan-10-ol (244) and (5-
(Methylthio)azonan-5-yl)methanol (245). According to the general procedure, the 
reaction of amide 58 (0.0322 g, 0.16 mmol, 1.0 equiv) and NaBH4 (0.018 g, 0.48 
mmol, 3.0 equiv) in EtOH (10 mL) for 18 h at rt afforded after chromatography 
(1/10/90 NH4OH/MeOH/CH2Cl2) 244 as oil (Rf = 0.65, 1/10/90 
NH4OH/MeOH/CH2Cl2), yield 40% (0.0129 g, 0.064 mmol), and 245 as oil (Rf = 
0.17, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 48% (0.0161 g, 0.079 mmol). 
Compound 244: 1H NMR (400 MHz, CDCl3) δ 1.43-1.73 (m, 5H), 1.74-2.05 (m, 5H), 
2.12 (s, 3H), 2.34-2.42 (m, 1H), 2.58 (dd, J = 4.8, 14.2 Hz, 1H), 2.94-3.08 (m, 2H), 
3.34-3.45 (m, 1H), 4.61 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 10.1, 22.6, 25.9, 
31.7, 32.0, 38.6, 43.7, 50.9, 55.1, 80.9; IR (neat) 2400, 2920, 2856, 1450, 1163, 1155, 
1113 cm-1; HRMS calcd for C10H20NOS (M+ + H) 202.1266, found 202.1263. 
Compound 245: 1H NMR (400 MHz, CDCl3) δ 1.44-1.55 (m, 4H), 1.58-1.78 (m, 5H), 
1.78-1.95 (m, 3H), 1.91 (s, 3H), 2.07-2.85 (m, 4H), 3.33 (q, J = 11.5 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 9.5, 17.5, 20.5, 25.6, 26.1, 28.4, 41.9, 47.7, 56.7, 63.6; IR 
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(neat) 3400, 2920, 2862, 1480, 1157, 1123, 748 cm-1; HRMS calcd for C10H22NOS 
(M+ + H) 204.1422, found 204.1420. 
 




6-(Phenylthio)-1-azabicyclo[4.3.1]decan-10-ol (246) and (5-
(Phenylthio)azonan-5-yl)methanol (247). According to the general procedure, the 
reaction of amide 73 (0.0245 g, 0.093 mmol, 1.0 equiv) and NaBH4 (0.011 g, 0.28 
mmol, 3.0 equiv) in EtOH (5 mL) for 18 h at rt afforded after chromatography (1/5/95 
NH4OH/MeOH/CH2Cl2) 246 as oil (Rf = 0.50, 1/10/90 NH4OH/MeOH/CH2Cl2), 
yield 62% (0.0151 g, 0.057 mmol), 83:17 mixture of diastereoisomers, and 247 as oil 
(Rf = 0.31, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 34% (0.0083 g, 0.031 mmol). 
Analysis of the crude reaction mixture by 1H NMR indicated 63:37 mixture of 246 to 
247. Compound 246: 1H NMR (400 MHz, CDCl3) (major isomer) δ 1.02-1.16 (m, 
1H), 1.48-1.65 (m, 5H), 1.78-1.91 (m, 3H), 2.18 (td, J = 4.6, 12.4 Hz, 1H), 2.34 (ddd, 
J = 3.4, 6.2, 15.8 Hz, 1H), 2.55 (dd, J = 4.9, 14.1 Hz, 1H), 2.86-2.99 (m, 2H), 3,44 
(td, J = 3.5, 13.7 Hz, 1H), 4.50 (s, 1H), 7.30-7.42 (m, 3H), 7.60 (dd, J = 1.8, 7.9 Hz, 
2H); (minor isomer, diagnostic peaks) δ 2.68-2.75 (m, 1H), 4.30 (s, 1H); 13C NMR 
(100 MHz, CDCl3) (major isomer) δ 22.9, 24.8, 31.2, 32.4, 38.1, 43.5, 54.5, 55.8, 
81.9, 128.8, 129.0, 130.9, 136.7; IR (neat) 3450, 3071, 3057, 2924, 2855, 1450, 1437, 
1350, 1150, 750 cm-1; HRMS calcd for C15H22NOS (M+ + H) 264.1422, found 
264.1422. Compound 247: 1H NMR (400 MHz, CDCl3) δ 1.39-1.65 (m, 6H), 1.65-
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2.16 (m, 6H), 2.63-2.71 (m, 1H), 2.73-2.87 (m, 3H), 3.24 (q, J = 11.6 Hz, 2H), 7.33-
7.43 (m, 3H), 7.51 (dd, J = 1.4, 6.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 17.5, 
20.7, 25.9, 26.3, 28.5, 41.5, 47.6, 62.3, 64.3, 128.9, 129.1, 130.0, 137.3; IR (neat) 
3400, 3057, 2918, 2849, 1474, 1437, 1410, 1050, 750 cm-1; HRMS calcd for 






5-(Methylsulfonyl)azonane-1-carbaldehyde (248). According to the general 
procedure, the reaction of amide 84 (0.0110 g, 0.048 mmol, 1.0 equiv) and NaBH4 
(0.0054 g, 0.14 mmol, 3.0 equiv) in EtOH (4 mL) for 18 h at rt afforded after 
chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) 248 as oil (Rf = 0.35, 1/10/90 
NH4OH/MeOH/CH2Cl2). Yield 98% (0.0110 g, 0.047 mmol). 1H NMR (400 MHz, 
CDCl3) (60:40 mixture of rotamers) δ 1.61-1.99 (m, 7H), 2.06-2.37 (m, 3H), 2.84 (s, 
3H, minor rotamer), 2.85 (s, 3H, major rotamer), 2.89-3.02 (m, 1H), 3.08-3.37 (m, 
2H), 3.42-3.56 (m, 1H), 3.68-3.77 (m, 1H), 8.15 (s, 1H, major rotamer), 8.20 (s, 1H, 
minor rotamer); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 23.5, 23.8, 
24.3, 24.4, 25.3, 25.4, 25.6, 26.0, 26.6, 26.8, 37.7, 37.9, 45.1, 45.7, 49.6, 50.4, 62.1, 
62.2, 163.9, 164.3; IR (neat) 1651, 1283, 1128 cm-1; HRMS calcd for C10H20NO3S 











4-tert-Butyl-6-(4-nitrophenyl)azonane-1-carbaldehyde (249). According to 
the general procedure, the reaction of amide 36 (0.0221 g, 0.067 mmol, 1.0 equiv) 
and NaBH4 (0.008 g, 0.20 mmol, 3.0 equiv) in EtOH (10 mL) for 20 h at rt afforded 
249 as 42:68 mixture of diastereoisomers (determined by 1H NMR of the crude 
reaction mixture). PTLC (1/10/90 NH4OH/MeOH/CH2Cl2) afforded minor 
diastereoisomer 249a as oil (Rf = 0.54, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 36% 
(0.0081 g, 0.024 mmol), and major diastereoisomer 249b as oil (Rf = 0.46, 1/10/90 
NH4OH/MeOH/CH2Cl2), yield 46% (0.0103 g, 0.031 mmol). Compound 249a: 1H 
NMR (400 MHz, CDCl3) (64:36 mixture of rotamers) δ 0.91 (s, 9H, major rotamer), 
0.94 (s, 9H, minor rotamer), 1.58-2.8 (m, 10H), 3.21-3.69 (m, 4H), 7.62-7.68 (m, 
2H), 8.16-8.22 (m, 2H), 8.32 (s, 1H, minor rotamer); 13C NMR (100 MHz, CDCl3) 
(mixture of rotamers) δ 21.8, 21.9, 27.6, 30.2, 33.4, 34.6, 34.7, 36.8, 37.7, 39.1, 40.8, 
42.5, 44.1, 45.8, 48.9, 50.1, 75.6, 76.2, 123.6, 123.6, 125.5, 125.7, 146.8, 157.6, 
164.0, 164.1; IR (neat) 2959, 2870, 1661, 1518, 1348, 733 cm-1; HRMS calcd for 
C19H29N2O3 (M+ + H) 333.2178, found 333.2159. Compound 249b: 1H NMR (400 
MHz, CDCl3) (55:45 mixture of rotamers) δ 0.45 (s, 9H, minor rotamer), 0.55 (s, 9H, 
major rotamer), 0.96-1.02 (m, 1H), 1.48-2.44 (m, 9H), 3.26-3.43 (m, 2H), 3.46-3.58 
(m, 1H), 3.61-3.71 (m, 1H, minor rotamer), 3.83 (td,  J = 4.3, 13.8 Hz, 1H, major 
rotamer), 7.66-7.73 (m, 2H), 8.16-8.20 (m, 2H), 8.22 (s, 1H, minor rotamer), 8.29 (s, 
1H, major rotamer); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 20.2, 20.8, 
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27.3, 27.5, 29.7, 31.2, 32.0, 33.2, 34.1, 34.3, 39.4, 39.6, 40.9, 42.6, 42.9, 43.7, 47.7, 
48.8, 123.3, 126.7, 127.0, 146.9, 155.9, 156.0, 163.9, 164.5; IR (neat) 2961, 2872, 
1659, 1518, 1349, 1076, 912, 856, 733 cm-1; HRMS calcd for C19H28N2O3Na (M+ + 
Na) 355.1997, found 355.2019. 
Reduction of Lactam 34. Representative entries from Table 15. Entry 2: 
According to the general procedure amide 34 (0.0205 g, 0.065 mmol, 1.0 equiv) was 
reacted with NaBH4 (0.0074 g, 0.20 mmol, 3.0 equiv) in MeOH (3 mL) for 20 h at rt. 
Analysis of the reaction mixture by 1H NMR indicated 32% conversion to the aminal 
238, dr = 86:14.  
Entry 3: To a solution of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) in EtOH 
(10 mL), CeCl3 (0.019 g, 0.053 mmol, 1.0 equiv) was added, followed by NaBH4 
(0.006 g, 0.16 mmol, 3.0 equiv), and the resulting mixture was stirred at rt for 24 h. 
Analysis of the crude reaction mixture by 1H NMR indicated 31% conversion to the 
aminal 238, dr = 81:19.  
Entry 4: According to the general procedure amide 34 (0.0150 g, 0.053 mmol, 
1.0 equiv) was reacted with LiBH4 (0.0037 g, 0.16 mmol, 3.0 equiv) in EOH (10 mL) 
for 20 h at rt, to afford aminal 238, yield 94% (0.0143 g, 0.050 mmol), dr = 82:18.  
Entry 5: To a solution of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) in THF 
(5 mL), LiAl(OtBu)3H (0.068 g, 0.26 mmol, 5.0 equiv) was added at rt, and the 
reaction mixture was stirred at rt for 24 h. After aqueous work-up, analysis of the 
crude reaction mixture indicated only the presence of the starting material.  
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Entry 6: To a solution of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) in THF 
(5 mL), L-Selectride (1.0 M in THF, 0.26 mL 0.26 mmol, 5.0 equiv) was added at rt, 
and the reaction mixture was stirred at rt for 24 h. After aqueous work-up, analysis of 
the crude reaction mixture indicated only the presence of the starting material.  
Entry 7: To a solution of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) in Et2O 
(5 mL), LiAlH4 (1.0 M in Et2O, 0.16 mL, 0.16 mmol, 3.0 equiv) was added at 0 °C, 
and the reaction mixture was stirred at rt for 5 h. Fieser and Fieser work-up, followed 
by chromatography afforded 238, yield 99% (0.0150 g, 0.052 mmol), dr = 82:18. 
Entry 8: To a solution of amide 34 (0.0181 g, 0.064 mmol, 1.0 equiv) in 
toluene (5 mL), Red-Al (65% in toluene, 0.10 mL, 0.31 mmol, 5.0 equiv) was added 
at rt, and the reaction mixture was heated to reflux for 2 h. Fieser and Fieser work-up, 
followed by chromatography afforded 238, yield 96% (0.0177 g, 0.062 mmol), dr = 
80:20. 
Entry 9: To a solution of amide 34 (0.0150 g, 0.053 mmol, 1.0 equiv) in 
toluene (5 mL), DIBAL-H (1.0 M in toluene, 0.26 mL, 0.26 mmol, 5.0 equiv) was 
added at rt, and the reaction mixture was heated to reflux for 2 h. Fieser and Fieser 
work-up, followed by chromatography afforded 238, yield 97% (0.0147 g, 0.051 
mmol), dr = 81:19. 
Entry 10: To a solution of amide 34 (0.040 g, 0.14 mmol, 1.0 equiv) in THF 
(10 mL), BH3•Me2S (2.0 M in THF, 0.35 mL, 0.70 mmol, 5.0 equiv) was added at rt, 
and the reaction mixture was heated to reflux for 24 h. The reaction was quenched 
with water, extracted with CH2Cl2, washed with brine, dried and concentrated. 
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Chromatography afforded 238, yield 47% (0.0187 g, 0.065 mmol), dr = 74:26. The 
remaining mass balance consisted of an unidentified compound (0.0209 g, possibly 







((7R)-7-tert-Butyl-5-phenylazonan-5-yl)methanol (250). To a solution of amide 34 
(0.0150 g, 0.05 mmol, 1.0 equiv) in THF (10 mL), LiEt3BH (1.0 M in THF, 0.26 mL, 
0.26 mmol, 5.0 equiv) was added dropwise at rt, and the resulting mixture was stirred 
for 3 h at rt. Aqueous work-up (quench with water, extraction with CH2Cl2), followed 
by chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) afforded aminal 238 (Rf = 0.45, 
1/10/90 NH4OH/MeOH/CH2Cl2), yield 38% (0.0055 g, 0.019 mmol), and alcohol 250 
(Rf = 0.13, 1/10/90 NH4OH/MeOH/CH2Cl2), yield  54% (0.0078 g, 0.027 mmol). 
Compound 250: 1H NMR (400 MHz, CDCl3) δ 0.40 (s, 9H), 1.25-1.99 (m, 10H), 2.56 
(d, J = 13.9 Hz, 1H), 2.65-2.90 (m, 4H), 3.54 (d, J = 11.4 Hz, 1H), 3.78 (dd, J = 1.4, 
11.3 Hz, 1H), 7.12 (t, J = 7.3 Hz, 1H), 7.27 (t, J = 8.2 Hz, 2H), 7.39 (d, J = 7.4 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 21.1, 23.3, 27.2, 34.2, 34.6, 37.7, 38.8, 47.2, 
47.4, 47.8, 68.4, 126.3, 127.5, 128.6, 145.4; IR (neat) 3350, 2947, 2870, 1557, 1487, 
1445, 1366, 1034, 911 cm-1; HRMS calcd for C19H32NO (M+ + H) 290.2484, found 
290.2462. Note: a number of other reductants were also tried with lactam 34 
(Bu3SnH/SiO2, Ph3SiH, NaBH4/BF3, NaBH4/TiCl4, NaCNBH3), however no reaction 
or complex reactions mixtures were obtained.  
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Attempted reduction of lactam 93. According to the general procedure, 
amide 93 (0.0383 g, 0.18 mmol, 1.0 equiv) was reacted with NaBH4 (0.0205 g, 0.54 
mmol, 3.0 equiv) in EtOH (10 mL) at rt for 18 h. Analysis of the crude reaction by 






Lactam 34 by Oxidation of 238. To a solution of alcohol 238 (0.0150 g, 
0.052 mmol, 1.0 equiv) in CH2Cl2 (5 mL) containing some MS 4Å, NMO (0.0122 g, 
0.104 mmol, 2.0 equiv) and TPAP (0.004 g, 0.01 mmol, 0.2 equiv) were added, and 
the resulting mixture was stirred at rt for 2 h. After solvent removal, chromatography 
(1/4 EtOAc/hexanes) afforded the title lactam. Yield 91% (0.0135 g, 0.047 mmol). 






(4R,6R)-4-tert-Butyl-6-phenyl-1-azabicyclo[4.3.1]decane (251). To a 
solution of aminal 238 (0.0252 g, 0.088 mmol, 1.0 equiv) in CH2Cl2 (10 mL) TFA 
(1.0 mL, excess) was added at rt, followed by Et3SiH (0.014 mL, 10 equiv) after 15 
min. The reaction mixture was warmed stirred at rt for 12 days. Quenched with sat. 
NaHCO3, extracted with CH2Cl2 (3 x 20 mL), washed with brine (1 x 20 mL), dried, 
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and concentrated. Chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) afforded the 
title product as oil (Rf = 0.33, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 73% (0.0174 g, 
0.064 mmol). 1H NMR (400 MHz, CDCl3) δ 0.89 (s, 9H), 1.25-1.36 (m, 1H), 1.42-
1.61 (m, 2H), 1.70 (t, J = 12.4 Hz, 1H), 1.78-2.01 (m, 3H), 2.04-2.16 (m, 1H), 2.30 
(d, J = 13.0 Hz, 1H), 2.61 (td, J = 3.6, 13.4 Hz, 1H), 2.91 (d, J = 7.2 Hz, 2H), 3.04 (d, 
J = 14.2 Hz, 1H), 3.61-3.72 (m, 2H), 7.18-7.24 (m, 1H), 7.31-7.42 (m, 4H); 13C NMR 
(100 MHz, CDCl3) δ 21.0, 27.5, 30.0, 33.8, 36.1, 37.4, 46.8, 48.3, 53.3, 54.1, 54.2, 
124.6, 125.8, 128.3, 151.9; IR (neat) 3056, 2944, 2917, 2849, 1576, 1540, 1470, 









decane (252). To a solution of aminal 239 (0.0280 g, 0.088 mmol, 1.0 equiv) in 
MeOH (5 mL), pTsOH (0.020 g, 0.11 mmol, 1.2 equiv) was added and the reaction 
mixture was stirred at rt. After 5 h 1.2 equiv of pTsOH was added, and the reaction 
was stirred for the next 19 h. The reaction was quenched with sat. NaHCO3, solvent 
was removed under reduced pressure, the aqueous layer was extracted with Et2O (3 x 
30 mL), dried and concentrated. Chromatography (100% EtOAc) afforded the title 
product as oil (Rf = 0.90, EtOAc, Rf = 0.63, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 
76% (0.0221 g, 0.067 mmol). Single diastereoisomer. 1H NMR (400 MHz, CDCl3) δ 
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0.86 (s, 9H), 1.24-1.44 (m, 2H), 1.46-1.52 (m, 1H), 1.73-1.88 (m, 3H), 2.02-2.17 (m, 
2H), 2.26-2.36 (m, 1H), 2.50 (dd, J = 4.7, 15.0 Hz, 1H), 2.73 (td, J = 5.6, 13.0 Hz, 
1H), 3.12-3.24 (m, 1H), 3.19 (s, 3H), 3.67 (dd, J = 5.2, 13.6 Hz, 1H), 3.81 (s, 3H), 
4.41 (s, 1H), 6.86 (d, J = 8.8 Hz, 2H), 7.20 (d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 21.7, 27.6, 31.1, 31.4, 33.7, 42.1, 45.2, 47.4, 48.1, 53.9, 54.0, 55.2, 90.7, 
113.3, 126.0, 143.6, 156.8; IR (neat) 2914, 2866, 1512, 1251, 1186, 1086 cm-1; 








[4.3.1] decane (253). According to the procedure described above, the reaction of the 
corresponding aminal 240 (0.0416 g, 0.12 mmol, 1.0 equiv) and pTsOH (0.0227 g, 
0.12 mmol, 1.0 equiv) in MeOH (10 mL) at rt for 36 h, afforded after 
chromatography (EtOAc) the title product as oil (Rf = 0.72, EtOAc, Rf = 0.78, 
1/10/90 NH4OH/MeOH/CH2Cl2), yield 67% (0.0290 g, 0.080 mmol). Single 
diastereoisomer. 1H NMR (400 MHz, CDCl3) δ 0.86 (s, 9H), 1.26-1.51 (m, 3H), 1.74-
1.88 (m, 3H), 1.99-2.13 (m, 2H), 2.24-2.35 (m, 1H), 2.49 (dd, J = 5.0, 14.4 Hz, 1H), 
2.71 (td, J = 5.7, 13.4 Hz, 1H), 3.18 (td, J = 4.2, 13.3 Hz, 1H), 3.20 (s, 3H), 3.62-3.69 
(m, 1H), 3.82 (s, 6H), 6.31 (t, J = 2.0 Hz, 1H), 6.46 (d, J = 2.2 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 21.8, 27.6, 31.1, 31.4, 33.8, 42.9, 45.1, 47.4, 47.6, 53.9, 54.0, 
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55.2, 90.7, 96.4, 104.2, 154.0, 160.2; IR (neat) 2941, 2866, 1595, 1456, 1204, 1151, 
1084 cm-1; HRMS calcd for C22H36NO3 (M+ + H) 362.2695, found 362.2694.  
Epimerization of aminal 238. A reference spectrum of 238 in DMSO-d6 
indicated dr = 76:24 favoring the same diastereoisomer as in CDCl3. A vial was 
charged with 238 (0.010 g, 0.025 mmol), DMSO-d6 (0.30 mL), and DCl (1.0 N in 
D2O, 0.3 mL). The vial was heated with a heat gun until a clear solution was obtained 
(~10-15 s). 1H NMR indicated dr = 36:64 favoring the opposite epimer. The NMR 
tube was heated with heat gun for ~5 min. NMR indicated no change in dr. DCl (1.0 
N in D2O, 0.1 mL) was added directly to the NMR tube, and the reaction was heated 
with a heat gun for ~ 1 min. NMR indicated no change in the dr. Note: a similar 
change in dr (from 71:29 to 38:62) was observed when CD3CN was used as a solvent. 
 
General procedure for Organometallic Addition to Bridged Amides: To a 
solution of bridged amide (1.0 equiv) in Et2O at -78 °C, organometallic reagent (3.0 
equiv) was added dropwise. The reaction mixture was stirred at -78 °C for 1 h, 
allowed to warm slowly to rt, quenched after next 2 h with water (10 mL) (overall 3 h 
reaction time), extracted with ether (3 x 50 mL), washed with brine (1 x 10 ml) and 










1-((5R,7R)-7-tert-Butyl-5-phenylazonan-5-yl)ethanone (254). According to 
the general procedure, the reaction of 34 (0.0100 g, 0.035 mmol, 1.0 equiv) and MeLi 
(1.6 M in Et2O, 0.070 mL, 0.11 mmol, 3.0 equiv) in Et2O (5.0 mL), afforded after 
chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title compound as oil (Rf = 
0.31-0.62, 1/10/90 NH3/MeOH/CH2Cl2). Yield 89% (0.0094 g, 0.031 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.38 (s, (9H), 1.38-1.99 (m, 9H), 1.91 (s, 3H), 2.18 (dd, J 
= 3.8, 12.7 Hz, 1H), 2.68-2.96 (m, 4H), 7.18-7.32 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 21.2, 24.0, 26.4, 27.4, 33.4, 33.8, 34.0, 37.6, 43.3, 46.4, 60.5, 126.8, 127.6, 
128.5, 144.1, 211.7; IR (neat) 2947, 2868, 1701, 1477, 1364, 1169, 1144 cm-1; HRMS 
calcd for C20H32NO (M+ + H) 302.2484, found 302.2474. Note: the reaction of 34 
(0.0100 g, 0.035 mmol, 1.0 equiv) and MeLi•LiBr (1.5 M, Et2O, 0.070 mL, 0.11 
mmol, 3.0 equiv) in Et2O (5 mL) afforded 254 in 85% yield (0.0090 g, 0.030 mmol). 
Resubmission of 254 (0.0094 g, 0.031 mmol) to the reaction with MeLi (1.6 M, Et2O, 
0.06 mL, 3.0 equiv) in Et2O (10 mL) for 3 h led to quantitative recovery of 254, 
suggesting that the further addition does not occur due to the steric hindrance around 
the ketone. Note: the reaction of 34 (0.010 g, 0.035 mmol, 1.0 equiv) and MeMgI (3.0 
M in Et2O, 0.035 mL, 0.11 mmol, 3.0 equiv) in Et2O (10 mL) for 24 h, afforded 254 











According to the general procedure, the reaction of 34 (0.0200 g, 0.070 mmol, 1.0 
equiv) and nBuLi (2.3 M in hexanes, 0.090 mL, 0.21 mmol, 3.0 equiv) in Et2O (10 
mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title 
compound as oil (Rf = 0.73, 1/10/90 NH3/MeOH/CH2Cl2). Yield 83% (0.0200 g, 
0.058 mmol). 1H NMR (400 MHz, CDCl3) δ 0.40 (s, 9H), 0.80 (t, J = 7.3 Hz, 3H), 
1.09-1.22 (m, 2H), 1.26-1.35 (m, 1H), 1.37-1.58 (m, 5H),1.64 (d, J = 16.0 Hz, 1H), 
1.72-1.84 (m, 1H), 1.98-2.10 (m, 1H), 2.11-28 (m, 4H), 2.69-2.95 (m, 5H), 7.18-7.38 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 13.9, 21.3, 22.4, 24.0, 26.8, 27.3, 33.3, 34.0, 
34.1, 37.5, 37.9, 43.4, 46.4, 60.3, 126.8, 127.7, 128.5, 144.1, 213.7; IR (neat) 3369, 
2955, 2870, 1701, 1474, 1364, 1130, 702 cm-1; HRMS calcd for C23H38NO (M+ + H) 









According to the general procedure, the reaction of 34 (0.0200 g, 0.070 mmol, 1.0 
equiv) and sec-BuLi (1.4 M in cyclohexane, 0.15 mL, 0.21 mmol, 3.0 equiv) in Et2O 
(10 mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title 
compound as oil (Rf = 0.54, 1/10/90 NH3/MeOH/CH2Cl2). Yield 93% (0.0223 g, 
0.065 mmol). 1H NMR (400 MHz, CDCl3) δ 0.44, 0.46 (s, 9H), 0.59 (t, J = 7.5 Hz, 
1H), 0.78-0.85 (m, 3H), 0.99 (d, J = 6.7 Hz, 2H), 1.19-1.68 (m, 7H), 1.70-1.81 (m, 
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2H), 2.01-2.13 (m, 1H), 2.28-2.41 (m, 2H), 2.64-2.93 (m, 4H), 2.97-3.09 (m, 1H), 
7.18-7.35 (m, 5H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers) δ 11.3, 11.4, 
17.6, 18.5, 23.1, 23.9, 24.2, 27.3, 27.4, 27.5, 28.4, 34.2, 34.3, 35.6, 35.9, 37.5, 37.7, 
42.7, 43.1, 46.3, 46.4, 47.4, 60.8, 60.9, 126.8, 126.8, 128.1, 128.2, 128.3, 128.3, 
142.9, 143.1, 217.7, 217.8; IR (neat) 3373, 2961, 2873, 1699, 1464, 1366, 1148, 










(257). According to the general procedure, the reaction of 34 (0.0200 g, 0.070 mmol, 
1.0 equiv) and tert-BuLi (1.7 M in pentanes, 0.12 mL, 0.21 mmol, 3.0 equiv) in Et2O 
(10 mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the title 
compound as oil (Rf = 0.37, 1/10/90 NH3/MeOH/CH2Cl2). Yield 80% (0.0192 g, 
0.056 mmol). 1H NMR (400 MHz, CDCl3) δ 0.39 (s, 9H), 0.98 (s, 9H), 1.24-1.44 (m, 
2H), 1.45-1.66 (m, 3H), 1.77-1.88 (m, 1H), 2.21-2.34 (m, 1H), 2.36 (dd, J = 5.2, 15.8 
Hz, 1H), 2.75-3.04 (m, 6H), 7.18-7.34 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 22.0, 
22.5, 27.2, 30.3, 33.7, 34.2, 37.2, 38.0, 45.0, 46.1, 46.5, 61.0, 126.8, 127.9, 128.3, 
143.4, 217.4; IR (neat) 3377, 2959, 2870, 1680, 1479, 1364, 1146, 1090, 1005, 910, 















1-(7-tert-Butylazonan-5-yl)ethanone (258) and 2-((7R)-7-tert-Butylazonan-
5-yl)propan-2-ol (259). According to the general procedure for addition of 
organometallic reagents, amide 3 (0.100 g, 0.48 mmol, 1.0 equiv) was reacted with 
MeLi (1.6 M in Et2O, 0.90 mL, 1.44 mmol, 3.0 equiv) in Et2O for 3 h, to afford after 
chromatography (1/5/95-1/10/90 NH4OH/MeOH/CH2Cl2) ketone 258 (Rf = 0.25, 
1/10/90 NH4OH/MeOH/CH2Cl2), yield 81% (0.0875 g, 0.39 mmol), and alcohol 259 
(Rf = 0.10, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 5% (0.0062 g, 0.026 mmol). 
Compound 258 exists as a mixture of ketone and enol tautomers stabilized by 
transannular interaction with the amine group. Compound 258: 1H NMR (400 MHz, 
CDCl3) δ 0.77 (s, 9H), 1.03-1.75 (m, 9H), 1.82-1.95 (m, 1H), 2.04 (s, 3H), 2.41 (s, 
1H), 2.55-2.92 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 22.8, 23.8, 27.6, 28.2, 28.6, 
31.8, 32.2, 34.1, 34.3, 41.2, 43.8, 44.3, 45.0, 46.7, 48.7, 49.9, 53.1, 164.0, 164.6, 
212.9; IR (neat) 3369, 2947, 2868, 1709, 1477, 1364, 1231, 1163, 1140, 926 cm-1; 
HRMS calcd for C14H28NO (M+ + H) 226.2171, found 226.2177. Compound 259: 1H 
NMR (500 MHz, CDCl3) δ 0.82 (s, 9H), 0.88-0.97 (m, 1H), 1.12 (s, 6H), 1.21-1.48 
(m, 4H), 1.48-1.81 (m, 6H), 2.57-2.71 (m, 2H), 2.72-2.78 (m, 1H), 2.78-2.86 (m, 1H); 
13C NMR (125 MHz, CDCl3) δ 27.1, 27.2, 27.5, 27.6, 27.6, 30.6, 32.1, 35.1, 47.0, 
47.9, 49.5, 50.9, 75.1; IR (neat) 3400, 2959, 2918, 1475, 1366, 1140, 913 cm-1; 
HRMS calcd for C15H32NO (M+ + H) 242.2484, found 242.2514. Note: performing 
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the reaction for 1 h at -78 °C (quenching at -78 °C) or for 24 h (-78 °C to rt) did not 




Me OH  
Aminal 261. According to the general procedure, the reaction of 230 (0.0189 
g, 0.099 mmol, 1.0 equiv) and MeLi (1.6 M in Et2O, 0.20 mL, 0.30 mmol, 3.0 equiv) 
in Et2O (10 mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) 
the title compound as solid (Mp = 107-108 °C, Rf = 0.10, 1/10/90 
NH3/MeOH/CH2Cl2). Yield 95% (0.0194 g, 0.094 mmol), dr > 10:1. 1H NMR (400 
MHz, CDCl3) δ 1.23-1.41 (m, 2H), 1.52 (s, 3H), 1.64-1.82 (m, 3H), 1.84-1.95 (m, 
2H), 1.96-2.11 (m, 2H), 2.35 (q, J = 14.4 Hz, 1H), 2.40-2.48 (m, 1H), 2.54-2.77 (m, 
2H), 2.86 (s, 1H), 3.05 (t, J = 13.5 Hz, 1H), 3.34-3.50 (m, 1H), 5.65 (s, 1H), 5.74 (s, 
1H); 13C NMR (125 MHz, CDCl3) δ 24.4, 25.8, 27.3, 31.4, 34.7, 34.9, 35.3, 49.4, 
51.8, 52.6, 86.5, 127.6, 134.9; IR (neat) 3350, 3011, 2949, 2914, 2866, 1462, 1447, 
1369, 1292, 1163, 1134, 1018, 924, 731, 708 cm-1 Note: ketone peak not detected; 






Aminal 262. According to the general procedure, the reaction of 260 (0.0200 
g, 0.086 mmol, 1.0 equiv) and MeLi (1.6 M in Et2O, 0.17 mL, 0.26 mmol, 3.0 equiv) 
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in Et2O (10 mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) 
the title compound as oil (Rf = 0.20, 1/10/90 NH3/MeOH/CH2Cl2). Yield 92% 
(0.0196 g, 0.079 mmol), dr > 10:1.1H NMR (500 MHz, CDCl3) δ 0.68-0.93 (m, 6H), 
1.26 (d, J = 13.8 Hz, 1H), 1.31-1.42 (m, 1H), 1.49 (s, 3H), 1.57 (m, 4H), 1.71-1.83 
(m, 2H), 1.86-1.92 (m, 1H), 1.97 (dt, J = 4.0, 16.9 Hz, 1H), 2.22-2.43 (m, 2H), 2.54-
2.66 (m, 2H), 2.69-2.78 (m, 1H), 3.22-3.33 (m, 1H), 5.47 (s, 1H), 5.75 (s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 17.5, 19.3, 24.9, 26.5, 28.5, 32.9, 34.5, 35.5, 35.8, 49.6, 
50.2, 73.5, 86.1, 125.4, 135.6; IR (neat) 3589, 3460, 3011, 2951, 2914, 1968, 1713 
(w), 1632, 1464, 1371, 1219, 1169, 1113, 1055, 943, 703 cm-1 Note: CO absorption < 





sBu OH  
Aminal 263. According to the general procedure, the reaction of 230 (0.0164 
g, 0.086 mmol, 1.0 equiv) and sec-BuLi (1.4 M in cyclohexane, 0.18 mL, 0.26 mmol, 
3.0 equiv) in Et2O (10 mL), afforded after chromatography (1/10/90 
NH4OH/MeOH/CH2Cl2) the title compound as oil (Rf = 0.57, 1/10/90 
NH3/MeOH/CH2Cl2). Yield 80% (0.0172 g, 0.069 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.78-2.25 (m, 19H), 2.31-2.52 (m, 2H), 2.582-.67 (m, 2H), 2.702-.85 (m, 
1H), 3.38-3.46 (m, 1H), 5.48-5.67 (m, 2H) 13C NMR (125 MHz, CDCl3) δ 10.7, 11.4, 
11.8, 13.6, 20.7, 23.7, 23.7, 24.4, 25.1, 25.2, 33.3, 33.4, 33.9, 34.3, 34.4, 37.5, 37.9, 
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48.6, 48.7, 50.5, 50.6, 88.2, 88.4, 126.4, 134.1, 134.1 IR (neat) 3591, 3450, 3013, 
2963, 2916, 2870, 1653, 1540, 1456, 1379, 1292, 1259, 1113, 1057, 1021, 912, 802, 
744 cm-1 Note: ketone peak not detected; HRMS calcd for C16H28NO (M+ + H) 






Aminal 264. According to the general procedure, the reaction of 260 (0.0200 
g, 0.086 mmol, 1.0 equiv) and sec-BuLi (1.4 M in cyclohexane, 0.18 mL, 0.26 mmol, 
3.0 equiv) in Et2O (10 mL), afforded after chromatography (1/1 EtOAc/hexanes) the 
title compound as oil (Rf = 0.26, 1/1 EtOAc/hexanes). Yield 88% (0.0219 g, 0.075 
mmol). 1H NMR (400 MHz, CDCl3) δ 0.82-1.07 (m, 12H), 1.21-1.46 (m, 3H), 1.58-
1.86 (m, 6H), 1.92-2.17 (m, 4H), 2.26-2.38 (m, 1H), 2.47 (q, J = 13.6 Hz, 1H), 2.53-
2.62 (m, 1H), 2.68-2.82 (m, 2H), 3.06-3.19 (m, 1H), 5.51-5.58 (m, 1H), 5.84-5.92 (m, 
1H); 13C NMR (125 MHz, CDCl3) (mixture of rotamers) δ 13.2, 13.3, 14.1, 18.4, 
18.5, 18.8, 19.0, 23.4, 24.2, 26.1, 26.3, 27.8, 28.1, 28.5, 32.8, 35.2, 35.3, 35.5, 35.6, 
35.7, 44.3, 44.5, 45.8, 49.7, 49.8, 73.2, 88.2, 88.4, 125.3, 136.1; IR (neat) 3595, 3013, 
3959, 3013, 2959, 2870, 2829, 1705 (vw), 1634, 1464, 1381, 1258, 1163, 1107, 1061, 
1011, 808, 704 cm-1 Note: CO absorption < 1:10 of the expected intensity; HRMS 











one (265). According to the general procedure, the reaction of 230 (0.0200 g, 0.105 
mmol, 1.0 equiv) and tert-BuLi (1.7 M in pentanes, 0.18 mL, 0.31 mmol, 3.0 equiv) 
in Et2O (10 mL), afforded after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) 
the title compound as oil (Rf = 0.14, 1/10/90 NH3/MeOH/CH2Cl2). Yield 90% 
(0.0235 g, 0.094 mmol). 1H NMR (400 MHz, CDCl3) δ 1.14 (s, 9H), 1.17-1.34 (m, 
3H), 1.56-1.68 (m, 1H), 1.72-1.96 (m, 4H), 2.07-2.17 (m, 1H), 2.46 (s, 1H), 2.67-2.84 
(m, 2H), 2.89-2.97 (m, 1H), 3.18-3.27 (m, 2H), 3.36-3.46 (m, 1H), 5.51-5.58 (m, 1H), 
5.85-5.92 (m, 1H); 13C NMR (100 MHz, CDCl3) (mixture of ketone and enol 
tautomers) δ 26.4, 28.8, 29.2, 29.6, 30.6, 38.6, 42.5, 45.6, 49.9, 50.8, 52.6, 130.7, 
132.5, 218.5; IR (neat) 3391, 3015, 2951, 2918, 2868, 1705, 1541, 1477, 1441, 1389, 
1364, 1317, 1099, 916, 735 cm-1; HRMS calcd for C16H28NO (M+ + H) 250.2171, 
found 250.2175. Note: after chromatography partial closure to the hemiaminal occur 








dimethyl propan-1-one (266). According to the general procedure, the reaction of 
260 (0.0200 g, 0.086 mmol, 1.0 equiv) and tert-BuLi (1.7 M in pentanes, 0.15 mL, 
372 
 
0.26 mmol, 3.0 equiv) in Et2O (10 mL), afforded after chromatography (1/10/90 
NH4OH/MeOH/CH2Cl2) the title compound as oil (Rf = 0.27, 1/10/90 
NH3/MeOH/CH2Cl2). Yield 90% (0.0226 g, 0.078 mmol).  1H NMR (400 MHz, 
CDCl3) δ 0.88-0.98 (m, 6H), 1.13 (s, 9H), 1.21-1.37 (m, 3H), 1.52-1.81 (m, 3H), 
1.86-2.29 (M, 5H), 2.31-2.80 (m, 4H), 3.16-3.32 (m, 1H), 5.57-5.71 (m, 1H), 5.82-
5.95 (m, 1H); 13C NMR (125 MHz, CDCl3) (mixture of slowly equilibrating ketone 
and enol tautomers) δ 19.9, 21.4, 21.7, 24.7, 26.0, 26.1, 26.4, 28.8, 29.7, 30.2, 30.9, 
32.5, 34.0, 36.6, 37.2, 38.8, 40.9, 43.1, 43.2, 45.7, 46.0, 50.9, 52.8, 130.4, 131.2, 
132.7, 132.9, 219.2, 220.5; IR (neat) 3597, 3375, 3013, 2955, 2924, 2868, 1697, 
1626, 1466, 1387, 1366, 1261, 1099, 910, 804 cm-1; HRMS calcd for C19H34NO (M+ 
+ H) 292.2641, found 292.2636. Note: a similar keto-enol equilibration was observed 
in analogous 9-membered heterocycle 258, in which α-position to the ketone is 
unsubstituted. We think that this effect arises from a transannular interaction of the 






azepine (268). According to the general procedure, the reaction of planar amide 267 
(0.0200 g, 0.070 mmol, 1.0 equiv) and MeLi•LiBr (1.5 M in Et2O, 0.14 mL, 0.21 
mmol, 3.0 equiv) in Et2O (5 mL) for 18 h, afforded after chromatography (1/15/85 
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NH4OH/MeOH/CH2Cl2) the title product as oil (Rf = 0.28, NH4OH/MeOH/CH2Cl2), 
yield 71% (0.0141 g, 0.050 mmol). 1H NMR (500 MHz, CDCl3) δ 0.84 (s, 9H), 1.12-
1.78 (m, 7H), 1.85-2.35 (m, 5H), 2.84-3.61 (m, 3H), 7.02-7.30 (m, 5H); 13C NMR 
(100 MHz, CDCl3) δ 20.7, 27.2, 27.7, 29.3, 31.7, 32.6, 39.8, 41.0, 43.3, 49.2, 69.1, 
74.5, 125.1, 126.1, 126.7, 128.1, 150.6, 151.8; IR (neat) 2959, 2866, 1632, 1445, 
1366, 731, 702 cm-1; HRMS calcd for C20H30N (M+ + H) 283.2378, found 283.2373. 
Note: the reaction was much slower than with the bridged analogue of 268. The 
structure of enamine was confirmed by reduction under acidic conditions (see below). 
The analogous reaction using nBuLi (3.0 equiv, 18 h) instead of MeLi led to a 
mixture of products, including starting material, ketone (as the major product), 






azepine (269). To a solution of enamine 268 (0.0121 g, 0.043 mmol, 1.0 equiv) in 
THF (5 mL), NaBH4 (0.005 g, 0.13 mmol, 5.0 equiv), followed by AcOH (0.05 mL, 
0.86 mmol, 20 equiv) was added at rt, and the resulting mixture was stirred at rt for 5 
h. The reaction was diluted with ether (15 mL), quenched with sat. NaHCO3, washed 
with brine, dried and concentrated. Chromatography (1/10/90 
NH4OH/MeOH/CH2Cl2) afforded the title product as oil (Rf = 0.65, 
NH4OH/MeOH/CH2Cl2, Rf = 0. 32, 1/10 EtOAc/hexanes), yield 83% (0.0102 g, 
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0.036 mmol). 4:1 mixture of diastereoisomers. 1H NMR (500 MHz, CDCl3) (major 
isomer) δ 0.84 (s, 9H), 1.20 (d, J = 6.9 Hz, 3H), 1.10-1.73 (m, 9H), 1.82 (dd, J = 6.4, 
12.2 Hz, 1H), 1.96-2.09 (m, 1H), 2.42 (d, J = 14.4 Hz, 1H), 2.89-3.06 (m, 2H), 7.04-
7.40 (m, 5H); 1H NMR (400 MHz, CDCl3) (minor isomer, diagnostic peaks) δ 0.86 
(s, 9H), 7.50 (d, J = 7.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) (major isomer) δ 23.2, 
27.7, 29.7, 29.7, 31.5, 33.7, 40.6, 44.0, 45.2, 45.3, 50.7, 67.3, 125.3, 126.2, 127.7, 
153.2; IR (neat) 2859, 2868, 1636, 1558, 1445, 1366, 910 cm-1; HRMS calcd for 





Amine 274. According to the general procedure, the planar tricyclic amide 
270 (0.080 g, 0.43 mmol, 1.0 equiv) was reacted with MeLi•LiBr (1.5 M in Et2O, 
0.84 mL, 1.26 mmol, 3.0 equiv) in Et2O (10 mL) for 18 h. Analysis of the crude 
reaction mixture indicated presence of enamine 271, ketone 272 and alcohol 273 in 
3:1:1 ratio as judged by 1H NMR. Due to the very similar and high polarity the 
products could not be separated at this stage. Compound 271: 13C NMR (100 MHz, 
CDCl3) δ 24.9, 26.4, 28.7, 29.9, 31.2, 37.1, 38.3, 47.4, 64.2, 74.7, 126.0, 131.5, 
151.8; HRMS calcd for C13H20N (M+ + H) 190.1596, found 190.1597. Compounds 
272 and 273: 13C NMR (100 MHz, CDCl3) δ 22.0, 22.7, 29.0, 29.3, 29.9, 31.0, 32.2, 
35.7, 38.0, 38.1, 44.0, 44.1, 44.8, 63.6, 63.7, 70.8, 126.8, 127.1, 130.5, 130.9, 209.0; 
HRMS calcd for C13H20NO (M+ + H) 208.1701, found 208.1734; HRMS calcd for 
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C14H26NO (M+ + H) 224.2014, found 224.2036. IR (neat) 3339, 3017, 2920, 2868, 
1715, 1613, 1408, 1356, 1161 cm-1. The above crude reaction mixture was subjected 
to the reduction under acidic conditions as described above for bicyclic enamine, 
using NaBH4 (0.080 g, 2.1 mmol, 5.0 equiv), AcOH (0.48 mL, 8.4 mmol, 20 equiv) 
in THF (10 mL) for 5 h at rt. Chromatography (1/4 EtOAc/hexanes) afforded 274 as 
oil (Rf = 0.82, 1/4 EtOAc/hexanes), yield 34% (2 steps, 0.0271 g, 0.14 mmol). 1H 
NMR (400 MHz, CDCl3) δ 1.18-2.22 (m, 10 H, 1.35 (d, J = 6.8 Hz, 3H), 2.33 (dt, J = 
4.5, 17.4 Hz, 1H), 2.65 (s, 1H), 2.86-3.08 (m, 2H), 3.14-3.26 (m, 1H), 3.87 (dd, J = 
4.0, 13.2 Hz, 1H), 5.34-5.43 (m, 1H), 5.57-5.66 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 22.2, 29.0, 30.7, 31.8, 32.8, 33.8, 35.3, 37.8, 54.9, 67.2, 79.2, 124.5, 132.8; 
IR (neat) 3019, 2920, 2851, 2352, 1450, 1383, 1196, 1163, 1084, 1013, 849 cm-1; 
HRMS calcd for C13H22N (M+ + H) 192.1752, found 192.1763. 
 



































According to the general procedure for addition of organometallic reagents, 
amide 34 (0.0300 g, 0.105 mmol, 1.0 equiv) was reacted with MeLi•LiBr (1.5 M in 
Et2O, 0.36 mL, 0.53 mmol, 5.0 equiv). After aqueous work-up, crude NMR (CDCl3) 
indicated the presence of 254 as a single major product. Purification by 
chromatography (1/10/90 NH3/MeOH/CH2Cl2) afforded 254 in 99% yield (0.0313 g, 
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0.104 mmol). 1H NMR and 13C NMR (CDCl3, 0.75 mL, 1000 scans) were identical 
with the previously described for 254; 1H NMR (400 MHz, CDCl3) δ 0.38 (s, (9H), 
1.38-1.99 (m, 9H), 1.91 (s, 3H), 2.18 (dd, J = 3.8, 12.7 Hz, 1H), 2.68-2.96 (m, 4H), 
7.18-7.32 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.2, 24.0, 26.4, 27.4, 33.4, 33.8, 
34.0, 37.6, 43.3, 46.4, 60.5, 126.8, 127.6, 128.5, 144.1, 211.7; no change was 
observed in comparison with the crude spectra, indicating that purification on SiO2 
does not influence the interaction between the ketone and the amine groups.  
The solvent was removed (rinsing with CH2Cl2), the sample dissolved in 
MeOD-d4 (0.75 mL), and NMR spectra were recorded after ~3 min. Major changes 
were not observed in 1H NMR, however 13C NMR indicated significant broadening of 
7 peaks; despite much longer acquisition time (23 700 scans) ketone peak was not 
detected. 1H NMR (400 MHz, CD3OD) δ 0.47 (s, 9H), 1.44 (s, 2H), 1.63 (d, J = 15.5 
Hz, 3H), 1.78-1.92 (m, 1H), 1.83 (s, 3H), 2.20 (dd, J = 4.8, 15.6 Hz, 2H), 2.58 (d, J = 
14.0 Hz, 1H), 2.71-2.84 (m, 2H), 2.84-3.02 (m, 2H), 7.19-7.38 (m, 5H); 13C NMR 
(100 MHz, CD3OD) δ 20.3, 25.0 (br), 25.2, 26.5, 31.2, 33.5, 34.5 (br), 38.6 (br), 43.2 
(br), 45.8, 58.7 (br), 126.6, 127.2, 128.3, 144.5 (br). 2D NMR correlations allowed 
for assignment of carbons corresponding to the broadened peaks, suggesting that the 
transannular interaction takes place over the western part of the amino ketone (box, 
shaded circles).  
NMR tube was kept at rt. 24 h after dissolution of 254 in MeOD-d4, 1H NMR 
was identical to the described above, for t = 3 min. At this time, 0.75 mL of MeOD-d4 
was added to the NMR tube, and 1/2 of the resulting mixture was transferred to 5 mL 
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round bottom flask, evaporated to dryness, and dissolved in CDCl3. NMR was 
identical to the described above for 254 in CDCl3, indicating that the interaction is 
reversible. To the remaining part of 254a in MeOD-d4, 0.2 mL of 1.0 N DCl in D2O 
was added, the NMR tube was wrapped in parafilm, and the reaction was mixed by 
turning the NMR tube upside down 5 times, followed by gentle shaking. NMR 
(recorded ~5 min after addition of acid) indicated 89:11 mixture of the protonated 
254b and hemiaminal 254c. As expected, peaks were much sharper than in MeOD-d4 
indicating that this time the interaction does not occur; 13C NMR  (4000 scans) 
showed a sharp ketone peak at 213.4 ppm, and a hemiaminal peak at 94.0 ppm. The 
ratio of 254b to 254c did not change after the next 24 h.  
Protonated 254b.1H NMR (400 MHz, CD3OD) δ 0.42 (s, 9H), 1.31 (s, 1H), 
1.52-1.73 (m, 2H), 1.78 (d, J = 16.2, 1H), 1.92-2.05 (m, 1H), 1.98 (s, 3H), 2.14 (td, J 
= 5.1, 16.4 Hz, 1H), 2.40-2.49 (m, 2H), 3.19-3.41 (m, 5H), 7.20-7.42 (m, 5H); 13C 
NMR (100 MHz, CD3OD) δ 17.7, 24.9, 25.6, 26.2, 28.6, 33.6, 33.8, 39.0, 42.3, 44.8, 
59.9, 127.3, 127.4, 128.8, 142.3, 213.4. Aminal 254c.1H NMR (400 MHz, CD3OD) 
(diagnostic peaks) δ 0.89 (s, 9H), 1.87 (t, J = 11.5 Hz, 1H), 2.30-2.40 (m, 2H), 2.60-
2.72 (m, 1H), 3.11-3.21 (m, 1H), 3.54 (td, J = 5.0, 14.1 Hz, 1H), 4.01-4.09 (m, 1H); 
13C NMR (100 MHz, CD3OD) δ 17.7, 24.4, 26.5, 27.0, 30.1, 33.5, 41.6, 45.2, 46.1, 
50.0, 53.0, 94.1, 126.5, 127.3, 128.1, 147.1.  
Note: a similar interaction does not occur upon dissolution of 254 in C6D6 and 
CD3CN, however in DMSO-d6 NMR showed formation of minor amounts of aminal 
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254c. Additionally, when more sterically hindered ketones 256 and 257 were treated 
with MeOD-d4 the transannular interaction has not been observed.  
Compound 254 in C6D6.1H NMR (400 MHz, C6D6) δ 0.61 (s, 9H), 1.21 (s, 2H), 
1.48 (s, 1H), 1.62-1.78 (m, 4H), 1.85 (s, 3H), 1.92 (d, J = 16.3 Hz, 1H), 2.38-2.72 (m, 
5H), 3.10 (d, J = 11.6 Hz, 1H), 7.07-7.40 (m, 5H); 13C NMR (100 MHz, C6D6) δ 
21.4, 23.9, 25.9, 27.5, 33.7, 33.9, 34.5, 37.6, 43.3, 46.3, 60.5, 126.7, 144.8, 209.1. 
Compound 254 in CD3CN.1H NMR (400 MHz, CD3CN) δ 0.41 (s, 9H), 1.21-1.65 
(m, 6H), 1.76 (s, 1H), 1.86 (s, 3H), 2.18-2.36 (m, 2H), 2.60-2.85 (m, 4H), 2.94-3.06 
(m, 1H), 7.18-7.37 (m, 5H); 13C NMR (100 MHz, CD3CN) δ 21.4, 24.0, 25.6, 26.8, 
33.4, 33.6, 34.3, 37.6, 43.7, 46.2, 60.4, 126.7, 127.6, 128.4, 144.5, 210.7. 
Compound 254 in DMSO-d6. Note: spectrum in DMSO-d6 at rt showed 71:29 
mixture of ketone to hemiaminal. 1H NMR (400 MHz, DMSO-d6) (diagnostic peaks) 
δ 0.34 (s, 9H), 1.41-1.52 (m, 2H), 1.84 (s, 3H), 2.06-2.14 (m, 1H), 2.93 (d, J = 12.4 
Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 21.5, 24.2, 26.5, 27.7, 34.1, 34.6, 37.6, 
43.9, 45.7, 46.4, 60.4, 127.1, 127.7, 129.0, 144.4, 210.8. Aminal 254c.1H NMR (400 
MHz, DMSO-d6) (diagnostic peaks) δ 0.82 (s, 9H), 3.15 (t, J = 13.0 Hz, 1H), 3.67 (d, 
J = 12.6 Hz, 1H), 5.26 (s, 1H), 7.68 (s, 1H); 13C NMR (100 MHz, DMSO-d6) 




Corey-Chaykovsky Reaction of Bridged Amides 
 
Preparation of Spiro-epoxyamines. General procedure: Round-bottom 
flask was charged with NaH (60% dispersion in mineral oil) and DMSO was added 
dropwise at rt. After stirring for 20 min at rt, THF was added and the reaction mixture 
was cooled to 0 °C. Trimethylsulfonium iodide was added in DMSO, and after 
stirring for 10 min at 0 °C, twisted amide was added dropwise in THF/DMSO 
mixture at 0 °C. The reaction mixture was slowly warmed to rt over 4-6 h, and stirred 
at rt for the remaining time. The reaction was quenched with water (20 mL), extracted 
with EtOAc (3 x 50 mL), washed with brine (5 x 50 mL), dried, concentrated and 
chromatographed to afford the final products. 
 
Concentration influence on the Corey-Chaykovsky reaction (Table 28). 
Entry 1: According to the general procedure, 34 (0.0200 g, 0.070 mmol, 1.0 equiv) 
was reacted with NaH (0.014 g, 0.35 mmol, 5.0 equiv), and sulfonium iodide (0.0295 
g, 0.14 mmol, 2.0 equiv) in DMSO (3 mL, 1.5 mL and 2 mL) and THF (5 mL and 2 
mL) (ctotal = 0.005 M, cylide = 0.007 M, camide = 0.018 M) for 15 h. Analysis of the 
crude reaction mixture by 1H NMR indicated 81% conversion.  
Entry 2: According to the general procedure, the reaction of 34 (0.0200 g, 
0.070 mmol, 1.0 equiv), NaH (0.0196 g, 0.49 mmol, 7.0 equiv), and sulfonium iodide 
(0.0368 g, 0.18 mmol, 2.5 equiv) in DMSO (3.0 mL, 2.0 mL, and 2.0 mL), and THF 
(5.0 mL and 3.0 mL) (ctotal = 0.005 M, cylide = 0.007 M, camide =  0.014 M) for 17 h at 
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rt afforded after chromatography (1/3 EtOAc-hexanes) 275 in 75% yield (0.0157 g, 
0.053 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion.  
Entry 3. According to the general procedure, the reaction of 34 (0.0200 g, 
0.070 mmol, 1.0 equiv), NaH (0.056 g, 1.40 mmol, 20.0 equiv), and sulfonium iodide 
(0.0736 g, 0.35 mmol, 5.0 equiv) in DMSO (3.0 mL, 1.5 mL, and 2.0 mL), and THF 
(5.0 mL and 2.0 mL) (ctotal = 0.005 M, cylide = 0.007 M, camide = 0.018 M) for 24 h at rt 
afforded after chromatography (1/3 EtOAc-hexanes) 275 in 80% yield (0.0167 g, 
0.056 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion. 
Entry 4. According to the general procedure, 34 (0.0300 g, 0.105 mmol, 1.0 
equiv) was reacted with NaH (0.0295 g, 0.74 mmol, 7.0 equiv), and sulfonium iodide 
(0.0552 g, 0.26 mmol, 2.5 equiv) in DMSO (3.0 mL, 2.0 mL, and 2.0 mL), and THF 
(5.0 mL and 3.0 mL) (ctotal = 0.007 M, cylide = 0.011 M, camide = 0.021 M) for 18 h at 
rt. Analysis of the crude reaction mixture by 1H NMR indicated only unidentified 
decomposition products. 
Entry 5. According to the general procedure, 34 (0.0300 g, 0.105 mmol, 1.0 
equiv) was reacted with NaH (0.0295 g, 0.74 mmol, 7.0 equiv), and sulfonium iodide 
(0.0552 g, 0.26 mmol, 2.5 equiv) in DMSO (5.0 mL, 2.5 mL, and 2.0 mL), and THF 
(10.0 mL and 3.0 mL) (ctotal = 0.005 M, cylide = 0.006 M, camide = 0.021 M) for 18 h at 
rt to afford after chromatography (1/3 hexanes/EtOAc) 275 in 53% yield (0.0276 g, 
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0.092 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion.  
Entry 6. According to the general procedure, 34 (0.0300 g, 0.105 mmol, 1.0 
equiv) was reacted with NaH (0.0295 g, 0.74 mmol, 7.0 equiv), and sulfonium iodide 
(0.0552 g, 0.26 mmol, 2.5 equiv) in DMSO (5.0 mL, 2.5 mL, and 2.0 mL), and THF 
(10.0 mL and 6.0 mL) (ctotal = 0.004 M, cylide = 0.006 M, camide = 0.013 M) for 18 h at 
rt to afford after chromatography (1/3 hexanes/EtOAc) 275 in 73% yield (0.0230 g, 
0.077 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion.  
Entry 7. According to the general procedure, 34 (0.0500 g, 0.175 mmol, 1.0 
equiv) was reacted with NaH (0.0491 g, 1.23 mmol, 7.0 equiv), and sulfonium iodide 
(0.0920 g, 0.44 mmol, 2.5 equiv) in DMSO (6.0 mL, 2.5 mL, and 2.0 mL), and THF 
(10.0 mL and 11.0 mL) (ctotal = 0.0050 M, cylide = 0.0095 M, camide = 0.013 M) for 18 
h at rt to afford after chromatography (1/3 hexanes/EtOAc) 275 in 78% yield (0.0408 
g, 0.137 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion.  
Entry 8. According to the general procedure, 34 (0.0300 g, 0.105 mmol, 1.0 
equiv) was reacted with NaH (0.0295 g, 0.74 mmol, 7.0 equiv), and sulfonium iodide 
(0.0552 g, 0.26 mmol, 2.5 equiv) in DMSO (5.0 mL, 2.0 mL, and 2.0 mL), and THF 
(20.0 mL and 3.0 mL) (ctotal = 0.003 M, cylide = 0.003 M, camide = 0.021 M) for 18 h at 
rt to afford after chromatography (1/3 hexanes/EtOAc) 275 in 88% yield (0.0276 g, 
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0.092 mmol). Analysis of the crude reaction mixture by 1H NMR indicated >95% 
conversion.  
Reaction rate: According to the general procedure, 34 (0.0300 g, 0.105 mmol, 
1.0 equiv) was reacted with NaH (0.0295 g, 0.74 mmol, 7.0 equiv), and sulfonium 
iodide (0.0552 g, 0.26 mmol, 2.5 equiv) in DMSO (5.0 mL, 2.5 mL, and 2.0 mL), and 
THF (10.0 mL and 6.0 mL) (ctotal = 0.004 M, cylide = 0.006 M, camide = 0.013 M). 3.0 
mL aliquots were taken, and analyzed by 1H NMR after aqueous work-up, indicated 
as follows: 5.9% conversion 10 min after the start of the reaction, 7.1% conversion 
after 30 min, 12.4% conversion after 2 h, 63% conversion after 6.5 h, 87% conversion 







(275). According to the general procedure, the reaction of 34 (0.0300 g, 0.105 mmol, 
1.0 equiv), NaH (0.0295 g, 0.74 mmol, 7.0 equiv) and sulfonium iodide (0.0552 g, 2.5 
equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) and THF (20.0 mL and 3.0 mL) 
for 18 h afforded after chromatography (1/4-1/1 EtOAc/hexanes) the title compound 
as oil (Rf = 0.39, 1/4 EtOAc/hexanes). Yield 88% (0.0276 g, 0.092 mmol). 1H NMR 
(500 MHz, CDCl3) δ 0.82 (s, 9H), 1.48-1.55 (m, 1H), 1.59-1.67 (m, 2H), 1.70 (d, J = 
6.3 Hz, 1H), 1.73-1.80 (m, 2H), 1.88 (m, 1H), 2.00-2.10 (m, 1H), 2.13-2.19 (m, 2H), 
2.32 (ddt, J = 2.1, 4.3, 13.2 Hz, 1H), 2.48-2.55 (m, 1H), 2.87-2.99 (m, 2H), 3.51 (dt, J 
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= 3.9, 13.0 Hz, 1H), 7.08-7.12 (m, 1H), 7.16-7.20 (m, 2H), 7.45 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 22.2, 27.5, 29.2, 33.9, 36.8, 42.7, 44.1, 48.2, 52.1, 53.2, 53.8, 
72.6, 126.0, 126.9, 127.6, 147.0; IR (neat) 3416, 2955, 2922, 2853, 1458, 1365, 1333, 







According to the general procedure, the reaction of 73 (0.0202 g, 0.077 mmol, 1.0 
equiv), NaH (0.0217 g, 0.54 mmol, 7.0 equiv) and sulfonium iodide (0.0379 g, 2.5 
equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) and THF (10.0 mL and 3.0 mL) 
for 17 h afforded after chromatography (1/4 EtOAc/hexanes) the title compound as 
oil (Rf = 0.37, 1/4 EtOAc/hexanes). Yield 81% (0.0171 g, 0.062 mmol). 1H NMR 
(400 MHz, CDCl3) δ 1.44-1.53 (m, 1H), 1.60-1.72 (m, 2H), 1.77-2.13 (m, 7H), 2.56 
(d, J = 6.5 Hz, 1H), 2.76 (m, 1H), 2.96-3.12 (m, 2H), 3.20-3.27 (m, 1H), 3.63 (d, J = 
6.5 Hz, 1H), 7.28-7.35 (m, 3H), 7.56-7.60 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
22.2, 24.3, 27.9, 37.4, 40.4, 50.7, 52.6, 52.8, 53.6, 74.4, 128.3, 128.4, 132.4, 136.6; 
IR (neat) 3057, 2931, 2855, 1474, 1447, 1439, 1329, 1264, 1165, 1017 cm-1; HRMS 









According to the general procedure, the reaction of 3 (0.0276 g, 0.132 mmol, 1.0 
equiv), NaH (0.0370 g, 0.92 mmol, 7.0 equiv) and sulfonium iodide (0.0694 g, 2.5 
equiv) in DMSO (6.0 mL and 2.5 mL and 2.0 mL) and THF (10.0 mL and 8.0 mL) 
for 18 h afforded after chromatography (5% MeOH/EtOAc) the title compound as oil 
(Rf = 0.55, 10% MeOH/EtOAc). Yield 41% (0.0121 g, 0.054 mmol). 1H NMR (400 
MHz, CDCl3) δ 0.92 (s, 9H), 1.26-1.84 (m, 9H), 1.94-2.04 (m, 1H), 2.45 (d, J = 6.2 
Hz, 1H), 2.50 (dt, J = 3.4, 12.9 Hz, 1H); 2.64 (d, J = 6.2 Hz, 1H), 2.90-3.05 (m, 2H), 
3.45 (dt, J = 3.5, 13.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 19.2, 27.6, 28.9, 31.5, 
33.1, 33.6, 36.1, 48.7, 522.4, 54.4, 55.3, 71.7; IR (neat) 2939, 2863, 1468, 1448, 
1364, 1337, 1263, 1227, 1186, 1149, 1119, 1082 cm-1; HRMS calcd for C14H24NO 





6-(Methylthio)-1-azaspiro[bicyclo[4.3.1]decane-10,2'-oxirane] (278). To a 
solution of sulfonium iodide (0.26 g, 1.23 mmol, 10.0 equiv) in THF (15 mL), nBuLi 
(2.5 M in hexanes, 0.38 mL, 0.96 mmol, 8.0 equiv) was added dropwise at 0 °C. 
After 5 min at 0 °C, amide 58 (0.0245 g, 0.12 mmol, 1.0 equiv) was added in THF 
(3.0 mL) dropwise at 0 °C. The reaction mixture was warmed slowly to rt over 3 h, 
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and stirred at rt for additional 2 h. The reaction mixture was quenched with water (20 
mL), extracted with EtOAc (3 x 50 mL), washed with brine (1 x 20 mL), dried, 
concentrated and purified by chromatography (1/3 EtOAc/hexanes) to afford the title 
compound as oil (Rf = 0.19, 1/4 EtOAc/hexanes). Yield 89% (0.0233 g, 0.11 mmol). 
1H NMR (400 MHz, CDCl3) δ 1.44-1.49 (m, 1H), 1.64-1.92 (m, 8H), 1.94 (s, 3H), 
2.00-2.08 (m, 1H), 2.24 (d, J = 6.8 Hz, 1H), 2,68-2.75 (m, 1H), 2.95-3.11 (m, 2H), 
3.20-3.27 (m, 1H), 3.47 (d, J = 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 13.1, 
22.2, 25.4, 29.6, 38.4, 39.1, 48.4, 51.1, 52.4, 53.9, 75.6; IR (neat) 3066, 2919, 2852, 
1448, 1330, 1263, 1217, 1164 cm-1; HRMS calcd for C11H20NOS (M+ + H) 214.1266, 
found 214.1262. Note: the compound is unstable at rt. The reaction of 58 under 







Epoxide 281. According to the general procedure, the reaction of 229 (0.0250 
g, 0.072 mmol, 1.0 equiv), NaH (0.0202 g, 0.51 mmol, 7.0 equiv) and sulfonium 
iodide (0.0375 g, 0.18 mmol, 2.5 equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) 
and THF (10.0 mL and 3.0 mL) for 18 h afforded after chromatography (1/1 
EtOAc/hexanes) the title compound as oil (Rf = 0.31, 1/1 EtOAc/hexanes). Yield 70% 
(0.0183 g, 0.051 mmol). 1H NMR (400 MHz, CDCl3) δ 1.32-1.43 (m, 1H), 1.46-1.53 
(m, 1H), 1.60-1.74 (m, 2H), 1.86 (dd, J = 4.1, 10.8 Hz, 1H), 2.01-2.11 (m, 1H), 2.16-
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2.29 (m, 2H), 2.50 (d, J = 6.1 Hz, 1H), 2.49-2.56 (m, 1H), 2.59-2.69 (m, 2H), 2.73 (d, 
J = 6.1 Hz, 1H), 3.11 (d, J = 10.6 Hz, 1H), 3.38 (dd, J = 8.1, 13.5 Hz, 1H), 3.50 (dd, J 
= 4.2, 12.0 Hz, 1H), 5.51 (d, J = 9.8 Hz, 1H), 5.98-6.04 (m, 1H), 7.06 (d, J = 8.2 Hz, 
2H), 7.45 (d, J = 8.1 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 24.5, 24.6, 35.0, 35.3, 
37.6, 48.1, 50.7, 52.7, 54.7, 58.7, 70.4, 120.3, 129.7, 129.8, 131.5, 134.7, 142.8; IR 
(neat) 3013, 2916, 2860, 1483, 1441, 1385, 1337, 1298, 1246, 1137, 1071, 1011 cm-1; 






Epoxide 282. According to the general procedure, the reaction of 279 (0.0272 
g, 0.084 mmol, 1.0 equiv), NaH (0.0234 g, 0.59 mmol, 7.0 equiv) and sulfonium 
iodide (0.0437 g, 0.21 mmol, 2.5 equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) 
and THF (10.0 mL and 5.0 mL) for 19 h afforded after chromatography (0-2.5% 
MeOH/EtOAc) the title compound as oil (Rf = 0.27, EtOAc). Yield 73% (0.0209 g, 
0.062 mmol). 1H NMR (400 MHz, CDCl3) δ 1.27-1.67 (m, 5H), 1.84-1.97 (m, 3H), 
2.04-2.26 (m, 3H), 2.32-2.44 (m, 1H), 2.44 (d, J = 6.1 Hz, 1H), 2.64 (t, J = 11.4 Hz, 
1H), 2.72 (d, J = 6.1 Hz, 1H), 2.72-2.84 (m, 1H), 3.42-3.52 (m, 2H), 2.55-3.63 (m, 
2H), 4.53 (s, 2H), 5.51 (d, J = 9.9 Hz, 1H), 5.82-5.87 (m, 1H), 7.29-7.38 (m 5H); 13C 
NMR (100 MHz, CDCl3) δ 24.4, 24.7, 32.2, 34.4, 34.8, 35.3, 41.0, 48.3, 53.0, 54.7, 
58.8, 68.0, 70.5, 73.1, 127.6, 127.6, 128.4, 130.0, 133.7, 138.5; IR (neat) 3009, 2914, 
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2860, 1481, 1453, 1385, 1364, 1294, 1258, 1142, 1102, 1053 cm-1; HRMS calcd for 





Epoxide 283. According to the general procedure, the reaction of 280 (0.0090 
g, 0.047 mmol, 1.0 equiv), NaH (0.0130 g, 0.33 mmol, 7.0 equiv) and sulfonium 
iodide (0.0240 g, 0.12 mmol, 2.5 equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) 
and THF (10.0 mL and 3.0 mL) for 18 h afforded after chromatography (10% 
MeOH/EtOAc) the title compound as oil (Rf = 0.36, 10% MeOH/EtOAc). Yield 77% 
(0.0075 g, 0.036 mmol). 1H NMR (400 MHz, CDCl3) δ 1.01-1.14 (m, 1H), 1.32-1.78 
(m, 10H), 1.85-2.05 (m, 2H), 2.14-2.25 (m, 2H), 2.43 (dd, J = 2.3, 6.1 Hz, 1H), 2.69 
(dd, J = 1.9, 6.2 Hz, 1H), 2.76-2.85 (m, 2H), 3.35 (dd, J = 8.4, 13.4 Hz, 1H), 3.49-
3.54 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 22.5, 25.0, 28.2, 30.9, 31.0, 32.0, 33.2, 
33.8, 52.1, 52.8, 54.6, 58.7, 71.0; IR (neat) 2918, 2859, 1484, 1453, 1443, 1383, 







Epoxide 284. According to the general procedure, the reaction of 260 (0.0258 
g, 0.11 mmol, 1.0 equiv), NaH (0.0310 g, 0.78 mmol, 7.0 equiv) and sulfonium iodide 
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(0.0572 g, 0.28 mmol, 2.5 equiv) in DMSO (5.0 mL and 2.0 mL and 2.0 mL) and 
THF (10.0 mL and 6.0 mL) for 18 h afforded after chromatography (2.5% 
EtOAc/hexanes) the title compound as oil (Rf = 0.84, 1/10 EtOAc/hexanes). Yield 
70% (0.0190 g, 0.077 mmol). 1H NMR (400 MHz, CDCl3) δ 0.80 (dd, J = 2.6, 6.8 
Hz, 6H), 1.37-1.61 (m, 5H), 1.65-1.72 (m, 1H), 1.80-1.89 (m, 1H), 1.97 (dd, J = 2.0, 
13.3 Hz, 1H), 2.01-2.17 (m, 3H), 2.35-2.43 (m, 1H), 2.41 (d, J = 6.6 Hz, 1H), 2.62 
(dd, J = 1.8, 11.2 Hz, 1H), 2.68 (d, J = 6.6 Hz, 1H), 2.74-2.84 (m, 1H), 3.41 (dd, J = 
8.0, 13.3 Hz, 1H), 5.55-5.63 (m, 1H), 5.77-5.84 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 17.9, 18.3, 25.6, 27.9, 29.9, 33.5, 33.7, 34.8, 36.1, 48.6, 53.4, 54.8, 69.9, 
74.7, 126.0, 133.8; IR (neat) 3015, 2954, 2927, 2669, 1463, 1451, 1393, 1378, 1341, 
1291, 1260, 1064 cm-1; HRMS calcd for C16H26NO (M+ + H) 248.2014, found 
248.2015. 
Attempted epoxidation of 93, [5.3.1] ring system. According to the general 
procedure, 93 (0.0228 g, 0.11 mmol, 1.0 equiv) was reacted with NaH (0.0300 g, 0.75 
mmol, 7.0 equiv) and sulfonium iodide (0.0563 g, 0.27 mmol, 2.5 equiv) in DMSO 
(5.0 mL and 2.0 mL and 2.0 mL) and THF (10.0 mL and 6.0 mL) for 17 h. Analysis 














4-tert-Butyl-6-(2-chloroacetyl)-6-phenylazonanium chloride (285).  To a 
10 ml round bottom flask charged with epoxide 275 (0.0041 g, 0.014 mmol, 1.0 
equiv) and MeOH (5.0 mL), HCl (4.0 M, dioxane, 0.40 mL, 1.6 mmol, 100 equiv) 
was added dropwise at rt, and the resulting reaction mixture was stirred at rt. After 19 
h the solvent was removed to provide the title compound as a white solid (m.p. = 230-
5 °C). Yield 99% (0.0050 g, 0.0135 mmol). 1H NMR (400 MHz, DMSO-d6) δ 0.34 
(s, 9H), 1.28-1.48 (m, 3H), 1.60 (m, 1H), 1.83 (m, 1H), 1.95 (m, 1H), 2.05 (m, 1H), 
2.17 (m, 1H), 2.57 (m, 1H), 3.00 (m, 2H), 3.14 (m, 2H), 4.12 (d, J = 16.0 Hz, 1H), 
4.48 (d, J = 16.0 Hz, 1H), 7.19 (d, J = 7.4 Hz, 2H), 7.30 (t, J = 7.1 Hz, 1H), 7.39 (t, J 
= 7.5 Hz, 2H), 8.76 (br, 1H), 9.51 (br, 1H); 13C NMR (100 MHz, DMSO-d6) δ 17.9, 
24.6, 27.2, 29.1, 33.9, 34.3, 37.9, 41.7, 44.6, 57.1, 59.6, 127.9, 128.0, 129.3, 142.1, 
204.6; IR (KBr) 3423, 2931, 1725, 1574, 1466, 1290, 1124, 1075 cm-1; HRMS calcd 
for C20H31ClNO (M+) 336.2094, found 336.2093. Note: the reaction of 275 (0.0163 g, 








To a solution of epoxide 275 (0.0232 g, 0.078 mmol, 1.0 equiv) in MeOH (10.0 mL), 
NaOMe (0.0882 g, 1.6 mmol, 20.0 equiv) was added, and the resulting mixture was 
refluxed for 48 h. The reaction mixture was cooled to rt, ether (10 mL) was added, 
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followed by water (10 mL), and the reaction mixture was extracted with EtOAc (3 x 
30 mL), washed with brine (1 x 20 mL), dried, concentrated and analyzed by NMR. 
Yield 38% (vs. nitromethane as the internal standard), dr = 84:16. Note: the 
compound is very unstable, it decomposes rapidly over time, attempted purification 
led only to decomposition products. (Rf = ~0.50, 1/1 EtOAc/hexanes). 1H NMR (400 
MHz, CDCl3) (major diastereomer) δ 0.88 (s, 9H), 1.53 (m, 3H), 1.80 (m, 2H), 1.86-
1.96 (m, 1H), 2.02-2.20 (m, 2H), 2.35-2.44 (m, 1H), 2.72 (dt, J = 4.7, 13.5 Hz, 2H), 
2.93 (dt, J = 3.9, 13.4 Hz, 1H), 3.77 (ddd, J = 1.8, 5.2, 13.6 Hz, 1H), 4.09 (s, 1H), 
7.17-7.55 (m, 5H), 9.44 (s, 1H); (minor diastereomer, diagnostic peaks) δ 4.20 (s, 
1H), 9.61 (s, 1H); 13C NMR (100 MHz, CDCl3) (major diastereomer) δ 21.6, 27.5, 
30.4, 32.5, 33.8, 38.9, 48.2, 49.3, 49.7, 56.3, 66.9, 125.1, 125.6, 128.4, 150.1, 199.7; 
IR (neat) 2956, 2943, 2706, 1726, 1444, 1365, 1224, 1155, 1099 cm-1; HRMS calcd 
for C20H30NO (M+ + H) 300.2327, found 300.2301. Note: the reaction of 275 with 
other bases, including sodium salt of dimethylmalonate, ethylmagnesium bromide, 







7-tert-Butyl-5-phenylazonan-5-yl)ethanone (287). To a solution of epoxide 
275 (0.0157 g, 0.053 mmol, 1.0 equiv) in Et2O (10 mL), LiAlH4 (1.0 M, Et2O, 0.26 
mL, 0.26 mmol, 5.0 equiv) was added at rt. After stirring for 20 h at rt, the reaction 
was quenched at 0 °C by sequential addition of H2O, 15% NaOH, H2O and Na2SO4 
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according to the procedure by Fieser and Fieser. Purification by chromatography 
(1/10/90 NH3/MeOH/CH2Cl2) afforded the title compound as oil (Rf = 0.31-0.62, 
1/10/90 NH3/MeOH/CH2Cl2). Yield 91% (0.0144 g, 0.048 mmol). Spectroscopic 








(288). To a 10 ml round bottom flask charged with epoxide 275 (0.0050 g, 0.017 
mmol, 1.0 equiv) and CH2Cl2 (2.0 mL), H2O (0.030 g, 1.7 mmol, 100 equiv) and TFA 
(2.0 mL) were added at rt. After the reaction mixture was stirred at rt for 18 h, the 
solvent was removed and the reaction was analyzed by NMR. Yield 76% (vs. 
nitromethane as the internal standard). Note: the compound is unstable, it decomposes 
at rt over time; attempted purification led only to products with diminished purity. (Rf 
= 0.65, 1/1 EtOAc/hexanes). 1H NMR (400 MHz, CDCl3) δ 0.95 (s, 9H), 1.75 (m, 
1H), 1.87 (d, J = 14.0 Hz, 1H), 2.04-2.21 (m, 5H), 2.37-2.47 (m, 2H), 2.59-2.66 (m, 
1H), 2.97-3.09 (m, 1H), 3.32 (d, J = 3.8 Hz, 1H), 3.50 (m, 2H), 4.20 (d, J = 13.6 Hz, 
1H), 7.24-7.58 (m, 5H) ; 13C NMR (100 MHz, CDCl3) δ 18.3, 26.7, 27.3, 33.6, 34.1, 
42.2, 43.1, 47.5, 50.3, 54.5, 55.3, 74.3, 127.7, 128.3, 128.6, 142.6; IR (neat) 3400, 









(289). To a solution of epoxide 275 (0.0154 g, 0.052 mmol, 1.0 equiv) in MeOH (10 
mL), 2 drops of H2SO4 were added, and the reaction mixture was heated to reflux for 
5 h. The reaction was cooled to rt, quenched with sat. NaHCO3 (10 mL), extracted 
with EtOAc (3 x 20 mL), washed with brine (1 x 20 mL), dried, concentrated and 
purified by chromatography (20% MeOH/EtOAc) to afford the title compound as oil 
(Rf = 0.27, 20% MeOH/EtOAc). Yield ca. 50% (0.0081 g, 0.025 mmol). Note: the 
title compound was obtained as 2:1 mixture with an unidentified by-product. 
Attempts to (1) separate the by-product using different solvent systems on silica gel 
or PTLC, (2) change the reaction time (1 h - partial conversion was observed and 17 
h), (3) resubmitting the final product to the reaction conditions or (4) use of other 
acids (pTsOH, HNO3, HClaq) always afforded the unidentified by-product in ratio ca. 
1:2.5 to 2z. 1H NMR (400 MHz, CDCl3) δ 0.87 (s, 9H), 1.43 (m 1H), 1.54-2.14 (m, 
6H), 2.18-2.56 (m, 4H), 2.71-2.81 (m, 1H), 2.83 (m, 1H), 3.12-3.28 (m, 1H), 3.37 (s, 
3H), 3.57-3.66 (m, 1H), 7.16-7.70 (m, 5H); diagnostic peaks of the unidentified 
impurity δ 0.94 (s, 9H), 5.48 (d, J = 5.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
21.6, 27.9, 30.7, 33.7, 33.9, 44.0, 45.1, 46.3, 50.6, 51.0, 53.2, 62.2, 92.6, 125.8, 127.6, 
128,7, 147.6; IR (neat) 3379, 2960, 1470, 1366, 1138, 1032 cm-1; HRMS calcd for 










Salt 290. To a solution of epoxide 275 (0.0146 g, 0.049 mmol, 1.0 equiv) in 
acetone (2.0 mL), pTsOH (0.0093 g, 0.049 mmol, 1.0 equiv) was added in acetone 
(0.5 mL). Et2O (2.5 mL) wad added and the reaction mixture was kept for 5 days at -
20 °C. The solvent was removed to afford the title compound as white foam. Yield 
99% (0.0238 g, 0.049 mmol). Note: the compound is unstable. 1H NMR (400 MHz, 
CDCl3) δ 0.93 (s, 9H), 1.72 (m, 1H), 1.84 (d, J = 14.0 Hz, 1H), 2.06-2.21 (m, 5H), 
2.32-2.45 (m, 2H), 2.34 (s, 3H), 2.62 (m, 1H), 3.05 (m, 1H), 3.47 (d, J = 3.9 Hz, 1H), 
3.63 (d, J = 7.7 Hz, 2H), 4.21-4.29 (m, 1H), 7.18 (d, J = 7.9 Hz, 2H), 2.27-7.38 (m, 
3H), 7.45 (m, 2H), 7.76 (d, J = 8.1 Hz, 2H), 11.29 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 18.3, 21.4, 26.7, 27.3, 33.6, 34.0, 42.1, 43.2, 47.4, 50.5, 55.0, 55.4, 74.4, 
126.0, 126.0, 127.6, 128.6, 128.9, 140.4, 141.3, 142.7; IR (neat) 3352, 2954, 2918, 
2848, 1718, 1458, 1365, 1273, 1226, 1165, 1120 cm-1; HRMS calcd for C20H30NO 






Lactam 34. A solution of epoxide 275 (0.0106 g, 0.035 mmol, 1.0 equiv), 
KCN (0.0455 g, 0.70 mmol, 20.0 equiv) in DMF (10 mL) was heated at 110 °C for 24 
h. The reaction mixture was cooled to rt, diluted with EtOAc (50 mL), washed with 
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water (4 x 20 mL), brine (1 x 20 mL), dried, concentrated and purified by 
chromatography (1/2 EtOAc/hexanes) the title compound. Yield 86% (0.0086 g, 
0.030 mmol). Spectroscopic properties matched those previously described. Note: the 
reaction of 275 (0.0252 g, 0.084 mmol) with KCN (0.0279 g, 0.42 mmol, 5.0 equiv) 
and LiClO4 (0.0447 g, 0.42 mmol, 5.0 equiv) in CH3CN (10 mL) at 70 °C for 80 h 






4-tert-Butyl-6-phenyl-1-azabicyclo[4.3.2]undecan-11-one (291). According 
to the procedure for 34, the reaction of 275 (0.0170 g, 0.057 mmol, 1.0 equiv) and 
NaI (0.17 g, 1.1 mmol, 20.0 equiv) in DMF (10 mL) at 110 °C for 16 h, afforded after 
chromatography (1/4 EtOAc/hexanes) the title compound as oil (Rf = 0.22, 1/4 
EtOAc/hexanes). Yield 51% (0.0087 g, 0.029 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.97 (s, 9H), 1.32-1.49 (m, 2H), 1.78-2.-2 (m, 3H), 2.14 (dd, J = 2.0, 13.0 Hz, 1H), 
2.33 (tt, J = 2.6, 13.4 Hz, 1H), 2.41-2.52 (m, 1H), 2.59 (dd, J = 3.7, 13.1 Hz, 1H), 
2.76 (dt, J = 4.0, 13.2 Hz, 1H), 3.14-3.31 (m, 2H), 3.59 (dt, J = 3.0, 14.5 Hz, 1H), 
3.73 (q, J = 16.9 Hz, 2H), 7.13-7.38 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 27.3, 
28.4, 31.5, 35.2, 40.9, 42.0, 46.6, 56.9, 57.1, 58.6, 65.5, 126.0, 126.2, 128.1, 151.6, 
203.1; IR (neat) 2960, 2918, 2870, 1697, 1444, 1365, 1163, 1116 cm-1; HRMS calcd 









10 mL MW vial (Biotage) was charged with epoxide 275 (0.0046 g, 0.015 mmol, 1.0 
equiv) and toluene (3.0 mL, 0.005 M), the vial was sealed and heated to 200 °C for 10 
h. The solvent was removed and the reaction was analyzed by NMR. Yield 81% (vs. 
nitromethane as the internal standard), dr = 86:14. Note: the compound is very 
unstable, it decomposes rapidly over time, attempted purification led only to 
decomposition products. Spectroscopic properties matched those previously 
described. Note: the reaction carried out in DMF (120 °C, 14 h) resulted in 
decomposition; in MeOH (150 °C, 2 h) (MW) a complex mixture was formed (27% 
yield of 3f); in PhCH3 (110 °C, 15 h) <5% conversion; in PhCH3 (150 °C, 14 h) 23% 






4-tert-Butyl-6-phenyl-1-azabicyclo[4.3.1]decane-10-carboxamide (292). A 
solution of epoxide 275 (0.0221 g, 0.074 mmol, 1.0 equiv), NaN3 (0.21 g, 3.3 mmol, 
50 equiv) and DMF (10 mL) was heated at 110 °C for 21 h. The reaction mixture was 
cooled to rt, diluted with EtOAc (50 mL), washed with water (4 x 20 mL), brine (1 x 
20 mL), dried, concentrated and purified by chromatography (1/10/90 
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NH3/MeOH/CH2Cl2) to afford the title compound as oil (Rf = 0.40, 1/10/90 
NH3/MeOH/CH2Cl2). Yield 62% (0.0143 g, 0.045 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.88 (s, 9H), 1.46-1.76 (m, 6H), 1.91 (dd, J = 6.9, 15.0 Hz, 1H), 2.11-2.29 
(m, 2H), 2.34 (d, J = 14.6 Hz, 1H), 2.57-2.72 (m, 2H), 2.04 (d, J = 15.0 Hz, 1H), 3.83 
(dt, J = 2.8, 15.2 Hz, 1H), 4.40 (dd, J = 4.8, 13.7 Hz, 1H), 4.29 (s, 1H), 7.13 (t, J = 
7.2 Hz, 1H), 7.28 (t, J = 7.4 Hz, 2H), 7.36 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 24.6, 26.2, 28.4, 34.0, 35.9, 39.3, 44.8, 48.9, 49.8, 51.1, 59.9, 126.1, 126.9, 
128.5, 149.7, 177.5; IR (neat) 3387, 2959, 2926, 1661, 1480, 1430, 1366, 1220, 1156, 
1100 cm-1; HRMS calcd for C20H31N2O (M+ + H) 315.24361, found 315.2430. 
 
Reactions of 275 under Lewis acidic conditions. General procedure: To a 
round-bottom flask charged with epoxide 275 and CH2Cl2, Lewis acid was added at 
rt, unless indicated otherwise. If an additive was used, it was added before the Lewis 
acid. After the reaction mixture was stirred for a specified time, the reaction was 
quenched with sat. NaHCO3, extracted with CH2Cl2, washed with brine, dried, 
concentrated and chromatographed to afford the final products. Stereochemistry 








According to the general procedure, the reaction of 275 (0.0147 g, 0.049 mmol, 1.0 
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equiv) and Et2AlCl (1.8 M, toluene, 0.055 mL, 0.10 mmol, 2.0 equiv) in CH2Cl2 (5.0 
mL) for 15 h at rt, afforded after chromatography (1/10/90 NH3/MeOH/CH2Cl2) the 
title compound as oil (Rf = 0.33, 1/10/90 NH3/MeOH/CH2Cl2). Yield 92% (0.0149 g, 
0.045 mmol), dr = 59:41. 1H NMR (400 MHz, CDCl3) (mixture of diastereoisomers) 
δ 0.40 (t, J = 6.9 Hz, 3H, minor isomer), 0.65 (t, J = 7.3 Hz, 3H, major isomer), 0.89 
(s, 9H), 1.53-2.05 (m, 16H), 2.08-2.31 (m, 4H), 2.48 (dt, J = 4.1, 13.6 Hz, 1H), 2.59 
(dd, J = 4.8, 14.6 Hz, 1H), 2.67-2.81 (m, 3H), 2.92-3.03 (m, 3H), 3.09-3.22 (m, 2H), 
3.32-3.41 (m, 1H), 3.53 (dd, J = 6.2, 11.0 Hz, 1H), 3.62 (dd, J = 4.6, 13.9 Hz, 1H), 
3.69 (dd, J = 3.7, 13.7 Hz, 1H), 7.19-7.49 (m, 10H); 13C NMR (100 MHz, CDCl3) 
(mixture of diastereoisomers) δ 10.3, 21.4, 21.7, 27.5, 27.5, 28.6, 30.1, 30.2, 31.0, 
31.6, 33.8, 34.0, 41.1, 46.2, 48.1, 48.2, 48.2, 48.5, 49.6, 56.6, 57.5, 59.0, 62.8, 67.7, 
125.7, 125.9, 126.0, 127.9, 128.2, 149.1, 149.2; IR (neat) 3304, 2959, 2870, 1720, 
1663, 1599, 1497, 1460, 1366, 1225. 1099 cm-1; HRMS calcd for C22H36NO (M+ + 








According to the general procedure, the reaction of 275 (0.0126 g, 0.042 mmol, 1.0 
equiv) and MeAlCl2 (1.0 M, hexanes, 0.084 mL, 0.084 mmol, 2.0 equiv) in CH2Cl2 
(5.0 mL) for 13 h at rt, afforded after chromatography (1/10/90-1/30/70 
NH3/MeOH/CH2Cl2) the title compound as oil (Rf = 0.31, 1/10/90 
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NH3/MeOH/CH2Cl2). Yield 58% (0.0076 g, 0.024 mmol). 1H NMR (400 MHz, 
CDCl3) δ 0.26 (d, J = 5.9 Hz, 3H), 0.90 (s, 9H), 1.54-1.63 (m, 3H), 1.78-1.93 (m, 
5H), 2.16-2.26 (m, 1H), 2.39-2.48 (m, 1H), 2.66-2.80 (m, 2H), 2.96 (d, J = 8.8 Hz, 
1H), 3.16 (dt, J = 4.4, 14.1 Hz, 1H), 3.54-3.61 (m, 1H), 3.62-3.70 (m, 1H), 7.18-7.38 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.6, 22.7, 27.5, 30.0, 31.5, 34.0, 40.9, 47.8, 
48.2, 48.6, 57.6, 62.8, 66.0, 126.0, 126.1, 128.0, 149.2; IR (neat) 3255, 2960, 2870, 
1652, 1465, 1446, 1367, 1224, 1112, 1084 cm-1; HRMS calcd for C21H34NO (M+ + 
H) 316.2641, found 316.2644. Note: the reaction of 275 (0.0124 g, 0.041 mmol, 1.0 
equiv) with Me3Al (2.0 M, toluene, 0.10 mL, 0.21 mmol, 5.0 equiv) in CH2Cl2 (10 








acetonitrile (295). According to the general procedure, the reaction of 275 (0.0156 g, 
0.052 mmol, 1.0 equiv), TMSCN (0.071 mL, 0.52 mmol, 10.0 equiv) and Et2AlCl 
(1.8 M, toluene, 0.060 mL, 0.10 mmol, 2.0 equiv) in CH2Cl2 (5.0 mL) for 15 h at rt, 
afforded after chromatography (1/1 EtOAc/hexanes) the title compound as oil (Rf = 
0.60, 1/1 EtOAc/hexanes). Yield 70% (0.0119 g, 0.037 mmol), dr = 65:35. 1H NMR 
(400 MHz, CDCl3) (mixture of diastereoisomers) δ 0.89 (s, 9H, major isomer), 0.92 
(s, 9H, minor isomer), 1.46-2.01 (m, 16H), 2.14-2.41 (m, 3H), 2.64-2.86 (m, 5H), 
3.06-3.18 (m, 1H), 3.37 (dt, J = 3.9, 14.9 Hz, 1H), 3.61 (t, J = 6.4 Hz, 2H), 3.65-3.74 
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(m, 2H), 3.92 (d, J = 9.1 Hz, 1H, minor isomer), 4.02 (d, J = 6.5 Hz, 1H, major 
isomer), 7.22-7.48 (m, 10H); 13C NMR (100 MHz, CDCl3) (mixture of 
diastereoisomers) δ 20.6, 20.7, 27.5, 27.5, 29.1, 29.8, 30.0. 30.8, 33.8, 34.0, 39.6, 
40.5, 47.1, 47.5, 47.9, 48.1, 48.2, 50.8, 56.3, 56.6, 56.8, 56.9, 60.8, 61.6, 119.6, 121.4, 
126.4, 126.6, 127.5, 128.6, 128.7, 144.8, 146.3; IR (neat) 3305, 2959, 2870, 1720, 
1669, 1600, 1463, 1446, 1366, 1227, 1094 cm-1; HRMS calcd for C21H30N2O (M+ + 








According to the general procedure, the reaction of 275 (0.0138 g, 0.046 mmol, 1.0 
equiv), Et3SiH (0.074 mL, 0.46 mmol, 10.0 equiv) and Et2AlCl (1.8 M, toluene, 0.051 
mL, 0.09 mmol, 2.0 equiv) in CH2Cl2 (5.0 mL) for 18 h at rt, afforded after 
chromatography (1/4 MeOH/EtOAc) the title compound as oil (Rf = 0.34, 20% 
MeOH/EtOAc). Yield 56% (0.0077 g, 0.026 mmol). 1H NMR (400 MHz, CDCl3) δ 
0.90 (s, 9H), 1.54-1.66 (m, 3H), 1.76-1.90 (m, 3H), 1.97 (d, J = 12.1 Hz, 1H), 2.05-
2.31 (m, 2H), 2.59 (dd, J = 4.4, 14.3 Hz, 1H), 2.73 (dt, J = 4.8, 13.7 Hz, 1H), 2.91-
3.02 (m, 2H), 3.14 (t, J = 10.7 Hz, 2H), 3.53 (dd, J = 5.6, 10.8 Hz, 1H), 3.69 (dd, J = 
5.0, 14.5 Hz, 1H), 7.12-7.55 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.4, 27.5, 30.1, 
31.0, 33.8, 39.6, 46.2, 48.2, 49.6, 56.6, 56.6, 59.0, 125.7, 125.9, 128.2, 149.1; IR 
(neat) 3357, 2957, 2944, 1459, 1366, 1324, 1274, 1226, 1037 cm-1; HRMS calcd for 
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C20H32NO (M+ + H) 302.2484, found 302.2481. Note: the reaction of 275 (0.0174 g, 
0.058 mmol, 1.0 equiv), allyltrimethylsilane (0.094 mL, 0.58 mmol, 10.0 equiv) and 
Et2AlCl (1.8 M, toluene, 0.064 mL, 0.11 mmol, 2.0 equiv) in CH2Cl2 (5.0 mL) at rt 







Compound 297. According to the general procedure, the reaction of 275 
(0.0129 g, 0.043 mmol, 1.0 equiv) and MeAlCl2 (1.0 M, hexanes, 0.086 mL, 0.086 
mmol, 2.0 equiv) in CH2Cl2 (5.0 mL) for 13 h at rt, afforded after chromatography 
(2/1 EtOAc/hexanes) the title compound as oil (Rf = 0.48, EtOAc). Yield 68% 
(0.0093 g, 0.029 mmol). 1H NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.42-1.55 (m, 
2H), 1.72-2.07 (m, 6H), 2.36 (dt, J = 2.5, 13.0 Hz, 1H), 2.65 (dt, J = 4.0, 13.6 Hz, 
1H), 2.75-2.83 (m, 1H), 31.4 (dt, J = 3.4, 12.7 Hz, 1H), 3.61 (d, J = 9.6 Hz, 1H), 
3.67-3.77 (m, 1H), 5.51 (d, J = 9.6 Hz, 1H), 7.13-7.18 (m, 1H), 7.25-7.32 (m, 2H), 
7.46-7.52 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 18.3, 27.7, 29.8, 33.8, 35.8, 41.2, 
41.8, 47.7, 47.7, 54.9, 60.8, 72.7, 121.7, 125.4, 126.9, 128.7, 138.4, 152.0; IR (neat) 
2943, 2866, 1471, 1458, 1363, 1095 cm-1; HRMS calcd for C20H29NCl (M+ + H) 
318.1988, found 318.1983. 
Attempted rearrangement of 275 using BF3•Et2O. According to the general 
procedure, 275 (0.0152 g, 0.051 mmol, 1.0 equiv) was reacted with BF3•Et2O (10 
drops, excess) in CH2Cl2 (5.0 mL) for 18 h at rt. Analysis of the crude reaction 
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mixture indicated only presence of the starting material. Note: the use of 275 (0.0073 
g, 0.024 mmol, 1.0 equiv), Et3SiH (0.040 mL, 0.24 mmol, 10.0 equiv) and BF3•Et2O 
(0.10 mL, excess) in CH2Cl2 (5.0 mL) for 14 h at rt, according to the procedure for 
296 also resulted in <5% conversion. Note: the use of other acids known to promote 
Meinwald rearrangement, also resulted in no conversion. For example, 275 (0.0129 g, 
0.043 mmol, 1.0 equiv) was reacted with Cu(BF4)2•H2O (0.0509 g, 0.22 mmol, 5.0 
equiv) in CH2Cl2 (5.0 mL) for 15 h, and 275 (0.0121 g, 0.041 mmol, 1.0 equiv) was 
reacted with Sc(OTf)3 (0.0299 g, 0.061 mmol, 1.5 equiv) in CH2Cl2 (5.0 mL) for 17 h 













(285A, Table 31, entry 8). Epoxide 275 (0.0156 g, 0.052 mmol, 1.0 equiv), MeI 
(0.065 mL, 1.04 mmol, 20.0 equiv) and CH2Cl2 (3.0 mL) were heated in a sealed MW 
tube (10 mL, Biotage) at 60 °C for 22 h. After the reaction was cooled to rt, the 
solvent was removed under reduced pressure to afford the title compound as white 
solid (m.p. = 175-180 °C, decomp.). Yield 90% (0.0272 g, 0.047 mmol). 1H NMR 
(400 MHz, DMSO-d6) δ 0.43 (s, 9H), 0.81-0.88 (m, 1H), 1.51-1.62 (m, 1H), 1.72-
2.16 (m, 5H), 2.28-2.43 (m, 2H), 2.55-2.64 (m, 1H), 3.05 (s, 3H), 3.10 (s, 3H), 3.58-
3.76 (m, 3H), 3.81 (d, J = 13.2, Hz, 1H), 4.15 (d, J = 13.2, Hz, 1H), 7.20-7.42 (m, 
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5H); 13C NMR (100 MHz, DMSO-d6) δ 8.1, 24.3, 26.7, 27.1, 34.6, 35.7, 43.3, 45.1, 
52.9, 53.4, 59.0, 59.9, 127.8, 127.9, 129.1, 142.3, 206.1; IR (KBr) 2960, 2869, 1689, 
1496, 1470, 1443, 1368, 1202, 1085 cm-1; HRMS calcd for C22H35NOI (M+) 
456.1763, found 456.1762. Note: when the reaction of 275 (0.0184, 0.062 mmol, 1.0 
equiv) and MeI (0.038 mL, 0.62 mmol, 10 equiv) in CH2Cl2 was carried out at rt for 
20 h, formation of the same product was observed along with the starting material.  
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4-tert-Butyl-6-phenyl-1-azabicyclo[4.3.1]decane-10-thione (299) and 4-
tert-Butyl-5a-phenyl-2,3,4,5,5a,6,7,8-octahydrothiepino[2,3-b]pyridine (300). 25 
ml round bottom flask was charged with amide 34 (0.0200 g, 0.07 mmol, 1.0 equiv), 
P4S10 (0.0080 g, 0.018 mmol, 0.25 equiv) and toluene (5.0 mL). After the reaction 
mixture was stirred at rt for 10 min, hexamethyldisiloxane (0.026 mL, 0.12 mmol, 1.7 
equiv) was added and the reaction was heated at 90 °C for 22 h. After the reaction 
was cooled to rt, the solvent was removed and the reaction mixture was purified by 
chromatography (1/1 EtOAc/hexanes followed by 1/10/90 NH3/MeOH/CH2Cl2) to 
afford 299 (Rf = 0.52, 1/4 EtOAc/hexanes) as oil (yield 5%, 0.0010 g, 0.0033 mmol) 
and 300 (Rf = 0.63, 1/10/90 NH3/MeOH/CH2Cl) as oil (yield 90%, 0.0189 g, 0.063 
mmol). Compound 299: 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 1.44 (q, J = 11.0 
Hz, 1H), 1.68-1.77 (m, 2H), 1.90-2.02 (m, 3H), 2.17 (d, J = 10.1 Hz, 1H), 2.33-2.42 
(m, 1H), 2.49 (d, J = 11.9 Hz, 1H), 3.03-3.11 (m, 1H), 3.44-3.52 (m, 1H), 3.72 (d, J = 
12.2 Hz, 1H), 4.39 (dd, J = 7.2, 13.4 Hz, 1H), 7.22-7.39 (m, 5H); 13C NMR (125 
MHz, CDCl3) δ 21.5, 22.2, 27.1, 33.2, 37.6, 41.8, 46.3, 54.0, 57.5, 65.0, 125.1, 127.2, 
127.5, 149.1, 225.5; IR (neat) 2955, 2918, 2851, 1491, 1445, 1367, 1315, 1180, 1080, 
1070, 1047 cm-1; HRMS calcd for C19H28NS (M+ + H) 302.1942, found 302.1955. 
Compound 300: 1H NMR (400 MHz, CDCl3) δ 0.96 (s, 9H), 1.26-1.48 (m, 2H), 160 
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(m, 2H), 1.84 (d, J = 13.0 Hz, 1H), 1.94-2.14 (m, 4H), 2.49 (dt, J = 4.6, 14.8 Hz, 1H), 
2.85 (m, 1H), 3.58-3.69 (m, 1H), 3.86 (ddt, J = 1.6, 5.4, 18.0 Hz, 1H), 7.22-7.43 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ 18.9, 27.4, 29.8, 32.0, 33.6, 39.8, 41.1, 43.9, 
51.4, 51.8, 126.5, 126.9, 128.3, 146.4, 173.0; IR (neat) 2941, 2866, 2212, 1670, 1605, 











pyridin-9-ium iodide (300a). To a solution of 300 (0.0308 g, 0.10 mmol, 1.0 equiv) 
in CH2Cl2 (6.0 mL), MeI (0.13 mL, 2.0 mmol, 20.0 equiv) was added at rt, and the 
resulting reaction mixture was stirred at rt for 24 h. The solvent was removed to 
afford the title compound as yellow solid. Yield 96% (0.0434 g, 0.098 mmol). 
Recrystallization from CHCl3 provided needles suitable for x-ray crystallography 
(m.p. = 167-8 °C). 1H NMR (400 MHz, CDCl3) δ 1.00 (s, 9H), 1.64 (m, 2H), 1.91 (m, 
2H), 2.06 (m, 3H), 2.33 (d, J = 14.5 Hz, 1H), 2.53 (td, J = 2.3, 13.2 Hz, 1H), 2.97 (td, 
J = 4.1, 15.0 Hz, 1H), 3.11 (dd, J = 3.5, 15.0 Hz, 1H), 3.99 (s, 3H), 4.07 (dd, J = 5.3, 
15.1 Hz, 1H), 4.49 (m, 1H), 7.21-7.45 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 18.2, 
27.1, 28.3, 30.8, 33.4, 38.9, 41.9, 42.7, 48.9, 55.3, 58.8, 125.8, 128.2, 129.5, 143.5, 
194.6; IR (neat) 2955, 2918, 2849, 2187, 1578, 1445, 1366, 1238 cm-1; HRMS calcd 











thiepino [2,3-b]pyridin-9-ium (300b). To a solution of 300 (0.0130 g, 0.043 mmol, 
1.0 equiv) in CH2Cl2 (6.0 mL), p-bromobenzylbromide (0.110 g, .043 mmol, 10.0 
equiv) was added at rt, and the resulting reaction mixture was stirred at rt for 72 h. 
The solvent was removed, and the residue was chromatographed (1/10/90-1/20/80 
NH3/MeOH/CH2Cl2) to afford the title compound as colorless oil. Yield 98% (0.0233 
g, 0.042 mmol). 1H NMR (400 MHz, CDCl3) δ 0.99 (s, 9H), 1.64 (m, 2H), 1.86 (m, 
2H), 2.07 (m, 3H), 2.31 (d, J = 14.5 Hz, 1H), 2.50 (dt, J = 3.2, 13.3 Hz, 1H), 3.04 (m, 
2H), 4.07 (dd, J = 2.8, 15.2 Hz, 1H), 4.55 (m, 1H), 5.64 (d, J = 15.6 Hz, 1H), 5.79 (d, 
J = 15.6 Hz, 1H),  7.25 (d, J = 7.3 Hz, 2H), 7.30-7.46 (m, 5H), 7.58 (d, J = 8.4 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 18.2, 27.1, 28.2, 31.2, 33.4, 39.3, 42.2, 42.9, 
55.8, 56.8, 63.0, 123.6, 125.6, 128.3, 129.4, 130.4, 130.9, 132.6, 143.7, 195.9; IR 
(neat) 2960, 2870, 2183, 1562, 1489, 1446, 1367, 1332 cm-1; HRMS calcd for 
C26H33BrNS (M+) 470.1517, found 470.1484. Note: the compound is not crystalline.  
 
Thionation of 34 with Lawesson’s reagent. 25 ml round bottom flask was 
charged with amide 34 (0.0200 g, 0.070 mmol, 1.0 equiv) Lawesson’s reagent 
(0.0871 g, 0.21 mmol, 3.0 equiv), and toluene (7.0 mL), and the resulting mixture was 
heated to reflux for 24 h. After the reaction was cooled to rt, the solvent was removed 
and the reaction was analyzed by NMR. 1H NMR indicated 31:6:63 mixture of 
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34:299:300. Note: the use of Lawesson’s reagent complicates the purification of the 
final products; the lactams exhibit similar polarity to the decomposition products of 






(301). According to the procedure described above, the reaction of amide 27 (0.0500 
g, 0.175 mmol, 1.0 equiv), Lawesson’s reagent (0.11 g, 0.26 mmol, 1.5 equiv) in 
toluene (7.0 mL) at reflux for 30 min, afforded after solvent removal and 
chromatography (1/10-1/4 EtOAc/hexanes), the title compound as white solid (m.p. = 
152-3 °C, Rf = 0.73, 1/1 EtOAc/hexanes). Yield 93% (0.0488 g, 0.0162 mmol). 1H 
NMR (400 MHz, CDCl3) δ 0.92 (s, 9H), 1.22-1.38 (m, 2H), 1.43-1.52 (m, 1H), 1.64 
(dd, J = 2.8, 10.8 Hz, 1H), 1.73-1.82 (m, 1H), 2.01 (m, 1H), 2.26 (m, 2H), 2.46 (d, J = 
13.6 Hz, 1H), 2.60 (td, J = 6.1, 12.8 Hz, 1H), 2.99 (ddd, J = 1.8, 5.0, 12.4 Hz, 1H), 
2.87-3.97 (m, 1H), 4.09 (dd, J = 4.8, 9.2 Hz, 1H), 7.12 (d, J = 7.4 Hz, 2H), 7.29 (t, J = 
7.2 Hz, 1H),  7.36 (t, J = 7.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 19.8, 26.8, 
27.0, 32.6, 39.6, 41.3, 42.7, 44.1, 56.0, 75.4, 124.8, 127.3, 128.7, 145.4, 200.5; IR 
(neat) 2950, 2916, 2868, 1470, 1443, 1367, 1331, 1252, 1148 cm-1; HRMS calcd for 
C19H28NS (M+ + H) 302.1942, found 302.1953. 
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(304). 25 mL round bottom flask was charged with amide 34 (0.0214 g, 0.75 mmol, 
1.0 equiv), toluene (6.0 mL), pyridine (0.06 mL) and Petasis reagent (0.58 M in 
toluene, 0.65 mL, 0.38 mmol, 5.0 equiv), sealed with septum, and the resulting 
reaction mixture was heated at 105 °C for 10 h. The reaction was cooled to rt, diluted 
with Et2O (5 mL) and hexanes (5 mL), stirred for 10 min, and filtered through a short 
plug of celite (eluting with Et2O). Chromatography (1/4 EtOAc/hexanes) afforded the 
title compound as oil (Rf = 0.21, 1/4 EtOAc/hexanes). Yield 95% (0.0201 g, 0.071 
mmol). Note: the compound is unstable. 1H NMR (400 MHz, CDCl3) δ 0.99 (s, 9H), 
1.57-1.81 (m, 6H), 1.86-1.98 (m, 1H), 2.07-2.19 (m, 1H), 2.30 (d, J = 9.9 Hz, 1H), 
2.59-2.71 (m, 1H), 2.99-3.09 (m, 1H), 3.39-3.48 (m, 1H), 3.52-3.59 (m, 1H), 4.19 (s, 
1H), 4.76 (s, 1H), 7.20 (tt, J = 1.1, 6.7 Hz, 1H), 7.29-7.36 (m, 2H), 7.46-7.53 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 22.2, 27.8, 28.1, 34.0, 39.9, 43.9, 45.0, 47.0, 54.6, 
55.4, 110.6, 125.6, 127.2, 127.7, 151.7, 157.0; IR (neat) 3088, 3055, 3028, 2943, 
2866, 1628, 1555, 1443, 1393, 1366, 1101, 866, 762 cm-1; HRMS calcd for C20H30N 









(305). To a solution of enamine 304 (0.0081 g, 0.029 mmol, 1.0 equiv) in EtOAc (3.0 
mL), Pd/C (5%, 0.010 g) was added, and the reaction was stirred under H2 balloon at 
rt for 15 h. Filtration through a short pad of celite (eluting with EtOAc/Et2O), 
followed by chromatography (20% MeOH/EtOAc-1/20/80 NH4OH/MeOH/CH2Cl2) 
afforded the title compound as oil (Rf = 0.36, 1/10/90 NH3/MeOH/CH2Cl2). Yield 
75% (0.0062 g, 0.022 mmol). 1H NMR (400 MHz, CDCl3) δ 1.04 (s, 9H), 1.07 (d, J 
=7.1 Hz, 3H), 1.61-1.74 (m, 2H), 1.84-2.07 (m, 5H), 2.15-2.28 (m, 2H), 2.76-2.86 (m, 
1H), 3.09-3.17 (m, 1H), 3.42 (td, J = 3.9, 13.7 Hz, 1H), 3.62-3.86 (m, 2H), 7.18-7.24 
(m, 1H), 7.31-7.37 (m, 2H), 7.42-7.47 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 14.0, 
20.7, 27.9, 29.5, 34.2, 36.4, 38.5, 41.5, 44.8, 50.6, 55.4, 62.5, 126.0, 126.1, 128.4, 
149.0; IR (neat) 2960, 2870, 1645, 1558, 1464, 1444, 1369, 1253, 1228, 1083 cm-1; 
HRMS calcd for C20H32N (M+ + H) 286.2535, found 286.2529.  
Attempted reduction of 304 under acidic conditions. To a solution of 
enamine 304 (0.0057 g, 0.020 mmol, 1.0 equiv) in THF (2 mL), NaBH4 (0.077 g, 
0.20 mmol, 10.0 equiv), followed by AcOH (0.024 mL, 0.40 mmol, 20.0 equiv) was 
added, and the reaction mixture was stirred at rt for 20 min. The reaction was basified 
with sat. NaHCO3, extracted with ether, washed with brine, dried and concentrated. 
Analysis of the crude reaction mixture by NMR indicated only the presence of the 
starting material. The reduction product was not present in the reaction mixture. Note: 
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(304a). To a solution of olefin 304 (0.0138 g, 0.049 mmol, 1.0 equiv) in DMF (5.0 
mL), PhI (0.0031 g, 0.15 mmol, 3.0 equiv), Pd(OAc)2 (0.0050 g, 0.022 mmol, 0.5 
equiv), PPh3 (0.0040 g, 0.015 mmol, 0.3 equiv), and Ag2CO3 (0.035 g, 0.13 mmol, 
2.5 equiv) were added, and the reaction mixture was stirred at 80 °C for 3.5 h. The 
reaction was cooled to rt, quenched with water (10 mL), extracted with EtOAc (3 x 
50 mL), washed with water (4 x 20 mL), brine (1 x 20 mL), dried and concentrated. 
Chromatography (1/20 EtOAc/hexanes) afforded the title compound as oil (Rf = 0.70, 
1/20 EtOAc/hexanes) Yield 21% (0.0037 g, 0.01 mmol). 1H NMR (400 MHz, CDCl3) 
δ 0.97 (s, 9H), 1.28-1.41 (m, 1H), 1.58-1.75 (m, 3H), 1.79-1.88 (m, 2H), 1.92-2.02 
(m, 1H), 2.13-2.20 (m, 1H), 2.41 (d, J = 11.5 Hz, 1H), 2.50 (dt, J = 4.9, 12.8 Hz, 1H), 
3.05-3.14 (m, 1H), 3.36-3.44 (m, 1H), 3.61-3.68 (m, 1H), 5.34 (s, 1H), 7.06-7.11 (m, 
1H), 7.19-7.38 (m, 5H), 7.51-7.58 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 22.5, 
27.9, 28.8, 30.0, 40.3, 44.7, 45.1, 48.4, 51.1, 54.6, 123.3, 125.5, 125.6, 127.8, 127.9, 
128.0, 137.6, 150.7, 151.7; IR (neat) 2947, 2866, 1491, 1444, 1394, 1365, 1224, 
1147, 1031, 912 cm-1; HRMS calcd for C26H34N (M+ + H) 360.2691, found 360.2649. 
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Miscellaneous Reactions (representative examples from Table 36) 
 
Attempted Wittig olefination. According to the procedure by Fitjer et al.400 
for demanding olefinations. To a solution of triphenyl methyl triphenylphosphonium 
bromide (0.256 g, 0.70 mmol, 10.0 equiv) in toluene (5 mL) KOtBu (0.089 g, 0.70 
mmol, 10.0 equiv) was added and the resulting mixture was heated at 105 °C for 1 h. 
The reaction was cooled to rt, amide 34 (0.0200 g, 0.070 mmol, 1.0 equiv) in toluene 
(2 mL) was added, and the reaction was heated at 105 °C for 24 h. The reaction was 
quenched with water (5 mL), extracted with ether (3 x 20 mL), washed with water (1 
x 10 mL), brine (1 x 10 mL), dried and concentrated. Analysis of the crude reaction 
mixture by NMR indicated only the presence of the starting material. Enamine 304 
was not present in the reaction mixture. Similarly, the reaction of amide 229 with 3.0 
equiv of triphenylphosphonium methylide (generated from methyl 
triphenylphosphonium bromide and nBuLi) in refluxing THF for 24 h did not afford 
the desired enamine. In addition, amide 230 was reacted with triphenyl methyl 
triphenylphosphonium bromide (10.0 equiv) and KOtBu (10.0 equiv) for 22 h at 105 











Imine 310. Lactam 229 (0.0100 g, 0.029 mmol, 1.0 equiv), benzylamine 
(0.063 mL, 0.058 mmol, 20.0 equiv) and pTsOH (1 crystal) were heated in toluene 
(20 mL) under Dean-Stark trap for 23 h. Solvent removal and chromatography (2/1 
EtOAc/hexanes) afforded the title compound as oil (Rf = 0.44, 1/1 EtOAc/hexanes). 
Yield 84% (0.0106 g, 0.024 mmol). The compound was obtained as a single imine 
isomer. Geometry was determined by HSQC, HMBC and NOESY correlations. 1H 
NMR (400 MHz, CDCl3) δ 1.25-1.72 (m, 5H), 1.86 (q, J = 11.0 Hz, 1H), 2.06-2.15 
(m, 1H), 2.48-2.62 (m, 2H), 2.70-2.80 (m, 1H), 2.91 (dd, J = 4.4, 10.8 Hz, 1H), 3.17 
(d, J = 10.8 Hz, 1H), 3.45 (dd, J = 6.1, 11.8 Hz, 1H), 3.54 (dt, J = 3.2, 11.9, 1H), 4.29 
(d, J = 14.6 Hz, 1H), 4.87 (d, J = 14.5 Hz, 1H), 5.56 (d, J = 9.8 Hz, 1H), 5.90-5.97 
(m, 1H), 7.05 (d, J = 8.3 Hz, 2H), 7.19-7.36 (m, 5H), 7.45 (d, J = 8.3 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 24.9, 26.0, 33.8, 39.4, 40.6, 49.6, 53.3, 53.7, 55.8, 56.2, 
120.2, 126.4, 128.1, 128.3, 129.8, 130.7, 131.5, 134.0, 140.8, 142.6, 165.8; IR (neat) 
3021, 2922, 2855, 1655, 1487, 1451, 1405, 1073 cm-1; HRMS calcd for C25H28BrN2 
(M+ + H) 435.1436, found 435.1410. Note: the reaction of bicyclic amide 34 under 
similar conditions did not afford the desired imine (only starting material was 
observed by NMR). More forcing conditions, for example, neat amide (1.0 equiv), 
benzylamine (50 equiv) and pTsOH (10 equiv) at 170 °C for 15 h led to 
decomposition of the starting material.  
It was also determined that the reaction of imine 310 under conditions used 
for epoxidation of bridged amides did not afford the desired oxaziridine (no 
conversion, recovery of the starting material). As expected only imines activated with 
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strong electron withdrawing substituent (e.g. Ts) undergo epoxidation with 
methylides under Corey-Chaykovsky conditions. However, such imines cannot be 
prepared from bridged tricylic amides due to the lower nuclophilicity of amine 
nitrogen. In addition, subjection of imine 310 to standard conditions used for 
oxidation of imines (mCPBA, -78 C, 0.5 h) led to the decomposition of the starting 
material, suggesting that N-oxidation and following elimination reactions are much 








Aminal 312. According to the general procedure, lactam 260 (0.0110 g, 0.047 
mmol, 1.0 equiv) was reacted with TMSCH2Li (1.0 M in pentanes, 0.47 mL, 0.47 
mmol, 10 equiv) to afford after chromatography (1/10/90 NH4OH/MeOH/CH2Cl2) the 
title compound as oil (Rf = 0.60, 1/10/90 NH4OH/MeOH/CH2Cl2), yield 96% (0.0146 
g, 0.045 mmol). 1H NMR (400 MHz, CDCl3) δ 0.07, 0.11 (s, 9H), 0.82-0.93 (m, 6H), 
1.22-2.13 (m, 11H), 2.26-2.46 (m, 2H), 2.62-2.86 (m, 3H), 3.31-3.42 (m, 1H), 3.64-
3.92 (m, 1H), 5.51-5.59 (m, 1H), 5.79-5.87 (m, 1H); 13C NMR (100 MHz, CDCl3) 
(mixture of isomers) δ -0.7, 0.6, 17.7, 19.4, 25.3, 26.8, 26.9, 28.6, 9.2, 29.7, 32.8, 
34.7, 35.5, 35.6, 35.7, 37.7, 50.4, 51.0, 63.0, 70.0, 73.2, 125.4, 135.6 (aminal peak 
was not detected, conformation assigned in analogy to 262); IR (neat) 3400, 3013, 
2951, 1456, 1381, 1248, 1223, 1107, 1069, 1007, 986 cm-1; HRMS calcd for 
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C19H36NOSi (M+ + H) 322.2566, found 322.2546. Note: the reaction of 34 under 
identical reaction conditions did not afford the addition product, only starting material 
was observed in analysis of the crude reaction mixture by NMR. 
 



























313 314 315  
(R)-3-((R)-2-tert-Butylbut-3-enyl)-1-methyl-3-phenylpiperidin-2-one 
(313), (R)-3-((R)-2-(2-Chloroethyl)-3,3-dimethylbutyl)-1-methyl-3-phenyl 
piperidin-2-one (314) and (4R,5aR)-4-tert-Butyl-9-methyl-5a-phenyl-
2,3,4,5,5a,6,7,8-octahydro oxepino[2,3-b]pyridin-9-ium iodide (315). 10 mL 
Biotage MW vial was charged with amide 1a (0.0200 g, 0.070 mmol, 1.0 equiv), 
dichloroethane (3.0 mL) and MeI (0.043 mL, 0.70 mmol, 10 equiv), the vial was 
sealed and heated in MW at 160 °C for 3 h. Solvent removal and chromatography 
(PTLC, 1/4 EtOAc/hexanes-EtOAc) afforded 313 and 314 (Rf = 0.51, 1/4 
EtOAc/hexanes) as inseparable mixture (2:1) in 62% yield (0.0135 g, 0.043 mmol) 
and 315 as oil (Rf = 0.60, 1/10 MeOH/EtOAc) in 35% yield (0.0105 g, 0.025 mmol). 
Compound 313 and 314: 1H NMR (400 MHz, CDCl3) δ 0.80 (s, 12.5 H), 1.58-180 
(m, 4H), 1.82-1.97 (m, 3H), 2.01-2.22 (m, 3H), 2.23-2.38 (m, 3H), 2.94 (s, 3H), 3.01 
(s, 1.5H), 3.09-3.21 (m, 1.5H), 3.24-3.43 (m, 2H), 3.51-3.58 (m, 0.5H), 4.86-5.02 (m, 
1H), 5.62-5.73 (m, 1H), 7.19-7.26 (m, 1.5H), 7.29-7.37 (m, 3H), 7.39-7.46 (m, 3H); 
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13C NMR (100 MHz, CDCl3) δ 19.1, 19.3, 27.6, 27.8, 23.0, 30.9, 32.9, 34.6, 35.4, 
35.5, 35.6, 39.7, 41.5, 43.0, 45.5, 50.1, 50.3, 50.6, 51.0, 51.4, 114.7, 126.2, 126.5, 
127.0, 127.1, 128.2, 128.4, 142.1, 143.8, 144.9, 172.7, 173.1; IR (neat) 2955, 2868, 
1636, 1495, 1470, 1447, 1396, 1366, 1329, 1202, 908 cm-1; HRMS calcd for 
C20H30NO (M+ + H) 300.2327, found 300.2321; HRMS calcd for C20H30NOCl (M+ + 
Na) 358.1914, found 358.1909. Compound 315: 1H NMR (400 MHz, CDCl3) δ 1.04 
(s, 9H), 1.26-1.32 (m, 1H), 1.43-1.53 (m, 1H), 1.71-1.80 (m, 1H), 1.94-2.08 (m, 2H), 
2.23-2.28 (m, 1H), 2.43-2.63 (m, 3H), 3.73 (s, 3H), 3.75-3.82 (m, 1H), 4.27-4.38 (m, 
2H), 4.81 (dd, J = 5.8, 12.0 Hz, 1H), 7.12 (d, J = 7.4 Hz, 1H), 7.40-7.46 (m, 1H), 7.51 
(t, J = 7.8 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 17.9, 26.9, 27.9, 33.2, 38.4, 41.2, 
41.7, 42.2, 51.1, 54.0, 72.9, 125.3, 128.8, 129.9, 141.4, 177.4; IR (neat) 2954, 2918, 
2866, 1635, 1446, 1406, 1348, 1242, 1031, 995 cm-1; HRMS calcd for C20H30NO 
(M+) 300.2327, found 300.2308. Note: the reaction of 34 for 10 h at 120 °C led to 
88% conversion; for 3 h at 160 °C > 95% conversion. Control reaction w/o MeI (120 
°C, 10 h) gave no conversion (only starting material observed by NMR). Control 
reaction with planar analogue of 34, lactam 27 (10 equiv of MeI, 160 °C, 3 h) resulted 
in no reaction (only starting material observed by NMR). Note: tricyclic amides 
undergo similar reaction at 40 °C.  

















































Attempted N-protonation of bicyclic amides. To amide 38 (0.0119 g, 0.038 
mmol, 1.0 equiv) dissolved in Et2O (5 mL), HCl (2.0 M in Et2O, 0.10 mL, 0.20 
mmol, 5.0 equiv) was added at rt, and the resulting solution was stirred at rt for 8 h. 
Solvent was removed under reduced pressure and analysis of the residue by NMR 
indicated 1.0:1.2 mixture of the starting material and the corresponding amino acid. 
The protonated amide was not detected.  
To amide 38 (0.0159 g, 0.051 mmol, 1.0 equiv) dissolved in acetone (5 mL), 
pTsOH (0.0096 g, 0.051 mmol, 1.0 equiv) in acetone (0.5 mL) was added, and the 
resulting mixture was put at -20 °C for 24 h. The reaction was allowed to warm to rt, 
solvent was removed under reduced pressure. Analysis of the residue by NMR 
indicated traces of the starting material and the corresponding amino acid (ratio 
<1:50). The protonated amide was not detected. Note: under identical conditions α-
unsubstituted amide 3 hydrolyzed to the corresponding amino acids, while tricyclic 
amides undergo efficient N-protonation (possibly via the open 9-membered amino 
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